data_1ans_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ans _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 3' ' ' CYS . 5.7 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.481 ' O ' ' O ' ' A' ' 2' ' ' SER . 74.1 m 38.61 96.27 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.352 1.072 . . . . 0.0 110.739 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.661 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 98.8 m -58.59 171.79 0.59 Allowed Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.7 Cg_endo -70.64 166.95 27.02 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.567 1.511 . . . . 0.0 110.532 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.7 p -57.66 -69.67 0.16 Allowed 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.192 -0.942 . . . . 0.0 111.604 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.533 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.64 -36.39 2.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.918 -1.114 . . . . 0.0 110.218 -179.129 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.688 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 9.7 t90 -118.75 64.58 0.77 Allowed 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.055 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -77.14 10.18 22.08 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 120.109 -1.043 . . . . 0.0 110.915 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.41 29.89 4.41 Favored Glycine 0 N--CA 1.487 2.04 0 O-C-N 120.722 -1.458 . . . . 0.0 109.492 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.65 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -80.39 177.83 2.74 Favored Pre-proline 0 C--N 1.294 -1.841 0 O-C-N 121.742 -0.858 . . . . 0.0 111.334 -178.357 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.688 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.61 -51.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 123.483 2.788 . . . . 0.0 113.089 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.59 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.8 p90 -78.63 33.92 0.21 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.673 -1.267 . . . . 0.0 111.476 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.481 ' CA ' ' SG ' ' A' ' 4' ' ' CYS . . . 177.76 -169.27 41.19 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.107 -1.52 . . . . 0.0 110.108 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 9' ' ' GLY . 8.3 mm100 -125.95 -145.45 0.32 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.413 -1.051 . . . . 0.0 109.626 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 0.2 OUTLIER -108.4 61.88 0.61 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.424 -0.798 . . . . 0.0 109.129 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.536 ' CA ' ' HA ' ' A' ' 27' ' ' VAL . 1.5 m -87.56 -5.1 58.91 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.261 -0.9 . . . . 0.0 110.078 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.535 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 40.2 m-85 -131.24 59.08 43.29 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.206 -0.934 . . . . 0.0 109.901 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.5 Cg_endo -78.27 -36.39 1.0 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.48 2.12 . . . . 0.0 110.52 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -135.46 50.64 2.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.326 -0.859 . . . . 0.0 109.929 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.87 108.56 0.21 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.5 m -73.76 -12.93 60.86 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.364 0.602 . . . . 0.0 110.343 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -145.72 8.41 1.13 Allowed 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.277 -0.889 . . . . 0.0 110.986 -178.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -62.19 -142.56 0.01 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -77.14 -165.77 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.106 1.871 . . . . 0.0 109.204 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -60.45 -68.17 0.32 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.634 -1.227 . . . . 0.0 108.047 178.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.536 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 1.8 t . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.438 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.535 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.517 ' SG ' ' CD ' ' A' ' 26' ' ' LYS . 91.5 m -149.19 93.9 2.15 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.245 -0.909 . . . . 0.0 109.05 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 32.8 m -42.68 166.66 0.08 OUTLIER Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.585 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 33.9 Cg_endo -76.26 153.5 35.97 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.34 2.027 . . . . 0.0 111.091 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.599 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -50.63 -71.21 0.07 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.226 -0.921 . . . . 0.0 110.699 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.585 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -39.75 -29.65 0.06 Allowed 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.918 -179.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.705 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.5 t90 -138.4 72.31 1.41 Allowed 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 118.751 -1.18 . . . . 0.0 109.763 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -77.33 -29.09 56.77 Favored Glycine 0 N--CA 1.502 3.063 0 O-C-N 121.275 -0.891 . . . . 0.0 111.229 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.33 13.79 31.89 Favored Glycine 0 N--CA 1.49 2.296 0 O-C-N 120.947 -1.326 . . . . 0.0 110.675 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -63.62 174.48 0.99 Allowed Pre-proline 0 C--N 1.297 -1.714 0 O-C-N 121.307 -1.114 . . . . 0.0 110.915 -178.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.705 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.7 -59.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 123.33 2.687 . . . . 0.0 112.637 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.57 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 23.4 p90 -73.3 127.44 32.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.761 -1.212 . . . . 0.0 109.824 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.535 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 95.37 -165.19 24.87 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.208 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.08 -152.14 0.5 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.563 -0.963 . . . . 0.0 109.957 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.25 65.41 0.63 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.514 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.6 m -87.2 -1.95 58.27 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.61 0.719 . . . . 0.0 109.896 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.599 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 67.0 m-85 -134.45 62.31 54.44 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.522 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.4 Cg_endo -79.5 -30.97 2.23 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.516 2.144 . . . . 0.0 110.297 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.99 -66.36 0.93 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 6' ' ' CYS . . . -144.78 -135.71 2.93 Favored Glycine 0 C--N 1.287 -2.168 0 N-CA-C 106.942 -2.463 . . . . 0.0 106.942 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 56.9 m -88.39 -20.85 24.73 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-O 122.074 0.94 . . . . 0.0 108.964 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.523 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER 45.4 55.5 6.47 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.371 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 37.87 -97.42 0.01 OUTLIER Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 23' ' ' SER . 32.3 Cg_endo -74.53 -160.64 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.392 2.061 . . . . 0.0 111.187 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.517 ' CD ' ' SG ' ' A' ' 3' ' ' CYS . 19.9 ttpp -39.17 -70.49 0.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.666 -0.646 . . . . 0.0 110.588 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 23' ' ' SER . 9.4 p . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.848 -1.157 . . . . 0.0 109.501 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 13' ' ' TRP . 43.2 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 2' ' ' SER . 81.6 m 40.83 97.14 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 122.227 1.013 . . . . 0.0 110.443 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.623 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 89.8 m -54.66 169.2 0.41 Allowed Pre-proline 0 C--N 1.295 -1.763 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.623 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.6 Cg_endo -71.79 155.77 57.83 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.783 1.655 . . . . 0.0 111.045 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.575 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -47.77 -69.5 0.12 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.519 -0.738 . . . . 0.0 111.172 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.58 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -42.48 -35.98 1.2 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.214 -0.929 . . . . 0.0 109.973 -179.14 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.683 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.2 t90 -123.42 65.06 1.01 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.863 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -77.47 8.0 36.19 Favored Glycine 0 N--CA 1.497 2.747 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.851 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.67 28.2 5.77 Favored Glycine 0 N--CA 1.485 1.965 0 O-C-N 120.764 -1.433 . . . . 0.0 109.547 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.64 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -79.05 176.83 3.32 Favored Pre-proline 0 C--N 1.294 -1.808 0 O-C-N 121.769 -0.842 . . . . 0.0 111.492 -178.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.683 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.39 -52.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 123.488 2.792 . . . . 0.0 113.117 -177.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.587 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.9 p90 -78.31 33.78 0.2 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.633 -1.292 . . . . 0.0 111.533 -177.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 2' ' ' SER . . . 177.38 -171.02 43.75 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 118.825 -1.655 . . . . 0.0 110.411 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 9' ' ' GLY . 8.2 mt-30 -121.1 -149.19 0.42 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.548 -0.972 . . . . 0.0 110.226 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 7.2 t-20 -109.15 64.46 0.61 Allowed 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 26' ' ' LYS . 1.6 m -87.5 4.92 41.57 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.296 -0.878 . . . . 0.0 109.877 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.54 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 73.5 m-85 -148.53 62.43 6.4 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.197 -0.94 . . . . 0.0 110.013 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.541 ' CG ' ' HB ' ' A' ' 27' ' ' VAL . 36.4 Cg_endo -79.36 -33.68 1.3 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.087 1.858 . . . . 0.0 109.515 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -137.25 53.74 1.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 25' ' ' PRO . . . 163.85 113.45 0.29 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.575 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -69.63 -10.55 58.66 Favored 'General case' 0 C--N 1.283 -2.286 0 O-C-N 122.313 -0.522 . . . . 0.0 111.2 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.461 ' O ' ' C ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -169.19 -50.75 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.876 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' SER . . . -38.49 -86.69 0.01 OUTLIER Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.476 ' HG2' ' HA3' ' A' ' 21' ' ' GLY . 31.3 Cg_endo -76.31 -161.01 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.747 2.298 . . . . 0.0 111.688 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 6.7 tttt -176.08 121.45 0.17 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.541 ' HB ' ' CG ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.15 -0.968 . . . . 0.0 109.936 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 3' ' ' CYS . 46.7 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.093 0.473 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 2' ' ' SER . 99.9 m 41.8 95.89 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.152 0.977 . . . . 0.0 110.472 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.681 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 82.5 m -46.49 171.93 0.06 OUTLIER Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.681 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.8 Cg_endo -70.51 172.88 12.51 Favored 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.75 1.633 . . . . 0.0 111.185 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.7 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 2.9 p -66.82 -42.67 85.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.422 -0.799 . . . . 0.0 111.307 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 1.8 p90 -69.26 -38.23 78.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.081 -1.012 . . . . 0.0 110.223 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.706 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 13.8 t90 -121.11 63.58 0.88 Allowed 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.784 -178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -67.39 -22.95 73.33 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.198 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.76 27.85 6.93 Favored Glycine 0 N--CA 1.488 2.148 0 O-C-N 120.525 -1.573 . . . . 0.0 110.697 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.621 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -81.16 172.71 9.11 Favored Pre-proline 0 C--N 1.294 -1.828 0 O-C-N 121.297 -1.119 . . . . 0.0 111.629 -178.456 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.706 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.6 Cg_endo -75.6 -52.03 0.1 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 123.875 3.05 . . . . 0.0 113.945 -176.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.613 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 33.2 p90 -77.0 32.92 0.14 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.679 -1.263 . . . . 0.0 111.784 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 2' ' ' SER . . . 177.31 -169.54 41.78 Favored Glycine 0 N--CA 1.484 1.897 0 C-N-CA 118.78 -1.676 . . . . 0.0 110.113 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.495 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -119.36 -156.12 0.64 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.518 -0.99 . . . . 0.0 109.899 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -107.79 68.32 0.71 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.586 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.5 m -86.91 -3.44 59.08 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 121.656 -0.653 . . . . 0.0 109.975 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.621 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -153.47 84.03 4.38 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.432 -0.792 . . . . 0.0 109.346 179.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.508 ' CG ' HG22 ' A' ' 27' ' ' VAL . 34.8 Cg_endo -77.83 -43.22 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.63 2.22 . . . . 0.0 109.809 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -137.78 12.74 2.92 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -92.54 24.74 21.73 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.7 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -35.69 -31.74 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.22 0 CA-C-O 121.877 0.846 . . . . 0.0 110.091 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' GLY . 1.2 m -116.08 -22.31 9.02 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.71 -0.619 . . . . 0.0 109.492 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.69 -173.42 46.88 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.31 -160.93 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.688 2.258 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 2.9 ttpt -58.82 176.64 0.19 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.539 -0.726 . . . . 0.0 109.356 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.508 HG22 ' CG ' ' A' ' 19' ' ' PRO . 9.2 p . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.514 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.479 ' HB2' ' HA2' ' A' ' 14' ' ' GLY . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 2' ' ' SER . 84.3 m 35.83 96.15 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 122.262 1.03 . . . . 0.0 110.898 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.709 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 69.1 m -54.29 173.35 0.22 Allowed Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.709 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.4 Cg_endo -71.52 155.3 59.68 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.704 1.602 . . . . 0.0 110.832 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.571 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -47.92 -69.19 0.13 Allowed 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.406 -0.808 . . . . 0.0 111.334 -178.418 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 2.0 p90 -44.25 -36.96 2.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.96 . . . . 0.0 109.863 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.682 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.2 t90 -119.89 64.28 0.82 Allowed 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 118.943 -1.103 . . . . 0.0 109.969 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -75.62 6.78 29.86 Favored Glycine 0 N--CA 1.496 2.694 0 C-N-CA 120.262 -0.97 . . . . 0.0 111.13 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.66 27.76 5.89 Favored Glycine 0 N--CA 1.486 1.998 0 O-C-N 120.612 -1.523 . . . . 0.0 109.868 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.65 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -78.43 177.96 2.51 Favored Pre-proline 0 C--N 1.294 -1.839 0 O-C-N 121.641 -0.917 . . . . 0.0 111.457 -178.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.682 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.8 Cg_endo -76.9 -52.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 123.489 2.793 . . . . 0.0 113.15 -177.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.585 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.6 p90 -78.1 33.08 0.18 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.719 -1.238 . . . . 0.0 111.677 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.494 ' CA ' ' SG ' ' A' ' 4' ' ' CYS . . . 177.78 -170.45 42.8 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 118.812 -1.661 . . . . 0.0 110.488 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -121.85 -151.74 0.49 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.547 -0.973 . . . . 0.0 110.391 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 19.6 t-20 -108.78 64.03 0.61 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.537 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 2.1 m -87.74 -10.59 50.63 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 121.775 0.798 . . . . 0.0 109.792 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 29.7 m-85 -127.83 67.89 74.14 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.661 -0.65 . . . . 0.0 109.259 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HB3' ' OD1' ' A' ' 16' ' ' ASN . 36.5 Cg_endo -78.16 -44.55 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.547 2.165 . . . . 0.0 110.926 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.96 48.71 2.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.112 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.52 108.18 0.22 Allowed Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.571 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -67.35 -15.63 63.79 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-O 121.55 0.691 . . . . 0.0 109.582 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 24' ' ' GLY . 6.4 t -129.89 -18.4 3.41 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.641 -0.662 . . . . 0.0 110.225 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -50.43 -179.64 0.03 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -77.55 -160.78 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.38 2.053 . . . . 0.0 110.762 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.537 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -79.26 172.4 13.85 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.716 -0.615 . . . . 0.0 109.576 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.49 -179.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' ' 13' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 2' ' ' SER . 73.1 m 40.96 97.2 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.279 1.038 . . . . 0.0 110.644 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.664 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 95.0 m -54.36 171.55 0.28 Allowed Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.664 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.2 Cg_endo -71.73 157.78 54.71 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 121.772 1.648 . . . . 0.0 110.876 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.558 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -49.2 -70.93 0.07 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.471 -0.768 . . . . 0.0 111.361 -178.389 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.572 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -42.16 -36.54 1.21 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.158 -0.964 . . . . 0.0 110.034 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.69 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.1 t90 -121.59 64.65 0.9 Allowed 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.805 -1.158 . . . . 0.0 109.896 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -76.88 6.92 37.62 Favored Glycine 0 N--CA 1.497 2.703 0 C-N-CA 120.222 -0.989 . . . . 0.0 110.759 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.81 27.34 6.24 Favored Glycine 0 N--CA 1.486 2.011 0 O-C-N 120.706 -1.467 . . . . 0.0 109.671 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.643 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -77.83 176.49 3.52 Favored Pre-proline 0 C--N 1.294 -1.836 0 O-C-N 121.706 -0.879 . . . . 0.0 111.486 -178.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.69 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -75.99 -51.78 0.1 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 123.473 2.782 . . . . 0.0 113.029 -177.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.6 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.7 p90 -78.48 34.4 0.21 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.714 -1.241 . . . . 0.0 111.519 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.485 ' CA ' ' SG ' ' A' ' 4' ' ' CYS . . . 175.93 -170.46 43.38 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.792 -1.671 . . . . 0.0 110.618 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' GLY . 1.4 tt0 -120.67 -151.91 0.49 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.531 -0.982 . . . . 0.0 110.369 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 1.3 t-20 -108.98 64.57 0.61 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.547 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.9 m -87.99 -0.5 57.09 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.543 -0.723 . . . . 0.0 109.983 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.544 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 72.0 m-85 -140.33 60.36 14.22 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.801 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.4 Cg_endo -78.88 -30.3 2.93 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.451 2.101 . . . . 0.0 110.267 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.88 49.03 1.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 109.909 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.89 111.27 0.24 Allowed Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.7 m -67.8 -15.36 63.59 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-O 121.57 0.7 . . . . 0.0 109.646 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.89 4.46 2.09 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.675 -0.64 . . . . 0.0 109.88 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.72 -164.29 2.52 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -78.84 -160.41 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.374 2.05 . . . . 0.0 110.624 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.547 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -90.12 178.09 6.27 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.703 -0.623 . . . . 0.0 109.422 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.523 -179.953 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.52 ' HB2' ' CA ' ' A' ' 14' ' ' GLY . 4.9 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 4' ' ' CYS . 76.5 m 38.46 96.22 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.993 0.901 . . . . 0.0 110.597 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.558 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 56.2 m -40.68 166.38 0.06 OUTLIER Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.571 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.7 Cg_endo -70.97 161.65 45.38 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.204 1.936 . . . . 0.0 110.497 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.574 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.1 p -56.1 -72.53 0.07 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.267 -0.896 . . . . 0.0 111.494 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -43.09 -36.16 1.55 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.017 -1.052 . . . . 0.0 110.28 -179.003 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.711 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.3 t90 -124.17 64.93 1.06 Allowed 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.221 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -72.29 -30.31 65.08 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.68 8.43 35.35 Favored Glycine 0 N--CA 1.49 2.269 0 O-C-N 120.867 -1.372 . . . . 0.0 110.85 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.624 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -58.4 176.5 0.26 Allowed Pre-proline 0 C--N 1.298 -1.66 0 O-C-N 121.069 -1.254 . . . . 0.0 110.881 -179.004 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.711 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.94 -57.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 123.133 2.555 . . . . 0.0 112.306 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.61 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 25.4 p90 -73.84 115.19 12.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.74 -1.225 . . . . 0.0 109.758 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.52 ' CA ' ' HB2' ' A' ' 2' ' ' SER . . . 93.63 -172.76 33.13 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 4.9 mt-30 -116.64 -147.25 0.41 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.485 -1.009 . . . . 0.0 110.133 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.518 ' ND2' ' HB3' ' A' ' 19' ' ' PRO . 10.5 t30 -108.02 69.73 0.74 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.5 m -87.48 -7.35 57.74 Favored 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.532 -0.73 . . . . 0.0 110.713 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.538 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 66.0 m-85 -133.79 60.49 46.41 Favored Pre-proline 0 C--N 1.296 -1.738 0 O-C-N 121.291 -0.88 . . . . 0.0 110.234 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.1 Cg_endo -78.95 -24.79 6.67 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.388 2.058 . . . . 0.0 109.852 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.27 52.7 1.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 0.0 109.68 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.21 113.43 0.28 Allowed Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.574 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -75.03 -85.8 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.963 0.887 . . . . 0.0 109.799 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -76.18 -24.35 54.73 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.094 -179.171 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -59.97 -149.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.443 ' C ' ' HD3' ' A' ' 26' ' ' LYS . 35.0 Cg_endo -77.27 -160.34 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.288 1.992 . . . . 0.0 110.029 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.527 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -100.15 -96.05 0.25 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.431 -0.793 . . . . 0.0 109.559 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.461 ' CG1' ' O ' ' A' ' 27' ' ' VAL . 9.5 p . . . . . 0 C--N 1.299 -1.63 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.504 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.518 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.474 ' C ' ' O ' ' A' ' 2' ' ' SER . 81.2 m 34.06 95.69 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.239 1.019 . . . . 0.0 110.987 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.662 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 96.0 m -53.75 171.41 0.26 Allowed Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.662 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.8 Cg_endo -69.94 164.24 35.44 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.569 1.512 . . . . 0.0 110.558 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.55 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.6 p -54.82 -70.42 0.1 Allowed 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.248 -0.907 . . . . 0.0 111.713 -177.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.515 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.12 -38.7 2.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.968 -1.082 . . . . 0.0 110.208 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.691 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 9.7 t90 -116.74 63.02 0.72 Allowed 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 118.964 -1.095 . . . . 0.0 110.047 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -76.59 8.7 26.01 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.877 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.95 28.59 5.36 Favored Glycine 0 N--CA 1.486 1.991 0 O-C-N 120.707 -1.467 . . . . 0.0 109.511 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.649 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -78.98 177.3 2.96 Favored Pre-proline 0 C--N 1.295 -1.797 0 O-C-N 121.781 -0.835 . . . . 0.0 111.26 -178.404 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.691 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.3 Cg_endo -76.24 -52.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 123.505 2.803 . . . . 0.0 113.063 -177.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.584 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 28.5 p90 -78.14 31.55 0.18 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.724 -1.235 . . . . 0.0 111.597 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.518 ' HA2' ' CB ' ' A' ' 2' ' ' SER . . . -178.29 -172.03 42.26 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 118.714 -1.708 . . . . 0.0 110.517 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 9' ' ' GLY . 5.7 mt-30 -121.37 -150.67 0.46 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.498 -1.001 . . . . 0.0 110.29 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -108.49 62.99 0.61 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.516 ' O ' ' CA ' ' A' ' 27' ' ' VAL . 1.8 m -88.2 -11.14 47.58 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.396 -0.815 . . . . 0.0 109.938 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.538 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 23.3 m-85 -127.55 56.03 18.11 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.708 -0.62 . . . . 0.0 110.461 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.4 Cg_endo -76.73 -29.97 5.18 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.354 2.036 . . . . 0.0 110.491 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -138.84 51.28 1.82 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.918 . . . . 0.0 110.074 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.75 111.52 0.25 Allowed Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.4 m -77.04 -85.89 0.06 Allowed 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 122.083 0.944 . . . . 0.0 110.005 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.5 OUTLIER -79.95 -8.68 59.46 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.572 -178.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.89 -140.27 0.01 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -77.31 -164.18 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.028 1.819 . . . . 0.0 109.613 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.496 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 17.9 ttpp -51.98 -70.23 0.09 Allowed 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.516 ' CA ' ' O ' ' A' ' 17' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.034 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.527 ' O ' ' CG ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.273 0.559 . . . . 0.0 109.526 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.522 ' SG ' ' CD ' ' A' ' 26' ' ' LYS . 68.0 m -153.97 95.9 1.91 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.213 -0.929 . . . . 0.0 108.712 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.641 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 23.0 m -46.68 171.75 0.06 OUTLIER Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.822 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.641 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.7 Cg_endo -71.9 162.89 40.55 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 121.904 1.736 . . . . 0.0 110.904 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.531 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -53.6 -72.8 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.562 -0.711 . . . . 0.0 111.72 -178.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.57 ' CE2' ' HB2' ' A' ' 8' ' ' TRP . 6.6 p90 -45.61 -33.53 2.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.125 -0.984 . . . . 0.0 110.7 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.702 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 11.6 t90 -122.77 64.89 0.96 Allowed 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 118.362 -1.335 . . . . 0.0 110.961 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -66.66 -23.07 72.13 Favored Glycine 0 N--CA 1.498 2.828 0 O-C-N 121.237 -0.914 . . . . 0.0 111.414 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.07 29.84 8.86 Favored Glycine 0 N--CA 1.492 2.375 0 O-C-N 120.468 -1.607 . . . . 0.0 111.556 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.662 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -80.66 175.5 4.76 Favored Pre-proline 0 C--N 1.291 -1.953 0 O-C-N 121.281 -1.129 . . . . 0.0 111.217 -178.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.702 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 40.8 Cg_endo -77.84 -55.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 123.857 3.038 . . . . 0.0 114.608 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.444 ' CZ3' ' CZ3' ' A' ' 8' ' ' TRP . 20.7 p90 -73.51 10.24 1.12 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.667 -1.271 . . . . 0.0 112.2 -176.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' C ' ' SG ' ' A' ' 4' ' ' CYS . . . -151.66 173.36 30.98 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.785 -1.674 . . . . 0.0 109.954 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.527 ' CG ' ' O ' ' A' ' 2' ' ' SER . 24.7 mt-30 -93.56 -155.86 0.46 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.331 -1.099 . . . . 0.0 108.889 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -108.43 61.88 0.61 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 108.697 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.616 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 1.6 m -88.72 -94.19 0.1 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.144 -0.973 . . . . 0.0 108.564 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CE2' ' OXT' ' A' ' 27' ' ' VAL . 66.0 m-85 -29.62 88.84 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.89 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.765 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -77.31 -83.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.23 1.953 . . . . 0.0 109.498 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -120.64 22.85 11.05 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.05 91.42 0.21 Allowed Glycine 0 N--CA 1.481 1.642 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 23.8 m -48.44 -21.8 0.61 Allowed 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.45 -0.875 . . . . 0.0 110.726 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.496 ' O ' ' OXT' ' A' ' 27' ' ' VAL . 1.6 p -115.71 -87.64 0.59 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.445 -0.784 . . . . 0.0 110.089 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 39.57 -149.29 0.12 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.512 ' O ' ' C ' ' A' ' 26' ' ' LYS . 35.5 Cg_endo -77.47 -156.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.952 2.434 . . . . 0.0 110.112 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.522 ' CD ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -33.62 -35.79 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.54 0.686 . . . . 0.0 109.188 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.603 ' OXT' ' CE2' ' A' ' 18' ' ' TYR . 13.2 m . . . . . 0 C--N 1.3 -1.579 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.051 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.472 ' OG ' ' CA ' ' A' ' 14' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.481 ' HB3' ' CE1' ' A' ' 18' ' ' TYR . 79.8 m 36.79 93.99 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.696 0.76 . . . . 0.0 110.62 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.578 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 80.2 m -42.71 164.93 0.11 Allowed Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 27.3 Cg_endo -65.31 144.64 81.19 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.487 1.458 . . . . 0.0 110.296 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.575 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 14.6 p -50.97 -42.59 60.18 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.381 -0.824 . . . . 0.0 110.238 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -58.62 -38.42 78.0 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.706 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.6 t90 -126.18 67.54 1.21 Allowed 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.343 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 4' ' ' CYS . . . -75.7 -27.15 63.51 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 120.31 -0.947 . . . . 0.0 111.216 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.31 12.63 37.71 Favored Glycine 0 N--CA 1.49 2.277 0 O-C-N 120.936 -1.332 . . . . 0.0 110.859 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.596 ' HB2' ' CE2' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -58.38 174.1 0.37 Allowed Pre-proline 0 C--N 1.296 -1.739 0 O-C-N 121.259 -1.142 . . . . 0.0 111.064 -178.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.706 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -72.38 -57.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 123.398 2.732 . . . . 0.0 112.29 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.553 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 24.5 p90 -73.33 -167.27 0.41 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.877 -1.139 . . . . 0.0 109.344 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.472 ' CA ' ' OG ' ' A' ' 2' ' ' SER . . . 40.45 -143.36 0.6 Allowed Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 14' ' ' GLY . 3.2 mt-30 -147.57 -155.27 0.61 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.486 -1.008 . . . . 0.0 109.988 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.53 71.13 0.78 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.525 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.4 m -87.45 -28.39 22.12 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.521 -0.737 . . . . 0.0 110.762 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.575 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -137.81 63.8 40.29 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.25 -0.906 . . . . 0.0 109.007 177.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 37.5 Cg_endo -83.46 -35.02 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.787 2.325 . . . . 0.0 110.869 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -90.64 9.73 28.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.9 . . . . 0.0 110.522 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 22' ' ' CYS . . . 129.73 123.54 2.54 Favored Glycine 0 C--N 1.304 -1.25 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.545 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.2 m -29.42 -47.12 0.06 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 122.3 1.047 . . . . 0.0 109.494 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.511 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 18.1 m 43.76 35.73 1.13 Allowed 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.621 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.95 -112.18 3.49 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.511 ' HD2' ' O ' ' A' ' 23' ' ' SER . 33.2 Cg_endo -74.42 -156.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.603 2.202 . . . . 0.0 111.409 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.525 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -52.3 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.798 0.809 . . . . 0.0 110.85 -178.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 17' ' ' CYS . 9.1 p . . . . . 0 C--N 1.304 -1.41 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.625 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 3' ' ' CYS . 5.6 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.495 ' C ' ' O ' ' A' ' 2' ' ' SER . 90.6 m 31.03 90.33 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.91 0.862 . . . . 0.0 110.904 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.57 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 99.5 m -41.33 166.42 0.06 OUTLIER Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.3 Cg_endo -71.28 160.99 47.19 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.057 1.838 . . . . 0.0 110.579 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.557 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.3 p -55.0 -69.35 0.13 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.265 -0.897 . . . . 0.0 111.552 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.554 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -41.42 -38.45 1.25 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.205 -0.935 . . . . 0.0 109.931 -178.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.705 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.6 t90 -126.45 66.89 1.23 Allowed 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.908 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -75.02 -26.41 66.69 Favored Glycine 0 N--CA 1.496 2.65 0 O-C-N 121.22 -0.925 . . . . 0.0 111.07 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.37 13.72 38.61 Favored Glycine 0 N--CA 1.488 2.157 0 O-C-N 120.858 -1.377 . . . . 0.0 110.75 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.601 ' HB2' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -62.93 175.63 0.63 Allowed Pre-proline 0 C--N 1.297 -1.703 0 O-C-N 121.239 -1.154 . . . . 0.0 111.036 -178.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.705 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.6 Cg_endo -74.46 -58.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 123.46 2.773 . . . . 0.0 112.747 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.596 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 26.0 p90 -73.17 121.39 20.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.73 -1.231 . . . . 0.0 109.604 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.52 -147.36 18.55 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -141.58 -156.73 0.7 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.509 -0.995 . . . . 0.0 109.921 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 12.0 t-20 -107.64 68.46 0.71 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.527 ' CA ' ' HA ' ' A' ' 27' ' ' VAL . 1.5 m -87.47 -1.21 57.77 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.376 0.607 . . . . 0.0 110.531 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 77.8 m-85 -138.93 62.7 28.07 Favored Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 120.828 -1.17 . . . . 0.0 110.376 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 35.6 Cg_endo -79.47 -25.35 5.67 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.519 2.146 . . . . 0.0 110.257 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 7.7 pt-20 -147.0 50.45 1.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.267 -0.895 . . . . 0.0 109.845 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.32 110.68 0.24 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.557 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.5 m -75.31 -12.12 60.2 Favored 'General case' 0 C--N 1.286 -2.194 0 O-C-N 122.218 -0.577 . . . . 0.0 110.359 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -143.07 8.19 1.64 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.197 -0.939 . . . . 0.0 111.234 -178.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.37 -148.59 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -77.01 -166.37 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.102 1.868 . . . . 0.0 109.136 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 2.1 tttm -51.95 -71.57 0.06 Allowed 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.523 -1.271 . . . . 0.0 107.837 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.527 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 7.1 p . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.389 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.488 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 3.1 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.29 0.566 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 79.4 m -143.16 90.75 2.21 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 122.087 0.946 . . . . 0.0 109.262 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.712 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 68.3 m -54.64 173.67 0.22 Allowed Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.712 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.5 Cg_endo -70.81 159.3 53.08 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.601 1.534 . . . . 0.0 110.679 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.572 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.2 p -50.07 -68.26 0.19 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.444 -0.785 . . . . 0.0 111.819 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 5' ' ' PRO . 8.1 p90 -46.83 -43.44 18.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.001 -1.062 . . . . 0.0 110.167 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.692 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.3 t90 -110.71 61.08 0.61 Allowed 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.779 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -72.69 5.13 18.22 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.374 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.56 26.58 6.55 Favored Glycine 0 N--CA 1.487 2.075 0 O-C-N 120.622 -1.516 . . . . 0.0 109.923 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.658 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.74 178.57 1.95 Allowed Pre-proline 0 C--N 1.293 -1.86 0 O-C-N 121.626 -0.926 . . . . 0.0 111.44 -178.577 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.692 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.8 Cg_endo -77.28 -52.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.969 0 C-N-CA 123.449 2.766 . . . . 0.0 113.277 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.586 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.9 p90 -77.62 32.88 0.16 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.56 -1.337 . . . . 0.0 111.755 -177.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 176.8 -173.55 46.38 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 118.849 -1.643 . . . . 0.0 110.282 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 2' ' ' SER . 0.2 OUTLIER -118.77 -149.43 0.44 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.478 -1.013 . . . . 0.0 109.909 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 5.6 t-20 -108.35 64.09 0.62 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.548 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.7 m -88.08 1.26 54.68 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.476 -0.765 . . . . 0.0 110.321 -178.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.547 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 66.5 m-85 -142.4 60.17 9.84 Favored Pre-proline 0 C--N 1.299 -1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 109.834 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.6 Cg_endo -79.22 -25.48 5.82 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.429 2.086 . . . . 0.0 110.232 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 26.2 tt0 -140.18 47.85 1.79 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 110.045 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.88 111.19 0.24 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.572 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -71.51 -15.72 62.32 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 121.658 0.742 . . . . 0.0 109.697 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 24' ' ' GLY . 32.6 t -130.24 -22.31 2.82 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.641 -0.662 . . . . 0.0 110.173 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -50.43 -178.8 0.02 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.44 -161.14 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.44 2.093 . . . . 0.0 110.565 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.548 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -72.01 -174.03 1.15 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.639 -0.663 . . . . 0.0 109.458 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.496 -179.782 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.532 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 1.1 p . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.26 0.552 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 4' ' ' CYS . 69.7 m -152.09 95.97 2.14 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.249 -0.907 . . . . 0.0 109.39 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.572 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 33.7 m -40.73 168.03 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.8 Cg_endo -70.92 171.6 15.42 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.29 1.993 . . . . 0.0 112.3 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.616 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 14.0 p -64.6 -41.67 96.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.741 -0.599 . . . . 0.0 111.754 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.525 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -78.69 -35.42 45.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.866 -1.146 . . . . 0.0 110.414 -178.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.704 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.4 t90 -121.03 63.28 0.87 Allowed 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.127 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.475 ' HA2' ' CB ' ' A' ' 4' ' ' CYS . . . -68.14 -26.71 73.98 Favored Glycine 0 N--CA 1.499 2.876 0 O-C-N 121.457 -0.777 . . . . 0.0 111.416 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.42 16.53 29.27 Favored Glycine 0 N--CA 1.491 2.311 0 O-C-N 120.912 -1.346 . . . . 0.0 110.54 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.66 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -69.56 174.79 2.68 Favored Pre-proline 0 C--N 1.296 -1.732 0 O-C-N 121.434 -1.039 . . . . 0.0 111.169 -178.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.704 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.8 Cg_endo -72.73 -60.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 123.267 2.644 . . . . 0.0 111.949 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 19.4 p90 -73.09 125.76 28.43 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.913 -1.117 . . . . 0.0 108.502 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 2' ' ' SER . . . 89.29 168.98 44.02 Favored Glycine 0 N--CA 1.482 1.732 0 C-N-CA 119.259 -1.448 . . . . 0.0 109.67 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -103.36 -148.42 0.39 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.481 -1.011 . . . . 0.0 109.731 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.89 69.11 0.7 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.5 m -87.1 -14.48 41.26 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.603 -0.686 . . . . 0.0 110.74 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.616 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 65.7 m-85 -123.33 47.17 1.58 Allowed Pre-proline 0 C--N 1.295 -1.797 0 O-C-N 121.241 -0.912 . . . . 0.0 111.407 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.604 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 38.1 Cg_endo -80.19 -1.29 11.27 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.818 1.678 . . . . 0.0 109.618 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.7 -21.77 22.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.903 . . . . 0.0 110.79 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 23' ' ' SER . . . 121.88 127.19 3.33 Favored Glycine 0 C--N 1.293 -1.858 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.52 ' HA ' ' HB2' ' A' ' 6' ' ' CYS . 16.9 m -30.43 -37.09 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 122.017 0.913 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 21' ' ' GLY . 1.9 t -54.28 -60.83 2.81 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.431 0.634 . . . . 0.0 109.628 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.62 142.38 24.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 26' ' ' LYS . 33.5 Cg_endo -78.57 141.26 17.44 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.266 1.978 . . . . 0.0 110.906 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 37.56 -158.99 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.105 0.479 . . . . 0.0 110.06 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.455 HG23 ' HE3' ' A' ' 26' ' ' LYS . 4.8 m . . . . . 0 N--CA 1.489 1.507 0 O-C-N 120.988 -1.07 . . . . 0.0 109.53 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.294 0.568 . . . . 0.0 109.554 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 99.6 m -146.47 93.45 2.3 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.972 0.892 . . . . 0.0 108.754 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.622 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 22.9 m -50.21 170.9 0.16 Allowed Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.6 Cg_endo -70.4 159.45 52.89 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 121.903 1.735 . . . . 0.0 110.289 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.562 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.2 p -55.05 -70.66 0.1 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.176 -0.952 . . . . 0.0 111.475 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.25 -38.57 2.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.015 -1.053 . . . . 0.0 110.26 -178.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.711 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.2 t90 -122.3 65.99 0.93 Allowed 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.207 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -72.02 -25.42 74.77 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.059 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.7 19.31 20.94 Favored Glycine 0 N--CA 1.49 2.285 0 O-C-N 120.685 -1.48 . . . . 0.0 110.854 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.63 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -71.2 174.43 3.77 Favored Pre-proline 0 C--N 1.296 -1.76 0 O-C-N 121.276 -1.131 . . . . 0.0 111.328 -178.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.711 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.7 Cg_endo -76.16 -56.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 123.814 3.009 . . . . 0.0 114.216 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.545 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 24.9 p90 -74.34 24.51 0.08 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.682 -1.261 . . . . 0.0 112.288 -176.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.46 ' CA ' ' SG ' ' A' ' 4' ' ' CYS . . . -167.51 175.94 42.4 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.558 -1.782 . . . . 0.0 110.363 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 9' ' ' GLY . 2.9 tp60 -104.34 -154.64 0.51 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.463 -1.022 . . . . 0.0 109.802 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.34 62.19 0.62 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.547 ' O ' ' O ' ' A' ' 26' ' ' LYS . 1.6 m -87.8 -12.42 45.1 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.807 0.813 . . . . 0.0 110.178 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.503 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 68.7 m-85 -130.18 62.86 66.66 Favored Pre-proline 0 C--N 1.291 -1.945 0 O-C-N 120.639 -1.288 . . . . 0.0 110.487 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.5 Cg_endo -79.33 -30.54 2.53 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.549 2.166 . . . . 0.0 109.938 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 19' ' ' PRO . 1.2 mm-40 -143.12 53.12 1.36 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.835 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.49 110.57 0.23 Allowed Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.562 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.4 m -75.23 -12.04 60.2 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.259 0.552 . . . . 0.0 110.234 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -145.53 7.34 1.12 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.142 -178.597 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.9 -144.67 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -77.0 -168.68 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.185 1.924 . . . . 0.0 109.03 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.547 ' O ' ' O ' ' A' ' 17' ' ' CYS . 6.8 ttmm -62.57 -66.85 0.48 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.136 -1.426 . . . . 0.0 108.203 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 17' ' ' CYS . 2.2 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.06 -0.972 . . . . 0.0 109.294 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.479 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 46.9 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 65.0 m -146.9 94.31 2.4 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.407 -0.808 . . . . 0.0 108.988 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.605 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 68.9 m -42.84 167.76 0.07 OUTLIER Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 28.8 Cg_endo -67.98 168.45 18.85 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.803 1.668 . . . . 0.0 110.428 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.669 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 1.1 p -65.44 -47.96 74.37 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.05 -1.031 . . . . 0.0 111.137 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.538 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -62.11 -49.62 75.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.826 -1.171 . . . . 0.0 109.651 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.714 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.9 t90 -109.56 59.8 0.6 Allowed 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.704 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -67.41 -27.72 73.56 Favored Glycine 0 N--CA 1.496 2.699 0 O-C-N 121.428 -0.795 . . . . 0.0 111.204 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.35 12.52 38.53 Favored Glycine 0 N--CA 1.49 2.256 0 O-C-N 120.869 -1.371 . . . . 0.0 110.841 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -63.39 176.56 0.57 Allowed Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.252 -1.146 . . . . 0.0 110.959 -178.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.714 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.2 Cg_endo -73.72 -58.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 123.129 2.553 . . . . 0.0 112.168 -177.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.607 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 24.8 p90 -73.62 115.45 13.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.753 -1.217 . . . . 0.0 109.122 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 90.55 177.43 44.24 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.512 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 40.8 mt-30 -111.07 -146.47 0.41 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.382 -1.07 . . . . 0.0 109.796 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.455 ' OD1' ' HB3' ' A' ' 19' ' ' PRO . 19.5 t-20 -108.69 75.62 0.98 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 3' ' ' CYS . 1.3 m -87.55 -13.15 43.73 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.556 -0.715 . . . . 0.0 111.496 -177.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -135.16 67.14 68.52 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.125 -0.984 . . . . 0.0 109.972 178.499 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.455 ' HB3' ' OD1' ' A' ' 16' ' ' ASN . 32.9 Cg_endo -74.85 -29.97 7.95 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.205 1.937 . . . . 0.0 109.64 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -142.27 11.99 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -108.54 26.06 17.5 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.669 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.6 m -33.66 -32.82 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.218 0 CA-C-O 121.714 0.769 . . . . 0.0 110.639 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -135.29 -34.22 0.87 Allowed 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.684 -0.635 . . . . 0.0 110.138 -179.596 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.36 -131.78 0.01 OUTLIER Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -76.33 -164.92 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.005 1.803 . . . . 0.0 109.46 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 17' ' ' CYS . 9.4 ttpp -73.0 -64.92 0.87 Allowed 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.765 -1.174 . . . . 0.0 109.001 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.403 ' OXT' HG11 ' A' ' 27' ' ' VAL . 5.1 p . . . . . 0 N--CA 1.489 1.522 0 O-C-N 120.95 -1.094 . . . . 0.0 109.479 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.534 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 25.5 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.278 0.561 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.517 ' O ' ' O ' ' A' ' 4' ' ' CYS . 68.4 m -147.47 96.27 2.67 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.293 -0.88 . . . . 0.0 108.837 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 51.4 m -39.58 165.67 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.563 ' HB2' ' CE1' ' A' ' 7' ' ' TYR . 30.3 Cg_endo -70.02 165.03 32.63 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.224 1.949 . . . . 0.0 111.64 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.657 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -57.51 -46.56 83.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.572 -0.705 . . . . 0.0 111.479 -178.573 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.631 ' CD2' ' N ' ' A' ' 8' ' ' TRP . 42.7 p90 -72.69 -47.17 49.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.984 -1.073 . . . . 0.0 110.404 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.716 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.9 t90 -108.62 59.2 0.61 Allowed 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.902 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.535 ' HA2' ' CB ' ' A' ' 4' ' ' CYS . . . -67.92 -27.39 73.67 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.62 9.07 45.19 Favored Glycine 0 N--CA 1.49 2.279 0 O-C-N 120.875 -1.368 . . . . 0.0 110.403 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.653 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -61.74 176.94 0.39 Allowed Pre-proline 0 C--N 1.298 -1.636 0 O-C-N 121.317 -1.108 . . . . 0.0 111.135 -178.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.716 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.0 Cg_endo -75.35 -56.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 123.321 2.68 . . . . 0.0 112.743 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 30.0 p90 -73.16 123.14 23.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.727 -1.233 . . . . 0.0 109.8 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.534 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 93.95 -148.46 19.01 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 23.8 mt-30 -145.29 -143.73 0.14 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.5 -1.0 . . . . 0.0 109.34 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.16 67.04 0.64 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 1.5 m -87.19 -20.25 27.25 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.315 -0.865 . . . . 0.0 110.339 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.573 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 98.3 m-85 -128.88 72.57 81.67 Favored Pre-proline 0 C--N 1.293 -1.887 0 O-C-N 121.628 -0.67 . . . . 0.0 109.577 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.416 ' CD ' HG21 ' A' ' 27' ' ' VAL . 34.9 Cg_endo -77.3 -32.26 3.13 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.424 2.082 . . . . 0.0 109.869 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 20' ' ' GLU . 3.1 tm-20 -150.09 14.7 0.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.454 -0.779 . . . . 0.0 109.518 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -90.24 15.51 59.6 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.657 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -35.88 -31.84 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.187 0 CA-C-O 121.793 0.806 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 21' ' ' GLY . 91.4 p -112.85 -25.15 9.17 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 121.298 0.57 . . . . 0.0 109.47 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.79 -168.75 30.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 26' ' ' LYS . 35.7 Cg_endo -78.22 -159.93 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.623 2.215 . . . . 0.0 110.693 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -56.5 -159.49 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.57 -0.706 . . . . 0.0 109.655 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 17' ' ' CYS . 2.1 t . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.406 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 13' ' ' TRP . 4.1 p . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 74.2 m 39.2 95.29 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.117 0.961 . . . . 0.0 111.076 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.715 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 86.7 m -52.75 175.28 0.11 Allowed Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.715 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.2 Cg_endo -72.0 165.91 31.18 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 121.33 1.354 . . . . 0.0 110.539 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.538 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 0.6 OUTLIER -60.75 -47.98 83.85 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.29 -0.881 . . . . 0.0 110.738 -178.31 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.58 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -59.37 -47.03 86.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.838 -1.164 . . . . 0.0 109.469 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.68 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 11.4 t90 -111.11 61.95 0.61 Allowed 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.367 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.532 ' O ' ' CA ' ' A' ' 16' ' ' ASN . . . -73.48 7.36 12.82 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.253 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.73 27.72 6.15 Favored Glycine 0 N--CA 1.486 2.02 0 O-C-N 120.615 -1.521 . . . . 0.0 109.301 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.641 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -79.84 177.07 3.15 Favored Pre-proline 0 C--N 1.295 -1.804 0 O-C-N 121.721 -0.87 . . . . 0.0 111.637 -178.152 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.68 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.29 -48.07 0.14 Allowed 'Trans proline' 0 C--N 1.319 -1.014 0 C-N-CA 123.498 2.799 . . . . 0.0 113.211 -177.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.639 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 36.4 p90 -80.05 37.49 0.37 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.69 -1.256 . . . . 0.0 111.237 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.44 -168.05 39.8 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.05 -1.547 . . . . 0.0 110.182 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 8.5 mt-30 -123.48 -150.5 0.45 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.408 -1.054 . . . . 0.0 110.318 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.532 ' CA ' ' O ' ' A' ' 9' ' ' GLY . 0.6 OUTLIER -108.9 69.86 0.72 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.505 ' SG ' ' HG2' ' A' ' 26' ' ' LYS . 1.7 m -87.79 -10.07 52.05 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.376 -0.827 . . . . 0.0 110.492 -177.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.591 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 6.7 m-85 -136.16 56.16 13.64 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.25 -0.906 . . . . 0.0 110.138 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.591 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 38.0 Cg_endo -81.77 -49.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 122.43 2.086 . . . . 0.0 111.284 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -92.62 22.23 4.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.389 -0.819 . . . . 0.0 111.198 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.99 113.29 0.37 Allowed Glycine 0 N--CA 1.481 1.651 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.219 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 8.7 m -57.79 -69.07 0.19 Allowed 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.883 0.849 . . . . 0.0 109.455 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 24' ' ' GLY . 11.0 m -52.76 -44.46 66.52 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -44.0 166.65 0.03 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.04 -159.94 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.492 2.128 . . . . 0.0 110.782 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.505 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 1.2 mtmt -60.41 177.02 0.3 Allowed 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.295 0.569 . . . . 0.0 109.648 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.3 -1.567 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.503 -179.954 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.501 ' O ' ' C ' ' A' ' 3' ' ' CYS . 2.4 p . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.501 ' C ' ' O ' ' A' ' 2' ' ' SER . 78.6 m 30.57 91.42 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.944 0.878 . . . . 0.0 111.026 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.548 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 62.1 m -43.67 168.06 0.07 OUTLIER Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 33.5 Cg_endo -76.33 146.8 28.45 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.057 1.838 . . . . 0.0 110.52 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.606 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -46.82 -63.71 0.96 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 0.0 110.593 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.572 ' CE1' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -39.49 -37.48 0.48 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.893 0.854 . . . . 0.0 108.799 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.696 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.0 t90 -135.0 70.21 1.44 Allowed 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.683 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.9 -26.51 66.71 Favored Glycine 0 N--CA 1.5 2.948 0 O-C-N 121.279 -0.888 . . . . 0.0 111.34 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.13 17.27 23.92 Favored Glycine 0 N--CA 1.489 2.18 0 O-C-N 120.846 -1.385 . . . . 0.0 110.674 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.611 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -68.48 174.89 2.19 Favored Pre-proline 0 C--N 1.297 -1.708 0 O-C-N 121.28 -1.129 . . . . 0.0 111.075 -178.737 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.696 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.3 Cg_endo -74.36 -58.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 123.436 2.757 . . . . 0.0 112.776 -177.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 25.5 p90 -73.44 123.74 24.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.726 -1.234 . . . . 0.0 110.003 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 100.38 -146.16 17.54 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -144.41 -152.34 0.41 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.594 -0.945 . . . . 0.0 109.767 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.44 63.97 0.61 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.519 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.6 m -87.09 2.65 49.09 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.661 0.743 . . . . 0.0 109.908 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.606 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 73.3 m-85 -145.33 76.2 13.38 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.66 -37.7 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.701 2.268 . . . . 0.0 112.081 -178.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.9 38.74 1.47 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.817 -1.177 . . . . 0.0 111.264 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 22' ' ' CYS . . . 149.34 119.66 1.0 Allowed Glycine 0 N--CA 1.479 1.507 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.0 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 12.0 m -40.63 -38.57 0.9 Allowed 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 122.381 1.086 . . . . 0.0 108.775 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.521 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 23.2 t 44.31 56.8 4.7 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 40.9 -99.43 0.01 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 23' ' ' SER . 32.2 Cg_endo -74.02 -159.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.371 2.047 . . . . 0.0 111.051 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.519 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 1.5 ttpp -48.34 -179.97 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.536 0.684 . . . . 0.0 109.889 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.504 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 5.4 p . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.433 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.526 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 2.9 t . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.741 0.305 . . . . 0.0 110.614 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 4' ' ' CYS . 87.5 m -143.09 93.04 2.45 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 120.892 -1.13 . . . . 0.0 109.557 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.557 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 39.3 m -41.67 167.6 0.06 OUTLIER Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.7 Cg_endo -72.11 159.44 49.93 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.071 1.847 . . . . 0.0 110.294 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.569 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.2 p -53.88 -71.51 0.07 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.293 -0.88 . . . . 0.0 111.531 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.552 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -44.19 -44.33 7.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.99 -1.069 . . . . 0.0 109.985 -178.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.713 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.6 t90 -115.8 63.22 0.7 Allowed 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 119.135 -1.026 . . . . 0.0 109.861 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -73.41 -26.28 70.57 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.94 7.97 52.9 Favored Glycine 0 N--CA 1.489 2.187 0 O-C-N 120.846 -1.385 . . . . 0.0 110.396 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -58.92 177.26 0.25 Allowed Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.258 -1.143 . . . . 0.0 110.963 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.713 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.2 Cg_endo -74.34 -57.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 123.213 2.609 . . . . 0.0 112.647 -177.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.596 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 26.6 p90 -73.58 117.67 15.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.697 -1.252 . . . . 0.0 109.697 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.526 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 91.26 -171.54 35.41 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.496 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -124.14 -138.55 0.29 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.211 -1.17 . . . . 0.0 110.147 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.515 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -109.27 70.65 0.74 Allowed 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.959 -1.088 . . . . 0.0 109.014 -179.139 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.555 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.7 m -89.36 -4.2 58.16 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 121.307 -0.87 . . . . 0.0 110.153 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.539 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 67.2 m-85 -140.09 60.75 15.68 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.425 -0.797 . . . . 0.0 109.462 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.3 Cg_endo -78.78 -23.77 7.84 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.426 2.084 . . . . 0.0 110.675 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.3 46.7 1.31 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.062 -1.024 . . . . 0.0 110.403 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.93 110.33 0.23 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.569 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.5 m -69.45 -15.1 63.2 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.598 0.714 . . . . 0.0 109.626 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 24' ' ' GLY . 3.8 m -126.86 -24.99 3.41 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.618 -0.676 . . . . 0.0 109.963 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -48.5 176.41 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -77.3 -161.59 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.36 2.04 . . . . 0.0 110.615 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.555 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 10.2 ttmt -71.03 -172.17 0.65 Allowed 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.695 -0.628 . . . . 0.0 109.333 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 29.0 m . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.934 -1.031 . . . . 0.0 109.515 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.475 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 7.5 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 62.2 m -147.82 93.55 2.22 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.352 -0.842 . . . . 0.0 108.882 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.556 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 44.2 m -41.37 167.3 0.05 OUTLIER Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.6 Cg_endo -72.33 159.6 49.06 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.263 1.975 . . . . 0.0 110.614 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -55.99 -69.94 0.13 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.893 . . . . 0.0 111.202 -178.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.577 ' CE2' ' HB2' ' A' ' 8' ' ' TRP . 1.5 p90 -42.16 -37.96 1.59 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 109.604 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.703 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.0 t90 -126.27 67.22 1.21 Allowed 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 119.059 -1.057 . . . . 0.0 109.991 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -75.26 -26.45 66.06 Favored Glycine 0 N--CA 1.496 2.694 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.005 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.91 11.14 49.31 Favored Glycine 0 N--CA 1.49 2.294 0 O-C-N 120.877 -1.366 . . . . 0.0 110.532 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.636 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -61.5 176.13 0.45 Allowed Pre-proline 0 C--N 1.297 -1.702 0 O-C-N 121.361 -1.082 . . . . 0.0 110.948 -178.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.703 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.8 -58.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 123.195 2.596 . . . . 0.0 112.455 -177.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.598 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 24.4 p90 -73.4 118.84 16.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.719 -1.238 . . . . 0.0 109.367 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.475 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 93.51 -178.79 38.49 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 19.8 mt-30 -111.26 -145.91 0.4 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.405 -1.056 . . . . 0.0 109.8 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -108.77 66.13 0.63 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.593 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.6 m -87.97 13.25 11.37 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.417 -0.802 . . . . 0.0 110.885 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.593 ' CD1' ' O ' ' A' ' 17' ' ' CYS . 62.7 m-85 -155.21 63.23 3.68 Favored Pre-proline 0 C--N 1.296 -1.759 0 O-C-N 120.664 -1.272 . . . . 0.0 109.547 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.7 Cg_endo -79.65 -32.09 1.72 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.307 2.005 . . . . 0.0 110.321 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -142.03 51.41 1.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 110.147 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.04 110.46 0.23 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.578 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -70.03 -16.56 63.17 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 121.437 0.637 . . . . 0.0 109.888 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.575 ' O ' ' C ' ' A' ' 24' ' ' GLY . 20.4 m -135.46 -94.07 0.27 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.417 -0.802 . . . . 0.0 109.192 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 13.57 -127.97 0.01 OUTLIER Glycine 0 N--CA 1.511 3.657 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -81.93 -157.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.162 1.908 . . . . 0.0 107.999 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.576 ' CA ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -133.09 -38.11 0.97 Allowed 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.483 178.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.546 ' CG2' ' HA ' ' A' ' 17' ' ' CYS . 25.0 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 120.894 -1.129 . . . . 0.0 109.165 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.544 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 4' ' ' CYS . 73.5 m -143.18 89.76 2.13 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.042 -1.036 . . . . 0.0 110.255 -178.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.556 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 11.9 m -43.75 168.77 0.06 OUTLIER Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.4 Cg_endo -71.43 148.75 55.1 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.001 1.8 . . . . 0.0 110.621 179.41 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 1.6 p -55.08 -46.19 75.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 110.916 -178.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -59.12 -36.39 75.1 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.839 -1.163 . . . . 0.0 108.192 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.678 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 17.9 t90 -131.52 69.59 1.47 Allowed 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.424 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -73.05 -26.51 70.75 Favored Glycine 0 N--CA 1.499 2.834 0 O-C-N 121.358 -0.839 . . . . 0.0 111.371 -178.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.48 15.19 31.09 Favored Glycine 0 N--CA 1.491 2.343 0 O-C-N 120.842 -1.387 . . . . 0.0 110.353 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.642 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -68.17 175.85 1.63 Allowed Pre-proline 0 C--N 1.296 -1.736 0 O-C-N 121.438 -1.036 . . . . 0.0 111.124 -178.735 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.678 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.0 Cg_endo -73.48 -60.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 123.31 2.673 . . . . 0.0 112.322 -177.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 17.5 p90 -73.29 122.93 22.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 0.0 109.287 -179.039 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.544 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 99.2 -166.62 21.11 Favored Glycine 0 N--CA 1.485 1.929 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.053 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -129.24 -147.91 0.36 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.466 -1.02 . . . . 0.0 109.65 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.42 64.83 0.62 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.532 ' SG ' ' HG2' ' A' ' 26' ' ' LYS . 1.6 m -87.56 -4.34 58.97 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.45 -0.781 . . . . 0.0 110.217 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.548 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 57.2 m-85 -148.15 61.75 6.14 Favored Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 121.416 -0.803 . . . . 0.0 109.772 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 37.5 Cg_endo -82.27 -39.06 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.634 2.223 . . . . 0.0 111.536 -179.6 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -122.91 36.35 4.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.968 -1.082 . . . . 0.0 111.279 -178.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.19 113.48 0.46 Allowed Glycine 0 N--CA 1.483 1.829 0 C-N-CA 119.487 -1.34 . . . . 0.0 110.547 178.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.546 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 8.7 m -56.6 -41.61 77.32 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-O 122.074 0.94 . . . . 0.0 109.233 179.01 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 24' ' ' GLY . 1.8 t -81.33 -41.15 22.5 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.496 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -44.22 166.84 0.03 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.8 -159.64 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.341 2.027 . . . . 0.0 110.641 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.532 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 3.4 mtpp -69.84 175.31 4.41 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.592 0.71 . . . . 0.0 109.959 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.477 ' HB ' ' HG3' ' A' ' 19' ' ' PRO . 9.5 p . . . . . 0 C--N 1.302 -1.463 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.488 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.464 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.353 0.597 . . . . 0.0 109.458 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 4' ' ' CYS . 69.9 m -143.75 91.74 2.27 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.994 0.902 . . . . 0.0 108.628 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.649 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 68.2 m -44.64 170.32 0.05 OUTLIER Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.7 Cg_endo -72.74 158.28 50.65 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 C-N-CA 121.87 1.713 . . . . 0.0 110.672 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.558 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 0.5 OUTLIER -61.87 -47.82 83.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.331 -0.856 . . . . 0.0 110.464 -178.738 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.549 ' CE1' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -53.23 -31.53 43.72 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.45 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.699 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.6 t90 -139.26 74.59 1.48 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.693 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -76.45 -26.4 63.54 Favored Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.336 -178.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.49 26.79 6.13 Favored Glycine 0 N--CA 1.49 2.275 0 O-C-N 120.675 -1.485 . . . . 0.0 110.922 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.624 ' HA ' ' CZ2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.91 173.41 7.52 Favored Pre-proline 0 C--N 1.293 -1.879 0 O-C-N 121.314 -1.11 . . . . 0.0 111.379 -178.669 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.699 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.3 Cg_endo -75.8 -55.16 0.07 OUTLIER 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 123.771 2.98 . . . . 0.0 114.12 -177.012 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.591 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.4 p90 -74.73 28.47 0.09 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.718 -1.239 . . . . 0.0 112.274 -177.072 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.464 ' HA2' ' OG ' ' A' ' 2' ' ' SER . . . -177.2 179.67 47.93 Favored Glycine 0 N--CA 1.485 1.938 0 C-N-CA 118.61 -1.757 . . . . 0.0 110.197 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 35.4 mt-30 -101.22 -163.96 1.06 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.425 -1.044 . . . . 0.0 109.553 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -106.5 65.49 0.68 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.571 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.6 m -87.48 9.22 21.62 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.313 0.578 . . . . 0.0 110.145 -177.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.575 ' CE1' ' O ' ' A' ' 26' ' ' LYS . 65.8 m-85 -150.76 62.85 5.5 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 120.69 -1.256 . . . . 0.0 109.844 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.8 Cg_endo -80.39 -62.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.637 2.225 . . . . 0.0 110.867 -179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.9 37.05 2.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.65 105.22 0.18 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.553 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 37.1 m -62.47 -32.88 73.84 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.697 0.76 . . . . 0.0 110.708 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.491 ' O ' ' C ' ' A' ' 24' ' ' GLY . 11.8 t -99.07 -89.29 0.32 Allowed 'General case' 0 C--N 1.287 -2.125 0 O-C-N 121.68 -0.638 . . . . 0.0 109.55 -179.521 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 33.47 -149.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 26' ' ' LYS . 34.4 Cg_endo -79.21 -166.97 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.4 2.067 . . . . 0.0 108.981 178.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.575 ' O ' ' CE1' ' A' ' 18' ' ' TYR . 2.6 ttmm -50.33 -58.71 5.05 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.622 -1.231 . . . . 0.0 107.928 178.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.538 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 14.4 m . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.487 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 3' ' ' CYS . 60.1 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.495 ' C ' ' O ' ' A' ' 2' ' ' SER . 89.2 m 32.87 91.9 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.95 0.881 . . . . 0.0 110.898 179.207 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.54 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 58.4 m -43.35 168.1 0.07 OUTLIER Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.214 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 34.0 Cg_endo -77.03 146.35 25.6 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.19 1.926 . . . . 0.0 110.683 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.619 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -46.25 -63.95 0.87 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.086 -1.009 . . . . 0.0 110.587 -179.453 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -39.59 -37.93 0.55 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.874 0.845 . . . . 0.0 108.842 -179.737 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.696 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.2 t90 -134.97 70.11 1.44 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.633 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.0 -26.65 66.16 Favored Glycine 0 N--CA 1.501 2.986 0 O-C-N 121.275 -0.89 . . . . 0.0 111.387 -178.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.71 15.95 28.47 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.918 -1.343 . . . . 0.0 110.571 -179.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.613 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -66.99 174.75 1.76 Allowed Pre-proline 0 C--N 1.296 -1.735 0 O-C-N 121.295 -1.121 . . . . 0.0 111.04 -178.764 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.696 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.4 Cg_endo -74.1 -57.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 123.311 2.674 . . . . 0.0 112.833 -177.473 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 26.8 p90 -73.4 122.83 22.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.681 -1.262 . . . . 0.0 109.978 -178.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.415 ' C ' ' HG3' ' A' ' 15' ' ' GLN . . . 99.21 -147.39 18.41 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.415 ' HG3' ' C ' ' A' ' 14' ' ' GLY . 21.8 mt-30 -143.4 -149.86 0.29 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.466 -1.02 . . . . 0.0 109.793 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.69 63.74 0.61 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.478 ' O ' ' HB ' ' A' ' 27' ' ' VAL . 1.7 m -87.21 8.05 25.67 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.401 -0.812 . . . . 0.0 109.594 -178.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.619 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 77.2 m-85 -149.21 64.98 7.75 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.522 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.5 Cg_endo -80.75 -16.34 10.33 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.632 2.221 . . . . 0.0 111.809 -178.156 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.16 35.99 0.67 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.633 -1.292 . . . . 0.0 111.28 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 23' ' ' SER . . . 134.56 124.24 2.44 Favored Glycine 0 N--CA 1.476 1.328 0 C-N-CA 119.504 -1.332 . . . . 0.0 109.955 179.239 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.516 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 20.5 m -35.67 -34.58 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 122.442 1.115 . . . . 0.0 109.39 179.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.502 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 37.6 p 46.53 58.88 4.23 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.226 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 43.2 -101.75 0.03 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 23' ' ' SER . 33.8 Cg_endo -75.89 -160.39 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.29 1.993 . . . . 0.0 111.057 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.476 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -50.78 -172.59 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.365 0.603 . . . . 0.0 110.22 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 9.8 p . . . . . 0 C--N 1.303 -1.442 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.532 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.444 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.197 0.522 . . . . 0.0 109.779 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.51 ' O ' ' O ' ' A' ' 4' ' ' CYS . 53.9 m -150.73 96.46 2.36 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.327 -0.858 . . . . 0.0 108.729 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 8' ' ' TRP . 55.7 m -39.23 165.69 0.05 OUTLIER Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.862 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.8 Cg_endo -71.24 173.32 12.44 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.286 1.991 . . . . 0.0 111.319 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.694 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -69.58 -48.0 61.67 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.427 -0.796 . . . . 0.0 111.511 -178.397 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.544 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -66.11 -29.78 70.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.737 -1.227 . . . . 0.0 109.773 -179.612 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.705 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.0 t90 -131.99 68.12 1.5 Allowed 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 118.679 -1.209 . . . . 0.0 109.933 -178.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.464 ' HA2' ' CB ' ' A' ' 4' ' ' CYS . . . -74.09 -26.24 69.17 Favored Glycine 0 N--CA 1.5 2.929 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.292 -179.141 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.06 13.95 35.46 Favored Glycine 0 N--CA 1.489 2.189 0 O-C-N 120.788 -1.419 . . . . 0.0 110.313 -179.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.651 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -66.27 175.1 1.39 Allowed Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 121.442 -1.034 . . . . 0.0 111.056 -178.78 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.705 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.4 -58.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -1.019 0 C-N-CA 123.275 2.65 . . . . 0.0 112.485 -177.35 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 23.9 p90 -72.79 122.12 21.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.74 -1.225 . . . . 0.0 109.121 -179.039 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.444 ' HA2' ' OG ' ' A' ' 2' ' ' SER . . . 88.17 174.77 47.74 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.473 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 12.7 mt-30 -103.2 -149.49 0.4 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.257 -1.143 . . . . 0.0 109.408 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.456 ' OD1' ' HA3' ' A' ' 9' ' ' GLY . 16.7 t-20 -108.67 68.9 0.7 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 3' ' ' CYS . 1.7 m -86.87 -11.44 50.77 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.37 0.605 . . . . 0.0 109.944 -177.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.557 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 43.0 m-85 -132.46 77.15 70.69 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 27' ' ' VAL . 35.2 Cg_endo -76.47 -48.44 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.586 2.19 . . . . 0.0 109.835 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -143.33 16.23 1.86 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -92.49 25.75 16.95 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.694 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -35.73 -31.5 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.22 0 CA-C-O 121.79 0.805 . . . . 0.0 110.196 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -125.37 -30.73 3.1 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.757 -0.59 . . . . 0.0 109.603 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.29 -148.87 0.04 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -78.18 -160.67 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.69 2.26 . . . . 0.0 110.738 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 17' ' ' CYS . 20.5 ttpt -50.95 -76.26 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.527 -0.733 . . . . 0.0 109.165 179.549 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' A' ' 17' ' ' CYS . 5.2 m . . . . . 0 N--CA 1.49 1.556 0 O-C-N 120.955 -1.091 . . . . 0.0 109.43 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.529 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 3.3 t . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.169 0.509 . . . . 0.0 109.659 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.481 ' O ' ' O ' ' A' ' 4' ' ' CYS . 89.2 m -148.44 91.87 1.95 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.128 -0.982 . . . . 0.0 109.635 -179.279 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.611 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 80.9 m -43.12 167.04 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.611 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 26.4 Cg_endo -65.28 152.67 81.38 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.123 1.215 . . . . 0.0 109.519 179.559 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.604 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 16.4 p -59.45 -42.48 92.08 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.141 -0.974 . . . . 0.0 110.088 -177.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -57.43 -28.62 63.47 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.099 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.708 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.1 t90 -136.06 72.63 1.44 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.041 -179.03 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.487 ' HA2' ' HB2' ' A' ' 4' ' ' CYS . . . -79.73 -24.45 60.27 Favored Glycine 0 N--CA 1.5 2.929 0 O-C-N 121.12 -0.988 . . . . 0.0 111.121 -179.268 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.59 16.57 34.92 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.96 -1.318 . . . . 0.0 110.555 -179.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.598 ' HA ' ' CZ2' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -63.77 174.18 1.11 Allowed Pre-proline 0 C--N 1.296 -1.742 0 O-C-N 121.272 -1.134 . . . . 0.0 111.042 -178.82 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.708 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.8 Cg_endo -73.05 -58.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 123.352 2.701 . . . . 0.0 112.222 -177.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.551 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 22.8 p90 -73.28 -167.76 0.45 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.768 -1.207 . . . . 0.0 109.153 -179.181 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.529 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 37.86 -148.54 0.07 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.8 OUTLIER -139.69 -157.6 0.78 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.411 -1.052 . . . . 0.0 109.99 179.801 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.475 ' OD1' ' CG ' ' A' ' 19' ' ' PRO . 13.5 t-20 -109.23 70.83 0.75 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 179.567 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.532 ' C ' ' CG ' ' A' ' 18' ' ' TYR . 1.3 m -87.84 -2.05 58.36 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.453 0.644 . . . . 0.0 111.074 -177.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.604 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -165.83 76.84 1.24 Allowed Pre-proline 0 N--CA 1.496 1.825 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.101 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.475 ' CG ' ' OD1' ' A' ' 16' ' ' ASN . 37.6 Cg_endo -82.83 -54.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 123.028 2.485 . . . . 0.0 112.013 -178.038 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -94.18 15.98 15.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.102 -0.999 . . . . 0.0 111.563 -177.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 22' ' ' CYS . . . 149.03 120.25 1.06 Allowed Glycine 0 N--CA 1.475 1.241 0 C-N-CA 118.989 -1.577 . . . . 0.0 110.174 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.554 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.4 m -37.05 -46.18 0.65 Allowed 'General case' 0 C--N 1.288 -2.105 0 CA-C-O 122.364 1.078 . . . . 0.0 108.59 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.516 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER 46.28 36.55 3.39 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.446 179.067 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.04 -112.38 3.47 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 179.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 23' ' ' SER . 32.7 Cg_endo -74.76 -157.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.377 2.051 . . . . 0.0 111.109 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 25' ' ' PRO . 2.1 mtpt -46.16 177.91 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.67 0.747 . . . . 0.0 110.271 -179.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 17' ' ' CYS . 5.4 p . . . . . 0 C--N 1.301 -1.543 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.647 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 3' ' ' CYS . 6.6 t . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 2' ' ' SER . 75.1 m 35.34 95.63 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.26 1.029 . . . . 0.0 110.758 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.652 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 57.7 m -52.36 170.68 0.23 Allowed Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.652 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.0 Cg_endo -71.93 166.38 29.73 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.068 1.846 . . . . 0.0 111.355 -179.604 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.67 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -62.52 -44.48 96.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.54 -0.725 . . . . 0.0 110.696 -179.034 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -67.49 -34.38 77.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.273 -0.892 . . . . 0.0 110.012 -178.929 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.702 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 13.4 t90 -126.63 65.61 1.26 Allowed 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.574 -178.445 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -65.66 -28.99 74.16 Favored Glycine 0 N--CA 1.498 2.77 0 O-C-N 121.344 -0.847 . . . . 0.0 111.542 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.09 29.89 4.54 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 120.68 -1.482 . . . . 0.0 111.283 -178.459 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.635 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -82.53 172.16 10.17 Favored Pre-proline 0 C--N 1.294 -1.836 0 O-C-N 121.211 -1.17 . . . . 0.0 111.427 -178.666 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.702 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.5 Cg_endo -75.55 -53.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 123.837 3.025 . . . . 0.0 113.997 -176.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.566 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 27.3 p90 -74.83 23.2 0.1 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.675 -1.266 . . . . 0.0 112.005 -177.294 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.409 ' C ' ' SG ' ' A' ' 4' ' ' CYS . . . -168.28 -174.92 37.5 Favored Glycine 0 N--CA 1.485 1.963 0 C-N-CA 118.949 -1.596 . . . . 0.0 110.028 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 35.8 mt-30 -116.99 -149.25 0.44 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.554 -0.968 . . . . 0.0 109.16 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.415 ' ND2' ' HA3' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -108.82 62.44 0.6 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.624 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.7 m -87.01 -19.95 27.94 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.258 -0.901 . . . . 0.0 109.147 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.597 ' CG ' ' HB2' ' A' ' 26' ' ' LYS . 6.6 m-85 -116.66 71.31 5.04 Favored Pre-proline 0 C--N 1.296 -1.723 0 O-C-N 121.666 -0.647 . . . . 0.0 109.815 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HD3' ' C ' ' A' ' 17' ' ' CYS . 34.7 Cg_endo -74.99 -44.54 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.159 1.906 . . . . 0.0 110.195 179.572 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -144.86 15.38 1.56 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.375 -0.828 . . . . 0.0 109.092 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -93.36 23.52 29.59 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.67 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.6 m -36.0 -29.45 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.361 0.601 . . . . 0.0 111.231 -179.675 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' GLY . 2.5 p -113.1 -74.15 0.64 Allowed 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.436 -0.79 . . . . 0.0 110.778 -178.759 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -59.47 -131.86 0.01 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.145 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.486 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 33.4 Cg_endo -74.98 -158.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.2 1.933 . . . . 0.0 109.836 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.597 ' HB2' ' CG ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -138.32 -36.85 0.57 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.184 -0.947 . . . . 0.0 109.935 -179.859 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.552 ' CG1' ' HG2' ' A' ' 26' ' ' LYS . 3.5 m . . . . . 0 N--CA 1.493 1.678 0 O-C-N 120.733 -1.229 . . . . 0.0 109.3 178.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 3' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.48 ' C ' ' O ' ' A' ' 2' ' ' SER . 73.8 m 33.15 91.78 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 122.133 0.968 . . . . 0.0 110.905 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.703 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 86.3 m -49.71 173.94 0.07 OUTLIER Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.061 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.703 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.4 Cg_endo -72.9 165.73 31.98 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.599 1.532 . . . . 0.0 111.35 -179.293 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.708 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -56.34 -46.95 79.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.453 -0.78 . . . . 0.0 111.343 -178.383 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -63.75 -40.08 95.84 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.034 -1.041 . . . . 0.0 110.375 -179.248 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.681 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.8 t90 -117.6 62.77 0.74 Allowed 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.24 -178.25 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -71.93 5.67 12.14 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.163 -0.961 . . . . 0.0 111.522 -179.242 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.68 28.64 5.88 Favored Glycine 0 N--CA 1.486 1.969 0 O-C-N 120.508 -1.583 . . . . 0.0 109.617 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.658 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -80.4 176.66 3.57 Favored Pre-proline 0 C--N 1.294 -1.848 0 O-C-N 121.654 -0.909 . . . . 0.0 111.664 -178.207 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.681 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.63 -50.21 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 123.569 2.846 . . . . 0.0 113.181 -177.015 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.633 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 34.6 p90 -78.58 34.79 0.22 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.675 -1.266 . . . . 0.0 111.585 -177.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.81 -163.26 32.1 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.834 -1.65 . . . . 0.0 110.502 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' GLY . 2.1 tt0 -128.3 -152.11 0.5 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.538 -0.978 . . . . 0.0 110.073 -179.337 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 12.7 t30 -109.21 64.59 0.61 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.486 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.6 m -87.46 -11.07 50.12 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.428 -0.795 . . . . 0.0 109.703 -179.0 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.532 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 96.9 m-85 -130.84 73.04 81.52 Favored Pre-proline 0 C--N 1.296 -1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 109.723 -179.232 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.524 ' CD ' ' O ' ' A' ' 27' ' ' VAL . 35.1 Cg_endo -77.67 -40.95 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.442 2.095 . . . . 0.0 109.477 179.581 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -141.2 13.03 2.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -94.9 25.67 22.5 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.557 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.708 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -38.67 -29.7 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.286 0 CA-C-O 121.751 0.786 . . . . 0.0 109.952 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 21' ' ' GLY . 48.5 t -147.97 54.58 1.04 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -157.24 -132.36 1.45 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -78.66 -160.58 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.388 2.059 . . . . 0.0 111.018 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.486 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 3.3 ttpt -122.64 87.61 2.78 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.753 -0.592 . . . . 0.0 109.545 179.598 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.524 ' O ' ' CD ' ' A' ' 19' ' ' PRO . 42.4 t . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.642 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.514 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.468 ' C ' ' O ' ' A' ' 2' ' ' SER . 71.6 m 34.36 95.98 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.127 0.965 . . . . 0.0 111.031 179.013 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.627 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 97.9 m -55.13 169.78 0.42 Allowed Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.5 Cg_endo -72.03 156.26 56.22 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.772 1.648 . . . . 0.0 111.068 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.549 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -48.17 -70.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.453 -0.779 . . . . 0.0 111.109 -178.487 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.583 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -41.16 -34.14 0.43 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.436 -0.79 . . . . 0.0 109.852 -178.886 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.69 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.1 t90 -126.0 66.47 1.2 Allowed 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.732 -179.31 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -78.32 5.95 53.32 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 120.162 -1.018 . . . . 0.0 110.871 -179.202 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.72 26.7 6.78 Favored Glycine 0 N--CA 1.485 1.955 0 O-C-N 120.773 -1.427 . . . . 0.0 109.637 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.643 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.91 176.47 3.42 Favored Pre-proline 0 C--N 1.294 -1.845 0 O-C-N 121.733 -0.863 . . . . 0.0 111.344 -178.402 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.69 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.8 Cg_endo -76.18 -52.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 123.423 2.748 . . . . 0.0 113.153 -177.154 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.583 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 28.9 p90 -78.0 31.73 0.17 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.745 -1.222 . . . . 0.0 111.625 -177.788 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.516 ' CA ' ' SG ' ' A' ' 4' ' ' CYS . . . -179.15 -171.73 42.62 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 118.595 -1.764 . . . . 0.0 110.595 179.555 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' GLY . 1.3 tt0 -118.87 -151.69 0.49 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.558 -0.966 . . . . 0.0 110.142 -179.522 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.487 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 27.0 t-20 -109.24 64.19 0.61 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.53 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.7 m -87.73 4.26 44.87 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.396 -0.815 . . . . 0.0 110.015 -178.516 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.547 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 73.0 m-85 -147.07 62.27 7.2 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.282 -0.886 . . . . 0.0 109.742 -178.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.526 ' CG ' HG21 ' A' ' 27' ' ' VAL . 35.4 Cg_endo -78.66 -38.8 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.587 2.191 . . . . 0.0 110.324 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 8.6 pt-20 -132.61 49.85 2.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 109.422 -179.899 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.25 112.31 0.26 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 179.71 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.7 m -64.9 -81.87 0.03 OUTLIER 'General case' 0 C--N 1.285 -2.232 0 CA-C-O 122.111 0.958 . . . . 0.0 109.079 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 24' ' ' GLY . 6.4 t -70.81 -8.77 54.92 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.314 179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -52.88 -173.44 0.04 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -78.96 -160.15 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.543 2.162 . . . . 0.0 110.952 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.53 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 2.1 ttmm -89.31 176.22 7.02 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.302 0.572 . . . . 0.0 109.581 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.526 HG21 ' CG ' ' A' ' 19' ' ' PRO . 45.6 t . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.42 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 2' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 3' ' ' CYS . 5.7 t -61.62 -129.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.415 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.481 ' O ' ' O ' ' A' ' 2' ' ' SER . 74.1 m 38.61 96.27 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.352 1.072 . . . . 0.0 110.739 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.661 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 98.8 m -58.59 171.79 0.59 Allowed Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.7 Cg_endo -70.64 166.95 27.02 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.567 1.511 . . . . 0.0 110.532 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.7 p -57.66 -69.67 0.16 Allowed 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.192 -0.942 . . . . 0.0 111.604 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.533 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.64 -36.39 2.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.918 -1.114 . . . . 0.0 110.218 -179.129 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.688 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 9.7 t90 -118.75 64.58 0.77 Allowed 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.055 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -77.14 10.18 22.08 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 120.109 -1.043 . . . . 0.0 110.915 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.41 29.89 4.41 Favored Glycine 0 N--CA 1.487 2.04 0 O-C-N 120.722 -1.458 . . . . 0.0 109.492 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.65 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -80.39 177.83 2.74 Favored Pre-proline 0 C--N 1.294 -1.841 0 O-C-N 121.742 -0.858 . . . . 0.0 111.334 -178.357 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.688 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.61 -51.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 123.483 2.788 . . . . 0.0 113.089 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.59 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.8 p90 -78.63 33.92 0.21 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.673 -1.267 . . . . 0.0 111.476 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.481 ' CA ' ' SG ' ' A' ' 4' ' ' CYS . . . 177.76 -169.27 41.19 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.107 -1.52 . . . . 0.0 110.108 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 9' ' ' GLY . 8.3 mm100 -125.95 -145.45 0.32 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.413 -1.051 . . . . 0.0 109.626 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 0.2 OUTLIER -108.4 61.88 0.61 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.424 -0.798 . . . . 0.0 109.129 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.536 ' CA ' ' HA ' ' A' ' 27' ' ' VAL . 1.5 m -87.56 -5.1 58.91 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.261 -0.9 . . . . 0.0 110.078 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.535 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 40.2 m-85 -131.24 59.08 43.29 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.206 -0.934 . . . . 0.0 109.901 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.5 Cg_endo -78.27 -36.39 1.0 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.48 2.12 . . . . 0.0 110.52 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -135.46 50.64 2.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.326 -0.859 . . . . 0.0 109.929 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.87 108.56 0.21 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.5 m -73.76 -12.93 60.86 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.364 0.602 . . . . 0.0 110.343 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -145.72 8.41 1.13 Allowed 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.277 -0.889 . . . . 0.0 110.986 -178.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -62.19 -142.56 0.01 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -77.14 -165.77 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.106 1.871 . . . . 0.0 109.204 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -60.45 -68.17 0.32 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.634 -1.227 . . . . 0.0 108.047 178.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.536 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 1.8 t . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.438 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.535 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 0.1 OUTLIER -87.24 82.1 7.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.397 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.517 ' SG ' ' CD ' ' A' ' 26' ' ' LYS . 91.5 m -149.19 93.9 2.15 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.245 -0.909 . . . . 0.0 109.05 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 32.8 m -42.68 166.66 0.08 OUTLIER Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.585 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 33.9 Cg_endo -76.26 153.5 35.97 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.34 2.027 . . . . 0.0 111.091 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.599 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -50.63 -71.21 0.07 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.226 -0.921 . . . . 0.0 110.699 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.585 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -39.75 -29.65 0.06 Allowed 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.918 -179.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.705 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.5 t90 -138.4 72.31 1.41 Allowed 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 118.751 -1.18 . . . . 0.0 109.763 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -77.33 -29.09 56.77 Favored Glycine 0 N--CA 1.502 3.063 0 O-C-N 121.275 -0.891 . . . . 0.0 111.229 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.33 13.79 31.89 Favored Glycine 0 N--CA 1.49 2.296 0 O-C-N 120.947 -1.326 . . . . 0.0 110.675 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -63.62 174.48 0.99 Allowed Pre-proline 0 C--N 1.297 -1.714 0 O-C-N 121.307 -1.114 . . . . 0.0 110.915 -178.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.705 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.7 -59.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 123.33 2.687 . . . . 0.0 112.637 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.57 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 23.4 p90 -73.3 127.44 32.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.761 -1.212 . . . . 0.0 109.824 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.535 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 95.37 -165.19 24.87 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.208 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -124.08 -152.14 0.5 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.563 -0.963 . . . . 0.0 109.957 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.25 65.41 0.63 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.514 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.6 m -87.2 -1.95 58.27 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.61 0.719 . . . . 0.0 109.896 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.599 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 67.0 m-85 -134.45 62.31 54.44 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.522 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.4 Cg_endo -79.5 -30.97 2.23 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.516 2.144 . . . . 0.0 110.297 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.99 -66.36 0.93 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 6' ' ' CYS . . . -144.78 -135.71 2.93 Favored Glycine 0 C--N 1.287 -2.168 0 N-CA-C 106.942 -2.463 . . . . 0.0 106.942 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 56.9 m -88.39 -20.85 24.73 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-O 122.074 0.94 . . . . 0.0 108.964 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.523 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER 45.4 55.5 6.47 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.371 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 37.87 -97.42 0.01 OUTLIER Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 23' ' ' SER . 32.3 Cg_endo -74.53 -160.64 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.392 2.061 . . . . 0.0 111.187 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.517 ' CD ' ' SG ' ' A' ' 3' ' ' CYS . 19.9 ttpp -39.17 -70.49 0.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.666 -0.646 . . . . 0.0 110.588 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 23' ' ' SER . 9.4 p . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.848 -1.157 . . . . 0.0 109.501 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.456 ' O ' ' HG3' ' A' ' 1' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 13' ' ' TRP . 43.2 t -86.09 -21.67 27.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.142 -0.974 . . . . 0.0 109.513 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 2' ' ' SER . 81.6 m 40.83 97.14 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 122.227 1.013 . . . . 0.0 110.443 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.623 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 89.8 m -54.66 169.2 0.41 Allowed Pre-proline 0 C--N 1.295 -1.763 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.623 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.6 Cg_endo -71.79 155.77 57.83 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.783 1.655 . . . . 0.0 111.045 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.575 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -47.77 -69.5 0.12 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.519 -0.738 . . . . 0.0 111.172 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.58 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -42.48 -35.98 1.2 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.214 -0.929 . . . . 0.0 109.973 -179.14 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.683 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.2 t90 -123.42 65.06 1.01 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.863 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -77.47 8.0 36.19 Favored Glycine 0 N--CA 1.497 2.747 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.851 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.67 28.2 5.77 Favored Glycine 0 N--CA 1.485 1.965 0 O-C-N 120.764 -1.433 . . . . 0.0 109.547 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.64 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -79.05 176.83 3.32 Favored Pre-proline 0 C--N 1.294 -1.808 0 O-C-N 121.769 -0.842 . . . . 0.0 111.492 -178.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.683 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.39 -52.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 123.488 2.792 . . . . 0.0 113.117 -177.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.587 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.9 p90 -78.31 33.78 0.2 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.633 -1.292 . . . . 0.0 111.533 -177.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 2' ' ' SER . . . 177.38 -171.02 43.75 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 118.825 -1.655 . . . . 0.0 110.411 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 9' ' ' GLY . 8.2 mt-30 -121.1 -149.19 0.42 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.548 -0.972 . . . . 0.0 110.226 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 7.2 t-20 -109.15 64.46 0.61 Allowed 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 26' ' ' LYS . 1.6 m -87.5 4.92 41.57 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.296 -0.878 . . . . 0.0 109.877 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.54 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 73.5 m-85 -148.53 62.43 6.4 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.197 -0.94 . . . . 0.0 110.013 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.541 ' CG ' ' HB ' ' A' ' 27' ' ' VAL . 36.4 Cg_endo -79.36 -33.68 1.3 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.087 1.858 . . . . 0.0 109.515 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -137.25 53.74 1.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 25' ' ' PRO . . . 163.85 113.45 0.29 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.575 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -69.63 -10.55 58.66 Favored 'General case' 0 C--N 1.283 -2.286 0 O-C-N 122.313 -0.522 . . . . 0.0 111.2 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.461 ' O ' ' C ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -169.19 -50.75 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.876 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' SER . . . -38.49 -86.69 0.01 OUTLIER Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.476 ' HG2' ' HA3' ' A' ' 21' ' ' GLY . 31.3 Cg_endo -76.31 -161.01 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.747 2.298 . . . . 0.0 111.688 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 6.7 tttt -176.08 121.45 0.17 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.541 ' HB ' ' CG ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.15 -0.968 . . . . 0.0 109.936 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.3 ptt85 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.248 0.547 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 3' ' ' CYS . 46.7 t -178.67 -28.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.342 -0.849 . . . . 0.0 109.784 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 2' ' ' SER . 99.9 m 41.8 95.89 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.152 0.977 . . . . 0.0 110.472 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.681 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 82.5 m -46.49 171.93 0.06 OUTLIER Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.681 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.8 Cg_endo -70.51 172.88 12.51 Favored 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.75 1.633 . . . . 0.0 111.185 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.7 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 2.9 p -66.82 -42.67 85.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.422 -0.799 . . . . 0.0 111.307 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 1.8 p90 -69.26 -38.23 78.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.081 -1.012 . . . . 0.0 110.223 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.706 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 13.8 t90 -121.11 63.58 0.88 Allowed 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.784 -178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -67.39 -22.95 73.33 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.198 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.76 27.85 6.93 Favored Glycine 0 N--CA 1.488 2.148 0 O-C-N 120.525 -1.573 . . . . 0.0 110.697 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.621 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -81.16 172.71 9.11 Favored Pre-proline 0 C--N 1.294 -1.828 0 O-C-N 121.297 -1.119 . . . . 0.0 111.629 -178.456 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.706 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.6 Cg_endo -75.6 -52.03 0.1 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 123.875 3.05 . . . . 0.0 113.945 -176.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.613 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 33.2 p90 -77.0 32.92 0.14 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.679 -1.263 . . . . 0.0 111.784 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 2' ' ' SER . . . 177.31 -169.54 41.78 Favored Glycine 0 N--CA 1.484 1.897 0 C-N-CA 118.78 -1.676 . . . . 0.0 110.113 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.495 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -119.36 -156.12 0.64 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.518 -0.99 . . . . 0.0 109.899 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -107.79 68.32 0.71 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.586 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.5 m -86.91 -3.44 59.08 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 121.656 -0.653 . . . . 0.0 109.975 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.621 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -153.47 84.03 4.38 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.432 -0.792 . . . . 0.0 109.346 179.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.508 ' CG ' HG22 ' A' ' 27' ' ' VAL . 34.8 Cg_endo -77.83 -43.22 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.63 2.22 . . . . 0.0 109.809 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -137.78 12.74 2.92 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -92.54 24.74 21.73 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.7 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -35.69 -31.74 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.22 0 CA-C-O 121.877 0.846 . . . . 0.0 110.091 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' GLY . 1.2 m -116.08 -22.31 9.02 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.71 -0.619 . . . . 0.0 109.492 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.69 -173.42 46.88 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.31 -160.93 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.688 2.258 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 2.9 ttpt -58.82 176.64 0.19 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.539 -0.726 . . . . 0.0 109.356 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.508 HG22 ' CG ' ' A' ' 19' ' ' PRO . 9.2 p . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.514 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.479 ' HB2' ' HA2' ' A' ' 14' ' ' GLY . 1.0 OUTLIER -83.99 -102.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 109.204 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 2' ' ' SER . 84.3 m 35.83 96.15 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 122.262 1.03 . . . . 0.0 110.898 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.709 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 69.1 m -54.29 173.35 0.22 Allowed Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.709 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.4 Cg_endo -71.52 155.3 59.68 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.704 1.602 . . . . 0.0 110.832 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.571 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -47.92 -69.19 0.13 Allowed 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.406 -0.808 . . . . 0.0 111.334 -178.418 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 2.0 p90 -44.25 -36.96 2.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.96 . . . . 0.0 109.863 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.682 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.2 t90 -119.89 64.28 0.82 Allowed 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 118.943 -1.103 . . . . 0.0 109.969 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -75.62 6.78 29.86 Favored Glycine 0 N--CA 1.496 2.694 0 C-N-CA 120.262 -0.97 . . . . 0.0 111.13 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.66 27.76 5.89 Favored Glycine 0 N--CA 1.486 1.998 0 O-C-N 120.612 -1.523 . . . . 0.0 109.868 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.65 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -78.43 177.96 2.51 Favored Pre-proline 0 C--N 1.294 -1.839 0 O-C-N 121.641 -0.917 . . . . 0.0 111.457 -178.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.682 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.8 Cg_endo -76.9 -52.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 123.489 2.793 . . . . 0.0 113.15 -177.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.585 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.6 p90 -78.1 33.08 0.18 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.719 -1.238 . . . . 0.0 111.677 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.494 ' CA ' ' SG ' ' A' ' 4' ' ' CYS . . . 177.78 -170.45 42.8 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 118.812 -1.661 . . . . 0.0 110.488 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -121.85 -151.74 0.49 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.547 -0.973 . . . . 0.0 110.391 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 19.6 t-20 -108.78 64.03 0.61 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.537 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 2.1 m -87.74 -10.59 50.63 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 121.775 0.798 . . . . 0.0 109.792 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 29.7 m-85 -127.83 67.89 74.14 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.661 -0.65 . . . . 0.0 109.259 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HB3' ' OD1' ' A' ' 16' ' ' ASN . 36.5 Cg_endo -78.16 -44.55 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.547 2.165 . . . . 0.0 110.926 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.96 48.71 2.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.112 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.52 108.18 0.22 Allowed Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.571 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -67.35 -15.63 63.79 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-O 121.55 0.691 . . . . 0.0 109.582 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 24' ' ' GLY . 6.4 t -129.89 -18.4 3.41 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.641 -0.662 . . . . 0.0 110.225 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -50.43 -179.64 0.03 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -77.55 -160.78 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.38 2.053 . . . . 0.0 110.762 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.537 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -79.26 172.4 13.85 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.716 -0.615 . . . . 0.0 109.576 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.49 -179.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' ' 13' ' ' TRP . 0.2 OUTLIER -44.16 -49.29 9.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -0.938 . . . . 0.0 109.444 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 2' ' ' SER . 73.1 m 40.96 97.2 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.279 1.038 . . . . 0.0 110.644 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.664 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 95.0 m -54.36 171.55 0.28 Allowed Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.664 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.2 Cg_endo -71.73 157.78 54.71 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 121.772 1.648 . . . . 0.0 110.876 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.558 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -49.2 -70.93 0.07 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.471 -0.768 . . . . 0.0 111.361 -178.389 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.572 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -42.16 -36.54 1.21 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.158 -0.964 . . . . 0.0 110.034 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.69 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.1 t90 -121.59 64.65 0.9 Allowed 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.805 -1.158 . . . . 0.0 109.896 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -76.88 6.92 37.62 Favored Glycine 0 N--CA 1.497 2.703 0 C-N-CA 120.222 -0.989 . . . . 0.0 110.759 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.81 27.34 6.24 Favored Glycine 0 N--CA 1.486 2.011 0 O-C-N 120.706 -1.467 . . . . 0.0 109.671 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.643 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -77.83 176.49 3.52 Favored Pre-proline 0 C--N 1.294 -1.836 0 O-C-N 121.706 -0.879 . . . . 0.0 111.486 -178.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.69 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -75.99 -51.78 0.1 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 123.473 2.782 . . . . 0.0 113.029 -177.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.6 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.7 p90 -78.48 34.4 0.21 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.714 -1.241 . . . . 0.0 111.519 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.485 ' CA ' ' SG ' ' A' ' 4' ' ' CYS . . . 175.93 -170.46 43.38 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.792 -1.671 . . . . 0.0 110.618 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' GLY . 1.4 tt0 -120.67 -151.91 0.49 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.531 -0.982 . . . . 0.0 110.369 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 1.3 t-20 -108.98 64.57 0.61 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.547 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.9 m -87.99 -0.5 57.09 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.543 -0.723 . . . . 0.0 109.983 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.544 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 72.0 m-85 -140.33 60.36 14.22 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.801 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.4 Cg_endo -78.88 -30.3 2.93 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.451 2.101 . . . . 0.0 110.267 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.88 49.03 1.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 109.909 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.89 111.27 0.24 Allowed Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.7 m -67.8 -15.36 63.59 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-O 121.57 0.7 . . . . 0.0 109.646 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.89 4.46 2.09 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.675 -0.64 . . . . 0.0 109.88 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.72 -164.29 2.52 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -78.84 -160.41 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.374 2.05 . . . . 0.0 110.624 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.547 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -90.12 178.09 6.27 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.703 -0.623 . . . . 0.0 109.422 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.523 -179.953 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.52 ' HB2' ' CA ' ' A' ' 14' ' ' GLY . 4.9 p -69.66 -93.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.962 . . . . 0.0 109.335 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 4' ' ' CYS . 76.5 m 38.46 96.22 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.993 0.901 . . . . 0.0 110.597 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.558 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 56.2 m -40.68 166.38 0.06 OUTLIER Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.571 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.7 Cg_endo -70.97 161.65 45.38 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.204 1.936 . . . . 0.0 110.497 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.574 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.1 p -56.1 -72.53 0.07 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.267 -0.896 . . . . 0.0 111.494 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -43.09 -36.16 1.55 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.017 -1.052 . . . . 0.0 110.28 -179.003 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.711 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.3 t90 -124.17 64.93 1.06 Allowed 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.221 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -72.29 -30.31 65.08 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.68 8.43 35.35 Favored Glycine 0 N--CA 1.49 2.269 0 O-C-N 120.867 -1.372 . . . . 0.0 110.85 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.624 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -58.4 176.5 0.26 Allowed Pre-proline 0 C--N 1.298 -1.66 0 O-C-N 121.069 -1.254 . . . . 0.0 110.881 -179.004 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.711 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.94 -57.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 123.133 2.555 . . . . 0.0 112.306 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.61 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 25.4 p90 -73.84 115.19 12.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.74 -1.225 . . . . 0.0 109.758 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.52 ' CA ' ' HB2' ' A' ' 2' ' ' SER . . . 93.63 -172.76 33.13 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 4.9 mt-30 -116.64 -147.25 0.41 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.485 -1.009 . . . . 0.0 110.133 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.518 ' ND2' ' HB3' ' A' ' 19' ' ' PRO . 10.5 t30 -108.02 69.73 0.74 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.5 m -87.48 -7.35 57.74 Favored 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.532 -0.73 . . . . 0.0 110.713 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.538 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 66.0 m-85 -133.79 60.49 46.41 Favored Pre-proline 0 C--N 1.296 -1.738 0 O-C-N 121.291 -0.88 . . . . 0.0 110.234 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.1 Cg_endo -78.95 -24.79 6.67 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.388 2.058 . . . . 0.0 109.852 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.27 52.7 1.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 0.0 109.68 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.21 113.43 0.28 Allowed Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.574 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -75.03 -85.8 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.963 0.887 . . . . 0.0 109.799 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -76.18 -24.35 54.73 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.094 -179.171 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -59.97 -149.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.443 ' C ' ' HD3' ' A' ' 26' ' ' LYS . 35.0 Cg_endo -77.27 -160.34 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.288 1.992 . . . . 0.0 110.029 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.527 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -100.15 -96.05 0.25 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.431 -0.793 . . . . 0.0 109.559 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.461 ' CG1' ' O ' ' A' ' 27' ' ' VAL . 9.5 p . . . . . 0 C--N 1.299 -1.63 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.504 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.518 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -90.33 -77.9 0.39 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 0.0 109.451 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.474 ' C ' ' O ' ' A' ' 2' ' ' SER . 81.2 m 34.06 95.69 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.239 1.019 . . . . 0.0 110.987 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.662 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 96.0 m -53.75 171.41 0.26 Allowed Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.662 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.8 Cg_endo -69.94 164.24 35.44 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.569 1.512 . . . . 0.0 110.558 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.55 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.6 p -54.82 -70.42 0.1 Allowed 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.248 -0.907 . . . . 0.0 111.713 -177.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.515 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.12 -38.7 2.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.968 -1.082 . . . . 0.0 110.208 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.691 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 9.7 t90 -116.74 63.02 0.72 Allowed 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 118.964 -1.095 . . . . 0.0 110.047 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -76.59 8.7 26.01 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.877 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.95 28.59 5.36 Favored Glycine 0 N--CA 1.486 1.991 0 O-C-N 120.707 -1.467 . . . . 0.0 109.511 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.649 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -78.98 177.3 2.96 Favored Pre-proline 0 C--N 1.295 -1.797 0 O-C-N 121.781 -0.835 . . . . 0.0 111.26 -178.404 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.691 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.3 Cg_endo -76.24 -52.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 123.505 2.803 . . . . 0.0 113.063 -177.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.584 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 28.5 p90 -78.14 31.55 0.18 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.724 -1.235 . . . . 0.0 111.597 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.518 ' HA2' ' CB ' ' A' ' 2' ' ' SER . . . -178.29 -172.03 42.26 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 118.714 -1.708 . . . . 0.0 110.517 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 9' ' ' GLY . 5.7 mt-30 -121.37 -150.67 0.46 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.498 -1.001 . . . . 0.0 110.29 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -108.49 62.99 0.61 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.516 ' O ' ' CA ' ' A' ' 27' ' ' VAL . 1.8 m -88.2 -11.14 47.58 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.396 -0.815 . . . . 0.0 109.938 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.538 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 23.3 m-85 -127.55 56.03 18.11 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.708 -0.62 . . . . 0.0 110.461 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.4 Cg_endo -76.73 -29.97 5.18 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.354 2.036 . . . . 0.0 110.491 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -138.84 51.28 1.82 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.918 . . . . 0.0 110.074 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.75 111.52 0.25 Allowed Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.4 m -77.04 -85.89 0.06 Allowed 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 122.083 0.944 . . . . 0.0 110.005 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.5 OUTLIER -79.95 -8.68 59.46 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.572 -178.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.89 -140.27 0.01 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -77.31 -164.18 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.028 1.819 . . . . 0.0 109.613 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.496 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 17.9 ttpp -51.98 -70.23 0.09 Allowed 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.516 ' CA ' ' O ' ' A' ' 17' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.034 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.527 ' O ' ' CG ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER 61.31 13.43 4.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.227 -0.921 . . . . 0.0 109.526 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.522 ' SG ' ' CD ' ' A' ' 26' ' ' LYS . 68.0 m -153.97 95.9 1.91 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.213 -0.929 . . . . 0.0 108.712 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.641 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 23.0 m -46.68 171.75 0.06 OUTLIER Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.822 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.641 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.7 Cg_endo -71.9 162.89 40.55 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 121.904 1.736 . . . . 0.0 110.904 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.531 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -53.6 -72.8 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.562 -0.711 . . . . 0.0 111.72 -178.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.57 ' CE2' ' HB2' ' A' ' 8' ' ' TRP . 6.6 p90 -45.61 -33.53 2.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.125 -0.984 . . . . 0.0 110.7 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.702 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 11.6 t90 -122.77 64.89 0.96 Allowed 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 118.362 -1.335 . . . . 0.0 110.961 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -66.66 -23.07 72.13 Favored Glycine 0 N--CA 1.498 2.828 0 O-C-N 121.237 -0.914 . . . . 0.0 111.414 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.07 29.84 8.86 Favored Glycine 0 N--CA 1.492 2.375 0 O-C-N 120.468 -1.607 . . . . 0.0 111.556 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.662 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -80.66 175.5 4.76 Favored Pre-proline 0 C--N 1.291 -1.953 0 O-C-N 121.281 -1.129 . . . . 0.0 111.217 -178.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.702 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 40.8 Cg_endo -77.84 -55.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 123.857 3.038 . . . . 0.0 114.608 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.444 ' CZ3' ' CZ3' ' A' ' 8' ' ' TRP . 20.7 p90 -73.51 10.24 1.12 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.667 -1.271 . . . . 0.0 112.2 -176.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' C ' ' SG ' ' A' ' 4' ' ' CYS . . . -151.66 173.36 30.98 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.785 -1.674 . . . . 0.0 109.954 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.527 ' CG ' ' O ' ' A' ' 2' ' ' SER . 24.7 mt-30 -93.56 -155.86 0.46 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.331 -1.099 . . . . 0.0 108.889 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -108.43 61.88 0.61 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 108.697 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.616 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 1.6 m -88.72 -94.19 0.1 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.144 -0.973 . . . . 0.0 108.564 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CE2' ' OXT' ' A' ' 27' ' ' VAL . 66.0 m-85 -29.62 88.84 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.89 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.765 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -77.31 -83.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.23 1.953 . . . . 0.0 109.498 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -120.64 22.85 11.05 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.05 91.42 0.21 Allowed Glycine 0 N--CA 1.481 1.642 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 23.8 m -48.44 -21.8 0.61 Allowed 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.45 -0.875 . . . . 0.0 110.726 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.496 ' O ' ' OXT' ' A' ' 27' ' ' VAL . 1.6 p -115.71 -87.64 0.59 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.445 -0.784 . . . . 0.0 110.089 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 39.57 -149.29 0.12 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.512 ' O ' ' C ' ' A' ' 26' ' ' LYS . 35.5 Cg_endo -77.47 -156.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.952 2.434 . . . . 0.0 110.112 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.522 ' CD ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -33.62 -35.79 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.54 0.686 . . . . 0.0 109.188 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.603 ' OXT' ' CE2' ' A' ' 18' ' ' TYR . 13.2 m . . . . . 0 C--N 1.3 -1.579 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.051 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.472 ' OG ' ' CA ' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -74.33 0.21 15.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.314 -0.866 . . . . 0.0 109.866 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.481 ' HB3' ' CE1' ' A' ' 18' ' ' TYR . 79.8 m 36.79 93.99 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.696 0.76 . . . . 0.0 110.62 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.578 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 80.2 m -42.71 164.93 0.11 Allowed Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 27.3 Cg_endo -65.31 144.64 81.19 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.487 1.458 . . . . 0.0 110.296 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.575 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 14.6 p -50.97 -42.59 60.18 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.381 -0.824 . . . . 0.0 110.238 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -58.62 -38.42 78.0 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.706 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.6 t90 -126.18 67.54 1.21 Allowed 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.343 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 4' ' ' CYS . . . -75.7 -27.15 63.51 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 120.31 -0.947 . . . . 0.0 111.216 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.31 12.63 37.71 Favored Glycine 0 N--CA 1.49 2.277 0 O-C-N 120.936 -1.332 . . . . 0.0 110.859 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.596 ' HB2' ' CE2' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -58.38 174.1 0.37 Allowed Pre-proline 0 C--N 1.296 -1.739 0 O-C-N 121.259 -1.142 . . . . 0.0 111.064 -178.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.706 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -72.38 -57.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 123.398 2.732 . . . . 0.0 112.29 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.553 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 24.5 p90 -73.33 -167.27 0.41 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.877 -1.139 . . . . 0.0 109.344 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.472 ' CA ' ' OG ' ' A' ' 2' ' ' SER . . . 40.45 -143.36 0.6 Allowed Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 14' ' ' GLY . 3.2 mt-30 -147.57 -155.27 0.61 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.486 -1.008 . . . . 0.0 109.988 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.53 71.13 0.78 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.525 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.4 m -87.45 -28.39 22.12 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.521 -0.737 . . . . 0.0 110.762 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.575 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -137.81 63.8 40.29 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.25 -0.906 . . . . 0.0 109.007 177.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 37.5 Cg_endo -83.46 -35.02 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.787 2.325 . . . . 0.0 110.869 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -90.64 9.73 28.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.9 . . . . 0.0 110.522 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 22' ' ' CYS . . . 129.73 123.54 2.54 Favored Glycine 0 C--N 1.304 -1.25 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.545 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.2 m -29.42 -47.12 0.06 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 122.3 1.047 . . . . 0.0 109.494 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.511 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 18.1 m 43.76 35.73 1.13 Allowed 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.621 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.95 -112.18 3.49 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.511 ' HD2' ' O ' ' A' ' 23' ' ' SER . 33.2 Cg_endo -74.42 -156.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.603 2.202 . . . . 0.0 111.409 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.525 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -52.3 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.798 0.809 . . . . 0.0 110.85 -178.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 17' ' ' CYS . 9.1 p . . . . . 0 C--N 1.304 -1.41 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.625 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 3' ' ' CYS . 5.6 t -114.12 -166.81 1.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 109.661 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.495 ' C ' ' O ' ' A' ' 2' ' ' SER . 90.6 m 31.03 90.33 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.91 0.862 . . . . 0.0 110.904 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.57 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 99.5 m -41.33 166.42 0.06 OUTLIER Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.3 Cg_endo -71.28 160.99 47.19 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.057 1.838 . . . . 0.0 110.579 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.557 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.3 p -55.0 -69.35 0.13 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.265 -0.897 . . . . 0.0 111.552 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.554 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -41.42 -38.45 1.25 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.205 -0.935 . . . . 0.0 109.931 -178.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.705 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.6 t90 -126.45 66.89 1.23 Allowed 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.908 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -75.02 -26.41 66.69 Favored Glycine 0 N--CA 1.496 2.65 0 O-C-N 121.22 -0.925 . . . . 0.0 111.07 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.37 13.72 38.61 Favored Glycine 0 N--CA 1.488 2.157 0 O-C-N 120.858 -1.377 . . . . 0.0 110.75 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.601 ' HB2' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -62.93 175.63 0.63 Allowed Pre-proline 0 C--N 1.297 -1.703 0 O-C-N 121.239 -1.154 . . . . 0.0 111.036 -178.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.705 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.6 Cg_endo -74.46 -58.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 123.46 2.773 . . . . 0.0 112.747 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.596 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 26.0 p90 -73.17 121.39 20.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.73 -1.231 . . . . 0.0 109.604 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.52 -147.36 18.55 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -141.58 -156.73 0.7 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.509 -0.995 . . . . 0.0 109.921 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 12.0 t-20 -107.64 68.46 0.71 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.527 ' CA ' ' HA ' ' A' ' 27' ' ' VAL . 1.5 m -87.47 -1.21 57.77 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.376 0.607 . . . . 0.0 110.531 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 77.8 m-85 -138.93 62.7 28.07 Favored Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 120.828 -1.17 . . . . 0.0 110.376 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 35.6 Cg_endo -79.47 -25.35 5.67 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.519 2.146 . . . . 0.0 110.257 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 7.7 pt-20 -147.0 50.45 1.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.267 -0.895 . . . . 0.0 109.845 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.32 110.68 0.24 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.557 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.5 m -75.31 -12.12 60.2 Favored 'General case' 0 C--N 1.286 -2.194 0 O-C-N 122.218 -0.577 . . . . 0.0 110.359 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -143.07 8.19 1.64 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.197 -0.939 . . . . 0.0 111.234 -178.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.37 -148.59 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -77.01 -166.37 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.102 1.868 . . . . 0.0 109.136 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 2.1 tttm -51.95 -71.57 0.06 Allowed 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.523 -1.271 . . . . 0.0 107.837 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.527 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 7.1 p . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.389 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.495 ' HA ' ' NH1' ' A' ' 1' ' ' ARG . 2.9 mmm180 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.488 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 3.1 t -92.63 54.07 2.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.908 . . . . 0.0 109.504 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 79.4 m -143.16 90.75 2.21 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 122.087 0.946 . . . . 0.0 109.262 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.712 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 68.3 m -54.64 173.67 0.22 Allowed Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.712 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.5 Cg_endo -70.81 159.3 53.08 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.601 1.534 . . . . 0.0 110.679 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.572 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.2 p -50.07 -68.26 0.19 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.444 -0.785 . . . . 0.0 111.819 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 5' ' ' PRO . 8.1 p90 -46.83 -43.44 18.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.001 -1.062 . . . . 0.0 110.167 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.692 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.3 t90 -110.71 61.08 0.61 Allowed 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.779 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -72.69 5.13 18.22 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.374 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.56 26.58 6.55 Favored Glycine 0 N--CA 1.487 2.075 0 O-C-N 120.622 -1.516 . . . . 0.0 109.923 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.658 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.74 178.57 1.95 Allowed Pre-proline 0 C--N 1.293 -1.86 0 O-C-N 121.626 -0.926 . . . . 0.0 111.44 -178.577 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.692 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.8 Cg_endo -77.28 -52.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.969 0 C-N-CA 123.449 2.766 . . . . 0.0 113.277 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.586 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.9 p90 -77.62 32.88 0.16 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.56 -1.337 . . . . 0.0 111.755 -177.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 176.8 -173.55 46.38 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 118.849 -1.643 . . . . 0.0 110.282 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 2' ' ' SER . 0.2 OUTLIER -118.77 -149.43 0.44 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.478 -1.013 . . . . 0.0 109.909 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 5.6 t-20 -108.35 64.09 0.62 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.548 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.7 m -88.08 1.26 54.68 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.476 -0.765 . . . . 0.0 110.321 -178.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.547 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 66.5 m-85 -142.4 60.17 9.84 Favored Pre-proline 0 C--N 1.299 -1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 109.834 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.6 Cg_endo -79.22 -25.48 5.82 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.429 2.086 . . . . 0.0 110.232 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 26.2 tt0 -140.18 47.85 1.79 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 110.045 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.88 111.19 0.24 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.572 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -71.51 -15.72 62.32 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 121.658 0.742 . . . . 0.0 109.697 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 24' ' ' GLY . 32.6 t -130.24 -22.31 2.82 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.641 -0.662 . . . . 0.0 110.173 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -50.43 -178.8 0.02 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.44 -161.14 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.44 2.093 . . . . 0.0 110.565 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.548 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -72.01 -174.03 1.15 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.639 -0.663 . . . . 0.0 109.458 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.496 -179.782 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.347 0.594 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.532 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 1.1 p -61.34 106.67 0.66 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -0.941 . . . . 0.0 109.52 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 4' ' ' CYS . 69.7 m -152.09 95.97 2.14 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.249 -0.907 . . . . 0.0 109.39 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.572 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 33.7 m -40.73 168.03 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.8 Cg_endo -70.92 171.6 15.42 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.29 1.993 . . . . 0.0 112.3 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.616 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 14.0 p -64.6 -41.67 96.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.741 -0.599 . . . . 0.0 111.754 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.525 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -78.69 -35.42 45.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.866 -1.146 . . . . 0.0 110.414 -178.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.704 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.4 t90 -121.03 63.28 0.87 Allowed 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.127 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.475 ' HA2' ' CB ' ' A' ' 4' ' ' CYS . . . -68.14 -26.71 73.98 Favored Glycine 0 N--CA 1.499 2.876 0 O-C-N 121.457 -0.777 . . . . 0.0 111.416 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.42 16.53 29.27 Favored Glycine 0 N--CA 1.491 2.311 0 O-C-N 120.912 -1.346 . . . . 0.0 110.54 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.66 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -69.56 174.79 2.68 Favored Pre-proline 0 C--N 1.296 -1.732 0 O-C-N 121.434 -1.039 . . . . 0.0 111.169 -178.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.704 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.8 Cg_endo -72.73 -60.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 123.267 2.644 . . . . 0.0 111.949 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 19.4 p90 -73.09 125.76 28.43 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.913 -1.117 . . . . 0.0 108.502 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 2' ' ' SER . . . 89.29 168.98 44.02 Favored Glycine 0 N--CA 1.482 1.732 0 C-N-CA 119.259 -1.448 . . . . 0.0 109.67 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -103.36 -148.42 0.39 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.481 -1.011 . . . . 0.0 109.731 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.89 69.11 0.7 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.5 m -87.1 -14.48 41.26 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.603 -0.686 . . . . 0.0 110.74 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.616 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 65.7 m-85 -123.33 47.17 1.58 Allowed Pre-proline 0 C--N 1.295 -1.797 0 O-C-N 121.241 -0.912 . . . . 0.0 111.407 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.604 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 38.1 Cg_endo -80.19 -1.29 11.27 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.818 1.678 . . . . 0.0 109.618 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.7 -21.77 22.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.903 . . . . 0.0 110.79 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 23' ' ' SER . . . 121.88 127.19 3.33 Favored Glycine 0 C--N 1.293 -1.858 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.52 ' HA ' ' HB2' ' A' ' 6' ' ' CYS . 16.9 m -30.43 -37.09 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 122.017 0.913 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 21' ' ' GLY . 1.9 t -54.28 -60.83 2.81 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.431 0.634 . . . . 0.0 109.628 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.62 142.38 24.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 26' ' ' LYS . 33.5 Cg_endo -78.57 141.26 17.44 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.266 1.978 . . . . 0.0 110.906 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 37.56 -158.99 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.105 0.479 . . . . 0.0 110.06 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.455 HG23 ' HE3' ' A' ' 26' ' ' LYS . 4.8 m . . . . . 0 N--CA 1.489 1.507 0 O-C-N 120.988 -1.07 . . . . 0.0 109.53 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER 56.15 97.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.554 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 99.6 m -146.47 93.45 2.3 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.972 0.892 . . . . 0.0 108.754 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.622 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 22.9 m -50.21 170.9 0.16 Allowed Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.6 Cg_endo -70.4 159.45 52.89 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 121.903 1.735 . . . . 0.0 110.289 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.562 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.2 p -55.05 -70.66 0.1 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.176 -0.952 . . . . 0.0 111.475 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.25 -38.57 2.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.015 -1.053 . . . . 0.0 110.26 -178.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.711 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.2 t90 -122.3 65.99 0.93 Allowed 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.207 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -72.02 -25.42 74.77 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.059 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.7 19.31 20.94 Favored Glycine 0 N--CA 1.49 2.285 0 O-C-N 120.685 -1.48 . . . . 0.0 110.854 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.63 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -71.2 174.43 3.77 Favored Pre-proline 0 C--N 1.296 -1.76 0 O-C-N 121.276 -1.131 . . . . 0.0 111.328 -178.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.711 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.7 Cg_endo -76.16 -56.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 123.814 3.009 . . . . 0.0 114.216 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.545 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 24.9 p90 -74.34 24.51 0.08 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.682 -1.261 . . . . 0.0 112.288 -176.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.46 ' CA ' ' SG ' ' A' ' 4' ' ' CYS . . . -167.51 175.94 42.4 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.558 -1.782 . . . . 0.0 110.363 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 9' ' ' GLY . 2.9 tp60 -104.34 -154.64 0.51 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.463 -1.022 . . . . 0.0 109.802 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.34 62.19 0.62 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.547 ' O ' ' O ' ' A' ' 26' ' ' LYS . 1.6 m -87.8 -12.42 45.1 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.807 0.813 . . . . 0.0 110.178 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.503 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 68.7 m-85 -130.18 62.86 66.66 Favored Pre-proline 0 C--N 1.291 -1.945 0 O-C-N 120.639 -1.288 . . . . 0.0 110.487 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.5 Cg_endo -79.33 -30.54 2.53 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.549 2.166 . . . . 0.0 109.938 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 19' ' ' PRO . 1.2 mm-40 -143.12 53.12 1.36 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.835 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.49 110.57 0.23 Allowed Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.562 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.4 m -75.23 -12.04 60.2 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.259 0.552 . . . . 0.0 110.234 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -145.53 7.34 1.12 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.142 -178.597 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.9 -144.67 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -77.0 -168.68 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.185 1.924 . . . . 0.0 109.03 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.547 ' O ' ' O ' ' A' ' 17' ' ' CYS . 6.8 ttmm -62.57 -66.85 0.48 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.136 -1.426 . . . . 0.0 108.203 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 17' ' ' CYS . 2.2 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.06 -0.972 . . . . 0.0 109.294 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.44 ' O ' ' HD2' ' A' ' 1' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.479 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 46.9 t -120.32 37.57 4.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.303 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 65.0 m -146.9 94.31 2.4 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.407 -0.808 . . . . 0.0 108.988 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.605 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 68.9 m -42.84 167.76 0.07 OUTLIER Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 28.8 Cg_endo -67.98 168.45 18.85 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.803 1.668 . . . . 0.0 110.428 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.669 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 1.1 p -65.44 -47.96 74.37 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.05 -1.031 . . . . 0.0 111.137 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.538 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -62.11 -49.62 75.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.826 -1.171 . . . . 0.0 109.651 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.714 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.9 t90 -109.56 59.8 0.6 Allowed 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.704 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -67.41 -27.72 73.56 Favored Glycine 0 N--CA 1.496 2.699 0 O-C-N 121.428 -0.795 . . . . 0.0 111.204 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.35 12.52 38.53 Favored Glycine 0 N--CA 1.49 2.256 0 O-C-N 120.869 -1.371 . . . . 0.0 110.841 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -63.39 176.56 0.57 Allowed Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.252 -1.146 . . . . 0.0 110.959 -178.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.714 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.2 Cg_endo -73.72 -58.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 123.129 2.553 . . . . 0.0 112.168 -177.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.607 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 24.8 p90 -73.62 115.45 13.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.753 -1.217 . . . . 0.0 109.122 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 90.55 177.43 44.24 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.512 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 40.8 mt-30 -111.07 -146.47 0.41 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.382 -1.07 . . . . 0.0 109.796 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.455 ' OD1' ' HB3' ' A' ' 19' ' ' PRO . 19.5 t-20 -108.69 75.62 0.98 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 3' ' ' CYS . 1.3 m -87.55 -13.15 43.73 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.556 -0.715 . . . . 0.0 111.496 -177.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -135.16 67.14 68.52 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.125 -0.984 . . . . 0.0 109.972 178.499 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.455 ' HB3' ' OD1' ' A' ' 16' ' ' ASN . 32.9 Cg_endo -74.85 -29.97 7.95 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.205 1.937 . . . . 0.0 109.64 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -142.27 11.99 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -108.54 26.06 17.5 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.669 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.6 m -33.66 -32.82 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.218 0 CA-C-O 121.714 0.769 . . . . 0.0 110.639 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -135.29 -34.22 0.87 Allowed 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.684 -0.635 . . . . 0.0 110.138 -179.596 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.36 -131.78 0.01 OUTLIER Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -76.33 -164.92 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.005 1.803 . . . . 0.0 109.46 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 17' ' ' CYS . 9.4 ttpp -73.0 -64.92 0.87 Allowed 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.765 -1.174 . . . . 0.0 109.001 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.403 ' OXT' HG11 ' A' ' 27' ' ' VAL . 5.1 p . . . . . 0 N--CA 1.489 1.522 0 O-C-N 120.95 -1.094 . . . . 0.0 109.479 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.534 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 25.5 p -113.12 69.5 0.7 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.497 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.517 ' O ' ' O ' ' A' ' 4' ' ' CYS . 68.4 m -147.47 96.27 2.67 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.293 -0.88 . . . . 0.0 108.837 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 51.4 m -39.58 165.67 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.563 ' HB2' ' CE1' ' A' ' 7' ' ' TYR . 30.3 Cg_endo -70.02 165.03 32.63 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.224 1.949 . . . . 0.0 111.64 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.657 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -57.51 -46.56 83.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.572 -0.705 . . . . 0.0 111.479 -178.573 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.631 ' CD2' ' N ' ' A' ' 8' ' ' TRP . 42.7 p90 -72.69 -47.17 49.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.984 -1.073 . . . . 0.0 110.404 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.716 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.9 t90 -108.62 59.2 0.61 Allowed 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.902 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.535 ' HA2' ' CB ' ' A' ' 4' ' ' CYS . . . -67.92 -27.39 73.67 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.62 9.07 45.19 Favored Glycine 0 N--CA 1.49 2.279 0 O-C-N 120.875 -1.368 . . . . 0.0 110.403 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.653 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -61.74 176.94 0.39 Allowed Pre-proline 0 C--N 1.298 -1.636 0 O-C-N 121.317 -1.108 . . . . 0.0 111.135 -178.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.716 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.0 Cg_endo -75.35 -56.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 123.321 2.68 . . . . 0.0 112.743 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 30.0 p90 -73.16 123.14 23.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.727 -1.233 . . . . 0.0 109.8 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.534 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 93.95 -148.46 19.01 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 23.8 mt-30 -145.29 -143.73 0.14 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.5 -1.0 . . . . 0.0 109.34 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.16 67.04 0.64 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 1.5 m -87.19 -20.25 27.25 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.315 -0.865 . . . . 0.0 110.339 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.573 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 98.3 m-85 -128.88 72.57 81.67 Favored Pre-proline 0 C--N 1.293 -1.887 0 O-C-N 121.628 -0.67 . . . . 0.0 109.577 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.416 ' CD ' HG21 ' A' ' 27' ' ' VAL . 34.9 Cg_endo -77.3 -32.26 3.13 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.424 2.082 . . . . 0.0 109.869 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 20' ' ' GLU . 3.1 tm-20 -150.09 14.7 0.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.454 -0.779 . . . . 0.0 109.518 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -90.24 15.51 59.6 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.657 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -35.88 -31.84 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.187 0 CA-C-O 121.793 0.806 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 21' ' ' GLY . 91.4 p -112.85 -25.15 9.17 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 121.298 0.57 . . . . 0.0 109.47 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.79 -168.75 30.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 26' ' ' LYS . 35.7 Cg_endo -78.22 -159.93 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.623 2.215 . . . . 0.0 110.693 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -56.5 -159.49 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.57 -0.706 . . . . 0.0 109.655 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 17' ' ' CYS . 2.1 t . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.406 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.492 ' NH1' ' HG2' ' A' ' 1' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 13' ' ' TRP . 4.1 p -92.08 30.16 1.48 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.205 -0.934 . . . . 0.0 109.449 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 74.2 m 39.2 95.29 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.117 0.961 . . . . 0.0 111.076 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.715 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 86.7 m -52.75 175.28 0.11 Allowed Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.715 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.2 Cg_endo -72.0 165.91 31.18 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 121.33 1.354 . . . . 0.0 110.539 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.538 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 0.6 OUTLIER -60.75 -47.98 83.85 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.29 -0.881 . . . . 0.0 110.738 -178.31 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.58 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -59.37 -47.03 86.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.838 -1.164 . . . . 0.0 109.469 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.68 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 11.4 t90 -111.11 61.95 0.61 Allowed 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.367 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.532 ' O ' ' CA ' ' A' ' 16' ' ' ASN . . . -73.48 7.36 12.82 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.253 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.73 27.72 6.15 Favored Glycine 0 N--CA 1.486 2.02 0 O-C-N 120.615 -1.521 . . . . 0.0 109.301 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.641 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -79.84 177.07 3.15 Favored Pre-proline 0 C--N 1.295 -1.804 0 O-C-N 121.721 -0.87 . . . . 0.0 111.637 -178.152 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.68 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.29 -48.07 0.14 Allowed 'Trans proline' 0 C--N 1.319 -1.014 0 C-N-CA 123.498 2.799 . . . . 0.0 113.211 -177.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.639 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 36.4 p90 -80.05 37.49 0.37 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.69 -1.256 . . . . 0.0 111.237 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.457 ' HA2' ' N ' ' A' ' 1' ' ' ARG . . . 166.44 -168.05 39.8 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.05 -1.547 . . . . 0.0 110.182 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 8.5 mt-30 -123.48 -150.5 0.45 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.408 -1.054 . . . . 0.0 110.318 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.532 ' CA ' ' O ' ' A' ' 9' ' ' GLY . 0.6 OUTLIER -108.9 69.86 0.72 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.505 ' SG ' ' HG2' ' A' ' 26' ' ' LYS . 1.7 m -87.79 -10.07 52.05 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.376 -0.827 . . . . 0.0 110.492 -177.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.591 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 6.7 m-85 -136.16 56.16 13.64 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.25 -0.906 . . . . 0.0 110.138 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.591 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 38.0 Cg_endo -81.77 -49.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 122.43 2.086 . . . . 0.0 111.284 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -92.62 22.23 4.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.389 -0.819 . . . . 0.0 111.198 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.99 113.29 0.37 Allowed Glycine 0 N--CA 1.481 1.651 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.219 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 8.7 m -57.79 -69.07 0.19 Allowed 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.883 0.849 . . . . 0.0 109.455 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 24' ' ' GLY . 11.0 m -52.76 -44.46 66.52 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -44.0 166.65 0.03 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.04 -159.94 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.492 2.128 . . . . 0.0 110.782 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.505 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 1.2 mtmt -60.41 177.02 0.3 Allowed 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.295 0.569 . . . . 0.0 109.648 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.3 -1.567 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.503 -179.954 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.494 ' CG ' ' O ' ' A' ' 1' ' ' ARG . 1.8 ptt180 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.501 ' O ' ' C ' ' A' ' 3' ' ' CYS . 2.4 p 42.84 -150.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.286 -0.884 . . . . 0.0 109.643 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.501 ' C ' ' O ' ' A' ' 2' ' ' SER . 78.6 m 30.57 91.42 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.944 0.878 . . . . 0.0 111.026 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.548 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 62.1 m -43.67 168.06 0.07 OUTLIER Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 33.5 Cg_endo -76.33 146.8 28.45 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.057 1.838 . . . . 0.0 110.52 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.606 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -46.82 -63.71 0.96 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 0.0 110.593 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.572 ' CE1' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -39.49 -37.48 0.48 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.893 0.854 . . . . 0.0 108.799 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.696 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.0 t90 -135.0 70.21 1.44 Allowed 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.683 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.9 -26.51 66.71 Favored Glycine 0 N--CA 1.5 2.948 0 O-C-N 121.279 -0.888 . . . . 0.0 111.34 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.13 17.27 23.92 Favored Glycine 0 N--CA 1.489 2.18 0 O-C-N 120.846 -1.385 . . . . 0.0 110.674 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.611 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -68.48 174.89 2.19 Favored Pre-proline 0 C--N 1.297 -1.708 0 O-C-N 121.28 -1.129 . . . . 0.0 111.075 -178.737 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.696 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.3 Cg_endo -74.36 -58.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 123.436 2.757 . . . . 0.0 112.776 -177.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 25.5 p90 -73.44 123.74 24.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.726 -1.234 . . . . 0.0 110.003 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 100.38 -146.16 17.54 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -144.41 -152.34 0.41 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.594 -0.945 . . . . 0.0 109.767 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.44 63.97 0.61 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.519 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.6 m -87.09 2.65 49.09 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.661 0.743 . . . . 0.0 109.908 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.606 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 73.3 m-85 -145.33 76.2 13.38 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.66 -37.7 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.701 2.268 . . . . 0.0 112.081 -178.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.9 38.74 1.47 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.817 -1.177 . . . . 0.0 111.264 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 22' ' ' CYS . . . 149.34 119.66 1.0 Allowed Glycine 0 N--CA 1.479 1.507 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.0 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 12.0 m -40.63 -38.57 0.9 Allowed 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 122.381 1.086 . . . . 0.0 108.775 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.521 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 23.2 t 44.31 56.8 4.7 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 40.9 -99.43 0.01 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 23' ' ' SER . 32.2 Cg_endo -74.02 -159.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.371 2.047 . . . . 0.0 111.051 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.519 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 1.5 ttpp -48.34 -179.97 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.536 0.684 . . . . 0.0 109.889 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.504 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 5.4 p . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.433 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.569 ' HG3' ' CD1' ' A' ' 13' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.526 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 2.9 t 170.04 -19.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.067 -1.021 . . . . 0.0 110.614 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 4' ' ' CYS . 87.5 m -143.09 93.04 2.45 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 120.892 -1.13 . . . . 0.0 109.557 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.557 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 39.3 m -41.67 167.6 0.06 OUTLIER Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.7 Cg_endo -72.11 159.44 49.93 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.071 1.847 . . . . 0.0 110.294 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.569 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.2 p -53.88 -71.51 0.07 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.293 -0.88 . . . . 0.0 111.531 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.552 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -44.19 -44.33 7.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.99 -1.069 . . . . 0.0 109.985 -178.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.713 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.6 t90 -115.8 63.22 0.7 Allowed 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 119.135 -1.026 . . . . 0.0 109.861 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -73.41 -26.28 70.57 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.94 7.97 52.9 Favored Glycine 0 N--CA 1.489 2.187 0 O-C-N 120.846 -1.385 . . . . 0.0 110.396 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -58.92 177.26 0.25 Allowed Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.258 -1.143 . . . . 0.0 110.963 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.713 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.2 Cg_endo -74.34 -57.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 123.213 2.609 . . . . 0.0 112.647 -177.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.596 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 26.6 p90 -73.58 117.67 15.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.697 -1.252 . . . . 0.0 109.697 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.526 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 91.26 -171.54 35.41 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.496 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -124.14 -138.55 0.29 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.211 -1.17 . . . . 0.0 110.147 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.515 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -109.27 70.65 0.74 Allowed 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.959 -1.088 . . . . 0.0 109.014 -179.139 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.555 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.7 m -89.36 -4.2 58.16 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 121.307 -0.87 . . . . 0.0 110.153 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.539 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 67.2 m-85 -140.09 60.75 15.68 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.425 -0.797 . . . . 0.0 109.462 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.3 Cg_endo -78.78 -23.77 7.84 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.426 2.084 . . . . 0.0 110.675 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.3 46.7 1.31 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.062 -1.024 . . . . 0.0 110.403 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.93 110.33 0.23 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.569 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.5 m -69.45 -15.1 63.2 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.598 0.714 . . . . 0.0 109.626 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 24' ' ' GLY . 3.8 m -126.86 -24.99 3.41 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.618 -0.676 . . . . 0.0 109.963 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -48.5 176.41 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -77.3 -161.59 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.36 2.04 . . . . 0.0 110.615 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.555 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 10.2 ttmt -71.03 -172.17 0.65 Allowed 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.695 -0.628 . . . . 0.0 109.333 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 29.0 m . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.934 -1.031 . . . . 0.0 109.515 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.475 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 7.5 t -92.17 58.42 3.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 62.2 m -147.82 93.55 2.22 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.352 -0.842 . . . . 0.0 108.882 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.556 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 44.2 m -41.37 167.3 0.05 OUTLIER Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.6 Cg_endo -72.33 159.6 49.06 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.263 1.975 . . . . 0.0 110.614 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -55.99 -69.94 0.13 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.893 . . . . 0.0 111.202 -178.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.577 ' CE2' ' HB2' ' A' ' 8' ' ' TRP . 1.5 p90 -42.16 -37.96 1.59 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 109.604 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.703 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.0 t90 -126.27 67.22 1.21 Allowed 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 119.059 -1.057 . . . . 0.0 109.991 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -75.26 -26.45 66.06 Favored Glycine 0 N--CA 1.496 2.694 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.005 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.91 11.14 49.31 Favored Glycine 0 N--CA 1.49 2.294 0 O-C-N 120.877 -1.366 . . . . 0.0 110.532 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.636 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -61.5 176.13 0.45 Allowed Pre-proline 0 C--N 1.297 -1.702 0 O-C-N 121.361 -1.082 . . . . 0.0 110.948 -178.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.703 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.8 -58.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 123.195 2.596 . . . . 0.0 112.455 -177.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.598 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 24.4 p90 -73.4 118.84 16.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.719 -1.238 . . . . 0.0 109.367 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.475 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 93.51 -178.79 38.49 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 19.8 mt-30 -111.26 -145.91 0.4 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.405 -1.056 . . . . 0.0 109.8 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -108.77 66.13 0.63 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.593 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.6 m -87.97 13.25 11.37 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.417 -0.802 . . . . 0.0 110.885 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.593 ' CD1' ' O ' ' A' ' 17' ' ' CYS . 62.7 m-85 -155.21 63.23 3.68 Favored Pre-proline 0 C--N 1.296 -1.759 0 O-C-N 120.664 -1.272 . . . . 0.0 109.547 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.7 Cg_endo -79.65 -32.09 1.72 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.307 2.005 . . . . 0.0 110.321 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -142.03 51.41 1.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 110.147 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.04 110.46 0.23 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.578 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -70.03 -16.56 63.17 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 121.437 0.637 . . . . 0.0 109.888 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.575 ' O ' ' C ' ' A' ' 24' ' ' GLY . 20.4 m -135.46 -94.07 0.27 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.417 -0.802 . . . . 0.0 109.192 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 13.57 -127.97 0.01 OUTLIER Glycine 0 N--CA 1.511 3.657 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -81.93 -157.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.162 1.908 . . . . 0.0 107.999 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.576 ' CA ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -133.09 -38.11 0.97 Allowed 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.483 178.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.546 ' CG2' ' HA ' ' A' ' 17' ' ' CYS . 25.0 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 120.894 -1.129 . . . . 0.0 109.165 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.544 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 0.1 OUTLIER -101.47 100.58 11.04 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.205 -0.935 . . . . 0.0 109.186 179.926 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 4' ' ' CYS . 73.5 m -143.18 89.76 2.13 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.042 -1.036 . . . . 0.0 110.255 -178.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.556 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 11.9 m -43.75 168.77 0.06 OUTLIER Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.4 Cg_endo -71.43 148.75 55.1 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.001 1.8 . . . . 0.0 110.621 179.41 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 1.6 p -55.08 -46.19 75.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 110.916 -178.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -59.12 -36.39 75.1 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.839 -1.163 . . . . 0.0 108.192 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.678 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 17.9 t90 -131.52 69.59 1.47 Allowed 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.424 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -73.05 -26.51 70.75 Favored Glycine 0 N--CA 1.499 2.834 0 O-C-N 121.358 -0.839 . . . . 0.0 111.371 -178.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.48 15.19 31.09 Favored Glycine 0 N--CA 1.491 2.343 0 O-C-N 120.842 -1.387 . . . . 0.0 110.353 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.642 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -68.17 175.85 1.63 Allowed Pre-proline 0 C--N 1.296 -1.736 0 O-C-N 121.438 -1.036 . . . . 0.0 111.124 -178.735 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.678 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.0 Cg_endo -73.48 -60.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 123.31 2.673 . . . . 0.0 112.322 -177.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 17.5 p90 -73.29 122.93 22.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 0.0 109.287 -179.039 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.544 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 99.2 -166.62 21.11 Favored Glycine 0 N--CA 1.485 1.929 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.053 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -129.24 -147.91 0.36 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.466 -1.02 . . . . 0.0 109.65 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.42 64.83 0.62 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.532 ' SG ' ' HG2' ' A' ' 26' ' ' LYS . 1.6 m -87.56 -4.34 58.97 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.45 -0.781 . . . . 0.0 110.217 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.548 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 57.2 m-85 -148.15 61.75 6.14 Favored Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 121.416 -0.803 . . . . 0.0 109.772 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 37.5 Cg_endo -82.27 -39.06 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.634 2.223 . . . . 0.0 111.536 -179.6 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -122.91 36.35 4.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.968 -1.082 . . . . 0.0 111.279 -178.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.19 113.48 0.46 Allowed Glycine 0 N--CA 1.483 1.829 0 C-N-CA 119.487 -1.34 . . . . 0.0 110.547 178.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.546 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 8.7 m -56.6 -41.61 77.32 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-O 122.074 0.94 . . . . 0.0 109.233 179.01 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 24' ' ' GLY . 1.8 t -81.33 -41.15 22.5 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.496 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -44.22 166.84 0.03 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.8 -159.64 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.341 2.027 . . . . 0.0 110.641 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.532 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 3.4 mtpp -69.84 175.31 4.41 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.592 0.71 . . . . 0.0 109.959 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.477 ' HB ' ' HG3' ' A' ' 19' ' ' PRO . 9.5 p . . . . . 0 C--N 1.302 -1.463 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.488 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.438 ' O ' ' OE1' ' A' ' 15' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.251 0.548 . . . . 0.0 109.54 . . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.464 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER 61.37 114.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.458 179.984 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 4' ' ' CYS . 69.9 m -143.75 91.74 2.27 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.994 0.902 . . . . 0.0 108.628 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.649 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 68.2 m -44.64 170.32 0.05 OUTLIER Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.7 Cg_endo -72.74 158.28 50.65 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 C-N-CA 121.87 1.713 . . . . 0.0 110.672 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.558 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 0.5 OUTLIER -61.87 -47.82 83.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.331 -0.856 . . . . 0.0 110.464 -178.738 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.549 ' CE1' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -53.23 -31.53 43.72 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.45 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.699 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.6 t90 -139.26 74.59 1.48 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.693 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -76.45 -26.4 63.54 Favored Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.336 -178.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.49 26.79 6.13 Favored Glycine 0 N--CA 1.49 2.275 0 O-C-N 120.675 -1.485 . . . . 0.0 110.922 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.624 ' HA ' ' CZ2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.91 173.41 7.52 Favored Pre-proline 0 C--N 1.293 -1.879 0 O-C-N 121.314 -1.11 . . . . 0.0 111.379 -178.669 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.699 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.3 Cg_endo -75.8 -55.16 0.07 OUTLIER 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 123.771 2.98 . . . . 0.0 114.12 -177.012 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.591 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.4 p90 -74.73 28.47 0.09 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.718 -1.239 . . . . 0.0 112.274 -177.072 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.464 ' HA2' ' OG ' ' A' ' 2' ' ' SER . . . -177.2 179.67 47.93 Favored Glycine 0 N--CA 1.485 1.938 0 C-N-CA 118.61 -1.757 . . . . 0.0 110.197 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 35.4 mt-30 -101.22 -163.96 1.06 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.425 -1.044 . . . . 0.0 109.553 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -106.5 65.49 0.68 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.571 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.6 m -87.48 9.22 21.62 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.313 0.578 . . . . 0.0 110.145 -177.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.575 ' CE1' ' O ' ' A' ' 26' ' ' LYS . 65.8 m-85 -150.76 62.85 5.5 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 120.69 -1.256 . . . . 0.0 109.844 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.8 Cg_endo -80.39 -62.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.637 2.225 . . . . 0.0 110.867 -179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.9 37.05 2.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.65 105.22 0.18 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.553 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 37.1 m -62.47 -32.88 73.84 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.697 0.76 . . . . 0.0 110.708 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.491 ' O ' ' C ' ' A' ' 24' ' ' GLY . 11.8 t -99.07 -89.29 0.32 Allowed 'General case' 0 C--N 1.287 -2.125 0 O-C-N 121.68 -0.638 . . . . 0.0 109.55 -179.521 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 33.47 -149.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 26' ' ' LYS . 34.4 Cg_endo -79.21 -166.97 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.4 2.067 . . . . 0.0 108.981 178.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.575 ' O ' ' CE1' ' A' ' 18' ' ' TYR . 2.6 ttmm -50.33 -58.71 5.05 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.622 -1.231 . . . . 0.0 107.928 178.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.538 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 14.4 m . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.487 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.342 0.591 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 3' ' ' CYS . 60.1 p -82.83 -143.88 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 109.389 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.495 ' C ' ' O ' ' A' ' 2' ' ' SER . 89.2 m 32.87 91.9 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.95 0.881 . . . . 0.0 110.898 179.207 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.54 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 58.4 m -43.35 168.1 0.07 OUTLIER Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.214 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 34.0 Cg_endo -77.03 146.35 25.6 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.19 1.926 . . . . 0.0 110.683 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.619 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -46.25 -63.95 0.87 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.086 -1.009 . . . . 0.0 110.587 -179.453 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -39.59 -37.93 0.55 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.874 0.845 . . . . 0.0 108.842 -179.737 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.696 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.2 t90 -134.97 70.11 1.44 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.633 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.0 -26.65 66.16 Favored Glycine 0 N--CA 1.501 2.986 0 O-C-N 121.275 -0.89 . . . . 0.0 111.387 -178.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.71 15.95 28.47 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.918 -1.343 . . . . 0.0 110.571 -179.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.613 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -66.99 174.75 1.76 Allowed Pre-proline 0 C--N 1.296 -1.735 0 O-C-N 121.295 -1.121 . . . . 0.0 111.04 -178.764 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.696 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.4 Cg_endo -74.1 -57.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 123.311 2.674 . . . . 0.0 112.833 -177.473 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 26.8 p90 -73.4 122.83 22.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.681 -1.262 . . . . 0.0 109.978 -178.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.415 ' C ' ' HG3' ' A' ' 15' ' ' GLN . . . 99.21 -147.39 18.41 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.415 ' HG3' ' C ' ' A' ' 14' ' ' GLY . 21.8 mt-30 -143.4 -149.86 0.29 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.466 -1.02 . . . . 0.0 109.793 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.69 63.74 0.61 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.478 ' O ' ' HB ' ' A' ' 27' ' ' VAL . 1.7 m -87.21 8.05 25.67 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.401 -0.812 . . . . 0.0 109.594 -178.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.619 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 77.2 m-85 -149.21 64.98 7.75 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.522 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.5 Cg_endo -80.75 -16.34 10.33 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.632 2.221 . . . . 0.0 111.809 -178.156 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.16 35.99 0.67 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.633 -1.292 . . . . 0.0 111.28 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 23' ' ' SER . . . 134.56 124.24 2.44 Favored Glycine 0 N--CA 1.476 1.328 0 C-N-CA 119.504 -1.332 . . . . 0.0 109.955 179.239 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.516 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 20.5 m -35.67 -34.58 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 122.442 1.115 . . . . 0.0 109.39 179.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.502 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 37.6 p 46.53 58.88 4.23 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.226 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 43.2 -101.75 0.03 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 23' ' ' SER . 33.8 Cg_endo -75.89 -160.39 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.29 1.993 . . . . 0.0 111.057 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.476 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -50.78 -172.59 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.365 0.603 . . . . 0.0 110.22 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 9.8 p . . . . . 0 C--N 1.303 -1.442 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.532 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.444 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -94.98 76.83 3.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.779 -179.821 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.51 ' O ' ' O ' ' A' ' 4' ' ' CYS . 53.9 m -150.73 96.46 2.36 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.327 -0.858 . . . . 0.0 108.729 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 8' ' ' TRP . 55.7 m -39.23 165.69 0.05 OUTLIER Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.862 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.8 Cg_endo -71.24 173.32 12.44 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.286 1.991 . . . . 0.0 111.319 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.694 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -69.58 -48.0 61.67 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.427 -0.796 . . . . 0.0 111.511 -178.397 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.544 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -66.11 -29.78 70.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.737 -1.227 . . . . 0.0 109.773 -179.612 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.705 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.0 t90 -131.99 68.12 1.5 Allowed 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 118.679 -1.209 . . . . 0.0 109.933 -178.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.464 ' HA2' ' CB ' ' A' ' 4' ' ' CYS . . . -74.09 -26.24 69.17 Favored Glycine 0 N--CA 1.5 2.929 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.292 -179.141 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.06 13.95 35.46 Favored Glycine 0 N--CA 1.489 2.189 0 O-C-N 120.788 -1.419 . . . . 0.0 110.313 -179.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.651 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -66.27 175.1 1.39 Allowed Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 121.442 -1.034 . . . . 0.0 111.056 -178.78 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.705 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.4 -58.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -1.019 0 C-N-CA 123.275 2.65 . . . . 0.0 112.485 -177.35 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 23.9 p90 -72.79 122.12 21.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.74 -1.225 . . . . 0.0 109.121 -179.039 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.444 ' HA2' ' OG ' ' A' ' 2' ' ' SER . . . 88.17 174.77 47.74 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.473 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 12.7 mt-30 -103.2 -149.49 0.4 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.257 -1.143 . . . . 0.0 109.408 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.456 ' OD1' ' HA3' ' A' ' 9' ' ' GLY . 16.7 t-20 -108.67 68.9 0.7 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 3' ' ' CYS . 1.7 m -86.87 -11.44 50.77 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.37 0.605 . . . . 0.0 109.944 -177.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.557 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 43.0 m-85 -132.46 77.15 70.69 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 27' ' ' VAL . 35.2 Cg_endo -76.47 -48.44 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.586 2.19 . . . . 0.0 109.835 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -143.33 16.23 1.86 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -92.49 25.75 16.95 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.694 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -35.73 -31.5 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.22 0 CA-C-O 121.79 0.805 . . . . 0.0 110.196 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -125.37 -30.73 3.1 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.757 -0.59 . . . . 0.0 109.603 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.29 -148.87 0.04 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -78.18 -160.67 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.69 2.26 . . . . 0.0 110.738 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 17' ' ' CYS . 20.5 ttpt -50.95 -76.26 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.527 -0.733 . . . . 0.0 109.165 179.549 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' A' ' 17' ' ' CYS . 5.2 m . . . . . 0 N--CA 1.49 1.556 0 O-C-N 120.955 -1.091 . . . . 0.0 109.43 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.456 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 2.1 mmm180 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.529 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 3.3 t -131.55 -1.56 3.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.349 -0.844 . . . . 0.0 109.659 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.481 ' O ' ' O ' ' A' ' 4' ' ' CYS . 89.2 m -148.44 91.87 1.95 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.128 -0.982 . . . . 0.0 109.635 -179.279 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.611 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 80.9 m -43.12 167.04 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.611 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 26.4 Cg_endo -65.28 152.67 81.38 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.123 1.215 . . . . 0.0 109.519 179.559 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.604 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 16.4 p -59.45 -42.48 92.08 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.141 -0.974 . . . . 0.0 110.088 -177.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -57.43 -28.62 63.47 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.099 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.708 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.1 t90 -136.06 72.63 1.44 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.041 -179.03 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.487 ' HA2' ' HB2' ' A' ' 4' ' ' CYS . . . -79.73 -24.45 60.27 Favored Glycine 0 N--CA 1.5 2.929 0 O-C-N 121.12 -0.988 . . . . 0.0 111.121 -179.268 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.59 16.57 34.92 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.96 -1.318 . . . . 0.0 110.555 -179.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.598 ' HA ' ' CZ2' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -63.77 174.18 1.11 Allowed Pre-proline 0 C--N 1.296 -1.742 0 O-C-N 121.272 -1.134 . . . . 0.0 111.042 -178.82 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.708 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.8 Cg_endo -73.05 -58.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 123.352 2.701 . . . . 0.0 112.222 -177.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.551 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 22.8 p90 -73.28 -167.76 0.45 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.768 -1.207 . . . . 0.0 109.153 -179.181 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.529 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 37.86 -148.54 0.07 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.8 OUTLIER -139.69 -157.6 0.78 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.411 -1.052 . . . . 0.0 109.99 179.801 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.475 ' OD1' ' CG ' ' A' ' 19' ' ' PRO . 13.5 t-20 -109.23 70.83 0.75 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 179.567 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.532 ' C ' ' CG ' ' A' ' 18' ' ' TYR . 1.3 m -87.84 -2.05 58.36 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.453 0.644 . . . . 0.0 111.074 -177.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.604 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -165.83 76.84 1.24 Allowed Pre-proline 0 N--CA 1.496 1.825 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.101 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.475 ' CG ' ' OD1' ' A' ' 16' ' ' ASN . 37.6 Cg_endo -82.83 -54.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 123.028 2.485 . . . . 0.0 112.013 -178.038 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -94.18 15.98 15.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.102 -0.999 . . . . 0.0 111.563 -177.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 22' ' ' CYS . . . 149.03 120.25 1.06 Allowed Glycine 0 N--CA 1.475 1.241 0 C-N-CA 118.989 -1.577 . . . . 0.0 110.174 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.554 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.4 m -37.05 -46.18 0.65 Allowed 'General case' 0 C--N 1.288 -2.105 0 CA-C-O 122.364 1.078 . . . . 0.0 108.59 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.516 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER 46.28 36.55 3.39 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.446 179.067 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.04 -112.38 3.47 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 179.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 23' ' ' SER . 32.7 Cg_endo -74.76 -157.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.377 2.051 . . . . 0.0 111.109 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 25' ' ' PRO . 2.1 mtpt -46.16 177.91 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.67 0.747 . . . . 0.0 110.271 -179.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 17' ' ' CYS . 5.4 p . . . . . 0 C--N 1.301 -1.543 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.647 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.31 0.576 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 3' ' ' CYS . 6.6 t -76.32 -136.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.866 . . . . 0.0 109.303 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 2' ' ' SER . 75.1 m 35.34 95.63 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.26 1.029 . . . . 0.0 110.758 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.652 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 57.7 m -52.36 170.68 0.23 Allowed Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.652 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.0 Cg_endo -71.93 166.38 29.73 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.068 1.846 . . . . 0.0 111.355 -179.604 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.67 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -62.52 -44.48 96.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.54 -0.725 . . . . 0.0 110.696 -179.034 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -67.49 -34.38 77.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.273 -0.892 . . . . 0.0 110.012 -178.929 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.702 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 13.4 t90 -126.63 65.61 1.26 Allowed 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.574 -178.445 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -65.66 -28.99 74.16 Favored Glycine 0 N--CA 1.498 2.77 0 O-C-N 121.344 -0.847 . . . . 0.0 111.542 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.09 29.89 4.54 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 120.68 -1.482 . . . . 0.0 111.283 -178.459 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.635 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -82.53 172.16 10.17 Favored Pre-proline 0 C--N 1.294 -1.836 0 O-C-N 121.211 -1.17 . . . . 0.0 111.427 -178.666 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.702 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.5 Cg_endo -75.55 -53.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 123.837 3.025 . . . . 0.0 113.997 -176.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.566 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 27.3 p90 -74.83 23.2 0.1 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.675 -1.266 . . . . 0.0 112.005 -177.294 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.409 ' C ' ' SG ' ' A' ' 4' ' ' CYS . . . -168.28 -174.92 37.5 Favored Glycine 0 N--CA 1.485 1.963 0 C-N-CA 118.949 -1.596 . . . . 0.0 110.028 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 35.8 mt-30 -116.99 -149.25 0.44 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.554 -0.968 . . . . 0.0 109.16 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.415 ' ND2' ' HA3' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -108.82 62.44 0.6 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.624 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.7 m -87.01 -19.95 27.94 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.258 -0.901 . . . . 0.0 109.147 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.597 ' CG ' ' HB2' ' A' ' 26' ' ' LYS . 6.6 m-85 -116.66 71.31 5.04 Favored Pre-proline 0 C--N 1.296 -1.723 0 O-C-N 121.666 -0.647 . . . . 0.0 109.815 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HD3' ' C ' ' A' ' 17' ' ' CYS . 34.7 Cg_endo -74.99 -44.54 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.159 1.906 . . . . 0.0 110.195 179.572 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -144.86 15.38 1.56 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.375 -0.828 . . . . 0.0 109.092 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -93.36 23.52 29.59 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.67 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.6 m -36.0 -29.45 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.361 0.601 . . . . 0.0 111.231 -179.675 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' GLY . 2.5 p -113.1 -74.15 0.64 Allowed 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.436 -0.79 . . . . 0.0 110.778 -178.759 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -59.47 -131.86 0.01 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.145 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.486 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 33.4 Cg_endo -74.98 -158.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.2 1.933 . . . . 0.0 109.836 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.597 ' HB2' ' CG ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -138.32 -36.85 0.57 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.184 -0.947 . . . . 0.0 109.935 -179.859 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.552 ' CG1' ' HG2' ' A' ' 26' ' ' LYS . 3.5 m . . . . . 0 N--CA 1.493 1.678 0 O-C-N 120.733 -1.229 . . . . 0.0 109.3 178.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 2' ' ' SER . 5.2 mtp180 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 3' ' ' CYS . 0.8 OUTLIER 52.21 175.63 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.229 -0.92 . . . . 0.0 109.502 -179.926 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.48 ' C ' ' O ' ' A' ' 2' ' ' SER . 73.8 m 33.15 91.78 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 122.133 0.968 . . . . 0.0 110.905 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.703 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 86.3 m -49.71 173.94 0.07 OUTLIER Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.061 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.703 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.4 Cg_endo -72.9 165.73 31.98 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.599 1.532 . . . . 0.0 111.35 -179.293 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.708 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -56.34 -46.95 79.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.453 -0.78 . . . . 0.0 111.343 -178.383 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -63.75 -40.08 95.84 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.034 -1.041 . . . . 0.0 110.375 -179.248 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.681 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.8 t90 -117.6 62.77 0.74 Allowed 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.24 -178.25 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -71.93 5.67 12.14 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.163 -0.961 . . . . 0.0 111.522 -179.242 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.68 28.64 5.88 Favored Glycine 0 N--CA 1.486 1.969 0 O-C-N 120.508 -1.583 . . . . 0.0 109.617 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.658 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -80.4 176.66 3.57 Favored Pre-proline 0 C--N 1.294 -1.848 0 O-C-N 121.654 -0.909 . . . . 0.0 111.664 -178.207 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.681 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.63 -50.21 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 123.569 2.846 . . . . 0.0 113.181 -177.015 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.633 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 34.6 p90 -78.58 34.79 0.22 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.675 -1.266 . . . . 0.0 111.585 -177.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.81 -163.26 32.1 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.834 -1.65 . . . . 0.0 110.502 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' GLY . 2.1 tt0 -128.3 -152.11 0.5 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.538 -0.978 . . . . 0.0 110.073 -179.337 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 12.7 t30 -109.21 64.59 0.61 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.486 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.6 m -87.46 -11.07 50.12 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.428 -0.795 . . . . 0.0 109.703 -179.0 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.532 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 96.9 m-85 -130.84 73.04 81.52 Favored Pre-proline 0 C--N 1.296 -1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 109.723 -179.232 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.524 ' CD ' ' O ' ' A' ' 27' ' ' VAL . 35.1 Cg_endo -77.67 -40.95 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.442 2.095 . . . . 0.0 109.477 179.581 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -141.2 13.03 2.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -94.9 25.67 22.5 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.557 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.708 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -38.67 -29.7 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.286 0 CA-C-O 121.751 0.786 . . . . 0.0 109.952 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 21' ' ' GLY . 48.5 t -147.97 54.58 1.04 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -157.24 -132.36 1.45 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -78.66 -160.58 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.388 2.059 . . . . 0.0 111.018 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.486 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 3.3 ttpt -122.64 87.61 2.78 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.753 -0.592 . . . . 0.0 109.545 179.598 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.524 ' O ' ' CD ' ' A' ' 19' ' ' PRO . 42.4 t . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.642 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.514 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -59.96 -76.95 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.369 -179.95 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.468 ' C ' ' O ' ' A' ' 2' ' ' SER . 71.6 m 34.36 95.98 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.127 0.965 . . . . 0.0 111.031 179.013 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.627 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 97.9 m -55.13 169.78 0.42 Allowed Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.5 Cg_endo -72.03 156.26 56.22 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.772 1.648 . . . . 0.0 111.068 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.549 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -48.17 -70.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.453 -0.779 . . . . 0.0 111.109 -178.487 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.583 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -41.16 -34.14 0.43 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.436 -0.79 . . . . 0.0 109.852 -178.886 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.69 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.1 t90 -126.0 66.47 1.2 Allowed 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.732 -179.31 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -78.32 5.95 53.32 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 120.162 -1.018 . . . . 0.0 110.871 -179.202 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.72 26.7 6.78 Favored Glycine 0 N--CA 1.485 1.955 0 O-C-N 120.773 -1.427 . . . . 0.0 109.637 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.643 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.91 176.47 3.42 Favored Pre-proline 0 C--N 1.294 -1.845 0 O-C-N 121.733 -0.863 . . . . 0.0 111.344 -178.402 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.69 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.8 Cg_endo -76.18 -52.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 123.423 2.748 . . . . 0.0 113.153 -177.154 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.583 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 28.9 p90 -78.0 31.73 0.17 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.745 -1.222 . . . . 0.0 111.625 -177.788 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.516 ' CA ' ' SG ' ' A' ' 4' ' ' CYS . . . -179.15 -171.73 42.62 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 118.595 -1.764 . . . . 0.0 110.595 179.555 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' GLY . 1.3 tt0 -118.87 -151.69 0.49 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.558 -0.966 . . . . 0.0 110.142 -179.522 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.487 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 27.0 t-20 -109.24 64.19 0.61 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.53 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.7 m -87.73 4.26 44.87 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.396 -0.815 . . . . 0.0 110.015 -178.516 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.547 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 73.0 m-85 -147.07 62.27 7.2 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.282 -0.886 . . . . 0.0 109.742 -178.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.526 ' CG ' HG21 ' A' ' 27' ' ' VAL . 35.4 Cg_endo -78.66 -38.8 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.587 2.191 . . . . 0.0 110.324 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 8.6 pt-20 -132.61 49.85 2.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 109.422 -179.899 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.25 112.31 0.26 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 179.71 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.7 m -64.9 -81.87 0.03 OUTLIER 'General case' 0 C--N 1.285 -2.232 0 CA-C-O 122.111 0.958 . . . . 0.0 109.079 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 24' ' ' GLY . 6.4 t -70.81 -8.77 54.92 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.314 179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -52.88 -173.44 0.04 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -78.96 -160.15 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.543 2.162 . . . . 0.0 110.952 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.53 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 2.1 ttmm -89.31 176.22 7.02 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.302 0.572 . . . . 0.0 109.581 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.526 HG21 ' CG ' ' A' ' 19' ' ' PRO . 45.6 t . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.42 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 3' ' ' CYS . 5.7 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 74.1 m 38.61 96.27 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.352 1.072 . . . . 0.0 110.739 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.698 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 98.8 m -58.59 171.79 0.59 Allowed Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.698 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.7 Cg_endo -70.64 166.95 27.02 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.567 1.511 . . . . 0.0 110.532 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.581 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.7 p -57.66 -69.67 0.16 Allowed 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.192 -0.942 . . . . 0.0 111.604 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.64 -36.39 2.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.918 -1.114 . . . . 0.0 110.218 -179.129 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.739 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 9.7 t90 -118.75 64.58 0.77 Allowed 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.055 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -77.14 10.18 22.08 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 120.109 -1.043 . . . . 0.0 110.915 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.41 29.89 4.41 Favored Glycine 0 N--CA 1.487 2.04 0 O-C-N 120.722 -1.458 . . . . 0.0 109.492 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.65 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -80.39 177.83 2.74 Favored Pre-proline 0 C--N 1.294 -1.841 0 O-C-N 121.742 -0.858 . . . . 0.0 111.334 -178.357 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.739 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.61 -51.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 123.483 2.788 . . . . 0.0 113.089 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.59 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.8 p90 -78.63 33.92 0.21 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.673 -1.267 . . . . 0.0 111.476 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.481 ' CA ' ' SG ' ' A' ' 4' ' ' CYS . . . 177.76 -169.27 41.19 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.107 -1.52 . . . . 0.0 110.108 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 9' ' ' GLY . 8.3 mm100 -125.95 -145.45 0.32 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.413 -1.051 . . . . 0.0 109.626 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 7.8 t-20 -108.4 61.88 0.61 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.424 -0.798 . . . . 0.0 109.129 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.549 ' CA ' ' HA ' ' A' ' 27' ' ' VAL . 1.5 m -87.56 -5.1 58.91 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.261 -0.9 . . . . 0.0 110.078 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.547 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 40.2 m-85 -131.24 59.08 43.29 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.206 -0.934 . . . . 0.0 109.901 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.5 Cg_endo -78.27 -36.39 1.0 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.48 2.12 . . . . 0.0 110.52 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -135.46 50.64 2.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.326 -0.859 . . . . 0.0 109.929 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.87 108.56 0.21 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.581 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.5 m -73.76 -12.93 60.86 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.364 0.602 . . . . 0.0 110.343 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -145.72 8.41 1.13 Allowed 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.277 -0.889 . . . . 0.0 110.986 -178.632 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -62.19 -142.56 0.01 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -77.14 -165.77 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.106 1.871 . . . . 0.0 109.204 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -60.45 -68.17 0.32 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.634 -1.227 . . . . 0.0 108.047 178.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.549 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 1.8 t . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.438 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.553 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.517 ' SG ' ' CD ' ' A' ' 26' ' ' LYS . 91.5 m -149.19 93.9 2.15 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.245 -0.909 . . . . 0.0 109.05 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 32.8 m -42.68 166.66 0.08 OUTLIER Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.607 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 33.9 Cg_endo -76.26 153.5 35.97 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.34 2.027 . . . . 0.0 111.091 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.639 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -50.63 -71.21 0.07 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.226 -0.921 . . . . 0.0 110.699 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.607 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -39.75 -29.65 0.06 Allowed 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.918 -179.241 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.757 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.5 t90 -138.4 72.31 1.41 Allowed 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 118.751 -1.18 . . . . 0.0 109.763 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -77.33 -29.09 56.77 Favored Glycine 0 N--CA 1.502 3.063 0 O-C-N 121.275 -0.891 . . . . 0.0 111.229 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.33 13.79 31.89 Favored Glycine 0 N--CA 1.49 2.296 0 O-C-N 120.947 -1.326 . . . . 0.0 110.675 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -63.62 174.48 0.99 Allowed Pre-proline 0 C--N 1.297 -1.714 0 O-C-N 121.307 -1.114 . . . . 0.0 110.915 -178.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.757 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.7 -59.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 123.33 2.687 . . . . 0.0 112.637 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.57 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 23.4 p90 -73.3 127.44 32.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.761 -1.212 . . . . 0.0 109.824 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.553 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 95.37 -165.19 24.87 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.208 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.455 ' H ' ' HA ' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -124.08 -152.14 0.5 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.563 -0.963 . . . . 0.0 109.957 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.25 65.41 0.63 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.514 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.6 m -87.2 -1.95 58.27 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.61 0.719 . . . . 0.0 109.896 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.639 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 67.0 m-85 -134.45 62.31 54.44 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.4 Cg_endo -79.5 -30.97 2.23 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.516 2.144 . . . . 0.0 110.297 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.99 -66.36 0.93 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' A' ' 6' ' ' CYS . . . -144.78 -135.71 2.93 Favored Glycine 0 C--N 1.287 -2.168 0 N-CA-C 106.942 -2.463 . . . . 0.0 106.942 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.552 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 56.9 m -88.39 -20.85 24.73 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-O 122.074 0.94 . . . . 0.0 108.964 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.517 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER 45.4 55.5 6.47 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.371 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 37.87 -97.42 0.01 OUTLIER Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 23' ' ' SER . 32.3 Cg_endo -74.53 -160.64 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.392 2.061 . . . . 0.0 111.187 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.517 ' CD ' ' SG ' ' A' ' 3' ' ' CYS . 19.9 ttpp -39.17 -70.49 0.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.666 -0.646 . . . . 0.0 110.588 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.543 HG22 ' OXT' ' A' ' 27' ' ' VAL . 9.4 p . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.848 -1.157 . . . . 0.0 109.501 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.505 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 43.2 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 81.6 m 40.83 97.14 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 122.227 1.013 . . . . 0.0 110.443 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.654 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 89.8 m -54.66 169.2 0.41 Allowed Pre-proline 0 C--N 1.295 -1.763 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.654 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.6 Cg_endo -71.79 155.77 57.83 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.783 1.655 . . . . 0.0 111.045 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -47.77 -69.5 0.12 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.519 -0.738 . . . . 0.0 111.172 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.597 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -42.48 -35.98 1.2 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.214 -0.929 . . . . 0.0 109.973 -179.14 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.736 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.2 t90 -123.42 65.06 1.01 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.863 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -77.47 8.0 36.19 Favored Glycine 0 N--CA 1.497 2.747 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.851 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.67 28.2 5.77 Favored Glycine 0 N--CA 1.485 1.965 0 O-C-N 120.764 -1.433 . . . . 0.0 109.547 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.64 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -79.05 176.83 3.32 Favored Pre-proline 0 C--N 1.294 -1.808 0 O-C-N 121.769 -0.842 . . . . 0.0 111.492 -178.298 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.736 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.39 -52.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 123.488 2.792 . . . . 0.0 113.117 -177.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.587 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.9 p90 -78.31 33.78 0.2 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.633 -1.292 . . . . 0.0 111.533 -177.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 2' ' ' SER . . . 177.38 -171.02 43.75 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 118.825 -1.655 . . . . 0.0 110.411 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 9' ' ' GLY . 8.2 mt-30 -121.1 -149.19 0.42 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.548 -0.972 . . . . 0.0 110.226 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 7.2 t-20 -109.15 64.46 0.61 Allowed 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 26' ' ' LYS . 1.6 m -87.5 4.92 41.57 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.296 -0.878 . . . . 0.0 109.877 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.58 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 73.5 m-85 -148.53 62.43 6.4 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.197 -0.94 . . . . 0.0 110.013 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.56 ' CG ' ' HB ' ' A' ' 27' ' ' VAL . 36.4 Cg_endo -79.36 -33.68 1.3 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.087 1.858 . . . . 0.0 109.515 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -137.25 53.74 1.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.512 ' HA3' ' HG2' ' A' ' 25' ' ' PRO . . . 163.85 113.45 0.29 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.615 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -69.63 -10.55 58.66 Favored 'General case' 0 C--N 1.283 -2.286 0 O-C-N 122.313 -0.522 . . . . 0.0 111.2 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.461 ' O ' ' C ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -169.19 -50.75 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.876 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' SER . . . -38.49 -86.69 0.01 OUTLIER Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.512 ' HG2' ' HA3' ' A' ' 21' ' ' GLY . 31.3 Cg_endo -76.31 -161.01 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.747 2.298 . . . . 0.0 111.688 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 6.7 tttt -176.08 121.45 0.17 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.56 ' HB ' ' CG ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.15 -0.968 . . . . 0.0 109.936 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.488 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 46.7 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.093 0.473 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 2' ' ' SER . 99.9 m 41.8 95.89 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.152 0.977 . . . . 0.0 110.472 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.723 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 82.5 m -46.49 171.93 0.06 OUTLIER Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.723 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.8 Cg_endo -70.51 172.88 12.51 Favored 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.75 1.633 . . . . 0.0 111.185 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.718 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 2.9 p -66.82 -42.67 85.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.422 -0.799 . . . . 0.0 111.307 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 1.8 p90 -69.26 -38.23 78.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.081 -1.012 . . . . 0.0 110.223 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.754 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 13.8 t90 -121.11 63.58 0.88 Allowed 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.784 -178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -67.39 -22.95 73.33 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.198 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.76 27.85 6.93 Favored Glycine 0 N--CA 1.488 2.148 0 O-C-N 120.525 -1.573 . . . . 0.0 110.697 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.621 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -81.16 172.71 9.11 Favored Pre-proline 0 C--N 1.294 -1.828 0 O-C-N 121.297 -1.119 . . . . 0.0 111.629 -178.456 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.754 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.6 Cg_endo -75.6 -52.03 0.1 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 123.875 3.05 . . . . 0.0 113.945 -176.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.613 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 33.2 p90 -77.0 32.92 0.14 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.679 -1.263 . . . . 0.0 111.784 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 2' ' ' SER . . . 177.31 -169.54 41.78 Favored Glycine 0 N--CA 1.484 1.897 0 C-N-CA 118.78 -1.676 . . . . 0.0 110.113 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.495 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -119.36 -156.12 0.64 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.518 -0.99 . . . . 0.0 109.899 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -107.79 68.32 0.71 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.586 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.5 m -86.91 -3.44 59.08 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 121.656 -0.653 . . . . 0.0 109.975 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.628 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -153.47 84.03 4.38 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.432 -0.792 . . . . 0.0 109.346 179.402 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.489 ' CD ' ' HB ' ' A' ' 27' ' ' VAL . 34.8 Cg_endo -77.83 -43.22 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.63 2.22 . . . . 0.0 109.809 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -137.78 12.74 2.92 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -92.54 24.74 21.73 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.718 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -35.69 -31.74 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.22 0 CA-C-O 121.877 0.846 . . . . 0.0 110.091 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' GLY . 1.2 m -116.08 -22.31 9.02 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.71 -0.619 . . . . 0.0 109.492 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.69 -173.42 46.88 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.31 -160.93 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.688 2.258 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 2.9 ttpt -58.82 176.64 0.19 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.539 -0.726 . . . . 0.0 109.356 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.538 HG22 ' OXT' ' A' ' 27' ' ' VAL . 9.2 p . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.514 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.519 ' HB2' ' HA2' ' A' ' 14' ' ' GLY . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 2' ' ' SER . 84.3 m 35.83 96.15 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 122.262 1.03 . . . . 0.0 110.898 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.753 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 69.1 m -54.29 173.35 0.22 Allowed Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.753 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.4 Cg_endo -71.52 155.3 59.68 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.704 1.602 . . . . 0.0 110.832 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.596 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -47.92 -69.19 0.13 Allowed 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.406 -0.808 . . . . 0.0 111.334 -178.418 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 2.0 p90 -44.25 -36.96 2.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.96 . . . . 0.0 109.863 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.732 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.2 t90 -119.89 64.28 0.82 Allowed 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 118.943 -1.103 . . . . 0.0 109.969 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -75.62 6.78 29.86 Favored Glycine 0 N--CA 1.496 2.694 0 C-N-CA 120.262 -0.97 . . . . 0.0 111.13 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.66 27.76 5.89 Favored Glycine 0 N--CA 1.486 1.998 0 O-C-N 120.612 -1.523 . . . . 0.0 109.868 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.65 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -78.43 177.96 2.51 Favored Pre-proline 0 C--N 1.294 -1.839 0 O-C-N 121.641 -0.917 . . . . 0.0 111.457 -178.417 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.732 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.8 Cg_endo -76.9 -52.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 123.489 2.793 . . . . 0.0 113.15 -177.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.585 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.6 p90 -78.1 33.08 0.18 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.719 -1.238 . . . . 0.0 111.677 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.519 ' HA2' ' HB2' ' A' ' 2' ' ' SER . . . 177.78 -170.45 42.8 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 118.812 -1.661 . . . . 0.0 110.488 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -121.85 -151.74 0.49 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.547 -0.973 . . . . 0.0 110.391 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 19.6 t-20 -108.78 64.03 0.61 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.537 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 2.1 m -87.74 -10.59 50.63 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 121.775 0.798 . . . . 0.0 109.792 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.527 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 29.7 m-85 -127.83 67.89 74.14 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.661 -0.65 . . . . 0.0 109.259 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HD3' ' C ' ' A' ' 17' ' ' CYS . 36.5 Cg_endo -78.16 -44.55 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.547 2.165 . . . . 0.0 110.926 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.96 48.71 2.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.112 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.52 108.18 0.22 Allowed Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -67.35 -15.63 63.79 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-O 121.55 0.691 . . . . 0.0 109.582 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 24' ' ' GLY . 6.4 t -129.89 -18.4 3.41 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.641 -0.662 . . . . 0.0 110.225 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -50.43 -179.64 0.03 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -77.55 -160.78 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.38 2.053 . . . . 0.0 110.762 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.537 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -79.26 172.4 13.85 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.716 -0.615 . . . . 0.0 109.576 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.49 -179.972 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.52 ' HB2' ' O ' ' A' ' 13' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 2' ' ' SER . 73.1 m 40.96 97.2 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.279 1.038 . . . . 0.0 110.644 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.701 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 95.0 m -54.36 171.55 0.28 Allowed Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.701 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.2 Cg_endo -71.73 157.78 54.71 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 121.772 1.648 . . . . 0.0 110.876 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.582 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -49.2 -70.93 0.07 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.471 -0.768 . . . . 0.0 111.361 -178.389 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.591 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -42.16 -36.54 1.21 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.158 -0.964 . . . . 0.0 110.034 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.74 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.1 t90 -121.59 64.65 0.9 Allowed 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.805 -1.158 . . . . 0.0 109.896 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -76.88 6.92 37.62 Favored Glycine 0 N--CA 1.497 2.703 0 C-N-CA 120.222 -0.989 . . . . 0.0 110.759 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.81 27.34 6.24 Favored Glycine 0 N--CA 1.486 2.011 0 O-C-N 120.706 -1.467 . . . . 0.0 109.671 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.643 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -77.83 176.49 3.52 Favored Pre-proline 0 C--N 1.294 -1.836 0 O-C-N 121.706 -0.879 . . . . 0.0 111.486 -178.438 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.74 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -75.99 -51.78 0.1 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 123.473 2.782 . . . . 0.0 113.029 -177.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.6 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.7 p90 -78.48 34.4 0.21 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.714 -1.241 . . . . 0.0 111.519 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.492 ' HA2' ' HB2' ' A' ' 2' ' ' SER . . . 175.93 -170.46 43.38 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.792 -1.671 . . . . 0.0 110.618 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' GLY . 1.4 tt0 -120.67 -151.91 0.49 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.531 -0.982 . . . . 0.0 110.369 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 1.3 t-20 -108.98 64.57 0.61 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.547 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.9 m -87.99 -0.5 57.09 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.543 -0.723 . . . . 0.0 109.983 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.574 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 72.0 m-85 -140.33 60.36 14.22 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.801 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.4 Cg_endo -78.88 -30.3 2.93 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.451 2.101 . . . . 0.0 110.267 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.88 49.03 1.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 109.909 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.89 111.27 0.24 Allowed Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.582 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.7 m -67.8 -15.36 63.59 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-O 121.57 0.7 . . . . 0.0 109.646 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.89 4.46 2.09 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.675 -0.64 . . . . 0.0 109.88 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.72 -164.29 2.52 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -78.84 -160.41 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.374 2.05 . . . . 0.0 110.624 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.547 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -90.12 178.09 6.27 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.703 -0.623 . . . . 0.0 109.422 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.471 ' OXT' HG13 ' A' ' 27' ' ' VAL . 7.4 p . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.523 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.531 ' HB2' ' CA ' ' A' ' 14' ' ' GLY . 4.9 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 4' ' ' CYS . 76.5 m 38.46 96.22 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.993 0.901 . . . . 0.0 110.597 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 56.2 m -40.68 166.38 0.06 OUTLIER Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.571 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.7 Cg_endo -70.97 161.65 45.38 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.204 1.936 . . . . 0.0 110.497 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.611 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.1 p -56.1 -72.53 0.07 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.267 -0.896 . . . . 0.0 111.494 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.09 -36.16 1.55 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.017 -1.052 . . . . 0.0 110.28 -179.003 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.764 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.3 t90 -124.17 64.93 1.06 Allowed 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.221 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -72.29 -30.31 65.08 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.68 8.43 35.35 Favored Glycine 0 N--CA 1.49 2.269 0 O-C-N 120.867 -1.372 . . . . 0.0 110.85 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.629 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -58.4 176.5 0.26 Allowed Pre-proline 0 C--N 1.298 -1.66 0 O-C-N 121.069 -1.254 . . . . 0.0 110.881 -179.004 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.764 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.94 -57.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 123.133 2.555 . . . . 0.0 112.306 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.61 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 25.4 p90 -73.84 115.19 12.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.74 -1.225 . . . . 0.0 109.758 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.531 ' CA ' ' HB2' ' A' ' 2' ' ' SER . . . 93.63 -172.76 33.13 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 4.9 mt-30 -116.64 -147.25 0.41 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.485 -1.009 . . . . 0.0 110.133 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.518 ' ND2' ' HB3' ' A' ' 19' ' ' PRO . 10.5 t30 -108.02 69.73 0.74 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.541 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.5 m -87.48 -7.35 57.74 Favored 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.532 -0.73 . . . . 0.0 110.713 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.548 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 66.0 m-85 -133.79 60.49 46.41 Favored Pre-proline 0 C--N 1.296 -1.738 0 O-C-N 121.291 -0.88 . . . . 0.0 110.234 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.1 Cg_endo -78.95 -24.79 6.67 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.388 2.058 . . . . 0.0 109.852 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.27 52.7 1.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 0.0 109.68 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.21 113.43 0.28 Allowed Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.611 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -75.03 -85.8 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.963 0.887 . . . . 0.0 109.799 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -76.18 -24.35 54.73 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.094 -179.171 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -59.97 -149.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.446 ' C ' ' HD3' ' A' ' 26' ' ' LYS . 35.0 Cg_endo -77.27 -160.34 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.288 1.992 . . . . 0.0 110.029 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.541 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -100.15 -96.05 0.25 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.431 -0.793 . . . . 0.0 109.559 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.5 p . . . . . 0 C--N 1.299 -1.63 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.504 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.532 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 81.2 m 34.06 95.69 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.239 1.019 . . . . 0.0 110.987 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.697 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 96.0 m -53.75 171.41 0.26 Allowed Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.697 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.8 Cg_endo -69.94 164.24 35.44 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.569 1.512 . . . . 0.0 110.558 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.586 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.6 p -54.82 -70.42 0.1 Allowed 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.248 -0.907 . . . . 0.0 111.713 -177.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.12 -38.7 2.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.968 -1.082 . . . . 0.0 110.208 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.741 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 9.7 t90 -116.74 63.02 0.72 Allowed 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 118.964 -1.095 . . . . 0.0 110.047 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -76.59 8.7 26.01 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.877 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.95 28.59 5.36 Favored Glycine 0 N--CA 1.486 1.991 0 O-C-N 120.707 -1.467 . . . . 0.0 109.511 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.649 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -78.98 177.3 2.96 Favored Pre-proline 0 C--N 1.295 -1.797 0 O-C-N 121.781 -0.835 . . . . 0.0 111.26 -178.404 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.741 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.3 Cg_endo -76.24 -52.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 123.505 2.803 . . . . 0.0 113.063 -177.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.584 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 28.5 p90 -78.14 31.55 0.18 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.724 -1.235 . . . . 0.0 111.597 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 2' ' ' SER . . . -178.29 -172.03 42.26 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 118.714 -1.708 . . . . 0.0 110.517 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 9' ' ' GLY . 5.7 mt-30 -121.37 -150.67 0.46 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.498 -1.001 . . . . 0.0 110.29 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -108.49 62.99 0.61 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.565 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.8 m -88.2 -11.14 47.58 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.396 -0.815 . . . . 0.0 109.938 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.559 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 23.3 m-85 -127.55 56.03 18.11 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.708 -0.62 . . . . 0.0 110.461 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.696 ' HG2' HG23 ' A' ' 27' ' ' VAL . 36.4 Cg_endo -76.73 -29.97 5.18 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.354 2.036 . . . . 0.0 110.491 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -138.84 51.28 1.82 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.918 . . . . 0.0 110.074 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.75 111.52 0.25 Allowed Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.586 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.4 m -77.04 -85.89 0.06 Allowed 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 122.083 0.944 . . . . 0.0 110.005 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.5 OUTLIER -79.95 -8.68 59.46 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.572 -178.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.89 -140.27 0.01 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -77.31 -164.18 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.028 1.819 . . . . 0.0 109.613 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.565 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 17.9 ttpp -51.98 -70.23 0.09 Allowed 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.696 HG23 ' HG2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.034 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.527 ' O ' ' CG ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.273 0.559 . . . . 0.0 109.526 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.522 ' SG ' ' CD ' ' A' ' 26' ' ' LYS . 68.0 m -153.97 95.9 1.91 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.213 -0.929 . . . . 0.0 108.712 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.674 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 23.0 m -46.68 171.75 0.06 OUTLIER Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.822 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.674 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.7 Cg_endo -71.9 162.89 40.55 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 121.904 1.736 . . . . 0.0 110.904 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -53.6 -72.8 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.562 -0.711 . . . . 0.0 111.72 -178.255 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.589 ' CE2' ' HB2' ' A' ' 8' ' ' TRP . 6.6 p90 -45.61 -33.53 2.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.125 -0.984 . . . . 0.0 110.7 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.755 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 11.6 t90 -122.77 64.89 0.96 Allowed 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 118.362 -1.335 . . . . 0.0 110.961 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -66.66 -23.07 72.13 Favored Glycine 0 N--CA 1.498 2.828 0 O-C-N 121.237 -0.914 . . . . 0.0 111.414 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.07 29.84 8.86 Favored Glycine 0 N--CA 1.492 2.375 0 O-C-N 120.468 -1.607 . . . . 0.0 111.556 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.662 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -80.66 175.5 4.76 Favored Pre-proline 0 C--N 1.291 -1.953 0 O-C-N 121.281 -1.129 . . . . 0.0 111.217 -178.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.755 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 40.8 Cg_endo -77.84 -55.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 123.857 3.038 . . . . 0.0 114.608 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.444 ' CZ3' ' CZ3' ' A' ' 8' ' ' TRP . 20.7 p90 -73.51 10.24 1.12 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.667 -1.271 . . . . 0.0 112.2 -176.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' C ' ' SG ' ' A' ' 4' ' ' CYS . . . -151.66 173.36 30.98 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.785 -1.674 . . . . 0.0 109.954 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.527 ' CG ' ' O ' ' A' ' 2' ' ' SER . 24.7 mt-30 -93.56 -155.86 0.46 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.331 -1.099 . . . . 0.0 108.889 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 0.6 OUTLIER -108.43 61.88 0.61 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 108.697 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.921 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.6 m -88.72 -94.19 0.1 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.144 -0.973 . . . . 0.0 108.564 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CE2' ' OXT' ' A' ' 27' ' ' VAL . 66.0 m-85 -29.62 88.84 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.89 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.765 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 27' ' ' VAL . 37.0 Cg_endo -77.31 -83.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.23 1.953 . . . . 0.0 109.498 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -120.64 22.85 11.05 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.05 91.42 0.21 Allowed Glycine 0 N--CA 1.481 1.642 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 23.8 m -48.44 -21.8 0.61 Allowed 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.45 -0.875 . . . . 0.0 110.726 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.496 ' O ' ' OXT' ' A' ' 27' ' ' VAL . 1.6 p -115.71 -87.64 0.59 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.445 -0.784 . . . . 0.0 110.089 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 39.57 -149.29 0.12 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.512 ' O ' ' C ' ' A' ' 26' ' ' LYS . 35.5 Cg_endo -77.47 -156.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.952 2.434 . . . . 0.0 110.112 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.522 ' CD ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -33.62 -35.79 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.54 0.686 . . . . 0.0 109.188 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.921 HG12 ' CB ' ' A' ' 17' ' ' CYS . 13.2 m . . . . . 0 C--N 1.3 -1.579 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.051 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.475 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.517 ' HB3' ' CE1' ' A' ' 18' ' ' TYR . 79.8 m 36.79 93.99 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.696 0.76 . . . . 0.0 110.62 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.591 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 80.2 m -42.71 164.93 0.11 Allowed Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 27.3 Cg_endo -65.31 144.64 81.19 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.487 1.458 . . . . 0.0 110.296 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.578 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 14.6 p -50.97 -42.59 60.18 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.381 -0.824 . . . . 0.0 110.238 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -58.62 -38.42 78.0 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.759 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.6 t90 -126.18 67.54 1.21 Allowed 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.343 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.51 ' HA2' ' HB2' ' A' ' 4' ' ' CYS . . . -75.7 -27.15 63.51 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 120.31 -0.947 . . . . 0.0 111.216 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.31 12.63 37.71 Favored Glycine 0 N--CA 1.49 2.277 0 O-C-N 120.936 -1.332 . . . . 0.0 110.859 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.61 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -58.38 174.1 0.37 Allowed Pre-proline 0 C--N 1.296 -1.739 0 O-C-N 121.259 -1.142 . . . . 0.0 111.064 -178.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.759 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -72.38 -57.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 123.398 2.732 . . . . 0.0 112.29 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.553 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 24.5 p90 -73.33 -167.27 0.41 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.877 -1.139 . . . . 0.0 109.344 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . 40.45 -143.36 0.6 Allowed Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 14' ' ' GLY . 12.8 mt-30 -147.57 -155.27 0.61 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.486 -1.008 . . . . 0.0 109.988 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.53 71.13 0.78 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.525 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.4 m -87.45 -28.39 22.12 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.521 -0.737 . . . . 0.0 110.762 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.576 ' HB2' ' CB ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -137.81 63.8 40.29 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.25 -0.906 . . . . 0.0 109.007 177.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 37.5 Cg_endo -83.46 -35.02 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.787 2.325 . . . . 0.0 110.869 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -90.64 9.73 28.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.9 . . . . 0.0 110.522 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 22' ' ' CYS . . . 129.73 123.54 2.54 Favored Glycine 0 C--N 1.304 -1.25 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.578 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.2 m -29.42 -47.12 0.06 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 122.3 1.047 . . . . 0.0 109.494 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.527 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 18.1 m 43.76 35.73 1.13 Allowed 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.621 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.95 -112.18 3.49 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 23' ' ' SER . 33.2 Cg_endo -74.42 -156.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.603 2.202 . . . . 0.0 111.409 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.525 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -52.3 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.798 0.809 . . . . 0.0 110.85 -178.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.573 HG22 ' OXT' ' A' ' 27' ' ' VAL . 9.1 p . . . . . 0 C--N 1.304 -1.41 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.625 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 3' ' ' CYS . 5.6 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.495 ' C ' ' O ' ' A' ' 2' ' ' SER . 90.6 m 31.03 90.33 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.91 0.862 . . . . 0.0 110.904 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.582 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 99.5 m -41.33 166.42 0.06 OUTLIER Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.3 Cg_endo -71.28 160.99 47.19 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.057 1.838 . . . . 0.0 110.579 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.592 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.3 p -55.0 -69.35 0.13 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.265 -0.897 . . . . 0.0 111.552 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -41.42 -38.45 1.25 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.205 -0.935 . . . . 0.0 109.931 -178.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.757 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.6 t90 -126.45 66.89 1.23 Allowed 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.908 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -75.02 -26.41 66.69 Favored Glycine 0 N--CA 1.496 2.65 0 O-C-N 121.22 -0.925 . . . . 0.0 111.07 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.37 13.72 38.61 Favored Glycine 0 N--CA 1.488 2.157 0 O-C-N 120.858 -1.377 . . . . 0.0 110.75 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.611 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -62.93 175.63 0.63 Allowed Pre-proline 0 C--N 1.297 -1.703 0 O-C-N 121.239 -1.154 . . . . 0.0 111.036 -178.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.757 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.6 Cg_endo -74.46 -58.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 123.46 2.773 . . . . 0.0 112.747 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.596 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 26.0 p90 -73.17 121.39 20.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.73 -1.231 . . . . 0.0 109.604 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.52 -147.36 18.55 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -141.58 -156.73 0.7 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.509 -0.995 . . . . 0.0 109.921 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 12.0 t-20 -107.64 68.46 0.71 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 1.5 m -87.47 -1.21 57.77 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.376 0.607 . . . . 0.0 110.531 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.57 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 77.8 m-85 -138.93 62.7 28.07 Favored Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 120.828 -1.17 . . . . 0.0 110.376 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 35.6 Cg_endo -79.47 -25.35 5.67 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.519 2.146 . . . . 0.0 110.257 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 7.7 pt-20 -147.0 50.45 1.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.267 -0.895 . . . . 0.0 109.845 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.32 110.68 0.24 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.5 m -75.31 -12.12 60.2 Favored 'General case' 0 C--N 1.286 -2.194 0 O-C-N 122.218 -0.577 . . . . 0.0 110.359 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -143.07 8.19 1.64 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.197 -0.939 . . . . 0.0 111.234 -178.563 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.37 -148.59 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -77.01 -166.37 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.102 1.868 . . . . 0.0 109.136 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 2.1 tttm -51.95 -71.57 0.06 Allowed 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.523 -1.271 . . . . 0.0 107.837 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.539 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 7.1 p . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.389 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.506 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 3.1 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.29 0.566 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 79.4 m -143.16 90.75 2.21 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 122.087 0.946 . . . . 0.0 109.262 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.752 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 68.3 m -54.64 173.67 0.22 Allowed Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.752 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.5 Cg_endo -70.81 159.3 53.08 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.601 1.534 . . . . 0.0 110.679 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.599 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.2 p -50.07 -68.26 0.19 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.444 -0.785 . . . . 0.0 111.819 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 5' ' ' PRO . 8.1 p90 -46.83 -43.44 18.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.001 -1.062 . . . . 0.0 110.167 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.744 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.3 t90 -110.71 61.08 0.61 Allowed 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.779 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -72.69 5.13 18.22 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.374 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.56 26.58 6.55 Favored Glycine 0 N--CA 1.487 2.075 0 O-C-N 120.622 -1.516 . . . . 0.0 109.923 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.658 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.74 178.57 1.95 Allowed Pre-proline 0 C--N 1.293 -1.86 0 O-C-N 121.626 -0.926 . . . . 0.0 111.44 -178.577 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.744 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.8 Cg_endo -77.28 -52.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.969 0 C-N-CA 123.449 2.766 . . . . 0.0 113.277 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.586 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.9 p90 -77.62 32.88 0.16 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.56 -1.337 . . . . 0.0 111.755 -177.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 176.8 -173.55 46.38 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 118.849 -1.643 . . . . 0.0 110.282 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 2' ' ' SER . 0.2 OUTLIER -118.77 -149.43 0.44 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.478 -1.013 . . . . 0.0 109.909 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 5.6 t-20 -108.35 64.09 0.62 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.548 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.7 m -88.08 1.26 54.68 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.476 -0.765 . . . . 0.0 110.321 -178.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.576 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 66.5 m-85 -142.4 60.17 9.84 Favored Pre-proline 0 C--N 1.299 -1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 109.834 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.6 Cg_endo -79.22 -25.48 5.82 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.429 2.086 . . . . 0.0 110.232 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 26.2 tt0 -140.18 47.85 1.79 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 110.045 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.88 111.19 0.24 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.599 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -71.51 -15.72 62.32 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 121.658 0.742 . . . . 0.0 109.697 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 24' ' ' GLY . 32.6 t -130.24 -22.31 2.82 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.641 -0.662 . . . . 0.0 110.173 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -50.43 -178.8 0.02 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.44 -161.14 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.44 2.093 . . . . 0.0 110.565 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.662 ' HE2' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -72.01 -174.03 1.15 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.639 -0.663 . . . . 0.0 109.458 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.662 HG12 ' HE2' ' A' ' 26' ' ' LYS . 8.9 p . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.496 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.535 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 1.1 p . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.26 0.552 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 4' ' ' CYS . 69.7 m -152.09 95.97 2.14 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.249 -0.907 . . . . 0.0 109.39 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.603 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 33.7 m -40.73 168.03 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.8 Cg_endo -70.92 171.6 15.42 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.29 1.993 . . . . 0.0 112.3 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.62 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 14.0 p -64.6 -41.67 96.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.741 -0.599 . . . . 0.0 111.754 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.525 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -78.69 -35.42 45.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.866 -1.146 . . . . 0.0 110.414 -178.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.754 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.4 t90 -121.03 63.28 0.87 Allowed 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.127 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.472 ' HA2' ' CB ' ' A' ' 4' ' ' CYS . . . -68.14 -26.71 73.98 Favored Glycine 0 N--CA 1.499 2.876 0 O-C-N 121.457 -0.777 . . . . 0.0 111.416 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.42 16.53 29.27 Favored Glycine 0 N--CA 1.491 2.311 0 O-C-N 120.912 -1.346 . . . . 0.0 110.54 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.66 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -69.56 174.79 2.68 Favored Pre-proline 0 C--N 1.296 -1.732 0 O-C-N 121.434 -1.039 . . . . 0.0 111.169 -178.754 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.754 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.8 Cg_endo -72.73 -60.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 123.267 2.644 . . . . 0.0 111.949 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.58 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 19.4 p90 -73.09 125.76 28.43 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.913 -1.117 . . . . 0.0 108.502 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.535 ' HA2' ' CB ' ' A' ' 2' ' ' SER . . . 89.29 168.98 44.02 Favored Glycine 0 N--CA 1.482 1.732 0 C-N-CA 119.259 -1.448 . . . . 0.0 109.67 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -103.36 -148.42 0.39 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.481 -1.011 . . . . 0.0 109.731 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.89 69.11 0.7 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.526 ' C ' ' HD3' ' A' ' 19' ' ' PRO . 1.5 m -87.1 -14.48 41.26 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.603 -0.686 . . . . 0.0 110.74 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.639 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 65.7 m-85 -123.33 47.17 1.58 Allowed Pre-proline 0 C--N 1.295 -1.797 0 O-C-N 121.241 -0.912 . . . . 0.0 111.407 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.639 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 38.1 Cg_endo -80.19 -1.29 11.27 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.818 1.678 . . . . 0.0 109.618 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.7 -21.77 22.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.903 . . . . 0.0 110.79 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 23' ' ' SER . . . 121.88 127.19 3.33 Favored Glycine 0 C--N 1.293 -1.858 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.56 ' HA ' ' HB2' ' A' ' 6' ' ' CYS . 16.9 m -30.43 -37.09 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 122.017 0.913 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 21' ' ' GLY . 1.9 t -54.28 -60.83 2.81 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.431 0.634 . . . . 0.0 109.628 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.62 142.38 24.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 26' ' ' LYS . 33.5 Cg_endo -78.57 141.26 17.44 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.266 1.978 . . . . 0.0 110.906 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.656 ' HE3' HG22 ' A' ' 27' ' ' VAL . 0.0 OUTLIER 37.56 -158.99 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.105 0.479 . . . . 0.0 110.06 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.656 HG22 ' HE3' ' A' ' 26' ' ' LYS . 4.8 m . . . . . 0 N--CA 1.489 1.507 0 O-C-N 120.988 -1.07 . . . . 0.0 109.53 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.294 0.568 . . . . 0.0 109.554 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 99.6 m -146.47 93.45 2.3 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.972 0.892 . . . . 0.0 108.754 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.652 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 22.9 m -50.21 170.9 0.16 Allowed Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.652 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.6 Cg_endo -70.4 159.45 52.89 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 121.903 1.735 . . . . 0.0 110.289 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.594 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.2 p -55.05 -70.66 0.1 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.176 -0.952 . . . . 0.0 111.475 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.25 -38.57 2.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.015 -1.053 . . . . 0.0 110.26 -178.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.761 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.2 t90 -122.3 65.99 0.93 Allowed 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.207 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -72.02 -25.42 74.77 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.059 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.7 19.31 20.94 Favored Glycine 0 N--CA 1.49 2.285 0 O-C-N 120.685 -1.48 . . . . 0.0 110.854 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.63 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -71.2 174.43 3.77 Favored Pre-proline 0 C--N 1.296 -1.76 0 O-C-N 121.276 -1.131 . . . . 0.0 111.328 -178.686 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.761 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.7 Cg_endo -76.16 -56.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 123.814 3.009 . . . . 0.0 114.216 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.545 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 24.9 p90 -74.34 24.51 0.08 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.682 -1.261 . . . . 0.0 112.288 -176.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.46 ' CA ' ' SG ' ' A' ' 4' ' ' CYS . . . -167.51 175.94 42.4 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.558 -1.782 . . . . 0.0 110.363 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 9' ' ' GLY . 2.9 tp60 -104.34 -154.64 0.51 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.463 -1.022 . . . . 0.0 109.802 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.34 62.19 0.62 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 1.6 m -87.8 -12.42 45.1 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.807 0.813 . . . . 0.0 110.178 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 68.7 m-85 -130.18 62.86 66.66 Favored Pre-proline 0 C--N 1.291 -1.945 0 O-C-N 120.639 -1.288 . . . . 0.0 110.487 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.5 Cg_endo -79.33 -30.54 2.53 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.549 2.166 . . . . 0.0 109.938 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 19' ' ' PRO . 1.2 mm-40 -143.12 53.12 1.36 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.835 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.49 110.57 0.23 Allowed Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.4 m -75.23 -12.04 60.2 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.259 0.552 . . . . 0.0 110.234 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -145.53 7.34 1.12 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.142 -178.597 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.9 -144.67 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -77.0 -168.68 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.185 1.924 . . . . 0.0 109.03 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.565 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 6.8 ttmm -62.57 -66.85 0.48 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.136 -1.426 . . . . 0.0 108.203 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 17' ' ' CYS . 2.2 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.06 -0.972 . . . . 0.0 109.294 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.499 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 46.9 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 65.0 m -146.9 94.31 2.4 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.407 -0.808 . . . . 0.0 108.988 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.634 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 68.9 m -42.84 167.76 0.07 OUTLIER Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.634 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 28.8 Cg_endo -67.98 168.45 18.85 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.803 1.668 . . . . 0.0 110.428 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.68 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 1.1 p -65.44 -47.96 74.37 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.05 -1.031 . . . . 0.0 111.137 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -62.11 -49.62 75.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.826 -1.171 . . . . 0.0 109.651 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.767 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.9 t90 -109.56 59.8 0.6 Allowed 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.704 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -67.41 -27.72 73.56 Favored Glycine 0 N--CA 1.496 2.699 0 O-C-N 121.428 -0.795 . . . . 0.0 111.204 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.35 12.52 38.53 Favored Glycine 0 N--CA 1.49 2.256 0 O-C-N 120.869 -1.371 . . . . 0.0 110.841 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -63.39 176.56 0.57 Allowed Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.252 -1.146 . . . . 0.0 110.959 -178.956 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.767 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.2 Cg_endo -73.72 -58.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 123.129 2.553 . . . . 0.0 112.168 -177.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.607 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 24.8 p90 -73.62 115.45 13.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.753 -1.217 . . . . 0.0 109.122 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 90.55 177.43 44.24 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 40.8 mt-30 -111.07 -146.47 0.41 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.382 -1.07 . . . . 0.0 109.796 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 19.5 t-20 -108.69 75.62 0.98 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 3' ' ' CYS . 1.3 m -87.55 -13.15 43.73 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.556 -0.715 . . . . 0.0 111.496 -177.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.595 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -135.16 67.14 68.52 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.125 -0.984 . . . . 0.0 109.972 178.499 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HB3' ' OD1' ' A' ' 16' ' ' ASN . 32.9 Cg_endo -74.85 -29.97 7.95 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.205 1.937 . . . . 0.0 109.64 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -142.27 11.99 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -108.54 26.06 17.5 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.68 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.6 m -33.66 -32.82 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.218 0 CA-C-O 121.714 0.769 . . . . 0.0 110.639 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -135.29 -34.22 0.87 Allowed 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.684 -0.635 . . . . 0.0 110.138 -179.596 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.36 -131.78 0.01 OUTLIER Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -76.33 -164.92 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.005 1.803 . . . . 0.0 109.46 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 18' ' ' TYR . 9.4 ttpp -73.0 -64.92 0.87 Allowed 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.765 -1.174 . . . . 0.0 109.001 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.489 1.522 0 O-C-N 120.95 -1.094 . . . . 0.0 109.479 179.558 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.556 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 25.5 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.278 0.561 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.517 ' O ' ' O ' ' A' ' 4' ' ' CYS . 68.4 m -147.47 96.27 2.67 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.293 -0.88 . . . . 0.0 108.837 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.565 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 51.4 m -39.58 165.67 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.58 ' HB2' ' CE1' ' A' ' 7' ' ' TYR . 30.3 Cg_endo -70.02 165.03 32.63 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.224 1.949 . . . . 0.0 111.64 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.676 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -57.51 -46.56 83.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.572 -0.705 . . . . 0.0 111.479 -178.573 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.631 ' CD2' ' N ' ' A' ' 8' ' ' TRP . 42.7 p90 -72.69 -47.17 49.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.984 -1.073 . . . . 0.0 110.404 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.769 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.9 t90 -108.62 59.2 0.61 Allowed 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.902 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 4' ' ' CYS . . . -67.92 -27.39 73.67 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.62 9.07 45.19 Favored Glycine 0 N--CA 1.49 2.279 0 O-C-N 120.875 -1.368 . . . . 0.0 110.403 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.653 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -61.74 176.94 0.39 Allowed Pre-proline 0 C--N 1.298 -1.636 0 O-C-N 121.317 -1.108 . . . . 0.0 111.135 -178.864 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.769 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.0 Cg_endo -75.35 -56.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 123.321 2.68 . . . . 0.0 112.743 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.58 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 30.0 p90 -73.16 123.14 23.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.727 -1.233 . . . . 0.0 109.8 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.556 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 93.95 -148.46 19.01 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 23.8 mt-30 -145.29 -143.73 0.14 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.5 -1.0 . . . . 0.0 109.34 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.16 67.04 0.64 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 3' ' ' CYS . 1.5 m -87.19 -20.25 27.25 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.315 -0.865 . . . . 0.0 110.339 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.568 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 98.3 m-85 -128.88 72.57 81.67 Favored Pre-proline 0 C--N 1.293 -1.887 0 O-C-N 121.628 -0.67 . . . . 0.0 109.577 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.517 ' CD ' HG22 ' A' ' 27' ' ' VAL . 34.9 Cg_endo -77.3 -32.26 3.13 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.424 2.082 . . . . 0.0 109.869 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.444 ' O ' ' OE2' ' A' ' 20' ' ' GLU . 3.1 tm-20 -150.09 14.7 0.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.454 -0.779 . . . . 0.0 109.518 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -90.24 15.51 59.6 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.676 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -35.88 -31.84 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.187 0 CA-C-O 121.793 0.806 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 21' ' ' GLY . 91.4 p -112.85 -25.15 9.17 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 121.298 0.57 . . . . 0.0 109.47 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.79 -168.75 30.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 26' ' ' LYS . 35.7 Cg_endo -78.22 -159.93 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.623 2.215 . . . . 0.0 110.693 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -56.5 -159.49 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.57 -0.706 . . . . 0.0 109.655 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.517 HG22 ' CD ' ' A' ' 19' ' ' PRO . 2.1 t . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.406 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 3' ' ' CYS . 4.1 p . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 74.2 m 39.2 95.29 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.117 0.961 . . . . 0.0 111.076 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.756 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 86.7 m -52.75 175.28 0.11 Allowed Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.756 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.2 Cg_endo -72.0 165.91 31.18 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 121.33 1.354 . . . . 0.0 110.539 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.556 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -60.75 -47.98 83.85 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.29 -0.881 . . . . 0.0 110.738 -178.31 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.596 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -59.37 -47.03 86.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.838 -1.164 . . . . 0.0 109.469 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.732 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 11.4 t90 -111.11 61.95 0.61 Allowed 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.367 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.532 ' O ' ' CA ' ' A' ' 16' ' ' ASN . . . -73.48 7.36 12.82 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.253 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.73 27.72 6.15 Favored Glycine 0 N--CA 1.486 2.02 0 O-C-N 120.615 -1.521 . . . . 0.0 109.301 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.641 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -79.84 177.07 3.15 Favored Pre-proline 0 C--N 1.295 -1.804 0 O-C-N 121.721 -0.87 . . . . 0.0 111.637 -178.152 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.732 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.29 -48.07 0.14 Allowed 'Trans proline' 0 C--N 1.319 -1.014 0 C-N-CA 123.498 2.799 . . . . 0.0 113.211 -177.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.639 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 36.4 p90 -80.05 37.49 0.37 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.69 -1.256 . . . . 0.0 111.237 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.44 -168.05 39.8 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.05 -1.547 . . . . 0.0 110.182 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 8.5 mt-30 -123.48 -150.5 0.45 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.408 -1.054 . . . . 0.0 110.318 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.532 ' CA ' ' O ' ' A' ' 9' ' ' GLY . 0.6 OUTLIER -108.9 69.86 0.72 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.536 ' SG ' ' HG2' ' A' ' 26' ' ' LYS . 1.7 m -87.79 -10.07 52.05 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.376 -0.827 . . . . 0.0 110.492 -177.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.616 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 6.7 m-85 -136.16 56.16 13.64 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.25 -0.906 . . . . 0.0 110.138 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 38.0 Cg_endo -81.77 -49.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 122.43 2.086 . . . . 0.0 111.284 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -92.62 22.23 4.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.389 -0.819 . . . . 0.0 111.198 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.99 113.29 0.37 Allowed Glycine 0 N--CA 1.481 1.651 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.219 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.556 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 8.7 m -57.79 -69.07 0.19 Allowed 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.883 0.849 . . . . 0.0 109.455 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 24' ' ' GLY . 11.0 m -52.76 -44.46 66.52 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -44.0 166.65 0.03 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.04 -159.94 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.492 2.128 . . . . 0.0 110.782 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.536 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 1.2 mtmt -60.41 177.02 0.3 Allowed 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.295 0.569 . . . . 0.0 109.648 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 27' ' ' VAL . 9.8 p . . . . . 0 C--N 1.3 -1.567 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.503 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.501 ' O ' ' C ' ' A' ' 3' ' ' CYS . 2.4 p . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.501 ' C ' ' O ' ' A' ' 2' ' ' SER . 78.6 m 30.57 91.42 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.944 0.878 . . . . 0.0 111.026 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.568 ' HB3' ' O ' ' A' ' 8' ' ' TRP . 62.1 m -43.67 168.06 0.07 OUTLIER Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 33.5 Cg_endo -76.33 146.8 28.45 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.057 1.838 . . . . 0.0 110.52 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.62 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -46.82 -63.71 0.96 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 0.0 110.593 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -39.49 -37.48 0.48 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.893 0.854 . . . . 0.0 108.799 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.746 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.0 t90 -135.0 70.21 1.44 Allowed 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.683 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.9 -26.51 66.71 Favored Glycine 0 N--CA 1.5 2.948 0 O-C-N 121.279 -0.888 . . . . 0.0 111.34 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.13 17.27 23.92 Favored Glycine 0 N--CA 1.489 2.18 0 O-C-N 120.846 -1.385 . . . . 0.0 110.674 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.611 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -68.48 174.89 2.19 Favored Pre-proline 0 C--N 1.297 -1.708 0 O-C-N 121.28 -1.129 . . . . 0.0 111.075 -178.737 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.746 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.3 Cg_endo -74.36 -58.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 123.436 2.757 . . . . 0.0 112.776 -177.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.592 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 25.5 p90 -73.44 123.74 24.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.726 -1.234 . . . . 0.0 110.003 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 100.38 -146.16 17.54 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -144.41 -152.34 0.41 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.594 -0.945 . . . . 0.0 109.767 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.44 63.97 0.61 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.519 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.6 m -87.09 2.65 49.09 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.661 0.743 . . . . 0.0 109.908 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.62 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 73.3 m-85 -145.33 76.2 13.38 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.66 -37.7 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.701 2.268 . . . . 0.0 112.081 -178.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.9 38.74 1.47 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.817 -1.177 . . . . 0.0 111.264 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 22' ' ' CYS . . . 149.34 119.66 1.0 Allowed Glycine 0 N--CA 1.479 1.507 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.0 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 12.0 m -40.63 -38.57 0.9 Allowed 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 122.381 1.086 . . . . 0.0 108.775 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.518 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 23.2 t 44.31 56.8 4.7 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 40.9 -99.43 0.01 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 23' ' ' SER . 32.2 Cg_endo -74.02 -159.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.371 2.047 . . . . 0.0 111.051 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.594 ' NZ ' HG12 ' A' ' 27' ' ' VAL . 1.5 ttpp -48.34 -179.97 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.536 0.684 . . . . 0.0 109.889 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 27' ' ' VAL . 5.4 p . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.433 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.549 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 2.9 t . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.741 0.305 . . . . 0.0 110.614 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 4' ' ' CYS . 87.5 m -143.09 93.04 2.45 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 120.892 -1.13 . . . . 0.0 109.557 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.586 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 39.3 m -41.67 167.6 0.06 OUTLIER Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.7 Cg_endo -72.11 159.44 49.93 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.071 1.847 . . . . 0.0 110.294 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.606 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.2 p -53.88 -71.51 0.07 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.293 -0.88 . . . . 0.0 111.531 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -44.19 -44.33 7.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.99 -1.069 . . . . 0.0 109.985 -178.931 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.767 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.6 t90 -115.8 63.22 0.7 Allowed 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 119.135 -1.026 . . . . 0.0 109.861 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -73.41 -26.28 70.57 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.94 7.97 52.9 Favored Glycine 0 N--CA 1.489 2.187 0 O-C-N 120.846 -1.385 . . . . 0.0 110.396 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -58.92 177.26 0.25 Allowed Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.258 -1.143 . . . . 0.0 110.963 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.767 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.2 Cg_endo -74.34 -57.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 123.213 2.609 . . . . 0.0 112.647 -177.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.596 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 26.6 p90 -73.58 117.67 15.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.697 -1.252 . . . . 0.0 109.697 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.549 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 91.26 -171.54 35.41 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -124.14 -138.55 0.29 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.211 -1.17 . . . . 0.0 110.147 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.515 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -109.27 70.65 0.74 Allowed 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.959 -1.088 . . . . 0.0 109.014 -179.139 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.555 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.7 m -89.36 -4.2 58.16 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 121.307 -0.87 . . . . 0.0 110.153 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.561 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 67.2 m-85 -140.09 60.75 15.68 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.425 -0.797 . . . . 0.0 109.462 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.3 Cg_endo -78.78 -23.77 7.84 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.426 2.084 . . . . 0.0 110.675 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.3 46.7 1.31 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.062 -1.024 . . . . 0.0 110.403 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.93 110.33 0.23 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.5 m -69.45 -15.1 63.2 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.598 0.714 . . . . 0.0 109.626 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 24' ' ' GLY . 3.8 m -126.86 -24.99 3.41 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.618 -0.676 . . . . 0.0 109.963 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -48.5 176.41 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -77.3 -161.59 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.36 2.04 . . . . 0.0 110.615 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.555 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 10.2 ttmt -71.03 -172.17 0.65 Allowed 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.695 -0.628 . . . . 0.0 109.333 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 29.0 m . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.934 -1.031 . . . . 0.0 109.515 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.494 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 7.5 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 4' ' ' CYS . 62.2 m -147.82 93.55 2.22 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.352 -0.842 . . . . 0.0 108.882 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.582 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 44.2 m -41.37 167.3 0.05 OUTLIER Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.6 Cg_endo -72.33 159.6 49.06 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.263 1.975 . . . . 0.0 110.614 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.616 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -55.99 -69.94 0.13 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.893 . . . . 0.0 111.202 -178.685 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.596 ' CE2' ' HB2' ' A' ' 8' ' ' TRP . 1.5 p90 -42.16 -37.96 1.59 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 109.604 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.753 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.0 t90 -126.27 67.22 1.21 Allowed 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 119.059 -1.057 . . . . 0.0 109.991 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -75.26 -26.45 66.06 Favored Glycine 0 N--CA 1.496 2.694 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.005 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.91 11.14 49.31 Favored Glycine 0 N--CA 1.49 2.294 0 O-C-N 120.877 -1.366 . . . . 0.0 110.532 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.636 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -61.5 176.13 0.45 Allowed Pre-proline 0 C--N 1.297 -1.702 0 O-C-N 121.361 -1.082 . . . . 0.0 110.948 -178.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.753 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.8 -58.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 123.195 2.596 . . . . 0.0 112.455 -177.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.598 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 24.4 p90 -73.4 118.84 16.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.719 -1.238 . . . . 0.0 109.367 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.494 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 93.51 -178.79 38.49 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 19.8 mt-30 -111.26 -145.91 0.4 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.405 -1.056 . . . . 0.0 109.8 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -108.77 66.13 0.63 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.881 ' HA ' HG23 ' A' ' 27' ' ' VAL . 1.6 m -87.97 13.25 11.37 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.417 -0.802 . . . . 0.0 110.885 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.593 ' CD1' ' O ' ' A' ' 17' ' ' CYS . 62.7 m-85 -155.21 63.23 3.68 Favored Pre-proline 0 C--N 1.296 -1.759 0 O-C-N 120.664 -1.272 . . . . 0.0 109.547 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.7 Cg_endo -79.65 -32.09 1.72 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.307 2.005 . . . . 0.0 110.321 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -142.03 51.41 1.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 110.147 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.04 110.46 0.23 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.616 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -70.03 -16.56 63.17 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 121.437 0.637 . . . . 0.0 109.888 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.575 ' O ' ' C ' ' A' ' 24' ' ' GLY . 20.4 m -135.46 -94.07 0.27 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.417 -0.802 . . . . 0.0 109.192 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 13.57 -127.97 0.01 OUTLIER Glycine 0 N--CA 1.511 3.657 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -81.93 -157.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.162 1.908 . . . . 0.0 107.999 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.576 ' CA ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -133.09 -38.11 0.97 Allowed 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.483 178.916 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.881 HG23 ' HA ' ' A' ' 17' ' ' CYS . 25.0 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 120.894 -1.129 . . . . 0.0 109.165 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.56 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 4' ' ' CYS . 73.5 m -143.18 89.76 2.13 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.042 -1.036 . . . . 0.0 110.255 -178.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.568 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 11.9 m -43.75 168.77 0.06 OUTLIER Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.497 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.4 Cg_endo -71.43 148.75 55.1 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.001 1.8 . . . . 0.0 110.621 179.41 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.568 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 1.6 p -55.08 -46.19 75.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 110.916 -178.704 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -59.12 -36.39 75.1 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.839 -1.163 . . . . 0.0 108.192 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.726 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 17.9 t90 -131.52 69.59 1.47 Allowed 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.424 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -73.05 -26.51 70.75 Favored Glycine 0 N--CA 1.499 2.834 0 O-C-N 121.358 -0.839 . . . . 0.0 111.371 -178.625 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.48 15.19 31.09 Favored Glycine 0 N--CA 1.491 2.343 0 O-C-N 120.842 -1.387 . . . . 0.0 110.353 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.642 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -68.17 175.85 1.63 Allowed Pre-proline 0 C--N 1.296 -1.736 0 O-C-N 121.438 -1.036 . . . . 0.0 111.124 -178.735 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.726 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.0 Cg_endo -73.48 -60.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 123.31 2.673 . . . . 0.0 112.322 -177.475 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.58 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 17.5 p90 -73.29 122.93 22.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 0.0 109.287 -179.039 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.56 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 99.2 -166.62 21.11 Favored Glycine 0 N--CA 1.485 1.929 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.053 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -129.24 -147.91 0.36 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.466 -1.02 . . . . 0.0 109.65 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.42 64.83 0.62 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.562 ' SG ' ' HG2' ' A' ' 26' ' ' LYS . 1.6 m -87.56 -4.34 58.97 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.45 -0.781 . . . . 0.0 110.217 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.563 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 57.2 m-85 -148.15 61.75 6.14 Favored Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 121.416 -0.803 . . . . 0.0 109.772 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 37.5 Cg_endo -82.27 -39.06 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.634 2.223 . . . . 0.0 111.536 -179.6 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -122.91 36.35 4.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.968 -1.082 . . . . 0.0 111.279 -178.277 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.19 113.48 0.46 Allowed Glycine 0 N--CA 1.483 1.829 0 C-N-CA 119.487 -1.34 . . . . 0.0 110.547 178.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.568 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 8.7 m -56.6 -41.61 77.32 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-O 122.074 0.94 . . . . 0.0 109.233 179.01 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 24' ' ' GLY . 1.8 t -81.33 -41.15 22.5 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.496 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -44.22 166.84 0.03 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.8 -159.64 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.341 2.027 . . . . 0.0 110.641 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.562 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 3.4 mtpp -69.84 175.31 4.41 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.592 0.71 . . . . 0.0 109.959 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.567 HG22 ' OXT' ' A' ' 27' ' ' VAL . 9.5 p . . . . . 0 C--N 1.302 -1.463 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.488 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.47 ' OG ' ' HG3' ' A' ' 15' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.353 0.597 . . . . 0.0 109.458 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 4' ' ' CYS . 69.9 m -143.75 91.74 2.27 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.994 0.902 . . . . 0.0 108.628 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.678 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 68.2 m -44.64 170.32 0.05 OUTLIER Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.678 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.7 Cg_endo -72.74 158.28 50.65 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 C-N-CA 121.87 1.713 . . . . 0.0 110.672 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.579 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -61.87 -47.82 83.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.331 -0.856 . . . . 0.0 110.464 -178.738 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -53.23 -31.53 43.72 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.45 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.75 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.6 t90 -139.26 74.59 1.48 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.693 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -76.45 -26.4 63.54 Favored Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.336 -178.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.49 26.79 6.13 Favored Glycine 0 N--CA 1.49 2.275 0 O-C-N 120.675 -1.485 . . . . 0.0 110.922 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.624 ' HA ' ' CZ2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.91 173.41 7.52 Favored Pre-proline 0 C--N 1.293 -1.879 0 O-C-N 121.314 -1.11 . . . . 0.0 111.379 -178.669 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.75 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.3 Cg_endo -75.8 -55.16 0.07 OUTLIER 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 123.771 2.98 . . . . 0.0 114.12 -177.012 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.591 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.4 p90 -74.73 28.47 0.09 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.718 -1.239 . . . . 0.0 112.274 -177.072 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.459 ' HA2' ' OG ' ' A' ' 2' ' ' SER . . . -177.2 179.67 47.93 Favored Glycine 0 N--CA 1.485 1.938 0 C-N-CA 118.61 -1.757 . . . . 0.0 110.197 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 9' ' ' GLY . 35.4 mt-30 -101.22 -163.96 1.06 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.425 -1.044 . . . . 0.0 109.553 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -106.5 65.49 0.68 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.346 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.571 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.6 m -87.48 9.22 21.62 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.313 0.578 . . . . 0.0 110.145 -177.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.575 ' CE1' ' O ' ' A' ' 26' ' ' LYS . 65.8 m-85 -150.76 62.85 5.5 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 120.69 -1.256 . . . . 0.0 109.844 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.8 Cg_endo -80.39 -62.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.637 2.225 . . . . 0.0 110.867 -179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.9 37.05 2.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.65 105.22 0.18 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.426 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.579 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 37.1 m -62.47 -32.88 73.84 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.697 0.76 . . . . 0.0 110.708 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.491 ' O ' ' C ' ' A' ' 24' ' ' GLY . 11.8 t -99.07 -89.29 0.32 Allowed 'General case' 0 C--N 1.287 -2.125 0 O-C-N 121.68 -0.638 . . . . 0.0 109.55 -179.521 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 33.47 -149.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 26' ' ' LYS . 34.4 Cg_endo -79.21 -166.97 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.4 2.067 . . . . 0.0 108.981 178.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.575 ' O ' ' CE1' ' A' ' 18' ' ' TYR . 2.6 ttmm -50.33 -58.71 5.05 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.622 -1.231 . . . . 0.0 107.928 178.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.552 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 14.4 m . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.487 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 3' ' ' CYS . 60.1 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 89.2 m 32.87 91.9 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.95 0.881 . . . . 0.0 110.898 179.207 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 8' ' ' TRP . 58.4 m -43.35 168.1 0.07 OUTLIER Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.214 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 34.0 Cg_endo -77.03 146.35 25.6 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.19 1.926 . . . . 0.0 110.683 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.636 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -46.25 -63.95 0.87 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.086 -1.009 . . . . 0.0 110.587 -179.453 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -39.59 -37.93 0.55 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.874 0.845 . . . . 0.0 108.842 -179.737 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.747 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.2 t90 -134.97 70.11 1.44 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.633 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.0 -26.65 66.16 Favored Glycine 0 N--CA 1.501 2.986 0 O-C-N 121.275 -0.89 . . . . 0.0 111.387 -178.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.71 15.95 28.47 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.918 -1.343 . . . . 0.0 110.571 -179.086 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.613 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -66.99 174.75 1.76 Allowed Pre-proline 0 C--N 1.296 -1.735 0 O-C-N 121.295 -1.121 . . . . 0.0 111.04 -178.764 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.747 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.4 Cg_endo -74.1 -57.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 123.311 2.674 . . . . 0.0 112.833 -177.473 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.592 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 26.8 p90 -73.4 122.83 22.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.681 -1.262 . . . . 0.0 109.978 -178.493 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.432 ' C ' ' HG3' ' A' ' 15' ' ' GLN . . . 99.21 -147.39 18.41 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.432 ' HG3' ' C ' ' A' ' 14' ' ' GLY . 21.8 mt-30 -143.4 -149.86 0.29 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.466 -1.02 . . . . 0.0 109.793 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.69 63.74 0.61 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.507 ' SG ' ' HG2' ' A' ' 26' ' ' LYS . 1.7 m -87.21 8.05 25.67 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.401 -0.812 . . . . 0.0 109.594 -178.935 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.636 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 77.2 m-85 -149.21 64.98 7.75 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.5 Cg_endo -80.75 -16.34 10.33 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.632 2.221 . . . . 0.0 111.809 -178.156 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.16 35.99 0.67 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.633 -1.292 . . . . 0.0 111.28 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 23' ' ' SER . . . 134.56 124.24 2.44 Favored Glycine 0 N--CA 1.476 1.328 0 C-N-CA 119.504 -1.332 . . . . 0.0 109.955 179.239 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.533 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 20.5 m -35.67 -34.58 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 122.442 1.115 . . . . 0.0 109.39 179.354 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.491 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 37.6 p 46.53 58.88 4.23 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.226 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 43.2 -101.75 0.03 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 23' ' ' SER . 33.8 Cg_endo -75.89 -160.39 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.29 1.993 . . . . 0.0 111.057 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.507 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -50.78 -172.59 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.365 0.603 . . . . 0.0 110.22 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 9.8 p . . . . . 0 C--N 1.303 -1.442 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.532 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.443 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.197 0.522 . . . . 0.0 109.779 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.51 ' O ' ' O ' ' A' ' 4' ' ' CYS . 53.9 m -150.73 96.46 2.36 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.327 -0.858 . . . . 0.0 108.729 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.596 ' HB3' ' O ' ' A' ' 8' ' ' TRP . 55.7 m -39.23 165.69 0.05 OUTLIER Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.862 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.8 Cg_endo -71.24 173.32 12.44 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.286 1.991 . . . . 0.0 111.319 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.718 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -69.58 -48.0 61.67 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.427 -0.796 . . . . 0.0 111.511 -178.397 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.544 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -66.11 -29.78 70.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.737 -1.227 . . . . 0.0 109.773 -179.612 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.755 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.0 t90 -131.99 68.12 1.5 Allowed 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 118.679 -1.209 . . . . 0.0 109.933 -178.856 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.463 ' HA2' ' CB ' ' A' ' 4' ' ' CYS . . . -74.09 -26.24 69.17 Favored Glycine 0 N--CA 1.5 2.929 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.292 -179.141 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.06 13.95 35.46 Favored Glycine 0 N--CA 1.489 2.189 0 O-C-N 120.788 -1.419 . . . . 0.0 110.313 -179.455 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.651 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -66.27 175.1 1.39 Allowed Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 121.442 -1.034 . . . . 0.0 111.056 -178.78 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.755 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.4 -58.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -1.019 0 C-N-CA 123.275 2.65 . . . . 0.0 112.485 -177.35 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.581 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 23.9 p90 -72.79 122.12 21.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.74 -1.225 . . . . 0.0 109.121 -179.039 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' HA2' ' OG ' ' A' ' 2' ' ' SER . . . 88.17 174.77 47.74 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.473 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 12.7 mt-30 -103.2 -149.49 0.4 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.257 -1.143 . . . . 0.0 109.408 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.455 ' OD1' ' HA3' ' A' ' 9' ' ' GLY . 16.7 t-20 -108.67 68.9 0.7 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.892 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.531 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.7 m -86.87 -11.44 50.77 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.37 0.605 . . . . 0.0 109.944 -177.941 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.542 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 43.0 m-85 -132.46 77.15 70.69 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.51 ' HD2' ' HA ' ' A' ' 27' ' ' VAL . 35.2 Cg_endo -76.47 -48.44 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.586 2.19 . . . . 0.0 109.835 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -143.33 16.23 1.86 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -92.49 25.75 16.95 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.718 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -35.73 -31.5 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.22 0 CA-C-O 121.79 0.805 . . . . 0.0 110.196 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -125.37 -30.73 3.1 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.757 -0.59 . . . . 0.0 109.603 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.29 -148.87 0.04 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -78.18 -160.67 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.69 2.26 . . . . 0.0 110.738 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.531 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 20.5 ttpt -50.95 -76.26 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.527 -0.733 . . . . 0.0 109.165 179.549 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.51 ' HA ' ' HD2' ' A' ' 19' ' ' PRO . 5.2 m . . . . . 0 N--CA 1.49 1.556 0 O-C-N 120.955 -1.091 . . . . 0.0 109.43 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.543 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 3.3 t . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.169 0.509 . . . . 0.0 109.659 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 89.2 m -148.44 91.87 1.95 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.128 -0.982 . . . . 0.0 109.635 -179.279 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.631 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 80.9 m -43.12 167.04 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.776 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.631 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 26.4 Cg_endo -65.28 152.67 81.38 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.123 1.215 . . . . 0.0 109.519 179.559 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.617 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 16.4 p -59.45 -42.48 92.08 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.141 -0.974 . . . . 0.0 110.088 -177.954 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -57.43 -28.62 63.47 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.099 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.763 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.1 t90 -136.06 72.63 1.44 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.041 -179.03 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 4' ' ' CYS . . . -79.73 -24.45 60.27 Favored Glycine 0 N--CA 1.5 2.929 0 O-C-N 121.12 -0.988 . . . . 0.0 111.121 -179.268 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.59 16.57 34.92 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.96 -1.318 . . . . 0.0 110.555 -179.146 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.618 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -63.77 174.18 1.11 Allowed Pre-proline 0 C--N 1.296 -1.742 0 O-C-N 121.272 -1.134 . . . . 0.0 111.042 -178.82 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.763 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.8 Cg_endo -73.05 -58.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 123.352 2.701 . . . . 0.0 112.222 -177.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.551 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 22.8 p90 -73.28 -167.76 0.45 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.768 -1.207 . . . . 0.0 109.153 -179.181 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.543 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 37.86 -148.54 0.07 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.8 OUTLIER -139.69 -157.6 0.78 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.411 -1.052 . . . . 0.0 109.99 179.801 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.475 ' OD1' ' CG ' ' A' ' 19' ' ' PRO . 13.5 t-20 -109.23 70.83 0.75 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 179.567 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.532 ' C ' ' CG ' ' A' ' 18' ' ' TYR . 1.3 m -87.84 -2.05 58.36 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.453 0.644 . . . . 0.0 111.074 -177.719 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.617 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -165.83 76.84 1.24 Allowed Pre-proline 0 N--CA 1.496 1.825 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.101 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.475 ' CG ' ' OD1' ' A' ' 16' ' ' ASN . 37.6 Cg_endo -82.83 -54.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 123.028 2.485 . . . . 0.0 112.013 -178.038 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -94.18 15.98 15.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.102 -0.999 . . . . 0.0 111.563 -177.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 22' ' ' CYS . . . 149.03 120.25 1.06 Allowed Glycine 0 N--CA 1.475 1.241 0 C-N-CA 118.989 -1.577 . . . . 0.0 110.174 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.598 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.4 m -37.05 -46.18 0.65 Allowed 'General case' 0 C--N 1.288 -2.105 0 CA-C-O 122.364 1.078 . . . . 0.0 108.59 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.527 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER 46.28 36.55 3.39 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.446 179.067 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.04 -112.38 3.47 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 179.441 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 23' ' ' SER . 32.7 Cg_endo -74.76 -157.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.377 2.051 . . . . 0.0 111.109 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 25' ' ' PRO . 2.1 mtpt -46.16 177.91 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.67 0.747 . . . . 0.0 110.271 -179.603 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 17' ' ' CYS . 5.4 p . . . . . 0 C--N 1.301 -1.543 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.647 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 3' ' ' CYS . 6.6 t . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 75.1 m 35.34 95.63 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.26 1.029 . . . . 0.0 110.758 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.676 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 57.7 m -52.36 170.68 0.23 Allowed Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.676 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.0 Cg_endo -71.93 166.38 29.73 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.068 1.846 . . . . 0.0 111.355 -179.604 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.68 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -62.52 -44.48 96.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.54 -0.725 . . . . 0.0 110.696 -179.034 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -67.49 -34.38 77.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.273 -0.892 . . . . 0.0 110.012 -178.929 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.751 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 13.4 t90 -126.63 65.61 1.26 Allowed 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.574 -178.445 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -65.66 -28.99 74.16 Favored Glycine 0 N--CA 1.498 2.77 0 O-C-N 121.344 -0.847 . . . . 0.0 111.542 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.09 29.89 4.54 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 120.68 -1.482 . . . . 0.0 111.283 -178.459 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.635 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -82.53 172.16 10.17 Favored Pre-proline 0 C--N 1.294 -1.836 0 O-C-N 121.211 -1.17 . . . . 0.0 111.427 -178.666 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.751 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.5 Cg_endo -75.55 -53.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 123.837 3.025 . . . . 0.0 113.997 -176.586 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.566 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 27.3 p90 -74.83 23.2 0.1 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.675 -1.266 . . . . 0.0 112.005 -177.294 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.409 ' C ' ' SG ' ' A' ' 4' ' ' CYS . . . -168.28 -174.92 37.5 Favored Glycine 0 N--CA 1.485 1.963 0 C-N-CA 118.949 -1.596 . . . . 0.0 110.028 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 9' ' ' GLY . 35.8 mt-30 -116.99 -149.25 0.44 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.554 -0.968 . . . . 0.0 109.16 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -108.82 62.44 0.6 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.7 m -87.01 -19.95 27.94 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.258 -0.901 . . . . 0.0 109.147 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.618 ' CG ' ' HB2' ' A' ' 26' ' ' LYS . 6.6 m-85 -116.66 71.31 5.04 Favored Pre-proline 0 C--N 1.296 -1.723 0 O-C-N 121.666 -0.647 . . . . 0.0 109.815 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.513 ' HD3' ' C ' ' A' ' 17' ' ' CYS . 34.7 Cg_endo -74.99 -44.54 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.159 1.906 . . . . 0.0 110.195 179.572 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -144.86 15.38 1.56 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.375 -0.828 . . . . 0.0 109.092 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 25' ' ' PRO . . . -93.36 23.52 29.59 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.716 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.68 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.6 m -36.0 -29.45 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.361 0.601 . . . . 0.0 111.231 -179.675 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' GLY . 2.5 p -113.1 -74.15 0.64 Allowed 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.436 -0.79 . . . . 0.0 110.778 -178.759 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -59.47 -131.86 0.01 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.145 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.52 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 33.4 Cg_endo -74.98 -158.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.2 1.933 . . . . 0.0 109.836 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 1.006 ' HG2' HG13 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -138.32 -36.85 0.57 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.184 -0.947 . . . . 0.0 109.935 -179.859 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.006 HG13 ' HG2' ' A' ' 26' ' ' LYS . 3.5 m . . . . . 0 N--CA 1.493 1.678 0 O-C-N 120.733 -1.229 . . . . 0.0 109.3 178.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 3' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.48 ' C ' ' O ' ' A' ' 2' ' ' SER . 73.8 m 33.15 91.78 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 122.133 0.968 . . . . 0.0 110.905 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.747 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 86.3 m -49.71 173.94 0.07 OUTLIER Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.061 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.747 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.4 Cg_endo -72.9 165.73 31.98 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.599 1.532 . . . . 0.0 111.35 -179.293 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.727 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -56.34 -46.95 79.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.453 -0.78 . . . . 0.0 111.343 -178.383 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -63.75 -40.08 95.84 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.034 -1.041 . . . . 0.0 110.375 -179.248 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.734 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.8 t90 -117.6 62.77 0.74 Allowed 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.24 -178.25 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -71.93 5.67 12.14 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.163 -0.961 . . . . 0.0 111.522 -179.242 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.68 28.64 5.88 Favored Glycine 0 N--CA 1.486 1.969 0 O-C-N 120.508 -1.583 . . . . 0.0 109.617 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.658 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -80.4 176.66 3.57 Favored Pre-proline 0 C--N 1.294 -1.848 0 O-C-N 121.654 -0.909 . . . . 0.0 111.664 -178.207 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.734 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.63 -50.21 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 123.569 2.846 . . . . 0.0 113.181 -177.015 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.633 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 34.6 p90 -78.58 34.79 0.22 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.675 -1.266 . . . . 0.0 111.585 -177.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.81 -163.26 32.1 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.834 -1.65 . . . . 0.0 110.502 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' GLY . 2.1 tt0 -128.3 -152.11 0.5 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.538 -0.978 . . . . 0.0 110.073 -179.337 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 12.7 t30 -109.21 64.59 0.61 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.536 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.6 m -87.46 -11.07 50.12 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.428 -0.795 . . . . 0.0 109.703 -179.0 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.527 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 96.9 m-85 -130.84 73.04 81.52 Favored Pre-proline 0 C--N 1.296 -1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 109.723 -179.232 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.524 ' CD ' ' O ' ' A' ' 27' ' ' VAL . 35.1 Cg_endo -77.67 -40.95 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.442 2.095 . . . . 0.0 109.477 179.581 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -141.2 13.03 2.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.352 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -94.9 25.67 22.5 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.557 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.727 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -38.67 -29.7 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.286 0 CA-C-O 121.751 0.786 . . . . 0.0 109.952 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 21' ' ' GLY . 48.5 t -147.97 54.58 1.04 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -157.24 -132.36 1.45 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -78.66 -160.58 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.388 2.059 . . . . 0.0 111.018 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.536 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 3.3 ttpt -122.64 87.61 2.78 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.753 -0.592 . . . . 0.0 109.545 179.598 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.524 ' O ' ' CD ' ' A' ' 19' ' ' PRO . 42.4 t . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.642 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.531 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.468 ' C ' ' O ' ' A' ' 2' ' ' SER . 71.6 m 34.36 95.98 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.127 0.965 . . . . 0.0 111.031 179.013 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.658 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 97.9 m -55.13 169.78 0.42 Allowed Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.879 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.658 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.5 Cg_endo -72.03 156.26 56.22 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.772 1.648 . . . . 0.0 111.068 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.596 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -48.17 -70.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.453 -0.779 . . . . 0.0 111.109 -178.487 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.599 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -41.16 -34.14 0.43 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.436 -0.79 . . . . 0.0 109.852 -178.886 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.736 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.1 t90 -126.0 66.47 1.2 Allowed 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.732 -179.31 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -78.32 5.95 53.32 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 120.162 -1.018 . . . . 0.0 110.871 -179.202 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.72 26.7 6.78 Favored Glycine 0 N--CA 1.485 1.955 0 O-C-N 120.773 -1.427 . . . . 0.0 109.637 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.643 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.91 176.47 3.42 Favored Pre-proline 0 C--N 1.294 -1.845 0 O-C-N 121.733 -0.863 . . . . 0.0 111.344 -178.402 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.736 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.8 Cg_endo -76.18 -52.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 123.423 2.748 . . . . 0.0 113.153 -177.154 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.583 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 28.9 p90 -78.0 31.73 0.17 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.745 -1.222 . . . . 0.0 111.625 -177.788 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.531 ' HA2' ' CB ' ' A' ' 2' ' ' SER . . . -179.15 -171.73 42.62 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 118.595 -1.764 . . . . 0.0 110.595 179.555 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' GLY . 1.3 tt0 -118.87 -151.69 0.49 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.558 -0.966 . . . . 0.0 110.142 -179.522 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.582 ' O ' HG21 ' A' ' 27' ' ' VAL . 27.0 t-20 -109.24 64.19 0.61 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.53 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.7 m -87.73 4.26 44.87 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.396 -0.815 . . . . 0.0 110.015 -178.516 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.596 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 73.0 m-85 -147.07 62.27 7.2 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.282 -0.886 . . . . 0.0 109.742 -178.972 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.582 ' CG ' HG22 ' A' ' 27' ' ' VAL . 35.4 Cg_endo -78.66 -38.8 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.587 2.191 . . . . 0.0 110.324 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -132.61 49.85 2.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 109.422 -179.899 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.25 112.31 0.26 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 179.71 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.7 m -64.9 -81.87 0.03 OUTLIER 'General case' 0 C--N 1.285 -2.232 0 CA-C-O 122.111 0.958 . . . . 0.0 109.079 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 24' ' ' GLY . 6.4 t -70.81 -8.77 54.92 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.314 179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -52.88 -173.44 0.04 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -78.96 -160.15 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.543 2.162 . . . . 0.0 110.952 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.53 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 2.1 ttmm -89.31 176.22 7.02 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.302 0.572 . . . . 0.0 109.581 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.582 HG21 ' O ' ' A' ' 16' ' ' ASN . 45.6 t . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.42 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 2' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 3' ' ' CYS . 5.7 t -61.62 -129.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.415 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 74.1 m 38.61 96.27 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.352 1.072 . . . . 0.0 110.739 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.698 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 98.8 m -58.59 171.79 0.59 Allowed Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.698 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.7 Cg_endo -70.64 166.95 27.02 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.567 1.511 . . . . 0.0 110.532 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.581 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.7 p -57.66 -69.67 0.16 Allowed 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.192 -0.942 . . . . 0.0 111.604 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.64 -36.39 2.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.918 -1.114 . . . . 0.0 110.218 -179.129 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.739 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 9.7 t90 -118.75 64.58 0.77 Allowed 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.055 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -77.14 10.18 22.08 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 120.109 -1.043 . . . . 0.0 110.915 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.41 29.89 4.41 Favored Glycine 0 N--CA 1.487 2.04 0 O-C-N 120.722 -1.458 . . . . 0.0 109.492 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.65 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -80.39 177.83 2.74 Favored Pre-proline 0 C--N 1.294 -1.841 0 O-C-N 121.742 -0.858 . . . . 0.0 111.334 -178.357 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.739 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.61 -51.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 123.483 2.788 . . . . 0.0 113.089 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.59 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.8 p90 -78.63 33.92 0.21 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.673 -1.267 . . . . 0.0 111.476 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.481 ' CA ' ' SG ' ' A' ' 4' ' ' CYS . . . 177.76 -169.27 41.19 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.107 -1.52 . . . . 0.0 110.108 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 9' ' ' GLY . 8.3 mm100 -125.95 -145.45 0.32 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.413 -1.051 . . . . 0.0 109.626 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 7.8 t-20 -108.4 61.88 0.61 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.424 -0.798 . . . . 0.0 109.129 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.549 ' CA ' ' HA ' ' A' ' 27' ' ' VAL . 1.5 m -87.56 -5.1 58.91 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.261 -0.9 . . . . 0.0 110.078 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.547 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 40.2 m-85 -131.24 59.08 43.29 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.206 -0.934 . . . . 0.0 109.901 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.5 Cg_endo -78.27 -36.39 1.0 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.48 2.12 . . . . 0.0 110.52 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -135.46 50.64 2.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.326 -0.859 . . . . 0.0 109.929 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.87 108.56 0.21 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.581 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.5 m -73.76 -12.93 60.86 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.364 0.602 . . . . 0.0 110.343 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -145.72 8.41 1.13 Allowed 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.277 -0.889 . . . . 0.0 110.986 -178.632 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -62.19 -142.56 0.01 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -77.14 -165.77 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.106 1.871 . . . . 0.0 109.204 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -60.45 -68.17 0.32 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.634 -1.227 . . . . 0.0 108.047 178.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.549 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 1.8 t . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.438 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.553 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 0.1 OUTLIER -87.24 82.1 7.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.397 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.517 ' SG ' ' CD ' ' A' ' 26' ' ' LYS . 91.5 m -149.19 93.9 2.15 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.245 -0.909 . . . . 0.0 109.05 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 32.8 m -42.68 166.66 0.08 OUTLIER Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.607 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 33.9 Cg_endo -76.26 153.5 35.97 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.34 2.027 . . . . 0.0 111.091 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.639 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -50.63 -71.21 0.07 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.226 -0.921 . . . . 0.0 110.699 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.607 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -39.75 -29.65 0.06 Allowed 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.918 -179.241 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.757 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.5 t90 -138.4 72.31 1.41 Allowed 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 118.751 -1.18 . . . . 0.0 109.763 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -77.33 -29.09 56.77 Favored Glycine 0 N--CA 1.502 3.063 0 O-C-N 121.275 -0.891 . . . . 0.0 111.229 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.33 13.79 31.89 Favored Glycine 0 N--CA 1.49 2.296 0 O-C-N 120.947 -1.326 . . . . 0.0 110.675 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -63.62 174.48 0.99 Allowed Pre-proline 0 C--N 1.297 -1.714 0 O-C-N 121.307 -1.114 . . . . 0.0 110.915 -178.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.757 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.7 -59.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 123.33 2.687 . . . . 0.0 112.637 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.57 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 23.4 p90 -73.3 127.44 32.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.761 -1.212 . . . . 0.0 109.824 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.553 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 95.37 -165.19 24.87 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.208 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.455 ' H ' ' HA ' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -124.08 -152.14 0.5 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.563 -0.963 . . . . 0.0 109.957 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.25 65.41 0.63 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.514 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.6 m -87.2 -1.95 58.27 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.61 0.719 . . . . 0.0 109.896 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.639 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 67.0 m-85 -134.45 62.31 54.44 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.4 Cg_endo -79.5 -30.97 2.23 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.516 2.144 . . . . 0.0 110.297 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.99 -66.36 0.93 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' A' ' 6' ' ' CYS . . . -144.78 -135.71 2.93 Favored Glycine 0 C--N 1.287 -2.168 0 N-CA-C 106.942 -2.463 . . . . 0.0 106.942 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.552 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 56.9 m -88.39 -20.85 24.73 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-O 122.074 0.94 . . . . 0.0 108.964 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.517 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER 45.4 55.5 6.47 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.371 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 37.87 -97.42 0.01 OUTLIER Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 23' ' ' SER . 32.3 Cg_endo -74.53 -160.64 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.392 2.061 . . . . 0.0 111.187 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.517 ' CD ' ' SG ' ' A' ' 3' ' ' CYS . 19.9 ttpp -39.17 -70.49 0.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.666 -0.646 . . . . 0.0 110.588 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.543 HG22 ' OXT' ' A' ' 27' ' ' VAL . 9.4 p . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.848 -1.157 . . . . 0.0 109.501 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 1' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.505 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 43.2 t -86.09 -21.67 27.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.142 -0.974 . . . . 0.0 109.513 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 81.6 m 40.83 97.14 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 122.227 1.013 . . . . 0.0 110.443 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.654 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 89.8 m -54.66 169.2 0.41 Allowed Pre-proline 0 C--N 1.295 -1.763 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.654 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.6 Cg_endo -71.79 155.77 57.83 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.783 1.655 . . . . 0.0 111.045 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -47.77 -69.5 0.12 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.519 -0.738 . . . . 0.0 111.172 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.597 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -42.48 -35.98 1.2 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.214 -0.929 . . . . 0.0 109.973 -179.14 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.736 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.2 t90 -123.42 65.06 1.01 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.863 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -77.47 8.0 36.19 Favored Glycine 0 N--CA 1.497 2.747 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.851 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.67 28.2 5.77 Favored Glycine 0 N--CA 1.485 1.965 0 O-C-N 120.764 -1.433 . . . . 0.0 109.547 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.64 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -79.05 176.83 3.32 Favored Pre-proline 0 C--N 1.294 -1.808 0 O-C-N 121.769 -0.842 . . . . 0.0 111.492 -178.298 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.736 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.39 -52.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 123.488 2.792 . . . . 0.0 113.117 -177.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.587 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.9 p90 -78.31 33.78 0.2 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.633 -1.292 . . . . 0.0 111.533 -177.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 2' ' ' SER . . . 177.38 -171.02 43.75 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 118.825 -1.655 . . . . 0.0 110.411 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 9' ' ' GLY . 8.2 mt-30 -121.1 -149.19 0.42 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.548 -0.972 . . . . 0.0 110.226 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 7.2 t-20 -109.15 64.46 0.61 Allowed 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 26' ' ' LYS . 1.6 m -87.5 4.92 41.57 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.296 -0.878 . . . . 0.0 109.877 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.58 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 73.5 m-85 -148.53 62.43 6.4 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.197 -0.94 . . . . 0.0 110.013 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.56 ' CG ' ' HB ' ' A' ' 27' ' ' VAL . 36.4 Cg_endo -79.36 -33.68 1.3 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.087 1.858 . . . . 0.0 109.515 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -137.25 53.74 1.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.512 ' HA3' ' HG2' ' A' ' 25' ' ' PRO . . . 163.85 113.45 0.29 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.615 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -69.63 -10.55 58.66 Favored 'General case' 0 C--N 1.283 -2.286 0 O-C-N 122.313 -0.522 . . . . 0.0 111.2 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.461 ' O ' ' C ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -169.19 -50.75 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.876 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' SER . . . -38.49 -86.69 0.01 OUTLIER Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.512 ' HG2' ' HA3' ' A' ' 21' ' ' GLY . 31.3 Cg_endo -76.31 -161.01 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.747 2.298 . . . . 0.0 111.688 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 6.7 tttt -176.08 121.45 0.17 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.56 ' HB ' ' CG ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.15 -0.968 . . . . 0.0 109.936 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.3 ptt85 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.248 0.547 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.488 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 46.7 t -178.67 -28.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.342 -0.849 . . . . 0.0 109.784 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 2' ' ' SER . 99.9 m 41.8 95.89 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.152 0.977 . . . . 0.0 110.472 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.723 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 82.5 m -46.49 171.93 0.06 OUTLIER Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.723 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.8 Cg_endo -70.51 172.88 12.51 Favored 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.75 1.633 . . . . 0.0 111.185 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.718 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 2.9 p -66.82 -42.67 85.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.422 -0.799 . . . . 0.0 111.307 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 1.8 p90 -69.26 -38.23 78.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.081 -1.012 . . . . 0.0 110.223 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.754 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 13.8 t90 -121.11 63.58 0.88 Allowed 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.784 -178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -67.39 -22.95 73.33 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.198 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.76 27.85 6.93 Favored Glycine 0 N--CA 1.488 2.148 0 O-C-N 120.525 -1.573 . . . . 0.0 110.697 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.621 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -81.16 172.71 9.11 Favored Pre-proline 0 C--N 1.294 -1.828 0 O-C-N 121.297 -1.119 . . . . 0.0 111.629 -178.456 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.754 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.6 Cg_endo -75.6 -52.03 0.1 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 123.875 3.05 . . . . 0.0 113.945 -176.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.613 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 33.2 p90 -77.0 32.92 0.14 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.679 -1.263 . . . . 0.0 111.784 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 2' ' ' SER . . . 177.31 -169.54 41.78 Favored Glycine 0 N--CA 1.484 1.897 0 C-N-CA 118.78 -1.676 . . . . 0.0 110.113 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.495 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -119.36 -156.12 0.64 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.518 -0.99 . . . . 0.0 109.899 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -107.79 68.32 0.71 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.586 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.5 m -86.91 -3.44 59.08 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 121.656 -0.653 . . . . 0.0 109.975 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.628 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -153.47 84.03 4.38 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.432 -0.792 . . . . 0.0 109.346 179.402 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.489 ' CD ' ' HB ' ' A' ' 27' ' ' VAL . 34.8 Cg_endo -77.83 -43.22 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.63 2.22 . . . . 0.0 109.809 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -137.78 12.74 2.92 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -92.54 24.74 21.73 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.718 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -35.69 -31.74 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.22 0 CA-C-O 121.877 0.846 . . . . 0.0 110.091 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' GLY . 1.2 m -116.08 -22.31 9.02 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.71 -0.619 . . . . 0.0 109.492 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.69 -173.42 46.88 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.31 -160.93 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.688 2.258 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 2.9 ttpt -58.82 176.64 0.19 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.539 -0.726 . . . . 0.0 109.356 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.538 HG22 ' OXT' ' A' ' 27' ' ' VAL . 9.2 p . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.514 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.519 ' HB2' ' HA2' ' A' ' 14' ' ' GLY . 1.0 OUTLIER -83.99 -102.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 109.204 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 2' ' ' SER . 84.3 m 35.83 96.15 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 122.262 1.03 . . . . 0.0 110.898 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.753 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 69.1 m -54.29 173.35 0.22 Allowed Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.753 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.4 Cg_endo -71.52 155.3 59.68 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.704 1.602 . . . . 0.0 110.832 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.596 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -47.92 -69.19 0.13 Allowed 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.406 -0.808 . . . . 0.0 111.334 -178.418 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 2.0 p90 -44.25 -36.96 2.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.96 . . . . 0.0 109.863 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.732 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.2 t90 -119.89 64.28 0.82 Allowed 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 118.943 -1.103 . . . . 0.0 109.969 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -75.62 6.78 29.86 Favored Glycine 0 N--CA 1.496 2.694 0 C-N-CA 120.262 -0.97 . . . . 0.0 111.13 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.66 27.76 5.89 Favored Glycine 0 N--CA 1.486 1.998 0 O-C-N 120.612 -1.523 . . . . 0.0 109.868 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.65 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -78.43 177.96 2.51 Favored Pre-proline 0 C--N 1.294 -1.839 0 O-C-N 121.641 -0.917 . . . . 0.0 111.457 -178.417 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.732 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.8 Cg_endo -76.9 -52.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 123.489 2.793 . . . . 0.0 113.15 -177.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.585 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.6 p90 -78.1 33.08 0.18 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.719 -1.238 . . . . 0.0 111.677 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.519 ' HA2' ' HB2' ' A' ' 2' ' ' SER . . . 177.78 -170.45 42.8 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 118.812 -1.661 . . . . 0.0 110.488 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -121.85 -151.74 0.49 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.547 -0.973 . . . . 0.0 110.391 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 19.6 t-20 -108.78 64.03 0.61 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.537 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 2.1 m -87.74 -10.59 50.63 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 121.775 0.798 . . . . 0.0 109.792 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.527 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 29.7 m-85 -127.83 67.89 74.14 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.661 -0.65 . . . . 0.0 109.259 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HD3' ' C ' ' A' ' 17' ' ' CYS . 36.5 Cg_endo -78.16 -44.55 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.547 2.165 . . . . 0.0 110.926 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.96 48.71 2.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.112 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.52 108.18 0.22 Allowed Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -67.35 -15.63 63.79 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-O 121.55 0.691 . . . . 0.0 109.582 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 24' ' ' GLY . 6.4 t -129.89 -18.4 3.41 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.641 -0.662 . . . . 0.0 110.225 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -50.43 -179.64 0.03 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -77.55 -160.78 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.38 2.053 . . . . 0.0 110.762 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.537 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -79.26 172.4 13.85 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.716 -0.615 . . . . 0.0 109.576 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.49 -179.972 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.52 ' HB2' ' O ' ' A' ' 13' ' ' TRP . 0.2 OUTLIER -44.16 -49.29 9.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -0.938 . . . . 0.0 109.444 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 2' ' ' SER . 73.1 m 40.96 97.2 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.279 1.038 . . . . 0.0 110.644 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.701 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 95.0 m -54.36 171.55 0.28 Allowed Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.701 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.2 Cg_endo -71.73 157.78 54.71 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 121.772 1.648 . . . . 0.0 110.876 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.582 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -49.2 -70.93 0.07 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.471 -0.768 . . . . 0.0 111.361 -178.389 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.591 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -42.16 -36.54 1.21 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.158 -0.964 . . . . 0.0 110.034 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.74 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.1 t90 -121.59 64.65 0.9 Allowed 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.805 -1.158 . . . . 0.0 109.896 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -76.88 6.92 37.62 Favored Glycine 0 N--CA 1.497 2.703 0 C-N-CA 120.222 -0.989 . . . . 0.0 110.759 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.81 27.34 6.24 Favored Glycine 0 N--CA 1.486 2.011 0 O-C-N 120.706 -1.467 . . . . 0.0 109.671 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.643 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -77.83 176.49 3.52 Favored Pre-proline 0 C--N 1.294 -1.836 0 O-C-N 121.706 -0.879 . . . . 0.0 111.486 -178.438 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.74 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -75.99 -51.78 0.1 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 123.473 2.782 . . . . 0.0 113.029 -177.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.6 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.7 p90 -78.48 34.4 0.21 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.714 -1.241 . . . . 0.0 111.519 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.492 ' HA2' ' HB2' ' A' ' 2' ' ' SER . . . 175.93 -170.46 43.38 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.792 -1.671 . . . . 0.0 110.618 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' GLY . 1.4 tt0 -120.67 -151.91 0.49 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.531 -0.982 . . . . 0.0 110.369 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 1.3 t-20 -108.98 64.57 0.61 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.547 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.9 m -87.99 -0.5 57.09 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.543 -0.723 . . . . 0.0 109.983 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.574 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 72.0 m-85 -140.33 60.36 14.22 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.801 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.4 Cg_endo -78.88 -30.3 2.93 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.451 2.101 . . . . 0.0 110.267 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.88 49.03 1.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 109.909 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.89 111.27 0.24 Allowed Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.582 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.7 m -67.8 -15.36 63.59 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-O 121.57 0.7 . . . . 0.0 109.646 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.89 4.46 2.09 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.675 -0.64 . . . . 0.0 109.88 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.72 -164.29 2.52 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -78.84 -160.41 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.374 2.05 . . . . 0.0 110.624 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.547 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -90.12 178.09 6.27 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.703 -0.623 . . . . 0.0 109.422 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.471 ' OXT' HG13 ' A' ' 27' ' ' VAL . 7.4 p . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.523 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.531 ' HB2' ' CA ' ' A' ' 14' ' ' GLY . 4.9 p -69.66 -93.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.962 . . . . 0.0 109.335 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 4' ' ' CYS . 76.5 m 38.46 96.22 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.993 0.901 . . . . 0.0 110.597 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 56.2 m -40.68 166.38 0.06 OUTLIER Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.571 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.7 Cg_endo -70.97 161.65 45.38 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.204 1.936 . . . . 0.0 110.497 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.611 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.1 p -56.1 -72.53 0.07 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.267 -0.896 . . . . 0.0 111.494 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.09 -36.16 1.55 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.017 -1.052 . . . . 0.0 110.28 -179.003 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.764 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.3 t90 -124.17 64.93 1.06 Allowed 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.221 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -72.29 -30.31 65.08 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.68 8.43 35.35 Favored Glycine 0 N--CA 1.49 2.269 0 O-C-N 120.867 -1.372 . . . . 0.0 110.85 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.629 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -58.4 176.5 0.26 Allowed Pre-proline 0 C--N 1.298 -1.66 0 O-C-N 121.069 -1.254 . . . . 0.0 110.881 -179.004 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.764 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.94 -57.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 123.133 2.555 . . . . 0.0 112.306 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.61 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 25.4 p90 -73.84 115.19 12.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.74 -1.225 . . . . 0.0 109.758 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.531 ' CA ' ' HB2' ' A' ' 2' ' ' SER . . . 93.63 -172.76 33.13 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 4.9 mt-30 -116.64 -147.25 0.41 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.485 -1.009 . . . . 0.0 110.133 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.518 ' ND2' ' HB3' ' A' ' 19' ' ' PRO . 10.5 t30 -108.02 69.73 0.74 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.541 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.5 m -87.48 -7.35 57.74 Favored 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.532 -0.73 . . . . 0.0 110.713 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.548 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 66.0 m-85 -133.79 60.49 46.41 Favored Pre-proline 0 C--N 1.296 -1.738 0 O-C-N 121.291 -0.88 . . . . 0.0 110.234 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.1 Cg_endo -78.95 -24.79 6.67 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.388 2.058 . . . . 0.0 109.852 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.27 52.7 1.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 0.0 109.68 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.21 113.43 0.28 Allowed Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.611 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -75.03 -85.8 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.963 0.887 . . . . 0.0 109.799 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -76.18 -24.35 54.73 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.094 -179.171 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -59.97 -149.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.446 ' C ' ' HD3' ' A' ' 26' ' ' LYS . 35.0 Cg_endo -77.27 -160.34 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.288 1.992 . . . . 0.0 110.029 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.541 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -100.15 -96.05 0.25 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.431 -0.793 . . . . 0.0 109.559 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.5 p . . . . . 0 C--N 1.299 -1.63 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.504 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.532 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -90.33 -77.9 0.39 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 0.0 109.451 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 81.2 m 34.06 95.69 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.239 1.019 . . . . 0.0 110.987 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.697 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 96.0 m -53.75 171.41 0.26 Allowed Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.697 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.8 Cg_endo -69.94 164.24 35.44 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.569 1.512 . . . . 0.0 110.558 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.586 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.6 p -54.82 -70.42 0.1 Allowed 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.248 -0.907 . . . . 0.0 111.713 -177.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.12 -38.7 2.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.968 -1.082 . . . . 0.0 110.208 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.741 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 9.7 t90 -116.74 63.02 0.72 Allowed 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 118.964 -1.095 . . . . 0.0 110.047 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -76.59 8.7 26.01 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.877 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.95 28.59 5.36 Favored Glycine 0 N--CA 1.486 1.991 0 O-C-N 120.707 -1.467 . . . . 0.0 109.511 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.649 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -78.98 177.3 2.96 Favored Pre-proline 0 C--N 1.295 -1.797 0 O-C-N 121.781 -0.835 . . . . 0.0 111.26 -178.404 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.741 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.3 Cg_endo -76.24 -52.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 123.505 2.803 . . . . 0.0 113.063 -177.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.584 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 28.5 p90 -78.14 31.55 0.18 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.724 -1.235 . . . . 0.0 111.597 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 2' ' ' SER . . . -178.29 -172.03 42.26 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 118.714 -1.708 . . . . 0.0 110.517 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 9' ' ' GLY . 5.7 mt-30 -121.37 -150.67 0.46 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.498 -1.001 . . . . 0.0 110.29 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -108.49 62.99 0.61 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.565 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.8 m -88.2 -11.14 47.58 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.396 -0.815 . . . . 0.0 109.938 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.559 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 23.3 m-85 -127.55 56.03 18.11 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.708 -0.62 . . . . 0.0 110.461 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.696 ' HG2' HG23 ' A' ' 27' ' ' VAL . 36.4 Cg_endo -76.73 -29.97 5.18 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.354 2.036 . . . . 0.0 110.491 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -138.84 51.28 1.82 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.918 . . . . 0.0 110.074 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.75 111.52 0.25 Allowed Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.586 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.4 m -77.04 -85.89 0.06 Allowed 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 122.083 0.944 . . . . 0.0 110.005 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.5 OUTLIER -79.95 -8.68 59.46 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.572 -178.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.89 -140.27 0.01 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -77.31 -164.18 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.028 1.819 . . . . 0.0 109.613 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.565 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 17.9 ttpp -51.98 -70.23 0.09 Allowed 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.696 HG23 ' HG2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.034 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.527 ' O ' ' CG ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER 61.31 13.43 4.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.227 -0.921 . . . . 0.0 109.526 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.522 ' SG ' ' CD ' ' A' ' 26' ' ' LYS . 68.0 m -153.97 95.9 1.91 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.213 -0.929 . . . . 0.0 108.712 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.674 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 23.0 m -46.68 171.75 0.06 OUTLIER Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.822 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.674 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.7 Cg_endo -71.9 162.89 40.55 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 121.904 1.736 . . . . 0.0 110.904 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -53.6 -72.8 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.562 -0.711 . . . . 0.0 111.72 -178.255 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.589 ' CE2' ' HB2' ' A' ' 8' ' ' TRP . 6.6 p90 -45.61 -33.53 2.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.125 -0.984 . . . . 0.0 110.7 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.755 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 11.6 t90 -122.77 64.89 0.96 Allowed 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 118.362 -1.335 . . . . 0.0 110.961 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -66.66 -23.07 72.13 Favored Glycine 0 N--CA 1.498 2.828 0 O-C-N 121.237 -0.914 . . . . 0.0 111.414 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.07 29.84 8.86 Favored Glycine 0 N--CA 1.492 2.375 0 O-C-N 120.468 -1.607 . . . . 0.0 111.556 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.662 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -80.66 175.5 4.76 Favored Pre-proline 0 C--N 1.291 -1.953 0 O-C-N 121.281 -1.129 . . . . 0.0 111.217 -178.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.755 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 40.8 Cg_endo -77.84 -55.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 123.857 3.038 . . . . 0.0 114.608 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.444 ' CZ3' ' CZ3' ' A' ' 8' ' ' TRP . 20.7 p90 -73.51 10.24 1.12 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.667 -1.271 . . . . 0.0 112.2 -176.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' C ' ' SG ' ' A' ' 4' ' ' CYS . . . -151.66 173.36 30.98 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.785 -1.674 . . . . 0.0 109.954 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.527 ' CG ' ' O ' ' A' ' 2' ' ' SER . 24.7 mt-30 -93.56 -155.86 0.46 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.331 -1.099 . . . . 0.0 108.889 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 0.6 OUTLIER -108.43 61.88 0.61 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 108.697 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.921 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.6 m -88.72 -94.19 0.1 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.144 -0.973 . . . . 0.0 108.564 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CE2' ' OXT' ' A' ' 27' ' ' VAL . 66.0 m-85 -29.62 88.84 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.89 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.765 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 27' ' ' VAL . 37.0 Cg_endo -77.31 -83.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.23 1.953 . . . . 0.0 109.498 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -120.64 22.85 11.05 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.05 91.42 0.21 Allowed Glycine 0 N--CA 1.481 1.642 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 23.8 m -48.44 -21.8 0.61 Allowed 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.45 -0.875 . . . . 0.0 110.726 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.496 ' O ' ' OXT' ' A' ' 27' ' ' VAL . 1.6 p -115.71 -87.64 0.59 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.445 -0.784 . . . . 0.0 110.089 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 39.57 -149.29 0.12 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.512 ' O ' ' C ' ' A' ' 26' ' ' LYS . 35.5 Cg_endo -77.47 -156.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.952 2.434 . . . . 0.0 110.112 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.522 ' CD ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -33.62 -35.79 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.54 0.686 . . . . 0.0 109.188 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.921 HG12 ' CB ' ' A' ' 17' ' ' CYS . 13.2 m . . . . . 0 C--N 1.3 -1.579 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.051 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.475 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -74.33 0.21 15.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.314 -0.866 . . . . 0.0 109.866 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.517 ' HB3' ' CE1' ' A' ' 18' ' ' TYR . 79.8 m 36.79 93.99 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.696 0.76 . . . . 0.0 110.62 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.591 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 80.2 m -42.71 164.93 0.11 Allowed Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 27.3 Cg_endo -65.31 144.64 81.19 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.487 1.458 . . . . 0.0 110.296 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.578 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 14.6 p -50.97 -42.59 60.18 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.381 -0.824 . . . . 0.0 110.238 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -58.62 -38.42 78.0 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.759 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.6 t90 -126.18 67.54 1.21 Allowed 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.343 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.51 ' HA2' ' HB2' ' A' ' 4' ' ' CYS . . . -75.7 -27.15 63.51 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 120.31 -0.947 . . . . 0.0 111.216 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.31 12.63 37.71 Favored Glycine 0 N--CA 1.49 2.277 0 O-C-N 120.936 -1.332 . . . . 0.0 110.859 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.61 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -58.38 174.1 0.37 Allowed Pre-proline 0 C--N 1.296 -1.739 0 O-C-N 121.259 -1.142 . . . . 0.0 111.064 -178.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.759 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -72.38 -57.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 123.398 2.732 . . . . 0.0 112.29 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.553 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 24.5 p90 -73.33 -167.27 0.41 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.877 -1.139 . . . . 0.0 109.344 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . 40.45 -143.36 0.6 Allowed Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 14' ' ' GLY . 3.2 mt-30 -147.57 -155.27 0.61 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.486 -1.008 . . . . 0.0 109.988 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.53 71.13 0.78 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.525 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.4 m -87.45 -28.39 22.12 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.521 -0.737 . . . . 0.0 110.762 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.576 ' HB2' ' CB ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -137.81 63.8 40.29 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.25 -0.906 . . . . 0.0 109.007 177.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 37.5 Cg_endo -83.46 -35.02 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.787 2.325 . . . . 0.0 110.869 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -90.64 9.73 28.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.9 . . . . 0.0 110.522 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 22' ' ' CYS . . . 129.73 123.54 2.54 Favored Glycine 0 C--N 1.304 -1.25 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.578 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.2 m -29.42 -47.12 0.06 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 122.3 1.047 . . . . 0.0 109.494 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.527 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 18.1 m 43.76 35.73 1.13 Allowed 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.621 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.95 -112.18 3.49 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 23' ' ' SER . 33.2 Cg_endo -74.42 -156.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.603 2.202 . . . . 0.0 111.409 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.525 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -52.3 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.798 0.809 . . . . 0.0 110.85 -178.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.573 HG22 ' OXT' ' A' ' 27' ' ' VAL . 9.1 p . . . . . 0 C--N 1.304 -1.41 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.625 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 3' ' ' CYS . 5.6 t -114.12 -166.81 1.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 109.661 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.495 ' C ' ' O ' ' A' ' 2' ' ' SER . 90.6 m 31.03 90.33 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.91 0.862 . . . . 0.0 110.904 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.582 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 99.5 m -41.33 166.42 0.06 OUTLIER Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.3 Cg_endo -71.28 160.99 47.19 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.057 1.838 . . . . 0.0 110.579 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.592 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.3 p -55.0 -69.35 0.13 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.265 -0.897 . . . . 0.0 111.552 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -41.42 -38.45 1.25 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.205 -0.935 . . . . 0.0 109.931 -178.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.757 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.6 t90 -126.45 66.89 1.23 Allowed 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.908 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -75.02 -26.41 66.69 Favored Glycine 0 N--CA 1.496 2.65 0 O-C-N 121.22 -0.925 . . . . 0.0 111.07 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.37 13.72 38.61 Favored Glycine 0 N--CA 1.488 2.157 0 O-C-N 120.858 -1.377 . . . . 0.0 110.75 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.611 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -62.93 175.63 0.63 Allowed Pre-proline 0 C--N 1.297 -1.703 0 O-C-N 121.239 -1.154 . . . . 0.0 111.036 -178.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.757 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.6 Cg_endo -74.46 -58.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 123.46 2.773 . . . . 0.0 112.747 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.596 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 26.0 p90 -73.17 121.39 20.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.73 -1.231 . . . . 0.0 109.604 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.52 -147.36 18.55 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -141.58 -156.73 0.7 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.509 -0.995 . . . . 0.0 109.921 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 12.0 t-20 -107.64 68.46 0.71 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 1.5 m -87.47 -1.21 57.77 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.376 0.607 . . . . 0.0 110.531 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.57 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 77.8 m-85 -138.93 62.7 28.07 Favored Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 120.828 -1.17 . . . . 0.0 110.376 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 35.6 Cg_endo -79.47 -25.35 5.67 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.519 2.146 . . . . 0.0 110.257 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 7.7 pt-20 -147.0 50.45 1.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.267 -0.895 . . . . 0.0 109.845 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.32 110.68 0.24 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.5 m -75.31 -12.12 60.2 Favored 'General case' 0 C--N 1.286 -2.194 0 O-C-N 122.218 -0.577 . . . . 0.0 110.359 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -143.07 8.19 1.64 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.197 -0.939 . . . . 0.0 111.234 -178.563 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.37 -148.59 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -77.01 -166.37 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.102 1.868 . . . . 0.0 109.136 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 2.1 tttm -51.95 -71.57 0.06 Allowed 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.523 -1.271 . . . . 0.0 107.837 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.539 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 7.1 p . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.389 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.503 ' HA ' ' NH1' ' A' ' 1' ' ' ARG . 2.9 mmm180 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.506 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 3.1 t -92.63 54.07 2.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.908 . . . . 0.0 109.504 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 79.4 m -143.16 90.75 2.21 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 122.087 0.946 . . . . 0.0 109.262 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.752 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 68.3 m -54.64 173.67 0.22 Allowed Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.752 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.5 Cg_endo -70.81 159.3 53.08 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.601 1.534 . . . . 0.0 110.679 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.599 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.2 p -50.07 -68.26 0.19 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.444 -0.785 . . . . 0.0 111.819 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 5' ' ' PRO . 8.1 p90 -46.83 -43.44 18.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.001 -1.062 . . . . 0.0 110.167 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.744 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.3 t90 -110.71 61.08 0.61 Allowed 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.779 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -72.69 5.13 18.22 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.374 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.56 26.58 6.55 Favored Glycine 0 N--CA 1.487 2.075 0 O-C-N 120.622 -1.516 . . . . 0.0 109.923 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.658 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.74 178.57 1.95 Allowed Pre-proline 0 C--N 1.293 -1.86 0 O-C-N 121.626 -0.926 . . . . 0.0 111.44 -178.577 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.744 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.8 Cg_endo -77.28 -52.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.969 0 C-N-CA 123.449 2.766 . . . . 0.0 113.277 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.586 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.9 p90 -77.62 32.88 0.16 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.56 -1.337 . . . . 0.0 111.755 -177.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 176.8 -173.55 46.38 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 118.849 -1.643 . . . . 0.0 110.282 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 2' ' ' SER . 0.2 OUTLIER -118.77 -149.43 0.44 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.478 -1.013 . . . . 0.0 109.909 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 5.6 t-20 -108.35 64.09 0.62 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.548 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.7 m -88.08 1.26 54.68 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.476 -0.765 . . . . 0.0 110.321 -178.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.576 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 66.5 m-85 -142.4 60.17 9.84 Favored Pre-proline 0 C--N 1.299 -1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 109.834 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.6 Cg_endo -79.22 -25.48 5.82 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.429 2.086 . . . . 0.0 110.232 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 26.2 tt0 -140.18 47.85 1.79 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 110.045 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.88 111.19 0.24 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.599 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -71.51 -15.72 62.32 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 121.658 0.742 . . . . 0.0 109.697 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 24' ' ' GLY . 32.6 t -130.24 -22.31 2.82 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.641 -0.662 . . . . 0.0 110.173 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -50.43 -178.8 0.02 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.44 -161.14 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.44 2.093 . . . . 0.0 110.565 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.662 ' HE2' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -72.01 -174.03 1.15 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.639 -0.663 . . . . 0.0 109.458 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.662 HG12 ' HE2' ' A' ' 26' ' ' LYS . 8.9 p . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.496 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.347 0.594 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.535 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 1.1 p -61.34 106.67 0.66 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -0.941 . . . . 0.0 109.52 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 4' ' ' CYS . 69.7 m -152.09 95.97 2.14 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.249 -0.907 . . . . 0.0 109.39 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.603 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 33.7 m -40.73 168.03 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.8 Cg_endo -70.92 171.6 15.42 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.29 1.993 . . . . 0.0 112.3 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.62 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 14.0 p -64.6 -41.67 96.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.741 -0.599 . . . . 0.0 111.754 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.525 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -78.69 -35.42 45.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.866 -1.146 . . . . 0.0 110.414 -178.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.754 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.4 t90 -121.03 63.28 0.87 Allowed 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.127 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.472 ' HA2' ' CB ' ' A' ' 4' ' ' CYS . . . -68.14 -26.71 73.98 Favored Glycine 0 N--CA 1.499 2.876 0 O-C-N 121.457 -0.777 . . . . 0.0 111.416 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.42 16.53 29.27 Favored Glycine 0 N--CA 1.491 2.311 0 O-C-N 120.912 -1.346 . . . . 0.0 110.54 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.66 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -69.56 174.79 2.68 Favored Pre-proline 0 C--N 1.296 -1.732 0 O-C-N 121.434 -1.039 . . . . 0.0 111.169 -178.754 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.754 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.8 Cg_endo -72.73 -60.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 123.267 2.644 . . . . 0.0 111.949 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.58 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 19.4 p90 -73.09 125.76 28.43 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.913 -1.117 . . . . 0.0 108.502 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.535 ' HA2' ' CB ' ' A' ' 2' ' ' SER . . . 89.29 168.98 44.02 Favored Glycine 0 N--CA 1.482 1.732 0 C-N-CA 119.259 -1.448 . . . . 0.0 109.67 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -103.36 -148.42 0.39 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.481 -1.011 . . . . 0.0 109.731 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.89 69.11 0.7 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.526 ' C ' ' HD3' ' A' ' 19' ' ' PRO . 1.5 m -87.1 -14.48 41.26 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.603 -0.686 . . . . 0.0 110.74 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.639 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 65.7 m-85 -123.33 47.17 1.58 Allowed Pre-proline 0 C--N 1.295 -1.797 0 O-C-N 121.241 -0.912 . . . . 0.0 111.407 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.639 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 38.1 Cg_endo -80.19 -1.29 11.27 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.818 1.678 . . . . 0.0 109.618 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.7 -21.77 22.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.903 . . . . 0.0 110.79 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 23' ' ' SER . . . 121.88 127.19 3.33 Favored Glycine 0 C--N 1.293 -1.858 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.56 ' HA ' ' HB2' ' A' ' 6' ' ' CYS . 16.9 m -30.43 -37.09 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 122.017 0.913 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 21' ' ' GLY . 1.9 t -54.28 -60.83 2.81 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.431 0.634 . . . . 0.0 109.628 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.62 142.38 24.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 26' ' ' LYS . 33.5 Cg_endo -78.57 141.26 17.44 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.266 1.978 . . . . 0.0 110.906 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.656 ' HE3' HG22 ' A' ' 27' ' ' VAL . 0.0 OUTLIER 37.56 -158.99 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.105 0.479 . . . . 0.0 110.06 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.656 HG22 ' HE3' ' A' ' 26' ' ' LYS . 4.8 m . . . . . 0 N--CA 1.489 1.507 0 O-C-N 120.988 -1.07 . . . . 0.0 109.53 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER 56.15 97.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.554 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 99.6 m -146.47 93.45 2.3 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.972 0.892 . . . . 0.0 108.754 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.652 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 22.9 m -50.21 170.9 0.16 Allowed Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.652 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.6 Cg_endo -70.4 159.45 52.89 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 121.903 1.735 . . . . 0.0 110.289 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.594 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.2 p -55.05 -70.66 0.1 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.176 -0.952 . . . . 0.0 111.475 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.25 -38.57 2.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.015 -1.053 . . . . 0.0 110.26 -178.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.761 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.2 t90 -122.3 65.99 0.93 Allowed 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.207 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -72.02 -25.42 74.77 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.059 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.7 19.31 20.94 Favored Glycine 0 N--CA 1.49 2.285 0 O-C-N 120.685 -1.48 . . . . 0.0 110.854 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.63 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -71.2 174.43 3.77 Favored Pre-proline 0 C--N 1.296 -1.76 0 O-C-N 121.276 -1.131 . . . . 0.0 111.328 -178.686 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.761 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.7 Cg_endo -76.16 -56.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 123.814 3.009 . . . . 0.0 114.216 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.545 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 24.9 p90 -74.34 24.51 0.08 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.682 -1.261 . . . . 0.0 112.288 -176.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.46 ' CA ' ' SG ' ' A' ' 4' ' ' CYS . . . -167.51 175.94 42.4 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.558 -1.782 . . . . 0.0 110.363 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 9' ' ' GLY . 2.9 tp60 -104.34 -154.64 0.51 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.463 -1.022 . . . . 0.0 109.802 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.34 62.19 0.62 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 1.6 m -87.8 -12.42 45.1 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.807 0.813 . . . . 0.0 110.178 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 68.7 m-85 -130.18 62.86 66.66 Favored Pre-proline 0 C--N 1.291 -1.945 0 O-C-N 120.639 -1.288 . . . . 0.0 110.487 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.5 Cg_endo -79.33 -30.54 2.53 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.549 2.166 . . . . 0.0 109.938 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 19' ' ' PRO . 1.2 mm-40 -143.12 53.12 1.36 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.835 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.49 110.57 0.23 Allowed Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.4 m -75.23 -12.04 60.2 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.259 0.552 . . . . 0.0 110.234 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -145.53 7.34 1.12 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.142 -178.597 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.9 -144.67 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -77.0 -168.68 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.185 1.924 . . . . 0.0 109.03 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.565 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 6.8 ttmm -62.57 -66.85 0.48 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.136 -1.426 . . . . 0.0 108.203 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 17' ' ' CYS . 2.2 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.06 -0.972 . . . . 0.0 109.294 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.445 ' O ' ' HD2' ' A' ' 1' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.499 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 46.9 t -120.32 37.57 4.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.303 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 65.0 m -146.9 94.31 2.4 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.407 -0.808 . . . . 0.0 108.988 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.634 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 68.9 m -42.84 167.76 0.07 OUTLIER Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.634 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 28.8 Cg_endo -67.98 168.45 18.85 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.803 1.668 . . . . 0.0 110.428 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.68 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 1.1 p -65.44 -47.96 74.37 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.05 -1.031 . . . . 0.0 111.137 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -62.11 -49.62 75.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.826 -1.171 . . . . 0.0 109.651 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.767 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.9 t90 -109.56 59.8 0.6 Allowed 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.704 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -67.41 -27.72 73.56 Favored Glycine 0 N--CA 1.496 2.699 0 O-C-N 121.428 -0.795 . . . . 0.0 111.204 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.35 12.52 38.53 Favored Glycine 0 N--CA 1.49 2.256 0 O-C-N 120.869 -1.371 . . . . 0.0 110.841 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -63.39 176.56 0.57 Allowed Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.252 -1.146 . . . . 0.0 110.959 -178.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.767 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.2 Cg_endo -73.72 -58.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 123.129 2.553 . . . . 0.0 112.168 -177.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.607 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 24.8 p90 -73.62 115.45 13.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.753 -1.217 . . . . 0.0 109.122 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 90.55 177.43 44.24 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 40.8 mt-30 -111.07 -146.47 0.41 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.382 -1.07 . . . . 0.0 109.796 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 19.5 t-20 -108.69 75.62 0.98 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 3' ' ' CYS . 1.3 m -87.55 -13.15 43.73 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.556 -0.715 . . . . 0.0 111.496 -177.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.595 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -135.16 67.14 68.52 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.125 -0.984 . . . . 0.0 109.972 178.499 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HB3' ' OD1' ' A' ' 16' ' ' ASN . 32.9 Cg_endo -74.85 -29.97 7.95 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.205 1.937 . . . . 0.0 109.64 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -142.27 11.99 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -108.54 26.06 17.5 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.68 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.6 m -33.66 -32.82 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.218 0 CA-C-O 121.714 0.769 . . . . 0.0 110.639 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -135.29 -34.22 0.87 Allowed 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.684 -0.635 . . . . 0.0 110.138 -179.596 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.36 -131.78 0.01 OUTLIER Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -76.33 -164.92 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.005 1.803 . . . . 0.0 109.46 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 18' ' ' TYR . 9.4 ttpp -73.0 -64.92 0.87 Allowed 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.765 -1.174 . . . . 0.0 109.001 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.489 1.522 0 O-C-N 120.95 -1.094 . . . . 0.0 109.479 179.558 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.556 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 25.5 p -113.12 69.5 0.7 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.497 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.517 ' O ' ' O ' ' A' ' 4' ' ' CYS . 68.4 m -147.47 96.27 2.67 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.293 -0.88 . . . . 0.0 108.837 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.565 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 51.4 m -39.58 165.67 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.58 ' HB2' ' CE1' ' A' ' 7' ' ' TYR . 30.3 Cg_endo -70.02 165.03 32.63 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.224 1.949 . . . . 0.0 111.64 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.676 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -57.51 -46.56 83.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.572 -0.705 . . . . 0.0 111.479 -178.573 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.631 ' CD2' ' N ' ' A' ' 8' ' ' TRP . 42.7 p90 -72.69 -47.17 49.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.984 -1.073 . . . . 0.0 110.404 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.769 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.9 t90 -108.62 59.2 0.61 Allowed 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.902 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 4' ' ' CYS . . . -67.92 -27.39 73.67 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.62 9.07 45.19 Favored Glycine 0 N--CA 1.49 2.279 0 O-C-N 120.875 -1.368 . . . . 0.0 110.403 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.653 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -61.74 176.94 0.39 Allowed Pre-proline 0 C--N 1.298 -1.636 0 O-C-N 121.317 -1.108 . . . . 0.0 111.135 -178.864 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.769 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.0 Cg_endo -75.35 -56.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 123.321 2.68 . . . . 0.0 112.743 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.58 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 30.0 p90 -73.16 123.14 23.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.727 -1.233 . . . . 0.0 109.8 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.556 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 93.95 -148.46 19.01 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 23.8 mt-30 -145.29 -143.73 0.14 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.5 -1.0 . . . . 0.0 109.34 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.16 67.04 0.64 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 3' ' ' CYS . 1.5 m -87.19 -20.25 27.25 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.315 -0.865 . . . . 0.0 110.339 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.568 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 98.3 m-85 -128.88 72.57 81.67 Favored Pre-proline 0 C--N 1.293 -1.887 0 O-C-N 121.628 -0.67 . . . . 0.0 109.577 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.517 ' CD ' HG22 ' A' ' 27' ' ' VAL . 34.9 Cg_endo -77.3 -32.26 3.13 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.424 2.082 . . . . 0.0 109.869 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' O ' ' OE2' ' A' ' 20' ' ' GLU . 3.1 tm-20 -150.09 14.7 0.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.454 -0.779 . . . . 0.0 109.518 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -90.24 15.51 59.6 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.676 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -35.88 -31.84 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.187 0 CA-C-O 121.793 0.806 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 21' ' ' GLY . 91.4 p -112.85 -25.15 9.17 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 121.298 0.57 . . . . 0.0 109.47 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.79 -168.75 30.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 26' ' ' LYS . 35.7 Cg_endo -78.22 -159.93 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.623 2.215 . . . . 0.0 110.693 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -56.5 -159.49 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.57 -0.706 . . . . 0.0 109.655 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.517 HG22 ' CD ' ' A' ' 19' ' ' PRO . 2.1 t . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.406 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.491 ' HG2' ' NH1' ' A' ' 1' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 3' ' ' CYS . 4.1 p -92.08 30.16 1.48 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.205 -0.934 . . . . 0.0 109.449 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 74.2 m 39.2 95.29 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.117 0.961 . . . . 0.0 111.076 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.756 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 86.7 m -52.75 175.28 0.11 Allowed Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.756 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.2 Cg_endo -72.0 165.91 31.18 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 121.33 1.354 . . . . 0.0 110.539 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.556 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -60.75 -47.98 83.85 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.29 -0.881 . . . . 0.0 110.738 -178.31 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.596 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -59.37 -47.03 86.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.838 -1.164 . . . . 0.0 109.469 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.732 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 11.4 t90 -111.11 61.95 0.61 Allowed 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.367 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.532 ' O ' ' CA ' ' A' ' 16' ' ' ASN . . . -73.48 7.36 12.82 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.253 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.73 27.72 6.15 Favored Glycine 0 N--CA 1.486 2.02 0 O-C-N 120.615 -1.521 . . . . 0.0 109.301 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.641 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -79.84 177.07 3.15 Favored Pre-proline 0 C--N 1.295 -1.804 0 O-C-N 121.721 -0.87 . . . . 0.0 111.637 -178.152 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.732 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.29 -48.07 0.14 Allowed 'Trans proline' 0 C--N 1.319 -1.014 0 C-N-CA 123.498 2.799 . . . . 0.0 113.211 -177.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.639 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 36.4 p90 -80.05 37.49 0.37 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.69 -1.256 . . . . 0.0 111.237 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.452 ' HA2' ' N ' ' A' ' 1' ' ' ARG . . . 166.44 -168.05 39.8 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.05 -1.547 . . . . 0.0 110.182 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 8.5 mt-30 -123.48 -150.5 0.45 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.408 -1.054 . . . . 0.0 110.318 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.532 ' CA ' ' O ' ' A' ' 9' ' ' GLY . 0.6 OUTLIER -108.9 69.86 0.72 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.536 ' SG ' ' HG2' ' A' ' 26' ' ' LYS . 1.7 m -87.79 -10.07 52.05 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.376 -0.827 . . . . 0.0 110.492 -177.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.616 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 6.7 m-85 -136.16 56.16 13.64 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.25 -0.906 . . . . 0.0 110.138 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 38.0 Cg_endo -81.77 -49.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 122.43 2.086 . . . . 0.0 111.284 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -92.62 22.23 4.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.389 -0.819 . . . . 0.0 111.198 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.99 113.29 0.37 Allowed Glycine 0 N--CA 1.481 1.651 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.219 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.556 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 8.7 m -57.79 -69.07 0.19 Allowed 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.883 0.849 . . . . 0.0 109.455 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 24' ' ' GLY . 11.0 m -52.76 -44.46 66.52 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -44.0 166.65 0.03 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.04 -159.94 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.492 2.128 . . . . 0.0 110.782 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.536 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 1.2 mtmt -60.41 177.02 0.3 Allowed 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.295 0.569 . . . . 0.0 109.648 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 27' ' ' VAL . 9.8 p . . . . . 0 C--N 1.3 -1.567 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.503 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.494 ' CG ' ' O ' ' A' ' 1' ' ' ARG . 1.8 ptt180 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.501 ' O ' ' C ' ' A' ' 3' ' ' CYS . 2.4 p 42.84 -150.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.286 -0.884 . . . . 0.0 109.643 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.501 ' C ' ' O ' ' A' ' 2' ' ' SER . 78.6 m 30.57 91.42 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.944 0.878 . . . . 0.0 111.026 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.568 ' HB3' ' O ' ' A' ' 8' ' ' TRP . 62.1 m -43.67 168.06 0.07 OUTLIER Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 33.5 Cg_endo -76.33 146.8 28.45 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.057 1.838 . . . . 0.0 110.52 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.62 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -46.82 -63.71 0.96 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 0.0 110.593 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -39.49 -37.48 0.48 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.893 0.854 . . . . 0.0 108.799 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.746 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.0 t90 -135.0 70.21 1.44 Allowed 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.683 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.9 -26.51 66.71 Favored Glycine 0 N--CA 1.5 2.948 0 O-C-N 121.279 -0.888 . . . . 0.0 111.34 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.13 17.27 23.92 Favored Glycine 0 N--CA 1.489 2.18 0 O-C-N 120.846 -1.385 . . . . 0.0 110.674 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.611 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -68.48 174.89 2.19 Favored Pre-proline 0 C--N 1.297 -1.708 0 O-C-N 121.28 -1.129 . . . . 0.0 111.075 -178.737 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.746 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.3 Cg_endo -74.36 -58.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 123.436 2.757 . . . . 0.0 112.776 -177.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.592 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 25.5 p90 -73.44 123.74 24.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.726 -1.234 . . . . 0.0 110.003 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 100.38 -146.16 17.54 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -144.41 -152.34 0.41 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.594 -0.945 . . . . 0.0 109.767 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.44 63.97 0.61 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.519 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.6 m -87.09 2.65 49.09 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.661 0.743 . . . . 0.0 109.908 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.62 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 73.3 m-85 -145.33 76.2 13.38 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.66 -37.7 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.701 2.268 . . . . 0.0 112.081 -178.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.9 38.74 1.47 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.817 -1.177 . . . . 0.0 111.264 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 22' ' ' CYS . . . 149.34 119.66 1.0 Allowed Glycine 0 N--CA 1.479 1.507 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.0 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 12.0 m -40.63 -38.57 0.9 Allowed 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 122.381 1.086 . . . . 0.0 108.775 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.518 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 23.2 t 44.31 56.8 4.7 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 40.9 -99.43 0.01 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 23' ' ' SER . 32.2 Cg_endo -74.02 -159.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.371 2.047 . . . . 0.0 111.051 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.594 ' NZ ' HG12 ' A' ' 27' ' ' VAL . 1.5 ttpp -48.34 -179.97 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.536 0.684 . . . . 0.0 109.889 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 27' ' ' VAL . 5.4 p . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.433 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.559 ' HG3' ' CD1' ' A' ' 13' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.549 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 2.9 t 170.04 -19.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.067 -1.021 . . . . 0.0 110.614 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 4' ' ' CYS . 87.5 m -143.09 93.04 2.45 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 120.892 -1.13 . . . . 0.0 109.557 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.586 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 39.3 m -41.67 167.6 0.06 OUTLIER Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.7 Cg_endo -72.11 159.44 49.93 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.071 1.847 . . . . 0.0 110.294 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.606 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.2 p -53.88 -71.51 0.07 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.293 -0.88 . . . . 0.0 111.531 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -44.19 -44.33 7.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.99 -1.069 . . . . 0.0 109.985 -178.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.767 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.6 t90 -115.8 63.22 0.7 Allowed 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 119.135 -1.026 . . . . 0.0 109.861 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -73.41 -26.28 70.57 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.94 7.97 52.9 Favored Glycine 0 N--CA 1.489 2.187 0 O-C-N 120.846 -1.385 . . . . 0.0 110.396 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -58.92 177.26 0.25 Allowed Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.258 -1.143 . . . . 0.0 110.963 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.767 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.2 Cg_endo -74.34 -57.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 123.213 2.609 . . . . 0.0 112.647 -177.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.596 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 26.6 p90 -73.58 117.67 15.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.697 -1.252 . . . . 0.0 109.697 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.549 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 91.26 -171.54 35.41 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -124.14 -138.55 0.29 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.211 -1.17 . . . . 0.0 110.147 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.515 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -109.27 70.65 0.74 Allowed 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.959 -1.088 . . . . 0.0 109.014 -179.139 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.555 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.7 m -89.36 -4.2 58.16 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 121.307 -0.87 . . . . 0.0 110.153 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.561 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 67.2 m-85 -140.09 60.75 15.68 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.425 -0.797 . . . . 0.0 109.462 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.3 Cg_endo -78.78 -23.77 7.84 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.426 2.084 . . . . 0.0 110.675 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.3 46.7 1.31 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.062 -1.024 . . . . 0.0 110.403 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.93 110.33 0.23 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.5 m -69.45 -15.1 63.2 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.598 0.714 . . . . 0.0 109.626 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 24' ' ' GLY . 3.8 m -126.86 -24.99 3.41 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.618 -0.676 . . . . 0.0 109.963 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -48.5 176.41 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -77.3 -161.59 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.36 2.04 . . . . 0.0 110.615 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.555 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 10.2 ttmt -71.03 -172.17 0.65 Allowed 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.695 -0.628 . . . . 0.0 109.333 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 29.0 m . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.934 -1.031 . . . . 0.0 109.515 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.494 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 7.5 t -92.17 58.42 3.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 4' ' ' CYS . 62.2 m -147.82 93.55 2.22 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.352 -0.842 . . . . 0.0 108.882 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.582 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 44.2 m -41.37 167.3 0.05 OUTLIER Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.6 Cg_endo -72.33 159.6 49.06 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.263 1.975 . . . . 0.0 110.614 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.616 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -55.99 -69.94 0.13 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.893 . . . . 0.0 111.202 -178.685 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.596 ' CE2' ' HB2' ' A' ' 8' ' ' TRP . 1.5 p90 -42.16 -37.96 1.59 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 109.604 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.753 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.0 t90 -126.27 67.22 1.21 Allowed 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 119.059 -1.057 . . . . 0.0 109.991 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -75.26 -26.45 66.06 Favored Glycine 0 N--CA 1.496 2.694 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.005 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.91 11.14 49.31 Favored Glycine 0 N--CA 1.49 2.294 0 O-C-N 120.877 -1.366 . . . . 0.0 110.532 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.636 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -61.5 176.13 0.45 Allowed Pre-proline 0 C--N 1.297 -1.702 0 O-C-N 121.361 -1.082 . . . . 0.0 110.948 -178.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.753 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.8 -58.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 123.195 2.596 . . . . 0.0 112.455 -177.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.598 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 24.4 p90 -73.4 118.84 16.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.719 -1.238 . . . . 0.0 109.367 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.494 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 93.51 -178.79 38.49 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 19.8 mt-30 -111.26 -145.91 0.4 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.405 -1.056 . . . . 0.0 109.8 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -108.77 66.13 0.63 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.881 ' HA ' HG23 ' A' ' 27' ' ' VAL . 1.6 m -87.97 13.25 11.37 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.417 -0.802 . . . . 0.0 110.885 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.593 ' CD1' ' O ' ' A' ' 17' ' ' CYS . 62.7 m-85 -155.21 63.23 3.68 Favored Pre-proline 0 C--N 1.296 -1.759 0 O-C-N 120.664 -1.272 . . . . 0.0 109.547 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.7 Cg_endo -79.65 -32.09 1.72 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.307 2.005 . . . . 0.0 110.321 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -142.03 51.41 1.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 110.147 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.04 110.46 0.23 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.616 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -70.03 -16.56 63.17 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 121.437 0.637 . . . . 0.0 109.888 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.575 ' O ' ' C ' ' A' ' 24' ' ' GLY . 20.4 m -135.46 -94.07 0.27 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.417 -0.802 . . . . 0.0 109.192 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 13.57 -127.97 0.01 OUTLIER Glycine 0 N--CA 1.511 3.657 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -81.93 -157.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.162 1.908 . . . . 0.0 107.999 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.576 ' CA ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -133.09 -38.11 0.97 Allowed 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.483 178.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.881 HG23 ' HA ' ' A' ' 17' ' ' CYS . 25.0 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 120.894 -1.129 . . . . 0.0 109.165 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.56 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 0.1 OUTLIER -101.47 100.58 11.04 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.205 -0.935 . . . . 0.0 109.186 179.926 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 4' ' ' CYS . 73.5 m -143.18 89.76 2.13 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.042 -1.036 . . . . 0.0 110.255 -178.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.568 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 11.9 m -43.75 168.77 0.06 OUTLIER Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.497 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.4 Cg_endo -71.43 148.75 55.1 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.001 1.8 . . . . 0.0 110.621 179.41 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.568 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 1.6 p -55.08 -46.19 75.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 110.916 -178.704 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -59.12 -36.39 75.1 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.839 -1.163 . . . . 0.0 108.192 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.726 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 17.9 t90 -131.52 69.59 1.47 Allowed 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.424 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -73.05 -26.51 70.75 Favored Glycine 0 N--CA 1.499 2.834 0 O-C-N 121.358 -0.839 . . . . 0.0 111.371 -178.625 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.48 15.19 31.09 Favored Glycine 0 N--CA 1.491 2.343 0 O-C-N 120.842 -1.387 . . . . 0.0 110.353 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.642 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -68.17 175.85 1.63 Allowed Pre-proline 0 C--N 1.296 -1.736 0 O-C-N 121.438 -1.036 . . . . 0.0 111.124 -178.735 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.726 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.0 Cg_endo -73.48 -60.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 123.31 2.673 . . . . 0.0 112.322 -177.475 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.58 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 17.5 p90 -73.29 122.93 22.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 0.0 109.287 -179.039 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.56 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 99.2 -166.62 21.11 Favored Glycine 0 N--CA 1.485 1.929 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.053 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -129.24 -147.91 0.36 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.466 -1.02 . . . . 0.0 109.65 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.42 64.83 0.62 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.562 ' SG ' ' HG2' ' A' ' 26' ' ' LYS . 1.6 m -87.56 -4.34 58.97 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.45 -0.781 . . . . 0.0 110.217 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.563 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 57.2 m-85 -148.15 61.75 6.14 Favored Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 121.416 -0.803 . . . . 0.0 109.772 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 37.5 Cg_endo -82.27 -39.06 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.634 2.223 . . . . 0.0 111.536 -179.6 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -122.91 36.35 4.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.968 -1.082 . . . . 0.0 111.279 -178.277 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.19 113.48 0.46 Allowed Glycine 0 N--CA 1.483 1.829 0 C-N-CA 119.487 -1.34 . . . . 0.0 110.547 178.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.568 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 8.7 m -56.6 -41.61 77.32 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-O 122.074 0.94 . . . . 0.0 109.233 179.01 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 24' ' ' GLY . 1.8 t -81.33 -41.15 22.5 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.496 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -44.22 166.84 0.03 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.8 -159.64 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.341 2.027 . . . . 0.0 110.641 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.562 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 3.4 mtpp -69.84 175.31 4.41 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.592 0.71 . . . . 0.0 109.959 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.567 HG22 ' OXT' ' A' ' 27' ' ' VAL . 9.5 p . . . . . 0 C--N 1.302 -1.463 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.488 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.588 ' O ' ' NE2' ' A' ' 15' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.251 0.548 . . . . 0.0 109.54 . . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.47 ' OG ' ' HG3' ' A' ' 15' ' ' GLN . 0.0 OUTLIER 61.37 114.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.458 179.984 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 4' ' ' CYS . 69.9 m -143.75 91.74 2.27 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.994 0.902 . . . . 0.0 108.628 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.678 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 68.2 m -44.64 170.32 0.05 OUTLIER Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.678 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.7 Cg_endo -72.74 158.28 50.65 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 C-N-CA 121.87 1.713 . . . . 0.0 110.672 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.579 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -61.87 -47.82 83.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.331 -0.856 . . . . 0.0 110.464 -178.738 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -53.23 -31.53 43.72 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.45 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.75 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.6 t90 -139.26 74.59 1.48 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.693 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -76.45 -26.4 63.54 Favored Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.336 -178.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.49 26.79 6.13 Favored Glycine 0 N--CA 1.49 2.275 0 O-C-N 120.675 -1.485 . . . . 0.0 110.922 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.624 ' HA ' ' CZ2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.91 173.41 7.52 Favored Pre-proline 0 C--N 1.293 -1.879 0 O-C-N 121.314 -1.11 . . . . 0.0 111.379 -178.669 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.75 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.3 Cg_endo -75.8 -55.16 0.07 OUTLIER 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 123.771 2.98 . . . . 0.0 114.12 -177.012 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.591 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.4 p90 -74.73 28.47 0.09 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.718 -1.239 . . . . 0.0 112.274 -177.072 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.459 ' HA2' ' OG ' ' A' ' 2' ' ' SER . . . -177.2 179.67 47.93 Favored Glycine 0 N--CA 1.485 1.938 0 C-N-CA 118.61 -1.757 . . . . 0.0 110.197 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.588 ' NE2' ' O ' ' A' ' 1' ' ' ARG . 71.3 mt-30 -101.22 -163.96 1.06 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.425 -1.044 . . . . 0.0 109.553 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -106.5 65.49 0.68 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.346 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.571 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.6 m -87.48 9.22 21.62 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.313 0.578 . . . . 0.0 110.145 -177.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.575 ' CE1' ' O ' ' A' ' 26' ' ' LYS . 65.8 m-85 -150.76 62.85 5.5 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 120.69 -1.256 . . . . 0.0 109.844 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.8 Cg_endo -80.39 -62.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.637 2.225 . . . . 0.0 110.867 -179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.9 37.05 2.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.65 105.22 0.18 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.426 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.579 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 37.1 m -62.47 -32.88 73.84 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.697 0.76 . . . . 0.0 110.708 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.491 ' O ' ' C ' ' A' ' 24' ' ' GLY . 11.8 t -99.07 -89.29 0.32 Allowed 'General case' 0 C--N 1.287 -2.125 0 O-C-N 121.68 -0.638 . . . . 0.0 109.55 -179.521 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 33.47 -149.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 26' ' ' LYS . 34.4 Cg_endo -79.21 -166.97 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.4 2.067 . . . . 0.0 108.981 178.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.575 ' O ' ' CE1' ' A' ' 18' ' ' TYR . 2.6 ttmm -50.33 -58.71 5.05 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.622 -1.231 . . . . 0.0 107.928 178.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.552 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 14.4 m . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.487 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.342 0.591 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 3' ' ' CYS . 60.1 p -82.83 -143.88 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 109.389 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 89.2 m 32.87 91.9 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.95 0.881 . . . . 0.0 110.898 179.207 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 8' ' ' TRP . 58.4 m -43.35 168.1 0.07 OUTLIER Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.214 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 34.0 Cg_endo -77.03 146.35 25.6 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.19 1.926 . . . . 0.0 110.683 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.636 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -46.25 -63.95 0.87 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.086 -1.009 . . . . 0.0 110.587 -179.453 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -39.59 -37.93 0.55 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.874 0.845 . . . . 0.0 108.842 -179.737 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.747 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.2 t90 -134.97 70.11 1.44 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.633 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.0 -26.65 66.16 Favored Glycine 0 N--CA 1.501 2.986 0 O-C-N 121.275 -0.89 . . . . 0.0 111.387 -178.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.71 15.95 28.47 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.918 -1.343 . . . . 0.0 110.571 -179.086 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.613 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -66.99 174.75 1.76 Allowed Pre-proline 0 C--N 1.296 -1.735 0 O-C-N 121.295 -1.121 . . . . 0.0 111.04 -178.764 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.747 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.4 Cg_endo -74.1 -57.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 123.311 2.674 . . . . 0.0 112.833 -177.473 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.592 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 26.8 p90 -73.4 122.83 22.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.681 -1.262 . . . . 0.0 109.978 -178.493 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.432 ' C ' ' HG3' ' A' ' 15' ' ' GLN . . . 99.21 -147.39 18.41 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.432 ' HG3' ' C ' ' A' ' 14' ' ' GLY . 21.8 mt-30 -143.4 -149.86 0.29 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.466 -1.02 . . . . 0.0 109.793 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.69 63.74 0.61 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.507 ' SG ' ' HG2' ' A' ' 26' ' ' LYS . 1.7 m -87.21 8.05 25.67 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.401 -0.812 . . . . 0.0 109.594 -178.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.636 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 77.2 m-85 -149.21 64.98 7.75 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.5 Cg_endo -80.75 -16.34 10.33 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.632 2.221 . . . . 0.0 111.809 -178.156 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.16 35.99 0.67 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.633 -1.292 . . . . 0.0 111.28 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 23' ' ' SER . . . 134.56 124.24 2.44 Favored Glycine 0 N--CA 1.476 1.328 0 C-N-CA 119.504 -1.332 . . . . 0.0 109.955 179.239 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.533 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 20.5 m -35.67 -34.58 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 122.442 1.115 . . . . 0.0 109.39 179.354 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.491 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 37.6 p 46.53 58.88 4.23 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.226 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 43.2 -101.75 0.03 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 23' ' ' SER . 33.8 Cg_endo -75.89 -160.39 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.29 1.993 . . . . 0.0 111.057 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.507 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -50.78 -172.59 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.365 0.603 . . . . 0.0 110.22 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 9.8 p . . . . . 0 C--N 1.303 -1.442 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.532 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.443 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -94.98 76.83 3.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.779 -179.821 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.51 ' O ' ' O ' ' A' ' 4' ' ' CYS . 53.9 m -150.73 96.46 2.36 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.327 -0.858 . . . . 0.0 108.729 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.596 ' HB3' ' O ' ' A' ' 8' ' ' TRP . 55.7 m -39.23 165.69 0.05 OUTLIER Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.862 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.8 Cg_endo -71.24 173.32 12.44 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.286 1.991 . . . . 0.0 111.319 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.718 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -69.58 -48.0 61.67 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.427 -0.796 . . . . 0.0 111.511 -178.397 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.544 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -66.11 -29.78 70.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.737 -1.227 . . . . 0.0 109.773 -179.612 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.755 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.0 t90 -131.99 68.12 1.5 Allowed 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 118.679 -1.209 . . . . 0.0 109.933 -178.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.463 ' HA2' ' CB ' ' A' ' 4' ' ' CYS . . . -74.09 -26.24 69.17 Favored Glycine 0 N--CA 1.5 2.929 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.292 -179.141 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.06 13.95 35.46 Favored Glycine 0 N--CA 1.489 2.189 0 O-C-N 120.788 -1.419 . . . . 0.0 110.313 -179.455 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.651 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -66.27 175.1 1.39 Allowed Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 121.442 -1.034 . . . . 0.0 111.056 -178.78 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.755 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.4 -58.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -1.019 0 C-N-CA 123.275 2.65 . . . . 0.0 112.485 -177.35 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.581 ' O ' ' CD1' ' A' ' 13' ' ' TRP . 23.9 p90 -72.79 122.12 21.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.74 -1.225 . . . . 0.0 109.121 -179.039 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' HA2' ' OG ' ' A' ' 2' ' ' SER . . . 88.17 174.77 47.74 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.473 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 12.7 mt-30 -103.2 -149.49 0.4 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.257 -1.143 . . . . 0.0 109.408 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.455 ' OD1' ' HA3' ' A' ' 9' ' ' GLY . 16.7 t-20 -108.67 68.9 0.7 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.531 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.7 m -86.87 -11.44 50.77 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.37 0.605 . . . . 0.0 109.944 -177.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.542 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 43.0 m-85 -132.46 77.15 70.69 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.51 ' HD2' ' HA ' ' A' ' 27' ' ' VAL . 35.2 Cg_endo -76.47 -48.44 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.586 2.19 . . . . 0.0 109.835 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -143.33 16.23 1.86 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -92.49 25.75 16.95 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.718 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -35.73 -31.5 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.22 0 CA-C-O 121.79 0.805 . . . . 0.0 110.196 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -125.37 -30.73 3.1 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.757 -0.59 . . . . 0.0 109.603 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.29 -148.87 0.04 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -78.18 -160.67 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.69 2.26 . . . . 0.0 110.738 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.531 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 20.5 ttpt -50.95 -76.26 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.527 -0.733 . . . . 0.0 109.165 179.549 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.51 ' HA ' ' HD2' ' A' ' 19' ' ' PRO . 5.2 m . . . . . 0 N--CA 1.49 1.556 0 O-C-N 120.955 -1.091 . . . . 0.0 109.43 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.463 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 2.1 mmm180 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.543 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 3.3 t -131.55 -1.56 3.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.349 -0.844 . . . . 0.0 109.659 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 89.2 m -148.44 91.87 1.95 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.128 -0.982 . . . . 0.0 109.635 -179.279 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.631 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 80.9 m -43.12 167.04 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.631 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 26.4 Cg_endo -65.28 152.67 81.38 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.123 1.215 . . . . 0.0 109.519 179.559 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.617 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 16.4 p -59.45 -42.48 92.08 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.141 -0.974 . . . . 0.0 110.088 -177.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -57.43 -28.62 63.47 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.099 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.763 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.1 t90 -136.06 72.63 1.44 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.041 -179.03 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 4' ' ' CYS . . . -79.73 -24.45 60.27 Favored Glycine 0 N--CA 1.5 2.929 0 O-C-N 121.12 -0.988 . . . . 0.0 111.121 -179.268 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.59 16.57 34.92 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.96 -1.318 . . . . 0.0 110.555 -179.146 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.618 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -63.77 174.18 1.11 Allowed Pre-proline 0 C--N 1.296 -1.742 0 O-C-N 121.272 -1.134 . . . . 0.0 111.042 -178.82 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.763 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.8 Cg_endo -73.05 -58.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 123.352 2.701 . . . . 0.0 112.222 -177.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.551 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 22.8 p90 -73.28 -167.76 0.45 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.768 -1.207 . . . . 0.0 109.153 -179.181 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.543 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 37.86 -148.54 0.07 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.8 OUTLIER -139.69 -157.6 0.78 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.411 -1.052 . . . . 0.0 109.99 179.801 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.475 ' OD1' ' CG ' ' A' ' 19' ' ' PRO . 13.5 t-20 -109.23 70.83 0.75 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 179.567 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.532 ' C ' ' CG ' ' A' ' 18' ' ' TYR . 1.3 m -87.84 -2.05 58.36 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.453 0.644 . . . . 0.0 111.074 -177.719 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.617 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -165.83 76.84 1.24 Allowed Pre-proline 0 N--CA 1.496 1.825 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.101 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.475 ' CG ' ' OD1' ' A' ' 16' ' ' ASN . 37.6 Cg_endo -82.83 -54.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 123.028 2.485 . . . . 0.0 112.013 -178.038 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -94.18 15.98 15.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.102 -0.999 . . . . 0.0 111.563 -177.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 22' ' ' CYS . . . 149.03 120.25 1.06 Allowed Glycine 0 N--CA 1.475 1.241 0 C-N-CA 118.989 -1.577 . . . . 0.0 110.174 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.598 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.4 m -37.05 -46.18 0.65 Allowed 'General case' 0 C--N 1.288 -2.105 0 CA-C-O 122.364 1.078 . . . . 0.0 108.59 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.527 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER 46.28 36.55 3.39 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.446 179.067 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.04 -112.38 3.47 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 179.441 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 23' ' ' SER . 32.7 Cg_endo -74.76 -157.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.377 2.051 . . . . 0.0 111.109 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 25' ' ' PRO . 2.1 mtpt -46.16 177.91 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.67 0.747 . . . . 0.0 110.271 -179.603 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 17' ' ' CYS . 5.4 p . . . . . 0 C--N 1.301 -1.543 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.647 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.31 0.576 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 3' ' ' CYS . 6.6 t -76.32 -136.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.866 . . . . 0.0 109.303 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 75.1 m 35.34 95.63 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.26 1.029 . . . . 0.0 110.758 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.676 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 57.7 m -52.36 170.68 0.23 Allowed Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.676 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.0 Cg_endo -71.93 166.38 29.73 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.068 1.846 . . . . 0.0 111.355 -179.604 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.68 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -62.52 -44.48 96.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.54 -0.725 . . . . 0.0 110.696 -179.034 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -67.49 -34.38 77.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.273 -0.892 . . . . 0.0 110.012 -178.929 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.751 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 13.4 t90 -126.63 65.61 1.26 Allowed 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.574 -178.445 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -65.66 -28.99 74.16 Favored Glycine 0 N--CA 1.498 2.77 0 O-C-N 121.344 -0.847 . . . . 0.0 111.542 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.09 29.89 4.54 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 120.68 -1.482 . . . . 0.0 111.283 -178.459 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.635 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -82.53 172.16 10.17 Favored Pre-proline 0 C--N 1.294 -1.836 0 O-C-N 121.211 -1.17 . . . . 0.0 111.427 -178.666 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.751 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.5 Cg_endo -75.55 -53.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 123.837 3.025 . . . . 0.0 113.997 -176.586 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.566 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 27.3 p90 -74.83 23.2 0.1 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.675 -1.266 . . . . 0.0 112.005 -177.294 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.409 ' C ' ' SG ' ' A' ' 4' ' ' CYS . . . -168.28 -174.92 37.5 Favored Glycine 0 N--CA 1.485 1.963 0 C-N-CA 118.949 -1.596 . . . . 0.0 110.028 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 9' ' ' GLY . 35.8 mt-30 -116.99 -149.25 0.44 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.554 -0.968 . . . . 0.0 109.16 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -108.82 62.44 0.6 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.7 m -87.01 -19.95 27.94 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.258 -0.901 . . . . 0.0 109.147 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.618 ' CG ' ' HB2' ' A' ' 26' ' ' LYS . 6.6 m-85 -116.66 71.31 5.04 Favored Pre-proline 0 C--N 1.296 -1.723 0 O-C-N 121.666 -0.647 . . . . 0.0 109.815 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.513 ' HD3' ' C ' ' A' ' 17' ' ' CYS . 34.7 Cg_endo -74.99 -44.54 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.159 1.906 . . . . 0.0 110.195 179.572 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -144.86 15.38 1.56 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.375 -0.828 . . . . 0.0 109.092 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 25' ' ' PRO . . . -93.36 23.52 29.59 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.716 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.68 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.6 m -36.0 -29.45 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.361 0.601 . . . . 0.0 111.231 -179.675 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' GLY . 2.5 p -113.1 -74.15 0.64 Allowed 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.436 -0.79 . . . . 0.0 110.778 -178.759 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -59.47 -131.86 0.01 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.145 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.52 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 33.4 Cg_endo -74.98 -158.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.2 1.933 . . . . 0.0 109.836 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 1.006 ' HG2' HG13 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -138.32 -36.85 0.57 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.184 -0.947 . . . . 0.0 109.935 -179.859 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.006 HG13 ' HG2' ' A' ' 26' ' ' LYS . 3.5 m . . . . . 0 N--CA 1.493 1.678 0 O-C-N 120.733 -1.229 . . . . 0.0 109.3 178.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 2' ' ' SER . 5.2 mtp180 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 3' ' ' CYS . 0.8 OUTLIER 52.21 175.63 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.229 -0.92 . . . . 0.0 109.502 -179.926 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.48 ' C ' ' O ' ' A' ' 2' ' ' SER . 73.8 m 33.15 91.78 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 122.133 0.968 . . . . 0.0 110.905 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.747 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 86.3 m -49.71 173.94 0.07 OUTLIER Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.061 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.747 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.4 Cg_endo -72.9 165.73 31.98 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.599 1.532 . . . . 0.0 111.35 -179.293 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.727 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -56.34 -46.95 79.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.453 -0.78 . . . . 0.0 111.343 -178.383 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -63.75 -40.08 95.84 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.034 -1.041 . . . . 0.0 110.375 -179.248 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.734 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.8 t90 -117.6 62.77 0.74 Allowed 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.24 -178.25 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -71.93 5.67 12.14 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.163 -0.961 . . . . 0.0 111.522 -179.242 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.68 28.64 5.88 Favored Glycine 0 N--CA 1.486 1.969 0 O-C-N 120.508 -1.583 . . . . 0.0 109.617 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.658 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -80.4 176.66 3.57 Favored Pre-proline 0 C--N 1.294 -1.848 0 O-C-N 121.654 -0.909 . . . . 0.0 111.664 -178.207 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.734 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.63 -50.21 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 123.569 2.846 . . . . 0.0 113.181 -177.015 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.633 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 34.6 p90 -78.58 34.79 0.22 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.675 -1.266 . . . . 0.0 111.585 -177.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.81 -163.26 32.1 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.834 -1.65 . . . . 0.0 110.502 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' GLY . 2.1 tt0 -128.3 -152.11 0.5 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.538 -0.978 . . . . 0.0 110.073 -179.337 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 12.7 t30 -109.21 64.59 0.61 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.536 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.6 m -87.46 -11.07 50.12 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.428 -0.795 . . . . 0.0 109.703 -179.0 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.527 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 96.9 m-85 -130.84 73.04 81.52 Favored Pre-proline 0 C--N 1.296 -1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 109.723 -179.232 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.524 ' CD ' ' O ' ' A' ' 27' ' ' VAL . 35.1 Cg_endo -77.67 -40.95 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.442 2.095 . . . . 0.0 109.477 179.581 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -141.2 13.03 2.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.352 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -94.9 25.67 22.5 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.557 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.727 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -38.67 -29.7 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.286 0 CA-C-O 121.751 0.786 . . . . 0.0 109.952 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 21' ' ' GLY . 48.5 t -147.97 54.58 1.04 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -157.24 -132.36 1.45 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -78.66 -160.58 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.388 2.059 . . . . 0.0 111.018 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.536 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 3.3 ttpt -122.64 87.61 2.78 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.753 -0.592 . . . . 0.0 109.545 179.598 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.524 ' O ' ' CD ' ' A' ' 19' ' ' PRO . 42.4 t . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.642 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.531 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -59.96 -76.95 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.369 -179.95 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.468 ' C ' ' O ' ' A' ' 2' ' ' SER . 71.6 m 34.36 95.98 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.127 0.965 . . . . 0.0 111.031 179.013 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.658 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 97.9 m -55.13 169.78 0.42 Allowed Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.879 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.658 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.5 Cg_endo -72.03 156.26 56.22 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.772 1.648 . . . . 0.0 111.068 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.596 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -48.17 -70.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.453 -0.779 . . . . 0.0 111.109 -178.487 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.599 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -41.16 -34.14 0.43 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.436 -0.79 . . . . 0.0 109.852 -178.886 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.736 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.1 t90 -126.0 66.47 1.2 Allowed 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.732 -179.31 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -78.32 5.95 53.32 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 120.162 -1.018 . . . . 0.0 110.871 -179.202 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.72 26.7 6.78 Favored Glycine 0 N--CA 1.485 1.955 0 O-C-N 120.773 -1.427 . . . . 0.0 109.637 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.643 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.91 176.47 3.42 Favored Pre-proline 0 C--N 1.294 -1.845 0 O-C-N 121.733 -0.863 . . . . 0.0 111.344 -178.402 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.736 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.8 Cg_endo -76.18 -52.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 123.423 2.748 . . . . 0.0 113.153 -177.154 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.583 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 28.9 p90 -78.0 31.73 0.17 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.745 -1.222 . . . . 0.0 111.625 -177.788 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.531 ' HA2' ' CB ' ' A' ' 2' ' ' SER . . . -179.15 -171.73 42.62 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 118.595 -1.764 . . . . 0.0 110.595 179.555 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' GLY . 1.3 tt0 -118.87 -151.69 0.49 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.558 -0.966 . . . . 0.0 110.142 -179.522 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.582 ' O ' HG21 ' A' ' 27' ' ' VAL . 27.0 t-20 -109.24 64.19 0.61 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.53 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.7 m -87.73 4.26 44.87 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.396 -0.815 . . . . 0.0 110.015 -178.516 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.596 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 73.0 m-85 -147.07 62.27 7.2 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.282 -0.886 . . . . 0.0 109.742 -178.972 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.582 ' CG ' HG22 ' A' ' 27' ' ' VAL . 35.4 Cg_endo -78.66 -38.8 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.587 2.191 . . . . 0.0 110.324 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -132.61 49.85 2.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 109.422 -179.899 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.25 112.31 0.26 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 179.71 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.7 m -64.9 -81.87 0.03 OUTLIER 'General case' 0 C--N 1.285 -2.232 0 CA-C-O 122.111 0.958 . . . . 0.0 109.079 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 24' ' ' GLY . 6.4 t -70.81 -8.77 54.92 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.314 179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -52.88 -173.44 0.04 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -78.96 -160.15 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.543 2.162 . . . . 0.0 110.952 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.53 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 2.1 ttmm -89.31 176.22 7.02 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.302 0.572 . . . . 0.0 109.581 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.582 HG21 ' O ' ' A' ' 16' ' ' ASN . 45.6 t . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.42 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 3' ' ' CYS . 5.7 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 74.1 m 38.61 96.27 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.352 1.072 . . . . 0.0 110.739 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.698 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 98.8 m -58.59 171.79 0.59 Allowed Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.698 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.7 Cg_endo -70.64 166.95 27.02 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.567 1.511 . . . . 0.0 110.532 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.581 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.7 p -57.66 -69.67 0.16 Allowed 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.192 -0.942 . . . . 0.0 111.604 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.64 -36.39 2.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.918 -1.114 . . . . 0.0 110.218 -179.129 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.739 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 9.7 t90 -118.75 64.58 0.77 Allowed 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.055 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -77.14 10.18 22.08 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 120.109 -1.043 . . . . 0.0 110.915 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.41 29.89 4.41 Favored Glycine 0 N--CA 1.487 2.04 0 O-C-N 120.722 -1.458 . . . . 0.0 109.492 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.65 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -80.39 177.83 2.74 Favored Pre-proline 0 C--N 1.294 -1.841 0 O-C-N 121.742 -0.858 . . . . 0.0 111.334 -178.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.739 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.61 -51.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 123.483 2.788 . . . . 0.0 113.089 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.59 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.8 p90 -78.63 33.92 0.21 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.673 -1.267 . . . . 0.0 111.476 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.481 ' CA ' ' SG ' ' A' ' 4' ' ' CYS . . . 177.76 -169.27 41.19 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.107 -1.52 . . . . 0.0 110.108 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 9' ' ' GLY . 8.3 mm100 -125.95 -145.45 0.32 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.413 -1.051 . . . . 0.0 109.626 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 0.2 OUTLIER -108.4 61.88 0.61 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.424 -0.798 . . . . 0.0 109.129 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.549 ' CA ' ' HA ' ' A' ' 27' ' ' VAL . 1.5 m -87.56 -5.1 58.91 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.261 -0.9 . . . . 0.0 110.078 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.547 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 40.2 m-85 -131.24 59.08 43.29 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.206 -0.934 . . . . 0.0 109.901 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.5 Cg_endo -78.27 -36.39 1.0 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.48 2.12 . . . . 0.0 110.52 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -135.46 50.64 2.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.326 -0.859 . . . . 0.0 109.929 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.87 108.56 0.21 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.581 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.5 m -73.76 -12.93 60.86 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.364 0.602 . . . . 0.0 110.343 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -145.72 8.41 1.13 Allowed 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.277 -0.889 . . . . 0.0 110.986 -178.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -62.19 -142.56 0.01 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -77.14 -165.77 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.106 1.871 . . . . 0.0 109.204 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -60.45 -68.17 0.32 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.634 -1.227 . . . . 0.0 108.047 178.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.549 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 1.8 t . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.438 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.553 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.517 ' SG ' ' CD ' ' A' ' 26' ' ' LYS . 91.5 m -149.19 93.9 2.15 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.245 -0.909 . . . . 0.0 109.05 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 32.8 m -42.68 166.66 0.08 OUTLIER Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.607 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 33.9 Cg_endo -76.26 153.5 35.97 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.34 2.027 . . . . 0.0 111.091 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.639 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -50.63 -71.21 0.07 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.226 -0.921 . . . . 0.0 110.699 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.607 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -39.75 -29.65 0.06 Allowed 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.918 -179.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.757 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.5 t90 -138.4 72.31 1.41 Allowed 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 118.751 -1.18 . . . . 0.0 109.763 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -77.33 -29.09 56.77 Favored Glycine 0 N--CA 1.502 3.063 0 O-C-N 121.275 -0.891 . . . . 0.0 111.229 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.33 13.79 31.89 Favored Glycine 0 N--CA 1.49 2.296 0 O-C-N 120.947 -1.326 . . . . 0.0 110.675 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -63.62 174.48 0.99 Allowed Pre-proline 0 C--N 1.297 -1.714 0 O-C-N 121.307 -1.114 . . . . 0.0 110.915 -178.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.757 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.7 -59.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 123.33 2.687 . . . . 0.0 112.637 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.57 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 23.4 p90 -73.3 127.44 32.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.761 -1.212 . . . . 0.0 109.824 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.553 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 95.37 -165.19 24.87 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.208 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.455 ' H ' ' HA ' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -124.08 -152.14 0.5 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.563 -0.963 . . . . 0.0 109.957 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.25 65.41 0.63 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.514 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.6 m -87.2 -1.95 58.27 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.61 0.719 . . . . 0.0 109.896 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.639 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 67.0 m-85 -134.45 62.31 54.44 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.4 Cg_endo -79.5 -30.97 2.23 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.516 2.144 . . . . 0.0 110.297 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.99 -66.36 0.93 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' A' ' 6' ' ' CYS . . . -144.78 -135.71 2.93 Favored Glycine 0 C--N 1.287 -2.168 0 N-CA-C 106.942 -2.463 . . . . 0.0 106.942 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.552 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 56.9 m -88.39 -20.85 24.73 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-O 122.074 0.94 . . . . 0.0 108.964 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.517 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER 45.4 55.5 6.47 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 37.87 -97.42 0.01 OUTLIER Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 23' ' ' SER . 32.3 Cg_endo -74.53 -160.64 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.392 2.061 . . . . 0.0 111.187 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.517 ' CD ' ' SG ' ' A' ' 3' ' ' CYS . 19.9 ttpp -39.17 -70.49 0.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.666 -0.646 . . . . 0.0 110.588 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.543 HG22 ' OXT' ' A' ' 27' ' ' VAL . 9.4 p . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.848 -1.157 . . . . 0.0 109.501 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.505 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 43.2 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 81.6 m 40.83 97.14 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 122.227 1.013 . . . . 0.0 110.443 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.654 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 89.8 m -54.66 169.2 0.41 Allowed Pre-proline 0 C--N 1.295 -1.763 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.654 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.6 Cg_endo -71.79 155.77 57.83 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.783 1.655 . . . . 0.0 111.045 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -47.77 -69.5 0.12 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.519 -0.738 . . . . 0.0 111.172 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.597 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -42.48 -35.98 1.2 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.214 -0.929 . . . . 0.0 109.973 -179.14 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.736 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.2 t90 -123.42 65.06 1.01 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.863 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -77.47 8.0 36.19 Favored Glycine 0 N--CA 1.497 2.747 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.851 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.67 28.2 5.77 Favored Glycine 0 N--CA 1.485 1.965 0 O-C-N 120.764 -1.433 . . . . 0.0 109.547 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.64 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -79.05 176.83 3.32 Favored Pre-proline 0 C--N 1.294 -1.808 0 O-C-N 121.769 -0.842 . . . . 0.0 111.492 -178.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.736 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.39 -52.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 123.488 2.792 . . . . 0.0 113.117 -177.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.587 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.9 p90 -78.31 33.78 0.2 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.633 -1.292 . . . . 0.0 111.533 -177.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 2' ' ' SER . . . 177.38 -171.02 43.75 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 118.825 -1.655 . . . . 0.0 110.411 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 9' ' ' GLY . 8.2 mt-30 -121.1 -149.19 0.42 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.548 -0.972 . . . . 0.0 110.226 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 7.2 t-20 -109.15 64.46 0.61 Allowed 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 26' ' ' LYS . 1.6 m -87.5 4.92 41.57 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.296 -0.878 . . . . 0.0 109.877 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.58 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 73.5 m-85 -148.53 62.43 6.4 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.197 -0.94 . . . . 0.0 110.013 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.56 ' CG ' ' HB ' ' A' ' 27' ' ' VAL . 36.4 Cg_endo -79.36 -33.68 1.3 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.087 1.858 . . . . 0.0 109.515 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -137.25 53.74 1.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.512 ' HA3' ' HG2' ' A' ' 25' ' ' PRO . . . 163.85 113.45 0.29 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.615 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -69.63 -10.55 58.66 Favored 'General case' 0 C--N 1.283 -2.286 0 O-C-N 122.313 -0.522 . . . . 0.0 111.2 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.461 ' O ' ' C ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -169.19 -50.75 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.876 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' SER . . . -38.49 -86.69 0.01 OUTLIER Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.512 ' HG2' ' HA3' ' A' ' 21' ' ' GLY . 31.3 Cg_endo -76.31 -161.01 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.747 2.298 . . . . 0.0 111.688 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 6.7 tttt -176.08 121.45 0.17 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.56 ' HB ' ' CG ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.15 -0.968 . . . . 0.0 109.936 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.488 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 46.7 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.093 0.473 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 2' ' ' SER . 99.9 m 41.8 95.89 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.152 0.977 . . . . 0.0 110.472 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.723 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 82.5 m -46.49 171.93 0.06 OUTLIER Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.723 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.8 Cg_endo -70.51 172.88 12.51 Favored 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.75 1.633 . . . . 0.0 111.185 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.718 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 2.9 p -66.82 -42.67 85.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.422 -0.799 . . . . 0.0 111.307 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 1.8 p90 -69.26 -38.23 78.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.081 -1.012 . . . . 0.0 110.223 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.754 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 13.8 t90 -121.11 63.58 0.88 Allowed 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.784 -178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -67.39 -22.95 73.33 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.198 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.76 27.85 6.93 Favored Glycine 0 N--CA 1.488 2.148 0 O-C-N 120.525 -1.573 . . . . 0.0 110.697 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.621 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -81.16 172.71 9.11 Favored Pre-proline 0 C--N 1.294 -1.828 0 O-C-N 121.297 -1.119 . . . . 0.0 111.629 -178.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.754 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.6 Cg_endo -75.6 -52.03 0.1 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 123.875 3.05 . . . . 0.0 113.945 -176.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.613 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 33.2 p90 -77.0 32.92 0.14 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.679 -1.263 . . . . 0.0 111.784 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 2' ' ' SER . . . 177.31 -169.54 41.78 Favored Glycine 0 N--CA 1.484 1.897 0 C-N-CA 118.78 -1.676 . . . . 0.0 110.113 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.495 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -119.36 -156.12 0.64 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.518 -0.99 . . . . 0.0 109.899 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.403 HD21 ' CB ' ' A' ' 19' ' ' PRO . 1.2 t-20 -107.79 68.32 0.71 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.586 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.5 m -86.91 -3.44 59.08 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 121.656 -0.653 . . . . 0.0 109.975 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.628 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -153.47 84.03 4.38 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.432 -0.792 . . . . 0.0 109.346 179.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.489 ' CD ' ' HB ' ' A' ' 27' ' ' VAL . 34.8 Cg_endo -77.83 -43.22 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.63 2.22 . . . . 0.0 109.809 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -137.78 12.74 2.92 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -92.54 24.74 21.73 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.718 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -35.69 -31.74 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.22 0 CA-C-O 121.877 0.846 . . . . 0.0 110.091 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' GLY . 1.2 m -116.08 -22.31 9.02 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.71 -0.619 . . . . 0.0 109.492 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.69 -173.42 46.88 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.31 -160.93 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.688 2.258 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 2.9 ttpt -58.82 176.64 0.19 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.539 -0.726 . . . . 0.0 109.356 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.538 HG22 ' OXT' ' A' ' 27' ' ' VAL . 9.2 p . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.514 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.519 ' HB2' ' HA2' ' A' ' 14' ' ' GLY . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 2' ' ' SER . 84.3 m 35.83 96.15 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 122.262 1.03 . . . . 0.0 110.898 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.753 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 69.1 m -54.29 173.35 0.22 Allowed Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.753 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.4 Cg_endo -71.52 155.3 59.68 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.704 1.602 . . . . 0.0 110.832 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.596 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -47.92 -69.19 0.13 Allowed 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.406 -0.808 . . . . 0.0 111.334 -178.418 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 2.0 p90 -44.25 -36.96 2.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.96 . . . . 0.0 109.863 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.732 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.2 t90 -119.89 64.28 0.82 Allowed 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 118.943 -1.103 . . . . 0.0 109.969 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -75.62 6.78 29.86 Favored Glycine 0 N--CA 1.496 2.694 0 C-N-CA 120.262 -0.97 . . . . 0.0 111.13 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.66 27.76 5.89 Favored Glycine 0 N--CA 1.486 1.998 0 O-C-N 120.612 -1.523 . . . . 0.0 109.868 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.65 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -78.43 177.96 2.51 Favored Pre-proline 0 C--N 1.294 -1.839 0 O-C-N 121.641 -0.917 . . . . 0.0 111.457 -178.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.732 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.8 Cg_endo -76.9 -52.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 123.489 2.793 . . . . 0.0 113.15 -177.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.585 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.6 p90 -78.1 33.08 0.18 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.719 -1.238 . . . . 0.0 111.677 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.519 ' HA2' ' HB2' ' A' ' 2' ' ' SER . . . 177.78 -170.45 42.8 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 118.812 -1.661 . . . . 0.0 110.488 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -121.85 -151.74 0.49 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.547 -0.973 . . . . 0.0 110.391 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 19.6 t-20 -108.78 64.03 0.61 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.537 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 2.1 m -87.74 -10.59 50.63 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 121.775 0.798 . . . . 0.0 109.792 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.527 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 29.7 m-85 -127.83 67.89 74.14 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.661 -0.65 . . . . 0.0 109.259 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HD3' ' C ' ' A' ' 17' ' ' CYS . 36.5 Cg_endo -78.16 -44.55 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.547 2.165 . . . . 0.0 110.926 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.96 48.71 2.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.112 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.52 108.18 0.22 Allowed Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -67.35 -15.63 63.79 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-O 121.55 0.691 . . . . 0.0 109.582 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 24' ' ' GLY . 6.4 t -129.89 -18.4 3.41 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.641 -0.662 . . . . 0.0 110.225 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -50.43 -179.64 0.03 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -77.55 -160.78 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.38 2.053 . . . . 0.0 110.762 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.537 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -79.26 172.4 13.85 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.716 -0.615 . . . . 0.0 109.576 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.49 -179.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.52 ' HB2' ' O ' ' A' ' 13' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 2' ' ' SER . 73.1 m 40.96 97.2 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.279 1.038 . . . . 0.0 110.644 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.701 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 95.0 m -54.36 171.55 0.28 Allowed Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.701 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.2 Cg_endo -71.73 157.78 54.71 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 121.772 1.648 . . . . 0.0 110.876 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.582 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -49.2 -70.93 0.07 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.471 -0.768 . . . . 0.0 111.361 -178.389 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.591 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -42.16 -36.54 1.21 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.158 -0.964 . . . . 0.0 110.034 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.74 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.1 t90 -121.59 64.65 0.9 Allowed 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.805 -1.158 . . . . 0.0 109.896 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -76.88 6.92 37.62 Favored Glycine 0 N--CA 1.497 2.703 0 C-N-CA 120.222 -0.989 . . . . 0.0 110.759 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.81 27.34 6.24 Favored Glycine 0 N--CA 1.486 2.011 0 O-C-N 120.706 -1.467 . . . . 0.0 109.671 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.643 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -77.83 176.49 3.52 Favored Pre-proline 0 C--N 1.294 -1.836 0 O-C-N 121.706 -0.879 . . . . 0.0 111.486 -178.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.74 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -75.99 -51.78 0.1 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 123.473 2.782 . . . . 0.0 113.029 -177.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.6 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.7 p90 -78.48 34.4 0.21 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.714 -1.241 . . . . 0.0 111.519 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.492 ' HA2' ' HB2' ' A' ' 2' ' ' SER . . . 175.93 -170.46 43.38 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.792 -1.671 . . . . 0.0 110.618 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' GLY . 1.4 tt0 -120.67 -151.91 0.49 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.531 -0.982 . . . . 0.0 110.369 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 1.3 t-20 -108.98 64.57 0.61 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.547 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.9 m -87.99 -0.5 57.09 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.543 -0.723 . . . . 0.0 109.983 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.574 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 72.0 m-85 -140.33 60.36 14.22 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.801 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.4 Cg_endo -78.88 -30.3 2.93 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.451 2.101 . . . . 0.0 110.267 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.88 49.03 1.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 109.909 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.89 111.27 0.24 Allowed Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.582 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.7 m -67.8 -15.36 63.59 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-O 121.57 0.7 . . . . 0.0 109.646 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.89 4.46 2.09 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.675 -0.64 . . . . 0.0 109.88 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.72 -164.29 2.52 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -78.84 -160.41 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.374 2.05 . . . . 0.0 110.624 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.547 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -90.12 178.09 6.27 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.703 -0.623 . . . . 0.0 109.422 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.471 ' OXT' HG13 ' A' ' 27' ' ' VAL . 7.4 p . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.523 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.531 ' HB2' ' CA ' ' A' ' 14' ' ' GLY . 4.9 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 4' ' ' CYS . 76.5 m 38.46 96.22 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.993 0.901 . . . . 0.0 110.597 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 56.2 m -40.68 166.38 0.06 OUTLIER Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.571 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.7 Cg_endo -70.97 161.65 45.38 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.204 1.936 . . . . 0.0 110.497 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.611 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.1 p -56.1 -72.53 0.07 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.267 -0.896 . . . . 0.0 111.494 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.09 -36.16 1.55 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.017 -1.052 . . . . 0.0 110.28 -179.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.764 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.3 t90 -124.17 64.93 1.06 Allowed 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.221 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -72.29 -30.31 65.08 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.68 8.43 35.35 Favored Glycine 0 N--CA 1.49 2.269 0 O-C-N 120.867 -1.372 . . . . 0.0 110.85 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.629 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -58.4 176.5 0.26 Allowed Pre-proline 0 C--N 1.298 -1.66 0 O-C-N 121.069 -1.254 . . . . 0.0 110.881 -179.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.764 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.94 -57.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 123.133 2.555 . . . . 0.0 112.306 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.61 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 25.4 p90 -73.84 115.19 12.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.74 -1.225 . . . . 0.0 109.758 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.531 ' CA ' ' HB2' ' A' ' 2' ' ' SER . . . 93.63 -172.76 33.13 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 4.9 mt-30 -116.64 -147.25 0.41 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.485 -1.009 . . . . 0.0 110.133 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.518 ' ND2' ' HB3' ' A' ' 19' ' ' PRO . 10.5 t30 -108.02 69.73 0.74 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.541 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.5 m -87.48 -7.35 57.74 Favored 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.532 -0.73 . . . . 0.0 110.713 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.548 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 66.0 m-85 -133.79 60.49 46.41 Favored Pre-proline 0 C--N 1.296 -1.738 0 O-C-N 121.291 -0.88 . . . . 0.0 110.234 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.1 Cg_endo -78.95 -24.79 6.67 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.388 2.058 . . . . 0.0 109.852 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.27 52.7 1.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 0.0 109.68 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.21 113.43 0.28 Allowed Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.611 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -75.03 -85.8 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.963 0.887 . . . . 0.0 109.799 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -76.18 -24.35 54.73 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.094 -179.171 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -59.97 -149.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.446 ' C ' ' HD3' ' A' ' 26' ' ' LYS . 35.0 Cg_endo -77.27 -160.34 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.288 1.992 . . . . 0.0 110.029 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.541 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -100.15 -96.05 0.25 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.431 -0.793 . . . . 0.0 109.559 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.5 p . . . . . 0 C--N 1.299 -1.63 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.504 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.532 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 81.2 m 34.06 95.69 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.239 1.019 . . . . 0.0 110.987 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.697 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 96.0 m -53.75 171.41 0.26 Allowed Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.697 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.8 Cg_endo -69.94 164.24 35.44 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.569 1.512 . . . . 0.0 110.558 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.586 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.6 p -54.82 -70.42 0.1 Allowed 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.248 -0.907 . . . . 0.0 111.713 -177.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.12 -38.7 2.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.968 -1.082 . . . . 0.0 110.208 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.741 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 9.7 t90 -116.74 63.02 0.72 Allowed 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 118.964 -1.095 . . . . 0.0 110.047 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -76.59 8.7 26.01 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.877 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.95 28.59 5.36 Favored Glycine 0 N--CA 1.486 1.991 0 O-C-N 120.707 -1.467 . . . . 0.0 109.511 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.649 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -78.98 177.3 2.96 Favored Pre-proline 0 C--N 1.295 -1.797 0 O-C-N 121.781 -0.835 . . . . 0.0 111.26 -178.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.741 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.3 Cg_endo -76.24 -52.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 123.505 2.803 . . . . 0.0 113.063 -177.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.584 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 28.5 p90 -78.14 31.55 0.18 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.724 -1.235 . . . . 0.0 111.597 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 2' ' ' SER . . . -178.29 -172.03 42.26 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 118.714 -1.708 . . . . 0.0 110.517 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 9' ' ' GLY . 5.7 mt-30 -121.37 -150.67 0.46 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.498 -1.001 . . . . 0.0 110.29 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -108.49 62.99 0.61 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.565 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.8 m -88.2 -11.14 47.58 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.396 -0.815 . . . . 0.0 109.938 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.559 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 23.3 m-85 -127.55 56.03 18.11 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.708 -0.62 . . . . 0.0 110.461 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.696 ' HG2' HG23 ' A' ' 27' ' ' VAL . 36.4 Cg_endo -76.73 -29.97 5.18 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.354 2.036 . . . . 0.0 110.491 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -138.84 51.28 1.82 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.918 . . . . 0.0 110.074 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.75 111.52 0.25 Allowed Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.586 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.4 m -77.04 -85.89 0.06 Allowed 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 122.083 0.944 . . . . 0.0 110.005 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.5 OUTLIER -79.95 -8.68 59.46 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.572 -178.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.89 -140.27 0.01 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -77.31 -164.18 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.028 1.819 . . . . 0.0 109.613 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.565 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 17.9 ttpp -51.98 -70.23 0.09 Allowed 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.696 HG23 ' HG2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.034 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.527 ' O ' ' CG ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.273 0.559 . . . . 0.0 109.526 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.522 ' SG ' ' CD ' ' A' ' 26' ' ' LYS . 68.0 m -153.97 95.9 1.91 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.213 -0.929 . . . . 0.0 108.712 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.674 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 23.0 m -46.68 171.75 0.06 OUTLIER Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.822 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.674 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.7 Cg_endo -71.9 162.89 40.55 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 121.904 1.736 . . . . 0.0 110.904 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -53.6 -72.8 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.562 -0.711 . . . . 0.0 111.72 -178.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.589 ' CE2' ' HB2' ' A' ' 8' ' ' TRP . 6.6 p90 -45.61 -33.53 2.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.125 -0.984 . . . . 0.0 110.7 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.755 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 11.6 t90 -122.77 64.89 0.96 Allowed 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 118.362 -1.335 . . . . 0.0 110.961 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -66.66 -23.07 72.13 Favored Glycine 0 N--CA 1.498 2.828 0 O-C-N 121.237 -0.914 . . . . 0.0 111.414 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.07 29.84 8.86 Favored Glycine 0 N--CA 1.492 2.375 0 O-C-N 120.468 -1.607 . . . . 0.0 111.556 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.662 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -80.66 175.5 4.76 Favored Pre-proline 0 C--N 1.291 -1.953 0 O-C-N 121.281 -1.129 . . . . 0.0 111.217 -178.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.755 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 40.8 Cg_endo -77.84 -55.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 123.857 3.038 . . . . 0.0 114.608 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.444 ' CZ3' ' CZ3' ' A' ' 8' ' ' TRP . 20.7 p90 -73.51 10.24 1.12 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.667 -1.271 . . . . 0.0 112.2 -176.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' C ' ' SG ' ' A' ' 4' ' ' CYS . . . -151.66 173.36 30.98 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.785 -1.674 . . . . 0.0 109.954 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.527 ' CG ' ' O ' ' A' ' 2' ' ' SER . 24.7 mt-30 -93.56 -155.86 0.46 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.331 -1.099 . . . . 0.0 108.889 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -108.43 61.88 0.61 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 108.697 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.921 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.6 m -88.72 -94.19 0.1 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.144 -0.973 . . . . 0.0 108.564 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CE2' ' OXT' ' A' ' 27' ' ' VAL . 66.0 m-85 -29.62 88.84 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.89 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.765 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 27' ' ' VAL . 37.0 Cg_endo -77.31 -83.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.23 1.953 . . . . 0.0 109.498 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -120.64 22.85 11.05 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.05 91.42 0.21 Allowed Glycine 0 N--CA 1.481 1.642 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 23.8 m -48.44 -21.8 0.61 Allowed 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.45 -0.875 . . . . 0.0 110.726 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.496 ' O ' ' OXT' ' A' ' 27' ' ' VAL . 1.6 p -115.71 -87.64 0.59 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.445 -0.784 . . . . 0.0 110.089 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 39.57 -149.29 0.12 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.512 ' O ' ' C ' ' A' ' 26' ' ' LYS . 35.5 Cg_endo -77.47 -156.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.952 2.434 . . . . 0.0 110.112 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.522 ' CD ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -33.62 -35.79 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.54 0.686 . . . . 0.0 109.188 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.921 HG12 ' CB ' ' A' ' 17' ' ' CYS . 13.2 m . . . . . 0 C--N 1.3 -1.579 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.051 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.475 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.517 ' HB3' ' CE1' ' A' ' 18' ' ' TYR . 79.8 m 36.79 93.99 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.696 0.76 . . . . 0.0 110.62 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.591 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 80.2 m -42.71 164.93 0.11 Allowed Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 27.3 Cg_endo -65.31 144.64 81.19 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.487 1.458 . . . . 0.0 110.296 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.578 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 14.6 p -50.97 -42.59 60.18 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.381 -0.824 . . . . 0.0 110.238 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -58.62 -38.42 78.0 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.759 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.6 t90 -126.18 67.54 1.21 Allowed 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.343 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.51 ' HA2' ' HB2' ' A' ' 4' ' ' CYS . . . -75.7 -27.15 63.51 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 120.31 -0.947 . . . . 0.0 111.216 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.31 12.63 37.71 Favored Glycine 0 N--CA 1.49 2.277 0 O-C-N 120.936 -1.332 . . . . 0.0 110.859 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.61 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -58.38 174.1 0.37 Allowed Pre-proline 0 C--N 1.296 -1.739 0 O-C-N 121.259 -1.142 . . . . 0.0 111.064 -178.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.759 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -72.38 -57.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 123.398 2.732 . . . . 0.0 112.29 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.553 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 24.5 p90 -73.33 -167.27 0.41 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.877 -1.139 . . . . 0.0 109.344 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . 40.45 -143.36 0.6 Allowed Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 14' ' ' GLY . 3.2 mt-30 -147.57 -155.27 0.61 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.486 -1.008 . . . . 0.0 109.988 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.53 71.13 0.78 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.525 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.4 m -87.45 -28.39 22.12 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.521 -0.737 . . . . 0.0 110.762 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.576 ' HB2' ' CB ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -137.81 63.8 40.29 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.25 -0.906 . . . . 0.0 109.007 177.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 37.5 Cg_endo -83.46 -35.02 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.787 2.325 . . . . 0.0 110.869 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -90.64 9.73 28.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.9 . . . . 0.0 110.522 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 22' ' ' CYS . . . 129.73 123.54 2.54 Favored Glycine 0 C--N 1.304 -1.25 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.578 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.2 m -29.42 -47.12 0.06 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 122.3 1.047 . . . . 0.0 109.494 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.527 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 18.1 m 43.76 35.73 1.13 Allowed 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.621 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.95 -112.18 3.49 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 23' ' ' SER . 33.2 Cg_endo -74.42 -156.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.603 2.202 . . . . 0.0 111.409 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.525 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -52.3 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.798 0.809 . . . . 0.0 110.85 -178.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.573 HG22 ' OXT' ' A' ' 27' ' ' VAL . 9.1 p . . . . . 0 C--N 1.304 -1.41 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.625 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 3' ' ' CYS . 5.6 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.495 ' C ' ' O ' ' A' ' 2' ' ' SER . 90.6 m 31.03 90.33 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.91 0.862 . . . . 0.0 110.904 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.582 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 99.5 m -41.33 166.42 0.06 OUTLIER Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.3 Cg_endo -71.28 160.99 47.19 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.057 1.838 . . . . 0.0 110.579 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.592 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.3 p -55.0 -69.35 0.13 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.265 -0.897 . . . . 0.0 111.552 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -41.42 -38.45 1.25 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.205 -0.935 . . . . 0.0 109.931 -178.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.757 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.6 t90 -126.45 66.89 1.23 Allowed 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.908 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -75.02 -26.41 66.69 Favored Glycine 0 N--CA 1.496 2.65 0 O-C-N 121.22 -0.925 . . . . 0.0 111.07 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.37 13.72 38.61 Favored Glycine 0 N--CA 1.488 2.157 0 O-C-N 120.858 -1.377 . . . . 0.0 110.75 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.611 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -62.93 175.63 0.63 Allowed Pre-proline 0 C--N 1.297 -1.703 0 O-C-N 121.239 -1.154 . . . . 0.0 111.036 -178.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.757 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.6 Cg_endo -74.46 -58.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 123.46 2.773 . . . . 0.0 112.747 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.596 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 26.0 p90 -73.17 121.39 20.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.73 -1.231 . . . . 0.0 109.604 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.52 -147.36 18.55 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -141.58 -156.73 0.7 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.509 -0.995 . . . . 0.0 109.921 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 12.0 t-20 -107.64 68.46 0.71 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 1.5 m -87.47 -1.21 57.77 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.376 0.607 . . . . 0.0 110.531 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.57 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 77.8 m-85 -138.93 62.7 28.07 Favored Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 120.828 -1.17 . . . . 0.0 110.376 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 35.6 Cg_endo -79.47 -25.35 5.67 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.519 2.146 . . . . 0.0 110.257 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 7.7 pt-20 -147.0 50.45 1.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.267 -0.895 . . . . 0.0 109.845 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.32 110.68 0.24 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.5 m -75.31 -12.12 60.2 Favored 'General case' 0 C--N 1.286 -2.194 0 O-C-N 122.218 -0.577 . . . . 0.0 110.359 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -143.07 8.19 1.64 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.197 -0.939 . . . . 0.0 111.234 -178.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.37 -148.59 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -77.01 -166.37 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.102 1.868 . . . . 0.0 109.136 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 2.1 tttm -51.95 -71.57 0.06 Allowed 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.523 -1.271 . . . . 0.0 107.837 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.539 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 7.1 p . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.389 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.506 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 3.1 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.29 0.566 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 79.4 m -143.16 90.75 2.21 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 122.087 0.946 . . . . 0.0 109.262 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.752 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 68.3 m -54.64 173.67 0.22 Allowed Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.752 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.5 Cg_endo -70.81 159.3 53.08 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.601 1.534 . . . . 0.0 110.679 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.599 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.2 p -50.07 -68.26 0.19 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.444 -0.785 . . . . 0.0 111.819 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 5' ' ' PRO . 8.1 p90 -46.83 -43.44 18.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.001 -1.062 . . . . 0.0 110.167 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.744 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.3 t90 -110.71 61.08 0.61 Allowed 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.779 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -72.69 5.13 18.22 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.374 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.56 26.58 6.55 Favored Glycine 0 N--CA 1.487 2.075 0 O-C-N 120.622 -1.516 . . . . 0.0 109.923 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.658 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.74 178.57 1.95 Allowed Pre-proline 0 C--N 1.293 -1.86 0 O-C-N 121.626 -0.926 . . . . 0.0 111.44 -178.577 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.744 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.8 Cg_endo -77.28 -52.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.969 0 C-N-CA 123.449 2.766 . . . . 0.0 113.277 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.586 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.9 p90 -77.62 32.88 0.16 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.56 -1.337 . . . . 0.0 111.755 -177.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 176.8 -173.55 46.38 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 118.849 -1.643 . . . . 0.0 110.282 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 2' ' ' SER . 0.2 OUTLIER -118.77 -149.43 0.44 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.478 -1.013 . . . . 0.0 109.909 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 5.6 t-20 -108.35 64.09 0.62 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.548 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.7 m -88.08 1.26 54.68 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.476 -0.765 . . . . 0.0 110.321 -178.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.576 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 66.5 m-85 -142.4 60.17 9.84 Favored Pre-proline 0 C--N 1.299 -1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 109.834 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.6 Cg_endo -79.22 -25.48 5.82 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.429 2.086 . . . . 0.0 110.232 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 26.2 tt0 -140.18 47.85 1.79 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 110.045 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.88 111.19 0.24 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.599 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -71.51 -15.72 62.32 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 121.658 0.742 . . . . 0.0 109.697 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 24' ' ' GLY . 32.6 t -130.24 -22.31 2.82 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.641 -0.662 . . . . 0.0 110.173 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -50.43 -178.8 0.02 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.44 -161.14 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.44 2.093 . . . . 0.0 110.565 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.662 ' HE2' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -72.01 -174.03 1.15 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.639 -0.663 . . . . 0.0 109.458 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.662 HG12 ' HE2' ' A' ' 26' ' ' LYS . 8.9 p . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.496 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.535 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 1.1 p . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.26 0.552 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 4' ' ' CYS . 69.7 m -152.09 95.97 2.14 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.249 -0.907 . . . . 0.0 109.39 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.603 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 33.7 m -40.73 168.03 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.8 Cg_endo -70.92 171.6 15.42 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.29 1.993 . . . . 0.0 112.3 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.62 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 14.0 p -64.6 -41.67 96.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.741 -0.599 . . . . 0.0 111.754 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.525 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -78.69 -35.42 45.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.866 -1.146 . . . . 0.0 110.414 -178.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.754 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.4 t90 -121.03 63.28 0.87 Allowed 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.127 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.472 ' HA2' ' CB ' ' A' ' 4' ' ' CYS . . . -68.14 -26.71 73.98 Favored Glycine 0 N--CA 1.499 2.876 0 O-C-N 121.457 -0.777 . . . . 0.0 111.416 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.42 16.53 29.27 Favored Glycine 0 N--CA 1.491 2.311 0 O-C-N 120.912 -1.346 . . . . 0.0 110.54 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.66 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -69.56 174.79 2.68 Favored Pre-proline 0 C--N 1.296 -1.732 0 O-C-N 121.434 -1.039 . . . . 0.0 111.169 -178.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.754 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.8 Cg_endo -72.73 -60.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 123.267 2.644 . . . . 0.0 111.949 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 19.4 p90 -73.09 125.76 28.43 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.913 -1.117 . . . . 0.0 108.502 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.535 ' HA2' ' CB ' ' A' ' 2' ' ' SER . . . 89.29 168.98 44.02 Favored Glycine 0 N--CA 1.482 1.732 0 C-N-CA 119.259 -1.448 . . . . 0.0 109.67 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -103.36 -148.42 0.39 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.481 -1.011 . . . . 0.0 109.731 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.89 69.11 0.7 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.526 ' C ' ' HD3' ' A' ' 19' ' ' PRO . 1.5 m -87.1 -14.48 41.26 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.603 -0.686 . . . . 0.0 110.74 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.639 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 65.7 m-85 -123.33 47.17 1.58 Allowed Pre-proline 0 C--N 1.295 -1.797 0 O-C-N 121.241 -0.912 . . . . 0.0 111.407 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.639 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 38.1 Cg_endo -80.19 -1.29 11.27 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.818 1.678 . . . . 0.0 109.618 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.7 -21.77 22.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.903 . . . . 0.0 110.79 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 23' ' ' SER . . . 121.88 127.19 3.33 Favored Glycine 0 C--N 1.293 -1.858 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.56 ' HA ' ' HB2' ' A' ' 6' ' ' CYS . 16.9 m -30.43 -37.09 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 122.017 0.913 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 21' ' ' GLY . 1.9 t -54.28 -60.83 2.81 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.431 0.634 . . . . 0.0 109.628 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.62 142.38 24.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 26' ' ' LYS . 33.5 Cg_endo -78.57 141.26 17.44 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.266 1.978 . . . . 0.0 110.906 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.656 ' HE3' HG22 ' A' ' 27' ' ' VAL . 0.0 OUTLIER 37.56 -158.99 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.105 0.479 . . . . 0.0 110.06 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.656 HG22 ' HE3' ' A' ' 26' ' ' LYS . 4.8 m . . . . . 0 N--CA 1.489 1.507 0 O-C-N 120.988 -1.07 . . . . 0.0 109.53 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.294 0.568 . . . . 0.0 109.554 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 99.6 m -146.47 93.45 2.3 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.972 0.892 . . . . 0.0 108.754 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.652 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 22.9 m -50.21 170.9 0.16 Allowed Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.652 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.6 Cg_endo -70.4 159.45 52.89 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 121.903 1.735 . . . . 0.0 110.289 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.594 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.2 p -55.05 -70.66 0.1 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.176 -0.952 . . . . 0.0 111.475 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.25 -38.57 2.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.015 -1.053 . . . . 0.0 110.26 -178.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.761 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.2 t90 -122.3 65.99 0.93 Allowed 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.207 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -72.02 -25.42 74.77 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.059 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.7 19.31 20.94 Favored Glycine 0 N--CA 1.49 2.285 0 O-C-N 120.685 -1.48 . . . . 0.0 110.854 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.63 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -71.2 174.43 3.77 Favored Pre-proline 0 C--N 1.296 -1.76 0 O-C-N 121.276 -1.131 . . . . 0.0 111.328 -178.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.761 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.7 Cg_endo -76.16 -56.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 123.814 3.009 . . . . 0.0 114.216 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.545 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 24.9 p90 -74.34 24.51 0.08 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.682 -1.261 . . . . 0.0 112.288 -176.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.46 ' CA ' ' SG ' ' A' ' 4' ' ' CYS . . . -167.51 175.94 42.4 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.558 -1.782 . . . . 0.0 110.363 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 9' ' ' GLY . 2.9 tp60 -104.34 -154.64 0.51 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.463 -1.022 . . . . 0.0 109.802 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.34 62.19 0.62 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 1.6 m -87.8 -12.42 45.1 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.807 0.813 . . . . 0.0 110.178 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 68.7 m-85 -130.18 62.86 66.66 Favored Pre-proline 0 C--N 1.291 -1.945 0 O-C-N 120.639 -1.288 . . . . 0.0 110.487 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.5 Cg_endo -79.33 -30.54 2.53 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.549 2.166 . . . . 0.0 109.938 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 19' ' ' PRO . 1.2 mm-40 -143.12 53.12 1.36 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.835 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.49 110.57 0.23 Allowed Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.4 m -75.23 -12.04 60.2 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.259 0.552 . . . . 0.0 110.234 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -145.53 7.34 1.12 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.142 -178.597 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.9 -144.67 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -77.0 -168.68 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.185 1.924 . . . . 0.0 109.03 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.565 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 6.8 ttmm -62.57 -66.85 0.48 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.136 -1.426 . . . . 0.0 108.203 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 17' ' ' CYS . 2.2 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.06 -0.972 . . . . 0.0 109.294 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.499 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 46.9 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 65.0 m -146.9 94.31 2.4 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.407 -0.808 . . . . 0.0 108.988 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.634 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 68.9 m -42.84 167.76 0.07 OUTLIER Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.634 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 28.8 Cg_endo -67.98 168.45 18.85 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.803 1.668 . . . . 0.0 110.428 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.68 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 1.1 p -65.44 -47.96 74.37 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.05 -1.031 . . . . 0.0 111.137 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -62.11 -49.62 75.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.826 -1.171 . . . . 0.0 109.651 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.767 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.9 t90 -109.56 59.8 0.6 Allowed 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.704 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -67.41 -27.72 73.56 Favored Glycine 0 N--CA 1.496 2.699 0 O-C-N 121.428 -0.795 . . . . 0.0 111.204 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.35 12.52 38.53 Favored Glycine 0 N--CA 1.49 2.256 0 O-C-N 120.869 -1.371 . . . . 0.0 110.841 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -63.39 176.56 0.57 Allowed Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.252 -1.146 . . . . 0.0 110.959 -178.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.767 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.2 Cg_endo -73.72 -58.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 123.129 2.553 . . . . 0.0 112.168 -177.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.607 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 24.8 p90 -73.62 115.45 13.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.753 -1.217 . . . . 0.0 109.122 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 90.55 177.43 44.24 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 40.8 mt-30 -111.07 -146.47 0.41 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.382 -1.07 . . . . 0.0 109.796 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 19.5 t-20 -108.69 75.62 0.98 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 3' ' ' CYS . 1.3 m -87.55 -13.15 43.73 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.556 -0.715 . . . . 0.0 111.496 -177.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.595 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -135.16 67.14 68.52 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.125 -0.984 . . . . 0.0 109.972 178.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HB3' ' OD1' ' A' ' 16' ' ' ASN . 32.9 Cg_endo -74.85 -29.97 7.95 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.205 1.937 . . . . 0.0 109.64 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -142.27 11.99 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -108.54 26.06 17.5 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.68 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.6 m -33.66 -32.82 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.218 0 CA-C-O 121.714 0.769 . . . . 0.0 110.639 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -135.29 -34.22 0.87 Allowed 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.684 -0.635 . . . . 0.0 110.138 -179.596 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.36 -131.78 0.01 OUTLIER Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -76.33 -164.92 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.005 1.803 . . . . 0.0 109.46 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 18' ' ' TYR . 9.4 ttpp -73.0 -64.92 0.87 Allowed 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.765 -1.174 . . . . 0.0 109.001 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.489 1.522 0 O-C-N 120.95 -1.094 . . . . 0.0 109.479 179.558 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.556 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 25.5 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.278 0.561 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.517 ' O ' ' O ' ' A' ' 4' ' ' CYS . 68.4 m -147.47 96.27 2.67 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.293 -0.88 . . . . 0.0 108.837 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.565 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 51.4 m -39.58 165.67 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.58 ' HB2' ' CE1' ' A' ' 7' ' ' TYR . 30.3 Cg_endo -70.02 165.03 32.63 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.224 1.949 . . . . 0.0 111.64 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.676 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -57.51 -46.56 83.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.572 -0.705 . . . . 0.0 111.479 -178.573 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.631 ' CD2' ' N ' ' A' ' 8' ' ' TRP . 42.7 p90 -72.69 -47.17 49.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.984 -1.073 . . . . 0.0 110.404 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.769 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.9 t90 -108.62 59.2 0.61 Allowed 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.902 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 4' ' ' CYS . . . -67.92 -27.39 73.67 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.62 9.07 45.19 Favored Glycine 0 N--CA 1.49 2.279 0 O-C-N 120.875 -1.368 . . . . 0.0 110.403 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.653 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -61.74 176.94 0.39 Allowed Pre-proline 0 C--N 1.298 -1.636 0 O-C-N 121.317 -1.108 . . . . 0.0 111.135 -178.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.769 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.0 Cg_endo -75.35 -56.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 123.321 2.68 . . . . 0.0 112.743 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 30.0 p90 -73.16 123.14 23.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.727 -1.233 . . . . 0.0 109.8 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.556 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 93.95 -148.46 19.01 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 23.8 mt-30 -145.29 -143.73 0.14 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.5 -1.0 . . . . 0.0 109.34 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.16 67.04 0.64 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 3' ' ' CYS . 1.5 m -87.19 -20.25 27.25 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.315 -0.865 . . . . 0.0 110.339 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.568 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 98.3 m-85 -128.88 72.57 81.67 Favored Pre-proline 0 C--N 1.293 -1.887 0 O-C-N 121.628 -0.67 . . . . 0.0 109.577 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.517 ' CD ' HG22 ' A' ' 27' ' ' VAL . 34.9 Cg_endo -77.3 -32.26 3.13 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.424 2.082 . . . . 0.0 109.869 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 20' ' ' GLU . 3.1 tm-20 -150.09 14.7 0.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.454 -0.779 . . . . 0.0 109.518 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -90.24 15.51 59.6 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.676 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -35.88 -31.84 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.187 0 CA-C-O 121.793 0.806 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 21' ' ' GLY . 91.4 p -112.85 -25.15 9.17 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 121.298 0.57 . . . . 0.0 109.47 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.79 -168.75 30.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 26' ' ' LYS . 35.7 Cg_endo -78.22 -159.93 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.623 2.215 . . . . 0.0 110.693 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -56.5 -159.49 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.57 -0.706 . . . . 0.0 109.655 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.517 HG22 ' CD ' ' A' ' 19' ' ' PRO . 2.1 t . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.406 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 3' ' ' CYS . 4.1 p . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 74.2 m 39.2 95.29 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.117 0.961 . . . . 0.0 111.076 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.756 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 86.7 m -52.75 175.28 0.11 Allowed Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.756 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.2 Cg_endo -72.0 165.91 31.18 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 121.33 1.354 . . . . 0.0 110.539 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.556 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -60.75 -47.98 83.85 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.29 -0.881 . . . . 0.0 110.738 -178.31 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.596 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -59.37 -47.03 86.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.838 -1.164 . . . . 0.0 109.469 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.732 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 11.4 t90 -111.11 61.95 0.61 Allowed 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.367 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.532 ' O ' ' CA ' ' A' ' 16' ' ' ASN . . . -73.48 7.36 12.82 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.253 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.73 27.72 6.15 Favored Glycine 0 N--CA 1.486 2.02 0 O-C-N 120.615 -1.521 . . . . 0.0 109.301 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.641 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -79.84 177.07 3.15 Favored Pre-proline 0 C--N 1.295 -1.804 0 O-C-N 121.721 -0.87 . . . . 0.0 111.637 -178.152 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.732 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.29 -48.07 0.14 Allowed 'Trans proline' 0 C--N 1.319 -1.014 0 C-N-CA 123.498 2.799 . . . . 0.0 113.211 -177.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.639 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 36.4 p90 -80.05 37.49 0.37 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.69 -1.256 . . . . 0.0 111.237 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.44 -168.05 39.8 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.05 -1.547 . . . . 0.0 110.182 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 8.5 mt-30 -123.48 -150.5 0.45 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.408 -1.054 . . . . 0.0 110.318 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.532 ' CA ' ' O ' ' A' ' 9' ' ' GLY . 0.6 OUTLIER -108.9 69.86 0.72 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.536 ' SG ' ' HG2' ' A' ' 26' ' ' LYS . 1.7 m -87.79 -10.07 52.05 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.376 -0.827 . . . . 0.0 110.492 -177.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.616 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 6.7 m-85 -136.16 56.16 13.64 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.25 -0.906 . . . . 0.0 110.138 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 38.0 Cg_endo -81.77 -49.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 122.43 2.086 . . . . 0.0 111.284 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -92.62 22.23 4.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.389 -0.819 . . . . 0.0 111.198 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.99 113.29 0.37 Allowed Glycine 0 N--CA 1.481 1.651 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.219 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.556 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 8.7 m -57.79 -69.07 0.19 Allowed 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.883 0.849 . . . . 0.0 109.455 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 24' ' ' GLY . 11.0 m -52.76 -44.46 66.52 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -44.0 166.65 0.03 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.04 -159.94 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.492 2.128 . . . . 0.0 110.782 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.536 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 1.2 mtmt -60.41 177.02 0.3 Allowed 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.295 0.569 . . . . 0.0 109.648 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 27' ' ' VAL . 9.8 p . . . . . 0 C--N 1.3 -1.567 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.503 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.501 ' O ' ' C ' ' A' ' 3' ' ' CYS . 2.4 p . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.501 ' C ' ' O ' ' A' ' 2' ' ' SER . 78.6 m 30.57 91.42 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.944 0.878 . . . . 0.0 111.026 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.568 ' HB3' ' O ' ' A' ' 8' ' ' TRP . 62.1 m -43.67 168.06 0.07 OUTLIER Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 33.5 Cg_endo -76.33 146.8 28.45 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.057 1.838 . . . . 0.0 110.52 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.62 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -46.82 -63.71 0.96 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 0.0 110.593 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -39.49 -37.48 0.48 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.893 0.854 . . . . 0.0 108.799 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.746 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.0 t90 -135.0 70.21 1.44 Allowed 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.683 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.9 -26.51 66.71 Favored Glycine 0 N--CA 1.5 2.948 0 O-C-N 121.279 -0.888 . . . . 0.0 111.34 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.13 17.27 23.92 Favored Glycine 0 N--CA 1.489 2.18 0 O-C-N 120.846 -1.385 . . . . 0.0 110.674 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.611 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -68.48 174.89 2.19 Favored Pre-proline 0 C--N 1.297 -1.708 0 O-C-N 121.28 -1.129 . . . . 0.0 111.075 -178.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.746 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.3 Cg_endo -74.36 -58.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 123.436 2.757 . . . . 0.0 112.776 -177.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 25.5 p90 -73.44 123.74 24.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.726 -1.234 . . . . 0.0 110.003 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 100.38 -146.16 17.54 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -144.41 -152.34 0.41 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.594 -0.945 . . . . 0.0 109.767 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.44 63.97 0.61 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.519 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.6 m -87.09 2.65 49.09 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.661 0.743 . . . . 0.0 109.908 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.62 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 73.3 m-85 -145.33 76.2 13.38 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.66 -37.7 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.701 2.268 . . . . 0.0 112.081 -178.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.9 38.74 1.47 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.817 -1.177 . . . . 0.0 111.264 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 22' ' ' CYS . . . 149.34 119.66 1.0 Allowed Glycine 0 N--CA 1.479 1.507 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.0 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 12.0 m -40.63 -38.57 0.9 Allowed 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 122.381 1.086 . . . . 0.0 108.775 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.518 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 23.2 t 44.31 56.8 4.7 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 40.9 -99.43 0.01 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 23' ' ' SER . 32.2 Cg_endo -74.02 -159.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.371 2.047 . . . . 0.0 111.051 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.594 ' NZ ' HG12 ' A' ' 27' ' ' VAL . 1.5 ttpp -48.34 -179.97 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.536 0.684 . . . . 0.0 109.889 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 27' ' ' VAL . 5.4 p . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.433 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.549 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 2.9 t . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.741 0.305 . . . . 0.0 110.614 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 4' ' ' CYS . 87.5 m -143.09 93.04 2.45 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 120.892 -1.13 . . . . 0.0 109.557 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.586 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 39.3 m -41.67 167.6 0.06 OUTLIER Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.7 Cg_endo -72.11 159.44 49.93 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.071 1.847 . . . . 0.0 110.294 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.606 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.2 p -53.88 -71.51 0.07 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.293 -0.88 . . . . 0.0 111.531 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -44.19 -44.33 7.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.99 -1.069 . . . . 0.0 109.985 -178.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.767 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.6 t90 -115.8 63.22 0.7 Allowed 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 119.135 -1.026 . . . . 0.0 109.861 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -73.41 -26.28 70.57 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.94 7.97 52.9 Favored Glycine 0 N--CA 1.489 2.187 0 O-C-N 120.846 -1.385 . . . . 0.0 110.396 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -58.92 177.26 0.25 Allowed Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.258 -1.143 . . . . 0.0 110.963 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.767 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.2 Cg_endo -74.34 -57.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 123.213 2.609 . . . . 0.0 112.647 -177.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.596 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 26.6 p90 -73.58 117.67 15.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.697 -1.252 . . . . 0.0 109.697 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.549 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 91.26 -171.54 35.41 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -124.14 -138.55 0.29 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.211 -1.17 . . . . 0.0 110.147 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.515 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -109.27 70.65 0.74 Allowed 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.959 -1.088 . . . . 0.0 109.014 -179.139 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.555 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.7 m -89.36 -4.2 58.16 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 121.307 -0.87 . . . . 0.0 110.153 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.561 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 67.2 m-85 -140.09 60.75 15.68 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.425 -0.797 . . . . 0.0 109.462 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.3 Cg_endo -78.78 -23.77 7.84 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.426 2.084 . . . . 0.0 110.675 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.3 46.7 1.31 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.062 -1.024 . . . . 0.0 110.403 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.93 110.33 0.23 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.5 m -69.45 -15.1 63.2 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.598 0.714 . . . . 0.0 109.626 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 24' ' ' GLY . 3.8 m -126.86 -24.99 3.41 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.618 -0.676 . . . . 0.0 109.963 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -48.5 176.41 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -77.3 -161.59 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.36 2.04 . . . . 0.0 110.615 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.555 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 10.2 ttmt -71.03 -172.17 0.65 Allowed 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.695 -0.628 . . . . 0.0 109.333 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 29.0 m . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.934 -1.031 . . . . 0.0 109.515 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.494 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 7.5 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 4' ' ' CYS . 62.2 m -147.82 93.55 2.22 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.352 -0.842 . . . . 0.0 108.882 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.582 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 44.2 m -41.37 167.3 0.05 OUTLIER Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.6 Cg_endo -72.33 159.6 49.06 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.263 1.975 . . . . 0.0 110.614 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.616 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -55.99 -69.94 0.13 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.893 . . . . 0.0 111.202 -178.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.596 ' CE2' ' HB2' ' A' ' 8' ' ' TRP . 1.5 p90 -42.16 -37.96 1.59 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 109.604 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.753 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.0 t90 -126.27 67.22 1.21 Allowed 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 119.059 -1.057 . . . . 0.0 109.991 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -75.26 -26.45 66.06 Favored Glycine 0 N--CA 1.496 2.694 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.005 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.91 11.14 49.31 Favored Glycine 0 N--CA 1.49 2.294 0 O-C-N 120.877 -1.366 . . . . 0.0 110.532 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.636 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -61.5 176.13 0.45 Allowed Pre-proline 0 C--N 1.297 -1.702 0 O-C-N 121.361 -1.082 . . . . 0.0 110.948 -178.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.753 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.8 -58.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 123.195 2.596 . . . . 0.0 112.455 -177.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.598 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 24.4 p90 -73.4 118.84 16.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.719 -1.238 . . . . 0.0 109.367 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.494 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 93.51 -178.79 38.49 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 19.8 mt-30 -111.26 -145.91 0.4 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.405 -1.056 . . . . 0.0 109.8 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -108.77 66.13 0.63 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.881 ' HA ' HG23 ' A' ' 27' ' ' VAL . 1.6 m -87.97 13.25 11.37 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.417 -0.802 . . . . 0.0 110.885 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.593 ' CD1' ' O ' ' A' ' 17' ' ' CYS . 62.7 m-85 -155.21 63.23 3.68 Favored Pre-proline 0 C--N 1.296 -1.759 0 O-C-N 120.664 -1.272 . . . . 0.0 109.547 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.7 Cg_endo -79.65 -32.09 1.72 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.307 2.005 . . . . 0.0 110.321 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -142.03 51.41 1.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 110.147 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.04 110.46 0.23 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.616 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -70.03 -16.56 63.17 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 121.437 0.637 . . . . 0.0 109.888 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.575 ' O ' ' C ' ' A' ' 24' ' ' GLY . 20.4 m -135.46 -94.07 0.27 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.417 -0.802 . . . . 0.0 109.192 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 13.57 -127.97 0.01 OUTLIER Glycine 0 N--CA 1.511 3.657 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -81.93 -157.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.162 1.908 . . . . 0.0 107.999 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.576 ' CA ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -133.09 -38.11 0.97 Allowed 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.483 178.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.881 HG23 ' HA ' ' A' ' 17' ' ' CYS . 25.0 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 120.894 -1.129 . . . . 0.0 109.165 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.56 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 4' ' ' CYS . 73.5 m -143.18 89.76 2.13 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.042 -1.036 . . . . 0.0 110.255 -178.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.568 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 11.9 m -43.75 168.77 0.06 OUTLIER Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.4 Cg_endo -71.43 148.75 55.1 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.001 1.8 . . . . 0.0 110.621 179.41 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.568 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 1.6 p -55.08 -46.19 75.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 110.916 -178.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -59.12 -36.39 75.1 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.839 -1.163 . . . . 0.0 108.192 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.726 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 17.9 t90 -131.52 69.59 1.47 Allowed 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.424 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -73.05 -26.51 70.75 Favored Glycine 0 N--CA 1.499 2.834 0 O-C-N 121.358 -0.839 . . . . 0.0 111.371 -178.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.48 15.19 31.09 Favored Glycine 0 N--CA 1.491 2.343 0 O-C-N 120.842 -1.387 . . . . 0.0 110.353 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.642 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -68.17 175.85 1.63 Allowed Pre-proline 0 C--N 1.296 -1.736 0 O-C-N 121.438 -1.036 . . . . 0.0 111.124 -178.735 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.726 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.0 Cg_endo -73.48 -60.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 123.31 2.673 . . . . 0.0 112.322 -177.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 17.5 p90 -73.29 122.93 22.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 0.0 109.287 -179.039 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.56 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 99.2 -166.62 21.11 Favored Glycine 0 N--CA 1.485 1.929 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.053 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -129.24 -147.91 0.36 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.466 -1.02 . . . . 0.0 109.65 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.42 64.83 0.62 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.562 ' SG ' ' HG2' ' A' ' 26' ' ' LYS . 1.6 m -87.56 -4.34 58.97 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.45 -0.781 . . . . 0.0 110.217 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.563 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 57.2 m-85 -148.15 61.75 6.14 Favored Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 121.416 -0.803 . . . . 0.0 109.772 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 37.5 Cg_endo -82.27 -39.06 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.634 2.223 . . . . 0.0 111.536 -179.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -122.91 36.35 4.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.968 -1.082 . . . . 0.0 111.279 -178.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.19 113.48 0.46 Allowed Glycine 0 N--CA 1.483 1.829 0 C-N-CA 119.487 -1.34 . . . . 0.0 110.547 178.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.568 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 8.7 m -56.6 -41.61 77.32 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-O 122.074 0.94 . . . . 0.0 109.233 179.01 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 24' ' ' GLY . 1.8 t -81.33 -41.15 22.5 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.496 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -44.22 166.84 0.03 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.8 -159.64 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.341 2.027 . . . . 0.0 110.641 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.562 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 3.4 mtpp -69.84 175.31 4.41 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.592 0.71 . . . . 0.0 109.959 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.567 HG22 ' OXT' ' A' ' 27' ' ' VAL . 9.5 p . . . . . 0 C--N 1.302 -1.463 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.488 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.47 ' OG ' ' HG3' ' A' ' 15' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.353 0.597 . . . . 0.0 109.458 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 4' ' ' CYS . 69.9 m -143.75 91.74 2.27 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.994 0.902 . . . . 0.0 108.628 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.678 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 68.2 m -44.64 170.32 0.05 OUTLIER Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.678 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.7 Cg_endo -72.74 158.28 50.65 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 C-N-CA 121.87 1.713 . . . . 0.0 110.672 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.579 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -61.87 -47.82 83.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.331 -0.856 . . . . 0.0 110.464 -178.738 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -53.23 -31.53 43.72 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.45 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.75 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.6 t90 -139.26 74.59 1.48 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.693 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -76.45 -26.4 63.54 Favored Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.336 -178.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.49 26.79 6.13 Favored Glycine 0 N--CA 1.49 2.275 0 O-C-N 120.675 -1.485 . . . . 0.0 110.922 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.624 ' HA ' ' CZ2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.91 173.41 7.52 Favored Pre-proline 0 C--N 1.293 -1.879 0 O-C-N 121.314 -1.11 . . . . 0.0 111.379 -178.669 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.75 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.3 Cg_endo -75.8 -55.16 0.07 OUTLIER 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 123.771 2.98 . . . . 0.0 114.12 -177.012 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.591 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.4 p90 -74.73 28.47 0.09 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.718 -1.239 . . . . 0.0 112.274 -177.072 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.459 ' HA2' ' OG ' ' A' ' 2' ' ' SER . . . -177.2 179.67 47.93 Favored Glycine 0 N--CA 1.485 1.938 0 C-N-CA 118.61 -1.757 . . . . 0.0 110.197 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 9' ' ' GLY . 35.4 mt-30 -101.22 -163.96 1.06 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.425 -1.044 . . . . 0.0 109.553 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -106.5 65.49 0.68 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.571 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.6 m -87.48 9.22 21.62 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.313 0.578 . . . . 0.0 110.145 -177.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.575 ' CE1' ' O ' ' A' ' 26' ' ' LYS . 65.8 m-85 -150.76 62.85 5.5 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 120.69 -1.256 . . . . 0.0 109.844 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.8 Cg_endo -80.39 -62.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.637 2.225 . . . . 0.0 110.867 -179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.9 37.05 2.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.65 105.22 0.18 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.579 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 37.1 m -62.47 -32.88 73.84 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.697 0.76 . . . . 0.0 110.708 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.491 ' O ' ' C ' ' A' ' 24' ' ' GLY . 11.8 t -99.07 -89.29 0.32 Allowed 'General case' 0 C--N 1.287 -2.125 0 O-C-N 121.68 -0.638 . . . . 0.0 109.55 -179.521 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 33.47 -149.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 26' ' ' LYS . 34.4 Cg_endo -79.21 -166.97 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.4 2.067 . . . . 0.0 108.981 178.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.575 ' O ' ' CE1' ' A' ' 18' ' ' TYR . 2.6 ttmm -50.33 -58.71 5.05 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.622 -1.231 . . . . 0.0 107.928 178.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.552 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 14.4 m . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.487 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 3' ' ' CYS . 60.1 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 89.2 m 32.87 91.9 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.95 0.881 . . . . 0.0 110.898 179.207 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 8' ' ' TRP . 58.4 m -43.35 168.1 0.07 OUTLIER Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.214 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 34.0 Cg_endo -77.03 146.35 25.6 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.19 1.926 . . . . 0.0 110.683 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.636 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -46.25 -63.95 0.87 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.086 -1.009 . . . . 0.0 110.587 -179.453 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -39.59 -37.93 0.55 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.874 0.845 . . . . 0.0 108.842 -179.737 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.747 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.2 t90 -134.97 70.11 1.44 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.633 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.0 -26.65 66.16 Favored Glycine 0 N--CA 1.501 2.986 0 O-C-N 121.275 -0.89 . . . . 0.0 111.387 -178.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.71 15.95 28.47 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.918 -1.343 . . . . 0.0 110.571 -179.086 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.613 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -66.99 174.75 1.76 Allowed Pre-proline 0 C--N 1.296 -1.735 0 O-C-N 121.295 -1.121 . . . . 0.0 111.04 -178.764 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.747 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.4 Cg_endo -74.1 -57.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 123.311 2.674 . . . . 0.0 112.833 -177.473 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 26.8 p90 -73.4 122.83 22.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.681 -1.262 . . . . 0.0 109.978 -178.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.432 ' C ' ' HG3' ' A' ' 15' ' ' GLN . . . 99.21 -147.39 18.41 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.432 ' HG3' ' C ' ' A' ' 14' ' ' GLY . 21.8 mt-30 -143.4 -149.86 0.29 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.466 -1.02 . . . . 0.0 109.793 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.69 63.74 0.61 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.507 ' SG ' ' HG2' ' A' ' 26' ' ' LYS . 1.7 m -87.21 8.05 25.67 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.401 -0.812 . . . . 0.0 109.594 -178.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.636 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 77.2 m-85 -149.21 64.98 7.75 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.5 Cg_endo -80.75 -16.34 10.33 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.632 2.221 . . . . 0.0 111.809 -178.156 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.16 35.99 0.67 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.633 -1.292 . . . . 0.0 111.28 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 23' ' ' SER . . . 134.56 124.24 2.44 Favored Glycine 0 N--CA 1.476 1.328 0 C-N-CA 119.504 -1.332 . . . . 0.0 109.955 179.239 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.533 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 20.5 m -35.67 -34.58 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 122.442 1.115 . . . . 0.0 109.39 179.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.491 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 37.6 p 46.53 58.88 4.23 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.226 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 43.2 -101.75 0.03 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 23' ' ' SER . 33.8 Cg_endo -75.89 -160.39 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.29 1.993 . . . . 0.0 111.057 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.507 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -50.78 -172.59 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.365 0.603 . . . . 0.0 110.22 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 9.8 p . . . . . 0 C--N 1.303 -1.442 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.532 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.443 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.197 0.522 . . . . 0.0 109.779 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.51 ' O ' ' O ' ' A' ' 4' ' ' CYS . 53.9 m -150.73 96.46 2.36 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.327 -0.858 . . . . 0.0 108.729 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.596 ' HB3' ' O ' ' A' ' 8' ' ' TRP . 55.7 m -39.23 165.69 0.05 OUTLIER Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.862 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.8 Cg_endo -71.24 173.32 12.44 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.286 1.991 . . . . 0.0 111.319 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.718 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -69.58 -48.0 61.67 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.427 -0.796 . . . . 0.0 111.511 -178.397 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.544 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -66.11 -29.78 70.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.737 -1.227 . . . . 0.0 109.773 -179.612 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.755 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.0 t90 -131.99 68.12 1.5 Allowed 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 118.679 -1.209 . . . . 0.0 109.933 -178.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.463 ' HA2' ' CB ' ' A' ' 4' ' ' CYS . . . -74.09 -26.24 69.17 Favored Glycine 0 N--CA 1.5 2.929 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.292 -179.141 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.06 13.95 35.46 Favored Glycine 0 N--CA 1.489 2.189 0 O-C-N 120.788 -1.419 . . . . 0.0 110.313 -179.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.651 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -66.27 175.1 1.39 Allowed Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 121.442 -1.034 . . . . 0.0 111.056 -178.78 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.755 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.4 -58.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -1.019 0 C-N-CA 123.275 2.65 . . . . 0.0 112.485 -177.35 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 23.9 p90 -72.79 122.12 21.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.74 -1.225 . . . . 0.0 109.121 -179.039 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' HA2' ' OG ' ' A' ' 2' ' ' SER . . . 88.17 174.77 47.74 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.473 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 12.7 mt-30 -103.2 -149.49 0.4 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.257 -1.143 . . . . 0.0 109.408 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.455 ' OD1' ' HA3' ' A' ' 9' ' ' GLY . 16.7 t-20 -108.67 68.9 0.7 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.531 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.7 m -86.87 -11.44 50.77 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.37 0.605 . . . . 0.0 109.944 -177.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.542 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 43.0 m-85 -132.46 77.15 70.69 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.51 ' HD2' ' HA ' ' A' ' 27' ' ' VAL . 35.2 Cg_endo -76.47 -48.44 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.586 2.19 . . . . 0.0 109.835 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -143.33 16.23 1.86 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -92.49 25.75 16.95 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.718 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -35.73 -31.5 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.22 0 CA-C-O 121.79 0.805 . . . . 0.0 110.196 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -125.37 -30.73 3.1 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.757 -0.59 . . . . 0.0 109.603 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.29 -148.87 0.04 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -78.18 -160.67 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.69 2.26 . . . . 0.0 110.738 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.531 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 20.5 ttpt -50.95 -76.26 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.527 -0.733 . . . . 0.0 109.165 179.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.51 ' HA ' ' HD2' ' A' ' 19' ' ' PRO . 5.2 m . . . . . 0 N--CA 1.49 1.556 0 O-C-N 120.955 -1.091 . . . . 0.0 109.43 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.543 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 3.3 t . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.169 0.509 . . . . 0.0 109.659 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 89.2 m -148.44 91.87 1.95 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.128 -0.982 . . . . 0.0 109.635 -179.279 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.631 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 80.9 m -43.12 167.04 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.631 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 26.4 Cg_endo -65.28 152.67 81.38 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.123 1.215 . . . . 0.0 109.519 179.559 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.617 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 16.4 p -59.45 -42.48 92.08 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.141 -0.974 . . . . 0.0 110.088 -177.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -57.43 -28.62 63.47 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.099 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.763 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.1 t90 -136.06 72.63 1.44 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.041 -179.03 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 4' ' ' CYS . . . -79.73 -24.45 60.27 Favored Glycine 0 N--CA 1.5 2.929 0 O-C-N 121.12 -0.988 . . . . 0.0 111.121 -179.268 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.59 16.57 34.92 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.96 -1.318 . . . . 0.0 110.555 -179.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.618 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -63.77 174.18 1.11 Allowed Pre-proline 0 C--N 1.296 -1.742 0 O-C-N 121.272 -1.134 . . . . 0.0 111.042 -178.82 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.763 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.8 Cg_endo -73.05 -58.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 123.352 2.701 . . . . 0.0 112.222 -177.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.551 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 22.8 p90 -73.28 -167.76 0.45 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.768 -1.207 . . . . 0.0 109.153 -179.181 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.543 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 37.86 -148.54 0.07 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.8 OUTLIER -139.69 -157.6 0.78 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.411 -1.052 . . . . 0.0 109.99 179.801 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.475 ' OD1' ' CG ' ' A' ' 19' ' ' PRO . 13.5 t-20 -109.23 70.83 0.75 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 179.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.532 ' C ' ' CG ' ' A' ' 18' ' ' TYR . 1.3 m -87.84 -2.05 58.36 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.453 0.644 . . . . 0.0 111.074 -177.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.617 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -165.83 76.84 1.24 Allowed Pre-proline 0 N--CA 1.496 1.825 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.101 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.475 ' CG ' ' OD1' ' A' ' 16' ' ' ASN . 37.6 Cg_endo -82.83 -54.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 123.028 2.485 . . . . 0.0 112.013 -178.038 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -94.18 15.98 15.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.102 -0.999 . . . . 0.0 111.563 -177.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 22' ' ' CYS . . . 149.03 120.25 1.06 Allowed Glycine 0 N--CA 1.475 1.241 0 C-N-CA 118.989 -1.577 . . . . 0.0 110.174 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.598 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.4 m -37.05 -46.18 0.65 Allowed 'General case' 0 C--N 1.288 -2.105 0 CA-C-O 122.364 1.078 . . . . 0.0 108.59 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.527 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER 46.28 36.55 3.39 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.446 179.067 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.04 -112.38 3.47 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 179.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 23' ' ' SER . 32.7 Cg_endo -74.76 -157.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.377 2.051 . . . . 0.0 111.109 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 25' ' ' PRO . 2.1 mtpt -46.16 177.91 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.67 0.747 . . . . 0.0 110.271 -179.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 17' ' ' CYS . 5.4 p . . . . . 0 C--N 1.301 -1.543 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.647 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 3' ' ' CYS . 6.6 t . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 75.1 m 35.34 95.63 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.26 1.029 . . . . 0.0 110.758 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.676 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 57.7 m -52.36 170.68 0.23 Allowed Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.676 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.0 Cg_endo -71.93 166.38 29.73 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.068 1.846 . . . . 0.0 111.355 -179.604 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.68 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -62.52 -44.48 96.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.54 -0.725 . . . . 0.0 110.696 -179.034 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -67.49 -34.38 77.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.273 -0.892 . . . . 0.0 110.012 -178.929 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.751 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 13.4 t90 -126.63 65.61 1.26 Allowed 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.574 -178.445 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -65.66 -28.99 74.16 Favored Glycine 0 N--CA 1.498 2.77 0 O-C-N 121.344 -0.847 . . . . 0.0 111.542 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.09 29.89 4.54 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 120.68 -1.482 . . . . 0.0 111.283 -178.459 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.635 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -82.53 172.16 10.17 Favored Pre-proline 0 C--N 1.294 -1.836 0 O-C-N 121.211 -1.17 . . . . 0.0 111.427 -178.666 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.751 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.5 Cg_endo -75.55 -53.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 123.837 3.025 . . . . 0.0 113.997 -176.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.566 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 27.3 p90 -74.83 23.2 0.1 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.675 -1.266 . . . . 0.0 112.005 -177.294 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.409 ' C ' ' SG ' ' A' ' 4' ' ' CYS . . . -168.28 -174.92 37.5 Favored Glycine 0 N--CA 1.485 1.963 0 C-N-CA 118.949 -1.596 . . . . 0.0 110.028 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 9' ' ' GLY . 35.8 mt-30 -116.99 -149.25 0.44 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.554 -0.968 . . . . 0.0 109.16 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.414 ' ND2' ' HA3' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -108.82 62.44 0.6 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.624 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.7 m -87.01 -19.95 27.94 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.258 -0.901 . . . . 0.0 109.147 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.618 ' CG ' ' HB2' ' A' ' 26' ' ' LYS . 6.6 m-85 -116.66 71.31 5.04 Favored Pre-proline 0 C--N 1.296 -1.723 0 O-C-N 121.666 -0.647 . . . . 0.0 109.815 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.513 ' HD3' ' C ' ' A' ' 17' ' ' CYS . 34.7 Cg_endo -74.99 -44.54 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.159 1.906 . . . . 0.0 110.195 179.572 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -144.86 15.38 1.56 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.375 -0.828 . . . . 0.0 109.092 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 25' ' ' PRO . . . -93.36 23.52 29.59 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.68 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.6 m -36.0 -29.45 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.361 0.601 . . . . 0.0 111.231 -179.675 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' GLY . 2.5 p -113.1 -74.15 0.64 Allowed 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.436 -0.79 . . . . 0.0 110.778 -178.759 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -59.47 -131.86 0.01 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.145 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.52 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 33.4 Cg_endo -74.98 -158.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.2 1.933 . . . . 0.0 109.836 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 1.006 ' HG2' HG13 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -138.32 -36.85 0.57 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.184 -0.947 . . . . 0.0 109.935 -179.859 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.006 HG13 ' HG2' ' A' ' 26' ' ' LYS . 3.5 m . . . . . 0 N--CA 1.493 1.678 0 O-C-N 120.733 -1.229 . . . . 0.0 109.3 178.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 3' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.48 ' C ' ' O ' ' A' ' 2' ' ' SER . 73.8 m 33.15 91.78 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 122.133 0.968 . . . . 0.0 110.905 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.747 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 86.3 m -49.71 173.94 0.07 OUTLIER Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.061 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.747 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.4 Cg_endo -72.9 165.73 31.98 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.599 1.532 . . . . 0.0 111.35 -179.293 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.727 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -56.34 -46.95 79.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.453 -0.78 . . . . 0.0 111.343 -178.383 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -63.75 -40.08 95.84 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.034 -1.041 . . . . 0.0 110.375 -179.248 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.734 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.8 t90 -117.6 62.77 0.74 Allowed 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.24 -178.25 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -71.93 5.67 12.14 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.163 -0.961 . . . . 0.0 111.522 -179.242 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.68 28.64 5.88 Favored Glycine 0 N--CA 1.486 1.969 0 O-C-N 120.508 -1.583 . . . . 0.0 109.617 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.658 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -80.4 176.66 3.57 Favored Pre-proline 0 C--N 1.294 -1.848 0 O-C-N 121.654 -0.909 . . . . 0.0 111.664 -178.207 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.734 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.63 -50.21 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 123.569 2.846 . . . . 0.0 113.181 -177.015 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.633 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 34.6 p90 -78.58 34.79 0.22 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.675 -1.266 . . . . 0.0 111.585 -177.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.81 -163.26 32.1 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.834 -1.65 . . . . 0.0 110.502 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' GLY . 2.1 tt0 -128.3 -152.11 0.5 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.538 -0.978 . . . . 0.0 110.073 -179.337 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 12.7 t30 -109.21 64.59 0.61 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.536 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.6 m -87.46 -11.07 50.12 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.428 -0.795 . . . . 0.0 109.703 -179.0 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.527 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 96.9 m-85 -130.84 73.04 81.52 Favored Pre-proline 0 C--N 1.296 -1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 109.723 -179.232 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.524 ' CD ' ' O ' ' A' ' 27' ' ' VAL . 35.1 Cg_endo -77.67 -40.95 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.442 2.095 . . . . 0.0 109.477 179.581 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -141.2 13.03 2.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.352 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -94.9 25.67 22.5 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.557 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.727 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -38.67 -29.7 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.286 0 CA-C-O 121.751 0.786 . . . . 0.0 109.952 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 21' ' ' GLY . 48.5 t -147.97 54.58 1.04 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -157.24 -132.36 1.45 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -78.66 -160.58 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.388 2.059 . . . . 0.0 111.018 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.536 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 3.3 ttpt -122.64 87.61 2.78 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.753 -0.592 . . . . 0.0 109.545 179.598 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.524 ' O ' ' CD ' ' A' ' 19' ' ' PRO . 42.4 t . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.642 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.531 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.468 ' C ' ' O ' ' A' ' 2' ' ' SER . 71.6 m 34.36 95.98 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.127 0.965 . . . . 0.0 111.031 179.013 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.658 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 97.9 m -55.13 169.78 0.42 Allowed Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.658 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.5 Cg_endo -72.03 156.26 56.22 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.772 1.648 . . . . 0.0 111.068 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.596 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -48.17 -70.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.453 -0.779 . . . . 0.0 111.109 -178.487 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.599 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -41.16 -34.14 0.43 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.436 -0.79 . . . . 0.0 109.852 -178.886 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.736 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.1 t90 -126.0 66.47 1.2 Allowed 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.732 -179.31 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -78.32 5.95 53.32 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 120.162 -1.018 . . . . 0.0 110.871 -179.202 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.72 26.7 6.78 Favored Glycine 0 N--CA 1.485 1.955 0 O-C-N 120.773 -1.427 . . . . 0.0 109.637 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.643 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.91 176.47 3.42 Favored Pre-proline 0 C--N 1.294 -1.845 0 O-C-N 121.733 -0.863 . . . . 0.0 111.344 -178.402 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.736 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.8 Cg_endo -76.18 -52.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 123.423 2.748 . . . . 0.0 113.153 -177.154 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.583 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 28.9 p90 -78.0 31.73 0.17 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.745 -1.222 . . . . 0.0 111.625 -177.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.531 ' HA2' ' CB ' ' A' ' 2' ' ' SER . . . -179.15 -171.73 42.62 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 118.595 -1.764 . . . . 0.0 110.595 179.555 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' GLY . 1.3 tt0 -118.87 -151.69 0.49 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.558 -0.966 . . . . 0.0 110.142 -179.522 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.582 ' O ' HG21 ' A' ' 27' ' ' VAL . 27.0 t-20 -109.24 64.19 0.61 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.53 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.7 m -87.73 4.26 44.87 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.396 -0.815 . . . . 0.0 110.015 -178.516 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.596 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 73.0 m-85 -147.07 62.27 7.2 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.282 -0.886 . . . . 0.0 109.742 -178.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.582 ' CG ' HG22 ' A' ' 27' ' ' VAL . 35.4 Cg_endo -78.66 -38.8 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.587 2.191 . . . . 0.0 110.324 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -132.61 49.85 2.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 109.422 -179.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.25 112.31 0.26 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 179.71 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.7 m -64.9 -81.87 0.03 OUTLIER 'General case' 0 C--N 1.285 -2.232 0 CA-C-O 122.111 0.958 . . . . 0.0 109.079 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 24' ' ' GLY . 6.4 t -70.81 -8.77 54.92 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.314 179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -52.88 -173.44 0.04 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -78.96 -160.15 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.543 2.162 . . . . 0.0 110.952 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.53 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 2.1 ttmm -89.31 176.22 7.02 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.302 0.572 . . . . 0.0 109.581 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.582 HG21 ' O ' ' A' ' 16' ' ' ASN . 45.6 t . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.42 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 2' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 3' ' ' CYS . 5.7 t -61.62 -129.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.415 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 74.1 m 38.61 96.27 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.352 1.072 . . . . 0.0 110.739 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.698 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 98.8 m -58.59 171.79 0.59 Allowed Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.698 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.7 Cg_endo -70.64 166.95 27.02 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.567 1.511 . . . . 0.0 110.532 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.581 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.7 p -57.66 -69.67 0.16 Allowed 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.192 -0.942 . . . . 0.0 111.604 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.64 -36.39 2.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.918 -1.114 . . . . 0.0 110.218 -179.129 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.739 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 9.7 t90 -118.75 64.58 0.77 Allowed 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.055 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -77.14 10.18 22.08 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 120.109 -1.043 . . . . 0.0 110.915 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.41 29.89 4.41 Favored Glycine 0 N--CA 1.487 2.04 0 O-C-N 120.722 -1.458 . . . . 0.0 109.492 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.65 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -80.39 177.83 2.74 Favored Pre-proline 0 C--N 1.294 -1.841 0 O-C-N 121.742 -0.858 . . . . 0.0 111.334 -178.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.739 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.61 -51.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 123.483 2.788 . . . . 0.0 113.089 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.59 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.8 p90 -78.63 33.92 0.21 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.673 -1.267 . . . . 0.0 111.476 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.481 ' CA ' ' SG ' ' A' ' 4' ' ' CYS . . . 177.76 -169.27 41.19 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.107 -1.52 . . . . 0.0 110.108 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 9' ' ' GLY . 8.3 mm100 -125.95 -145.45 0.32 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.413 -1.051 . . . . 0.0 109.626 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 0.2 OUTLIER -108.4 61.88 0.61 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.424 -0.798 . . . . 0.0 109.129 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.549 ' CA ' ' HA ' ' A' ' 27' ' ' VAL . 1.5 m -87.56 -5.1 58.91 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.261 -0.9 . . . . 0.0 110.078 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.547 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 40.2 m-85 -131.24 59.08 43.29 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.206 -0.934 . . . . 0.0 109.901 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.5 Cg_endo -78.27 -36.39 1.0 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.48 2.12 . . . . 0.0 110.52 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -135.46 50.64 2.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.326 -0.859 . . . . 0.0 109.929 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.87 108.56 0.21 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.581 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.5 m -73.76 -12.93 60.86 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 121.364 0.602 . . . . 0.0 110.343 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -145.72 8.41 1.13 Allowed 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.277 -0.889 . . . . 0.0 110.986 -178.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -62.19 -142.56 0.01 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -77.14 -165.77 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.106 1.871 . . . . 0.0 109.204 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -60.45 -68.17 0.32 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.634 -1.227 . . . . 0.0 108.047 178.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.549 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 1.8 t . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.438 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.553 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 0.1 OUTLIER -87.24 82.1 7.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.397 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.517 ' SG ' ' CD ' ' A' ' 26' ' ' LYS . 91.5 m -149.19 93.9 2.15 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.245 -0.909 . . . . 0.0 109.05 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 32.8 m -42.68 166.66 0.08 OUTLIER Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.607 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 33.9 Cg_endo -76.26 153.5 35.97 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.34 2.027 . . . . 0.0 111.091 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.639 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -50.63 -71.21 0.07 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.226 -0.921 . . . . 0.0 110.699 -179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.607 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -39.75 -29.65 0.06 Allowed 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.918 -179.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.757 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.5 t90 -138.4 72.31 1.41 Allowed 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 118.751 -1.18 . . . . 0.0 109.763 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -77.33 -29.09 56.77 Favored Glycine 0 N--CA 1.502 3.063 0 O-C-N 121.275 -0.891 . . . . 0.0 111.229 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.33 13.79 31.89 Favored Glycine 0 N--CA 1.49 2.296 0 O-C-N 120.947 -1.326 . . . . 0.0 110.675 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -63.62 174.48 0.99 Allowed Pre-proline 0 C--N 1.297 -1.714 0 O-C-N 121.307 -1.114 . . . . 0.0 110.915 -178.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.757 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.7 -59.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 123.33 2.687 . . . . 0.0 112.637 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.57 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 23.4 p90 -73.3 127.44 32.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.761 -1.212 . . . . 0.0 109.824 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.553 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 95.37 -165.19 24.87 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.208 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.455 ' H ' ' HA ' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -124.08 -152.14 0.5 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.563 -0.963 . . . . 0.0 109.957 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.25 65.41 0.63 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.514 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.6 m -87.2 -1.95 58.27 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.61 0.719 . . . . 0.0 109.896 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.639 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 67.0 m-85 -134.45 62.31 54.44 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.4 Cg_endo -79.5 -30.97 2.23 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.516 2.144 . . . . 0.0 110.297 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.99 -66.36 0.93 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' A' ' 6' ' ' CYS . . . -144.78 -135.71 2.93 Favored Glycine 0 C--N 1.287 -2.168 0 N-CA-C 106.942 -2.463 . . . . 0.0 106.942 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.552 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 56.9 m -88.39 -20.85 24.73 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-O 122.074 0.94 . . . . 0.0 108.964 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.517 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER 45.4 55.5 6.47 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 37.87 -97.42 0.01 OUTLIER Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 23' ' ' SER . 32.3 Cg_endo -74.53 -160.64 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.392 2.061 . . . . 0.0 111.187 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.517 ' CD ' ' SG ' ' A' ' 3' ' ' CYS . 19.9 ttpp -39.17 -70.49 0.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.666 -0.646 . . . . 0.0 110.588 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.543 HG22 ' OXT' ' A' ' 27' ' ' VAL . 9.4 p . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.848 -1.157 . . . . 0.0 109.501 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 1' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.505 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 43.2 t -86.09 -21.67 27.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.142 -0.974 . . . . 0.0 109.513 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 81.6 m 40.83 97.14 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 122.227 1.013 . . . . 0.0 110.443 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.654 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 89.8 m -54.66 169.2 0.41 Allowed Pre-proline 0 C--N 1.295 -1.763 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.654 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.6 Cg_endo -71.79 155.77 57.83 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.783 1.655 . . . . 0.0 111.045 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -47.77 -69.5 0.12 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.519 -0.738 . . . . 0.0 111.172 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.597 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -42.48 -35.98 1.2 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.214 -0.929 . . . . 0.0 109.973 -179.14 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.736 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.2 t90 -123.42 65.06 1.01 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.838 -1.145 . . . . 0.0 109.863 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -77.47 8.0 36.19 Favored Glycine 0 N--CA 1.497 2.747 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.851 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.67 28.2 5.77 Favored Glycine 0 N--CA 1.485 1.965 0 O-C-N 120.764 -1.433 . . . . 0.0 109.547 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.64 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -79.05 176.83 3.32 Favored Pre-proline 0 C--N 1.294 -1.808 0 O-C-N 121.769 -0.842 . . . . 0.0 111.492 -178.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.736 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.39 -52.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 123.488 2.792 . . . . 0.0 113.117 -177.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.587 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.9 p90 -78.31 33.78 0.2 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.633 -1.292 . . . . 0.0 111.533 -177.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 2' ' ' SER . . . 177.38 -171.02 43.75 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 118.825 -1.655 . . . . 0.0 110.411 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 9' ' ' GLY . 8.2 mt-30 -121.1 -149.19 0.42 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.548 -0.972 . . . . 0.0 110.226 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 7.2 t-20 -109.15 64.46 0.61 Allowed 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 26' ' ' LYS . 1.6 m -87.5 4.92 41.57 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.296 -0.878 . . . . 0.0 109.877 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.58 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 73.5 m-85 -148.53 62.43 6.4 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.197 -0.94 . . . . 0.0 110.013 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.56 ' CG ' ' HB ' ' A' ' 27' ' ' VAL . 36.4 Cg_endo -79.36 -33.68 1.3 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.087 1.858 . . . . 0.0 109.515 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -137.25 53.74 1.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.512 ' HA3' ' HG2' ' A' ' 25' ' ' PRO . . . 163.85 113.45 0.29 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.615 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -69.63 -10.55 58.66 Favored 'General case' 0 C--N 1.283 -2.286 0 O-C-N 122.313 -0.522 . . . . 0.0 111.2 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.461 ' O ' ' C ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -169.19 -50.75 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.876 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 23' ' ' SER . . . -38.49 -86.69 0.01 OUTLIER Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.512 ' HG2' ' HA3' ' A' ' 21' ' ' GLY . 31.3 Cg_endo -76.31 -161.01 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.747 2.298 . . . . 0.0 111.688 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 17' ' ' CYS . 6.7 tttt -176.08 121.45 0.17 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.56 ' HB ' ' CG ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.15 -0.968 . . . . 0.0 109.936 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.3 ptt85 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.248 0.547 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.488 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 46.7 t -178.67 -28.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.342 -0.849 . . . . 0.0 109.784 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 2' ' ' SER . 99.9 m 41.8 95.89 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.152 0.977 . . . . 0.0 110.472 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.723 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 82.5 m -46.49 171.93 0.06 OUTLIER Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.723 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.8 Cg_endo -70.51 172.88 12.51 Favored 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.75 1.633 . . . . 0.0 111.185 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.718 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 2.9 p -66.82 -42.67 85.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.422 -0.799 . . . . 0.0 111.307 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 1.8 p90 -69.26 -38.23 78.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.081 -1.012 . . . . 0.0 110.223 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.754 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 13.8 t90 -121.11 63.58 0.88 Allowed 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.784 -178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -67.39 -22.95 73.33 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.198 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.76 27.85 6.93 Favored Glycine 0 N--CA 1.488 2.148 0 O-C-N 120.525 -1.573 . . . . 0.0 110.697 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.621 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -81.16 172.71 9.11 Favored Pre-proline 0 C--N 1.294 -1.828 0 O-C-N 121.297 -1.119 . . . . 0.0 111.629 -178.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.754 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.6 Cg_endo -75.6 -52.03 0.1 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 123.875 3.05 . . . . 0.0 113.945 -176.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.613 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 33.2 p90 -77.0 32.92 0.14 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.679 -1.263 . . . . 0.0 111.784 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 2' ' ' SER . . . 177.31 -169.54 41.78 Favored Glycine 0 N--CA 1.484 1.897 0 C-N-CA 118.78 -1.676 . . . . 0.0 110.113 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.495 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -119.36 -156.12 0.64 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.518 -0.99 . . . . 0.0 109.899 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.403 HD21 ' CB ' ' A' ' 19' ' ' PRO . 1.2 t-20 -107.79 68.32 0.71 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.586 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.5 m -86.91 -3.44 59.08 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 121.656 -0.653 . . . . 0.0 109.975 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.628 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -153.47 84.03 4.38 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.432 -0.792 . . . . 0.0 109.346 179.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.489 ' CD ' ' HB ' ' A' ' 27' ' ' VAL . 34.8 Cg_endo -77.83 -43.22 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.63 2.22 . . . . 0.0 109.809 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -137.78 12.74 2.92 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -92.54 24.74 21.73 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.718 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -35.69 -31.74 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.22 0 CA-C-O 121.877 0.846 . . . . 0.0 110.091 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' GLY . 1.2 m -116.08 -22.31 9.02 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.71 -0.619 . . . . 0.0 109.492 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.69 -173.42 46.88 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.31 -160.93 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.688 2.258 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 2.9 ttpt -58.82 176.64 0.19 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.539 -0.726 . . . . 0.0 109.356 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.538 HG22 ' OXT' ' A' ' 27' ' ' VAL . 9.2 p . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.514 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.519 ' HB2' ' HA2' ' A' ' 14' ' ' GLY . 1.0 OUTLIER -83.99 -102.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 109.204 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 2' ' ' SER . 84.3 m 35.83 96.15 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 122.262 1.03 . . . . 0.0 110.898 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.753 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 69.1 m -54.29 173.35 0.22 Allowed Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.753 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.4 Cg_endo -71.52 155.3 59.68 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.704 1.602 . . . . 0.0 110.832 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.596 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -47.92 -69.19 0.13 Allowed 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.406 -0.808 . . . . 0.0 111.334 -178.418 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 2.0 p90 -44.25 -36.96 2.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.96 . . . . 0.0 109.863 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.732 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.2 t90 -119.89 64.28 0.82 Allowed 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 118.943 -1.103 . . . . 0.0 109.969 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -75.62 6.78 29.86 Favored Glycine 0 N--CA 1.496 2.694 0 C-N-CA 120.262 -0.97 . . . . 0.0 111.13 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.66 27.76 5.89 Favored Glycine 0 N--CA 1.486 1.998 0 O-C-N 120.612 -1.523 . . . . 0.0 109.868 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.65 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -78.43 177.96 2.51 Favored Pre-proline 0 C--N 1.294 -1.839 0 O-C-N 121.641 -0.917 . . . . 0.0 111.457 -178.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.732 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.8 Cg_endo -76.9 -52.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 123.489 2.793 . . . . 0.0 113.15 -177.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.585 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.6 p90 -78.1 33.08 0.18 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.719 -1.238 . . . . 0.0 111.677 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.519 ' HA2' ' HB2' ' A' ' 2' ' ' SER . . . 177.78 -170.45 42.8 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 118.812 -1.661 . . . . 0.0 110.488 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -121.85 -151.74 0.49 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.547 -0.973 . . . . 0.0 110.391 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 19.6 t-20 -108.78 64.03 0.61 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.537 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 2.1 m -87.74 -10.59 50.63 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 121.775 0.798 . . . . 0.0 109.792 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.527 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 29.7 m-85 -127.83 67.89 74.14 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.661 -0.65 . . . . 0.0 109.259 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HD3' ' C ' ' A' ' 17' ' ' CYS . 36.5 Cg_endo -78.16 -44.55 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.547 2.165 . . . . 0.0 110.926 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.96 48.71 2.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.112 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.52 108.18 0.22 Allowed Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -67.35 -15.63 63.79 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-O 121.55 0.691 . . . . 0.0 109.582 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 24' ' ' GLY . 6.4 t -129.89 -18.4 3.41 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.641 -0.662 . . . . 0.0 110.225 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -50.43 -179.64 0.03 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -77.55 -160.78 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.38 2.053 . . . . 0.0 110.762 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.537 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -79.26 172.4 13.85 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.716 -0.615 . . . . 0.0 109.576 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.49 -179.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.52 ' HB2' ' O ' ' A' ' 13' ' ' TRP . 0.2 OUTLIER -44.16 -49.29 9.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -0.938 . . . . 0.0 109.444 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 2' ' ' SER . 73.1 m 40.96 97.2 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.279 1.038 . . . . 0.0 110.644 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.701 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 95.0 m -54.36 171.55 0.28 Allowed Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.701 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.2 Cg_endo -71.73 157.78 54.71 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 121.772 1.648 . . . . 0.0 110.876 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.582 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -49.2 -70.93 0.07 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.471 -0.768 . . . . 0.0 111.361 -178.389 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.591 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -42.16 -36.54 1.21 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.158 -0.964 . . . . 0.0 110.034 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.74 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.1 t90 -121.59 64.65 0.9 Allowed 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.805 -1.158 . . . . 0.0 109.896 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -76.88 6.92 37.62 Favored Glycine 0 N--CA 1.497 2.703 0 C-N-CA 120.222 -0.989 . . . . 0.0 110.759 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.81 27.34 6.24 Favored Glycine 0 N--CA 1.486 2.011 0 O-C-N 120.706 -1.467 . . . . 0.0 109.671 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.643 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -77.83 176.49 3.52 Favored Pre-proline 0 C--N 1.294 -1.836 0 O-C-N 121.706 -0.879 . . . . 0.0 111.486 -178.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.74 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -75.99 -51.78 0.1 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 123.473 2.782 . . . . 0.0 113.029 -177.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.6 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.7 p90 -78.48 34.4 0.21 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.714 -1.241 . . . . 0.0 111.519 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.492 ' HA2' ' HB2' ' A' ' 2' ' ' SER . . . 175.93 -170.46 43.38 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.792 -1.671 . . . . 0.0 110.618 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' GLY . 1.4 tt0 -120.67 -151.91 0.49 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.531 -0.982 . . . . 0.0 110.369 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 1.3 t-20 -108.98 64.57 0.61 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.547 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.9 m -87.99 -0.5 57.09 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.543 -0.723 . . . . 0.0 109.983 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.574 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 72.0 m-85 -140.33 60.36 14.22 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.801 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.4 Cg_endo -78.88 -30.3 2.93 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.451 2.101 . . . . 0.0 110.267 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.88 49.03 1.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 109.909 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.89 111.27 0.24 Allowed Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.582 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.7 m -67.8 -15.36 63.59 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-O 121.57 0.7 . . . . 0.0 109.646 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.89 4.46 2.09 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.675 -0.64 . . . . 0.0 109.88 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.72 -164.29 2.52 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -78.84 -160.41 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.374 2.05 . . . . 0.0 110.624 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.547 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -90.12 178.09 6.27 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.703 -0.623 . . . . 0.0 109.422 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.471 ' OXT' HG13 ' A' ' 27' ' ' VAL . 7.4 p . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.523 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.531 ' HB2' ' CA ' ' A' ' 14' ' ' GLY . 4.9 p -69.66 -93.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.962 . . . . 0.0 109.335 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 4' ' ' CYS . 76.5 m 38.46 96.22 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.993 0.901 . . . . 0.0 110.597 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 56.2 m -40.68 166.38 0.06 OUTLIER Pre-proline 0 C--N 1.301 -1.509 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.571 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.7 Cg_endo -70.97 161.65 45.38 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.204 1.936 . . . . 0.0 110.497 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.611 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.1 p -56.1 -72.53 0.07 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.267 -0.896 . . . . 0.0 111.494 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.09 -36.16 1.55 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.017 -1.052 . . . . 0.0 110.28 -179.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.764 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.3 t90 -124.17 64.93 1.06 Allowed 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.221 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -72.29 -30.31 65.08 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.68 8.43 35.35 Favored Glycine 0 N--CA 1.49 2.269 0 O-C-N 120.867 -1.372 . . . . 0.0 110.85 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.629 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -58.4 176.5 0.26 Allowed Pre-proline 0 C--N 1.298 -1.66 0 O-C-N 121.069 -1.254 . . . . 0.0 110.881 -179.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.764 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.94 -57.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 123.133 2.555 . . . . 0.0 112.306 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.61 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 25.4 p90 -73.84 115.19 12.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.74 -1.225 . . . . 0.0 109.758 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.531 ' CA ' ' HB2' ' A' ' 2' ' ' SER . . . 93.63 -172.76 33.13 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 4.9 mt-30 -116.64 -147.25 0.41 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.485 -1.009 . . . . 0.0 110.133 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.518 ' ND2' ' HB3' ' A' ' 19' ' ' PRO . 10.5 t30 -108.02 69.73 0.74 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.541 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.5 m -87.48 -7.35 57.74 Favored 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.532 -0.73 . . . . 0.0 110.713 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.548 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 66.0 m-85 -133.79 60.49 46.41 Favored Pre-proline 0 C--N 1.296 -1.738 0 O-C-N 121.291 -0.88 . . . . 0.0 110.234 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.1 Cg_endo -78.95 -24.79 6.67 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.388 2.058 . . . . 0.0 109.852 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.27 52.7 1.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 0.0 109.68 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.21 113.43 0.28 Allowed Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.611 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -75.03 -85.8 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.963 0.887 . . . . 0.0 109.799 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -76.18 -24.35 54.73 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.094 -179.171 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -59.97 -149.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.446 ' C ' ' HD3' ' A' ' 26' ' ' LYS . 35.0 Cg_endo -77.27 -160.34 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.288 1.992 . . . . 0.0 110.029 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.541 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -100.15 -96.05 0.25 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.431 -0.793 . . . . 0.0 109.559 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.5 p . . . . . 0 C--N 1.299 -1.63 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.504 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.532 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -90.33 -77.9 0.39 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 0.0 109.451 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 81.2 m 34.06 95.69 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.239 1.019 . . . . 0.0 110.987 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.697 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 96.0 m -53.75 171.41 0.26 Allowed Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.697 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.8 Cg_endo -69.94 164.24 35.44 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.569 1.512 . . . . 0.0 110.558 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.586 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.6 p -54.82 -70.42 0.1 Allowed 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.248 -0.907 . . . . 0.0 111.713 -177.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.12 -38.7 2.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.968 -1.082 . . . . 0.0 110.208 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.741 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 9.7 t90 -116.74 63.02 0.72 Allowed 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 118.964 -1.095 . . . . 0.0 110.047 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -76.59 8.7 26.01 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.877 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.95 28.59 5.36 Favored Glycine 0 N--CA 1.486 1.991 0 O-C-N 120.707 -1.467 . . . . 0.0 109.511 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.649 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -78.98 177.3 2.96 Favored Pre-proline 0 C--N 1.295 -1.797 0 O-C-N 121.781 -0.835 . . . . 0.0 111.26 -178.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.741 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.3 Cg_endo -76.24 -52.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 123.505 2.803 . . . . 0.0 113.063 -177.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.584 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 28.5 p90 -78.14 31.55 0.18 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.724 -1.235 . . . . 0.0 111.597 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 2' ' ' SER . . . -178.29 -172.03 42.26 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 118.714 -1.708 . . . . 0.0 110.517 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' O ' ' A' ' 9' ' ' GLY . 5.7 mt-30 -121.37 -150.67 0.46 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.498 -1.001 . . . . 0.0 110.29 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -108.49 62.99 0.61 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.565 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.8 m -88.2 -11.14 47.58 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.396 -0.815 . . . . 0.0 109.938 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.559 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 23.3 m-85 -127.55 56.03 18.11 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.708 -0.62 . . . . 0.0 110.461 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.696 ' HG2' HG23 ' A' ' 27' ' ' VAL . 36.4 Cg_endo -76.73 -29.97 5.18 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.354 2.036 . . . . 0.0 110.491 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -138.84 51.28 1.82 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.918 . . . . 0.0 110.074 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.75 111.52 0.25 Allowed Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.586 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.4 m -77.04 -85.89 0.06 Allowed 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 122.083 0.944 . . . . 0.0 110.005 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.5 OUTLIER -79.95 -8.68 59.46 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.572 -178.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.89 -140.27 0.01 OUTLIER Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -77.31 -164.18 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.028 1.819 . . . . 0.0 109.613 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.565 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 17.9 ttpp -51.98 -70.23 0.09 Allowed 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.696 HG23 ' HG2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.034 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.527 ' O ' ' CG ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER 61.31 13.43 4.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.227 -0.921 . . . . 0.0 109.526 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.522 ' SG ' ' CD ' ' A' ' 26' ' ' LYS . 68.0 m -153.97 95.9 1.91 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.213 -0.929 . . . . 0.0 108.712 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.674 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 23.0 m -46.68 171.75 0.06 OUTLIER Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.822 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.674 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.7 Cg_endo -71.9 162.89 40.55 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 121.904 1.736 . . . . 0.0 110.904 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -53.6 -72.8 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.562 -0.711 . . . . 0.0 111.72 -178.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.589 ' CE2' ' HB2' ' A' ' 8' ' ' TRP . 6.6 p90 -45.61 -33.53 2.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.125 -0.984 . . . . 0.0 110.7 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.755 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 11.6 t90 -122.77 64.89 0.96 Allowed 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 118.362 -1.335 . . . . 0.0 110.961 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -66.66 -23.07 72.13 Favored Glycine 0 N--CA 1.498 2.828 0 O-C-N 121.237 -0.914 . . . . 0.0 111.414 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.07 29.84 8.86 Favored Glycine 0 N--CA 1.492 2.375 0 O-C-N 120.468 -1.607 . . . . 0.0 111.556 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.662 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -80.66 175.5 4.76 Favored Pre-proline 0 C--N 1.291 -1.953 0 O-C-N 121.281 -1.129 . . . . 0.0 111.217 -178.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.755 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 40.8 Cg_endo -77.84 -55.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 123.857 3.038 . . . . 0.0 114.608 -176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.444 ' CZ3' ' CZ3' ' A' ' 8' ' ' TRP . 20.7 p90 -73.51 10.24 1.12 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.667 -1.271 . . . . 0.0 112.2 -176.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' C ' ' SG ' ' A' ' 4' ' ' CYS . . . -151.66 173.36 30.98 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.785 -1.674 . . . . 0.0 109.954 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.527 ' CG ' ' O ' ' A' ' 2' ' ' SER . 24.7 mt-30 -93.56 -155.86 0.46 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.331 -1.099 . . . . 0.0 108.889 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -108.43 61.88 0.61 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 108.697 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.921 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.6 m -88.72 -94.19 0.1 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.144 -0.973 . . . . 0.0 108.564 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CE2' ' OXT' ' A' ' 27' ' ' VAL . 66.0 m-85 -29.62 88.84 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.89 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.765 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 27' ' ' VAL . 37.0 Cg_endo -77.31 -83.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.23 1.953 . . . . 0.0 109.498 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -120.64 22.85 11.05 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.05 91.42 0.21 Allowed Glycine 0 N--CA 1.481 1.642 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 23.8 m -48.44 -21.8 0.61 Allowed 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.45 -0.875 . . . . 0.0 110.726 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.496 ' O ' ' OXT' ' A' ' 27' ' ' VAL . 1.6 p -115.71 -87.64 0.59 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.445 -0.784 . . . . 0.0 110.089 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 39.57 -149.29 0.12 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.512 ' O ' ' C ' ' A' ' 26' ' ' LYS . 35.5 Cg_endo -77.47 -156.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.952 2.434 . . . . 0.0 110.112 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.522 ' CD ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -33.62 -35.79 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.54 0.686 . . . . 0.0 109.188 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.921 HG12 ' CB ' ' A' ' 17' ' ' CYS . 13.2 m . . . . . 0 C--N 1.3 -1.579 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.051 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.475 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -74.33 0.21 15.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.314 -0.866 . . . . 0.0 109.866 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.517 ' HB3' ' CE1' ' A' ' 18' ' ' TYR . 79.8 m 36.79 93.99 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.696 0.76 . . . . 0.0 110.62 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.591 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 80.2 m -42.71 164.93 0.11 Allowed Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 27.3 Cg_endo -65.31 144.64 81.19 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.487 1.458 . . . . 0.0 110.296 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.578 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 14.6 p -50.97 -42.59 60.18 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.381 -0.824 . . . . 0.0 110.238 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -58.62 -38.42 78.0 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.759 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.6 t90 -126.18 67.54 1.21 Allowed 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.343 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.51 ' HA2' ' HB2' ' A' ' 4' ' ' CYS . . . -75.7 -27.15 63.51 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 120.31 -0.947 . . . . 0.0 111.216 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.31 12.63 37.71 Favored Glycine 0 N--CA 1.49 2.277 0 O-C-N 120.936 -1.332 . . . . 0.0 110.859 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.61 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -58.38 174.1 0.37 Allowed Pre-proline 0 C--N 1.296 -1.739 0 O-C-N 121.259 -1.142 . . . . 0.0 111.064 -178.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.759 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -72.38 -57.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 123.398 2.732 . . . . 0.0 112.29 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.553 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 24.5 p90 -73.33 -167.27 0.41 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.877 -1.139 . . . . 0.0 109.344 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 15' ' ' GLN . . . 40.45 -143.36 0.6 Allowed Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 14' ' ' GLY . 3.2 mt-30 -147.57 -155.27 0.61 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.486 -1.008 . . . . 0.0 109.988 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.53 71.13 0.78 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.525 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.4 m -87.45 -28.39 22.12 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.521 -0.737 . . . . 0.0 110.762 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.576 ' HB2' ' CB ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -137.81 63.8 40.29 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.25 -0.906 . . . . 0.0 109.007 177.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 37.5 Cg_endo -83.46 -35.02 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.787 2.325 . . . . 0.0 110.869 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -90.64 9.73 28.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.9 . . . . 0.0 110.522 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 22' ' ' CYS . . . 129.73 123.54 2.54 Favored Glycine 0 C--N 1.304 -1.25 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.578 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.2 m -29.42 -47.12 0.06 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 122.3 1.047 . . . . 0.0 109.494 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.527 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 18.1 m 43.76 35.73 1.13 Allowed 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.621 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.95 -112.18 3.49 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 23' ' ' SER . 33.2 Cg_endo -74.42 -156.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.603 2.202 . . . . 0.0 111.409 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.525 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -52.3 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.798 0.809 . . . . 0.0 110.85 -178.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.573 HG22 ' OXT' ' A' ' 27' ' ' VAL . 9.1 p . . . . . 0 C--N 1.304 -1.41 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.625 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 3' ' ' CYS . 5.6 t -114.12 -166.81 1.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 109.661 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.495 ' C ' ' O ' ' A' ' 2' ' ' SER . 90.6 m 31.03 90.33 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.91 0.862 . . . . 0.0 110.904 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.582 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 99.5 m -41.33 166.42 0.06 OUTLIER Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.3 Cg_endo -71.28 160.99 47.19 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.057 1.838 . . . . 0.0 110.579 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.592 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.3 p -55.0 -69.35 0.13 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.265 -0.897 . . . . 0.0 111.552 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -41.42 -38.45 1.25 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.205 -0.935 . . . . 0.0 109.931 -178.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.757 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.6 t90 -126.45 66.89 1.23 Allowed 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.908 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -75.02 -26.41 66.69 Favored Glycine 0 N--CA 1.496 2.65 0 O-C-N 121.22 -0.925 . . . . 0.0 111.07 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.37 13.72 38.61 Favored Glycine 0 N--CA 1.488 2.157 0 O-C-N 120.858 -1.377 . . . . 0.0 110.75 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.611 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -62.93 175.63 0.63 Allowed Pre-proline 0 C--N 1.297 -1.703 0 O-C-N 121.239 -1.154 . . . . 0.0 111.036 -178.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.757 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.6 Cg_endo -74.46 -58.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 123.46 2.773 . . . . 0.0 112.747 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.596 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 26.0 p90 -73.17 121.39 20.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.73 -1.231 . . . . 0.0 109.604 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.52 -147.36 18.55 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -141.58 -156.73 0.7 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.509 -0.995 . . . . 0.0 109.921 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 12.0 t-20 -107.64 68.46 0.71 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 1.5 m -87.47 -1.21 57.77 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.376 0.607 . . . . 0.0 110.531 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.57 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 77.8 m-85 -138.93 62.7 28.07 Favored Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 120.828 -1.17 . . . . 0.0 110.376 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 35.6 Cg_endo -79.47 -25.35 5.67 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.519 2.146 . . . . 0.0 110.257 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 7.7 pt-20 -147.0 50.45 1.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.267 -0.895 . . . . 0.0 109.845 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.32 110.68 0.24 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.5 m -75.31 -12.12 60.2 Favored 'General case' 0 C--N 1.286 -2.194 0 O-C-N 122.218 -0.577 . . . . 0.0 110.359 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -143.07 8.19 1.64 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.197 -0.939 . . . . 0.0 111.234 -178.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.37 -148.59 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -77.01 -166.37 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.102 1.868 . . . . 0.0 109.136 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 2.1 tttm -51.95 -71.57 0.06 Allowed 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.523 -1.271 . . . . 0.0 107.837 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.539 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 7.1 p . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.389 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.503 ' HA ' ' NH1' ' A' ' 1' ' ' ARG . 2.9 mmm180 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.506 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 3.1 t -92.63 54.07 2.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.908 . . . . 0.0 109.504 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 79.4 m -143.16 90.75 2.21 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 122.087 0.946 . . . . 0.0 109.262 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.752 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 68.3 m -54.64 173.67 0.22 Allowed Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.752 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.5 Cg_endo -70.81 159.3 53.08 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.601 1.534 . . . . 0.0 110.679 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.599 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.2 p -50.07 -68.26 0.19 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.444 -0.785 . . . . 0.0 111.819 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 5' ' ' PRO . 8.1 p90 -46.83 -43.44 18.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.001 -1.062 . . . . 0.0 110.167 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.744 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.3 t90 -110.71 61.08 0.61 Allowed 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.779 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -72.69 5.13 18.22 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.374 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.56 26.58 6.55 Favored Glycine 0 N--CA 1.487 2.075 0 O-C-N 120.622 -1.516 . . . . 0.0 109.923 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.658 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.74 178.57 1.95 Allowed Pre-proline 0 C--N 1.293 -1.86 0 O-C-N 121.626 -0.926 . . . . 0.0 111.44 -178.577 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.744 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.8 Cg_endo -77.28 -52.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.969 0 C-N-CA 123.449 2.766 . . . . 0.0 113.277 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.586 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.9 p90 -77.62 32.88 0.16 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.56 -1.337 . . . . 0.0 111.755 -177.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 176.8 -173.55 46.38 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 118.849 -1.643 . . . . 0.0 110.282 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 2' ' ' SER . 0.2 OUTLIER -118.77 -149.43 0.44 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.478 -1.013 . . . . 0.0 109.909 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 5.6 t-20 -108.35 64.09 0.62 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.548 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.7 m -88.08 1.26 54.68 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.476 -0.765 . . . . 0.0 110.321 -178.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.576 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 66.5 m-85 -142.4 60.17 9.84 Favored Pre-proline 0 C--N 1.299 -1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 109.834 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.6 Cg_endo -79.22 -25.48 5.82 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.429 2.086 . . . . 0.0 110.232 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 20' ' ' GLU . 26.2 tt0 -140.18 47.85 1.79 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 110.045 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.88 111.19 0.24 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.599 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -71.51 -15.72 62.32 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 121.658 0.742 . . . . 0.0 109.697 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 24' ' ' GLY . 32.6 t -130.24 -22.31 2.82 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.641 -0.662 . . . . 0.0 110.173 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -50.43 -178.8 0.02 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.44 -161.14 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.44 2.093 . . . . 0.0 110.565 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.662 ' HE2' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -72.01 -174.03 1.15 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.639 -0.663 . . . . 0.0 109.458 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.662 HG12 ' HE2' ' A' ' 26' ' ' LYS . 8.9 p . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.496 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.347 0.594 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.535 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 1.1 p -61.34 106.67 0.66 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -0.941 . . . . 0.0 109.52 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 4' ' ' CYS . 69.7 m -152.09 95.97 2.14 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.249 -0.907 . . . . 0.0 109.39 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.603 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 33.7 m -40.73 168.03 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.8 Cg_endo -70.92 171.6 15.42 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.29 1.993 . . . . 0.0 112.3 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.62 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 14.0 p -64.6 -41.67 96.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.741 -0.599 . . . . 0.0 111.754 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.525 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -78.69 -35.42 45.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.866 -1.146 . . . . 0.0 110.414 -178.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.754 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.4 t90 -121.03 63.28 0.87 Allowed 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.127 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.472 ' HA2' ' CB ' ' A' ' 4' ' ' CYS . . . -68.14 -26.71 73.98 Favored Glycine 0 N--CA 1.499 2.876 0 O-C-N 121.457 -0.777 . . . . 0.0 111.416 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.42 16.53 29.27 Favored Glycine 0 N--CA 1.491 2.311 0 O-C-N 120.912 -1.346 . . . . 0.0 110.54 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.66 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -69.56 174.79 2.68 Favored Pre-proline 0 C--N 1.296 -1.732 0 O-C-N 121.434 -1.039 . . . . 0.0 111.169 -178.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.754 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.8 Cg_endo -72.73 -60.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 123.267 2.644 . . . . 0.0 111.949 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 19.4 p90 -73.09 125.76 28.43 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.913 -1.117 . . . . 0.0 108.502 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.535 ' HA2' ' CB ' ' A' ' 2' ' ' SER . . . 89.29 168.98 44.02 Favored Glycine 0 N--CA 1.482 1.732 0 C-N-CA 119.259 -1.448 . . . . 0.0 109.67 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -103.36 -148.42 0.39 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.481 -1.011 . . . . 0.0 109.731 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.89 69.11 0.7 Allowed 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.526 ' C ' ' HD3' ' A' ' 19' ' ' PRO . 1.5 m -87.1 -14.48 41.26 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.603 -0.686 . . . . 0.0 110.74 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.639 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 65.7 m-85 -123.33 47.17 1.58 Allowed Pre-proline 0 C--N 1.295 -1.797 0 O-C-N 121.241 -0.912 . . . . 0.0 111.407 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.639 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 38.1 Cg_endo -80.19 -1.29 11.27 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.818 1.678 . . . . 0.0 109.618 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.7 -21.77 22.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.903 . . . . 0.0 110.79 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 23' ' ' SER . . . 121.88 127.19 3.33 Favored Glycine 0 C--N 1.293 -1.858 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.56 ' HA ' ' HB2' ' A' ' 6' ' ' CYS . 16.9 m -30.43 -37.09 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 122.017 0.913 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 21' ' ' GLY . 1.9 t -54.28 -60.83 2.81 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.431 0.634 . . . . 0.0 109.628 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.62 142.38 24.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 26' ' ' LYS . 33.5 Cg_endo -78.57 141.26 17.44 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.266 1.978 . . . . 0.0 110.906 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.656 ' HE3' HG22 ' A' ' 27' ' ' VAL . 0.0 OUTLIER 37.56 -158.99 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.105 0.479 . . . . 0.0 110.06 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.656 HG22 ' HE3' ' A' ' 26' ' ' LYS . 4.8 m . . . . . 0 N--CA 1.489 1.507 0 O-C-N 120.988 -1.07 . . . . 0.0 109.53 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER 56.15 97.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.554 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 99.6 m -146.47 93.45 2.3 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.972 0.892 . . . . 0.0 108.754 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.652 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 22.9 m -50.21 170.9 0.16 Allowed Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.652 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 29.6 Cg_endo -70.4 159.45 52.89 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 121.903 1.735 . . . . 0.0 110.289 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.594 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.2 p -55.05 -70.66 0.1 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.176 -0.952 . . . . 0.0 111.475 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -43.25 -38.57 2.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.015 -1.053 . . . . 0.0 110.26 -178.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.761 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.2 t90 -122.3 65.99 0.93 Allowed 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.207 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -72.02 -25.42 74.77 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.059 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.7 19.31 20.94 Favored Glycine 0 N--CA 1.49 2.285 0 O-C-N 120.685 -1.48 . . . . 0.0 110.854 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.63 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -71.2 174.43 3.77 Favored Pre-proline 0 C--N 1.296 -1.76 0 O-C-N 121.276 -1.131 . . . . 0.0 111.328 -178.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.761 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.7 Cg_endo -76.16 -56.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 123.814 3.009 . . . . 0.0 114.216 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.545 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 24.9 p90 -74.34 24.51 0.08 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.682 -1.261 . . . . 0.0 112.288 -176.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.46 ' CA ' ' SG ' ' A' ' 4' ' ' CYS . . . -167.51 175.94 42.4 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.558 -1.782 . . . . 0.0 110.363 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 9' ' ' GLY . 2.9 tp60 -104.34 -154.64 0.51 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.463 -1.022 . . . . 0.0 109.802 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.34 62.19 0.62 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 1.6 m -87.8 -12.42 45.1 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.807 0.813 . . . . 0.0 110.178 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 68.7 m-85 -130.18 62.86 66.66 Favored Pre-proline 0 C--N 1.291 -1.945 0 O-C-N 120.639 -1.288 . . . . 0.0 110.487 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.5 Cg_endo -79.33 -30.54 2.53 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.549 2.166 . . . . 0.0 109.938 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 19' ' ' PRO . 1.2 mm-40 -143.12 53.12 1.36 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.835 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.49 110.57 0.23 Allowed Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.4 m -75.23 -12.04 60.2 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.259 0.552 . . . . 0.0 110.234 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -145.53 7.34 1.12 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.142 -178.597 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.9 -144.67 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -77.0 -168.68 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.185 1.924 . . . . 0.0 109.03 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.565 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 6.8 ttmm -62.57 -66.85 0.48 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.136 -1.426 . . . . 0.0 108.203 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 17' ' ' CYS . 2.2 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.06 -0.972 . . . . 0.0 109.294 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.445 ' O ' ' HD2' ' A' ' 1' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.499 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 46.9 t -120.32 37.57 4.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.303 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 65.0 m -146.9 94.31 2.4 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.407 -0.808 . . . . 0.0 108.988 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.634 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 68.9 m -42.84 167.76 0.07 OUTLIER Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.634 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 28.8 Cg_endo -67.98 168.45 18.85 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.803 1.668 . . . . 0.0 110.428 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.68 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 1.1 p -65.44 -47.96 74.37 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.05 -1.031 . . . . 0.0 111.137 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -62.11 -49.62 75.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.826 -1.171 . . . . 0.0 109.651 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.767 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.9 t90 -109.56 59.8 0.6 Allowed 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.704 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -67.41 -27.72 73.56 Favored Glycine 0 N--CA 1.496 2.699 0 O-C-N 121.428 -0.795 . . . . 0.0 111.204 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.35 12.52 38.53 Favored Glycine 0 N--CA 1.49 2.256 0 O-C-N 120.869 -1.371 . . . . 0.0 110.841 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -63.39 176.56 0.57 Allowed Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.252 -1.146 . . . . 0.0 110.959 -178.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.767 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.2 Cg_endo -73.72 -58.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 123.129 2.553 . . . . 0.0 112.168 -177.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.607 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 24.8 p90 -73.62 115.45 13.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.753 -1.217 . . . . 0.0 109.122 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 90.55 177.43 44.24 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 40.8 mt-30 -111.07 -146.47 0.41 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.382 -1.07 . . . . 0.0 109.796 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 19.5 t-20 -108.69 75.62 0.98 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 3' ' ' CYS . 1.3 m -87.55 -13.15 43.73 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.556 -0.715 . . . . 0.0 111.496 -177.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.595 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -135.16 67.14 68.52 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.125 -0.984 . . . . 0.0 109.972 178.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HB3' ' OD1' ' A' ' 16' ' ' ASN . 32.9 Cg_endo -74.85 -29.97 7.95 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.205 1.937 . . . . 0.0 109.64 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -142.27 11.99 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -108.54 26.06 17.5 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.68 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.6 m -33.66 -32.82 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.218 0 CA-C-O 121.714 0.769 . . . . 0.0 110.639 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -135.29 -34.22 0.87 Allowed 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.684 -0.635 . . . . 0.0 110.138 -179.596 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -61.36 -131.78 0.01 OUTLIER Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -76.33 -164.92 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.005 1.803 . . . . 0.0 109.46 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 18' ' ' TYR . 9.4 ttpp -73.0 -64.92 0.87 Allowed 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.765 -1.174 . . . . 0.0 109.001 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.489 1.522 0 O-C-N 120.95 -1.094 . . . . 0.0 109.479 179.558 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.556 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 25.5 p -113.12 69.5 0.7 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 109.497 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.517 ' O ' ' O ' ' A' ' 4' ' ' CYS . 68.4 m -147.47 96.27 2.67 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.293 -0.88 . . . . 0.0 108.837 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.565 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 51.4 m -39.58 165.67 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.58 ' HB2' ' CE1' ' A' ' 7' ' ' TYR . 30.3 Cg_endo -70.02 165.03 32.63 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.224 1.949 . . . . 0.0 111.64 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.676 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -57.51 -46.56 83.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.572 -0.705 . . . . 0.0 111.479 -178.573 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.631 ' CD2' ' N ' ' A' ' 8' ' ' TRP . 42.7 p90 -72.69 -47.17 49.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.984 -1.073 . . . . 0.0 110.404 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.769 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.9 t90 -108.62 59.2 0.61 Allowed 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.902 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 4' ' ' CYS . . . -67.92 -27.39 73.67 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.62 9.07 45.19 Favored Glycine 0 N--CA 1.49 2.279 0 O-C-N 120.875 -1.368 . . . . 0.0 110.403 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.653 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -61.74 176.94 0.39 Allowed Pre-proline 0 C--N 1.298 -1.636 0 O-C-N 121.317 -1.108 . . . . 0.0 111.135 -178.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.769 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.0 Cg_endo -75.35 -56.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 123.321 2.68 . . . . 0.0 112.743 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 30.0 p90 -73.16 123.14 23.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.727 -1.233 . . . . 0.0 109.8 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.556 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 93.95 -148.46 19.01 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 23.8 mt-30 -145.29 -143.73 0.14 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.5 -1.0 . . . . 0.0 109.34 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.16 67.04 0.64 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 3' ' ' CYS . 1.5 m -87.19 -20.25 27.25 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.315 -0.865 . . . . 0.0 110.339 -178.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.568 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 98.3 m-85 -128.88 72.57 81.67 Favored Pre-proline 0 C--N 1.293 -1.887 0 O-C-N 121.628 -0.67 . . . . 0.0 109.577 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.517 ' CD ' HG22 ' A' ' 27' ' ' VAL . 34.9 Cg_endo -77.3 -32.26 3.13 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.424 2.082 . . . . 0.0 109.869 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 20' ' ' GLU . 3.1 tm-20 -150.09 14.7 0.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.454 -0.779 . . . . 0.0 109.518 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -90.24 15.51 59.6 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.676 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -35.88 -31.84 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.187 0 CA-C-O 121.793 0.806 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 21' ' ' GLY . 91.4 p -112.85 -25.15 9.17 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 121.298 0.57 . . . . 0.0 109.47 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.79 -168.75 30.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 26' ' ' LYS . 35.7 Cg_endo -78.22 -159.93 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.623 2.215 . . . . 0.0 110.693 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -56.5 -159.49 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.57 -0.706 . . . . 0.0 109.655 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.517 HG22 ' CD ' ' A' ' 19' ' ' PRO . 2.1 t . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.406 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.491 ' NH1' ' HG2' ' A' ' 1' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 3' ' ' CYS . 4.1 p -92.08 30.16 1.48 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.205 -0.934 . . . . 0.0 109.449 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 74.2 m 39.2 95.29 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.117 0.961 . . . . 0.0 111.076 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.756 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 86.7 m -52.75 175.28 0.11 Allowed Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.756 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.2 Cg_endo -72.0 165.91 31.18 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 121.33 1.354 . . . . 0.0 110.539 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.556 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -60.75 -47.98 83.85 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.29 -0.881 . . . . 0.0 110.738 -178.31 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.596 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -59.37 -47.03 86.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.838 -1.164 . . . . 0.0 109.469 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.732 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 11.4 t90 -111.11 61.95 0.61 Allowed 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.367 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.532 ' O ' ' CA ' ' A' ' 16' ' ' ASN . . . -73.48 7.36 12.82 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.253 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.73 27.72 6.15 Favored Glycine 0 N--CA 1.486 2.02 0 O-C-N 120.615 -1.521 . . . . 0.0 109.301 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.641 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -79.84 177.07 3.15 Favored Pre-proline 0 C--N 1.295 -1.804 0 O-C-N 121.721 -0.87 . . . . 0.0 111.637 -178.152 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.732 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.29 -48.07 0.14 Allowed 'Trans proline' 0 C--N 1.319 -1.014 0 C-N-CA 123.498 2.799 . . . . 0.0 113.211 -177.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.639 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 36.4 p90 -80.05 37.49 0.37 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.69 -1.256 . . . . 0.0 111.237 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.452 ' HA2' ' N ' ' A' ' 1' ' ' ARG . . . 166.44 -168.05 39.8 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.05 -1.547 . . . . 0.0 110.182 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 8.5 mt-30 -123.48 -150.5 0.45 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.408 -1.054 . . . . 0.0 110.318 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.532 ' CA ' ' O ' ' A' ' 9' ' ' GLY . 0.6 OUTLIER -108.9 69.86 0.72 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.536 ' SG ' ' HG2' ' A' ' 26' ' ' LYS . 1.7 m -87.79 -10.07 52.05 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.376 -0.827 . . . . 0.0 110.492 -177.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.616 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 6.7 m-85 -136.16 56.16 13.64 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.25 -0.906 . . . . 0.0 110.138 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 38.0 Cg_endo -81.77 -49.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 122.43 2.086 . . . . 0.0 111.284 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -92.62 22.23 4.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.389 -0.819 . . . . 0.0 111.198 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 157.99 113.29 0.37 Allowed Glycine 0 N--CA 1.481 1.651 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.219 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.556 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 8.7 m -57.79 -69.07 0.19 Allowed 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.883 0.849 . . . . 0.0 109.455 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 24' ' ' GLY . 11.0 m -52.76 -44.46 66.52 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -44.0 166.65 0.03 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.04 -159.94 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.492 2.128 . . . . 0.0 110.782 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.536 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 1.2 mtmt -60.41 177.02 0.3 Allowed 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.295 0.569 . . . . 0.0 109.648 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 27' ' ' VAL . 9.8 p . . . . . 0 C--N 1.3 -1.567 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.503 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.494 ' CG ' ' O ' ' A' ' 1' ' ' ARG . 1.8 ptt180 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.501 ' O ' ' C ' ' A' ' 3' ' ' CYS . 2.4 p 42.84 -150.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.286 -0.884 . . . . 0.0 109.643 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.501 ' C ' ' O ' ' A' ' 2' ' ' SER . 78.6 m 30.57 91.42 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.944 0.878 . . . . 0.0 111.026 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.568 ' HB3' ' O ' ' A' ' 8' ' ' TRP . 62.1 m -43.67 168.06 0.07 OUTLIER Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 33.5 Cg_endo -76.33 146.8 28.45 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.057 1.838 . . . . 0.0 110.52 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.62 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -46.82 -63.71 0.96 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 0.0 110.593 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -39.49 -37.48 0.48 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.893 0.854 . . . . 0.0 108.799 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.746 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.0 t90 -135.0 70.21 1.44 Allowed 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.683 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.9 -26.51 66.71 Favored Glycine 0 N--CA 1.5 2.948 0 O-C-N 121.279 -0.888 . . . . 0.0 111.34 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.13 17.27 23.92 Favored Glycine 0 N--CA 1.489 2.18 0 O-C-N 120.846 -1.385 . . . . 0.0 110.674 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.611 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -68.48 174.89 2.19 Favored Pre-proline 0 C--N 1.297 -1.708 0 O-C-N 121.28 -1.129 . . . . 0.0 111.075 -178.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.746 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.3 Cg_endo -74.36 -58.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 123.436 2.757 . . . . 0.0 112.776 -177.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 25.5 p90 -73.44 123.74 24.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.726 -1.234 . . . . 0.0 110.003 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 2' ' ' SER . . . 100.38 -146.16 17.54 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -144.41 -152.34 0.41 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.594 -0.945 . . . . 0.0 109.767 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.44 63.97 0.61 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.519 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.6 m -87.09 2.65 49.09 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.661 0.743 . . . . 0.0 109.908 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.62 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 73.3 m-85 -145.33 76.2 13.38 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.66 -37.7 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.701 2.268 . . . . 0.0 112.081 -178.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.9 38.74 1.47 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.817 -1.177 . . . . 0.0 111.264 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 22' ' ' CYS . . . 149.34 119.66 1.0 Allowed Glycine 0 N--CA 1.479 1.507 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.0 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 12.0 m -40.63 -38.57 0.9 Allowed 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 122.381 1.086 . . . . 0.0 108.775 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.518 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 23.2 t 44.31 56.8 4.7 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 40.9 -99.43 0.01 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 23' ' ' SER . 32.2 Cg_endo -74.02 -159.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.371 2.047 . . . . 0.0 111.051 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.594 ' NZ ' HG12 ' A' ' 27' ' ' VAL . 1.5 ttpp -48.34 -179.97 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.536 0.684 . . . . 0.0 109.889 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 27' ' ' VAL . 5.4 p . . . . . 0 C--N 1.3 -1.561 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.433 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.559 ' HG3' ' CD1' ' A' ' 13' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.549 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 2.9 t 170.04 -19.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.067 -1.021 . . . . 0.0 110.614 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 4' ' ' CYS . 87.5 m -143.09 93.04 2.45 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 120.892 -1.13 . . . . 0.0 109.557 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.586 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 39.3 m -41.67 167.6 0.06 OUTLIER Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.7 Cg_endo -72.11 159.44 49.93 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.071 1.847 . . . . 0.0 110.294 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.606 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.2 p -53.88 -71.51 0.07 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.293 -0.88 . . . . 0.0 111.531 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -44.19 -44.33 7.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.99 -1.069 . . . . 0.0 109.985 -178.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.767 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.6 t90 -115.8 63.22 0.7 Allowed 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 119.135 -1.026 . . . . 0.0 109.861 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -73.41 -26.28 70.57 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.94 7.97 52.9 Favored Glycine 0 N--CA 1.489 2.187 0 O-C-N 120.846 -1.385 . . . . 0.0 110.396 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.631 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -58.92 177.26 0.25 Allowed Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.258 -1.143 . . . . 0.0 110.963 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.767 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.2 Cg_endo -74.34 -57.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 123.213 2.609 . . . . 0.0 112.647 -177.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.596 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 26.6 p90 -73.58 117.67 15.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.697 -1.252 . . . . 0.0 109.697 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.549 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 91.26 -171.54 35.41 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -124.14 -138.55 0.29 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.211 -1.17 . . . . 0.0 110.147 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.515 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -109.27 70.65 0.74 Allowed 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.959 -1.088 . . . . 0.0 109.014 -179.139 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.555 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.7 m -89.36 -4.2 58.16 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 121.307 -0.87 . . . . 0.0 110.153 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.561 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 67.2 m-85 -140.09 60.75 15.68 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.425 -0.797 . . . . 0.0 109.462 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.3 Cg_endo -78.78 -23.77 7.84 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.426 2.084 . . . . 0.0 110.675 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.3 46.7 1.31 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.062 -1.024 . . . . 0.0 110.403 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.93 110.33 0.23 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.5 m -69.45 -15.1 63.2 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.598 0.714 . . . . 0.0 109.626 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 24' ' ' GLY . 3.8 m -126.86 -24.99 3.41 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.618 -0.676 . . . . 0.0 109.963 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -48.5 176.41 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -77.3 -161.59 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.36 2.04 . . . . 0.0 110.615 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.555 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 10.2 ttmt -71.03 -172.17 0.65 Allowed 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.695 -0.628 . . . . 0.0 109.333 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 16' ' ' ASN . 29.0 m . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.934 -1.031 . . . . 0.0 109.515 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.494 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 7.5 t -92.17 58.42 3.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 4' ' ' CYS . 62.2 m -147.82 93.55 2.22 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.352 -0.842 . . . . 0.0 108.882 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.582 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 44.2 m -41.37 167.3 0.05 OUTLIER Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.6 Cg_endo -72.33 159.6 49.06 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.263 1.975 . . . . 0.0 110.614 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.616 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -55.99 -69.94 0.13 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.893 . . . . 0.0 111.202 -178.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.596 ' CE2' ' HB2' ' A' ' 8' ' ' TRP . 1.5 p90 -42.16 -37.96 1.59 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 109.604 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.753 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.0 t90 -126.27 67.22 1.21 Allowed 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 119.059 -1.057 . . . . 0.0 109.991 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -75.26 -26.45 66.06 Favored Glycine 0 N--CA 1.496 2.694 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.005 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.91 11.14 49.31 Favored Glycine 0 N--CA 1.49 2.294 0 O-C-N 120.877 -1.366 . . . . 0.0 110.532 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.636 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -61.5 176.13 0.45 Allowed Pre-proline 0 C--N 1.297 -1.702 0 O-C-N 121.361 -1.082 . . . . 0.0 110.948 -178.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.753 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.8 -58.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 123.195 2.596 . . . . 0.0 112.455 -177.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.598 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 24.4 p90 -73.4 118.84 16.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.719 -1.238 . . . . 0.0 109.367 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.494 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 93.51 -178.79 38.49 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 19.8 mt-30 -111.26 -145.91 0.4 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.405 -1.056 . . . . 0.0 109.8 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -108.77 66.13 0.63 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.881 ' HA ' HG23 ' A' ' 27' ' ' VAL . 1.6 m -87.97 13.25 11.37 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.417 -0.802 . . . . 0.0 110.885 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.593 ' CD1' ' O ' ' A' ' 17' ' ' CYS . 62.7 m-85 -155.21 63.23 3.68 Favored Pre-proline 0 C--N 1.296 -1.759 0 O-C-N 120.664 -1.272 . . . . 0.0 109.547 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.7 Cg_endo -79.65 -32.09 1.72 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.307 2.005 . . . . 0.0 110.321 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -142.03 51.41 1.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 110.147 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.04 110.46 0.23 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.616 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 m -70.03 -16.56 63.17 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 121.437 0.637 . . . . 0.0 109.888 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.575 ' O ' ' C ' ' A' ' 24' ' ' GLY . 20.4 m -135.46 -94.07 0.27 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.417 -0.802 . . . . 0.0 109.192 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 13.57 -127.97 0.01 OUTLIER Glycine 0 N--CA 1.511 3.657 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -81.93 -157.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.162 1.908 . . . . 0.0 107.999 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.576 ' CA ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -133.09 -38.11 0.97 Allowed 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.483 178.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.881 HG23 ' HA ' ' A' ' 17' ' ' CYS . 25.0 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 120.894 -1.129 . . . . 0.0 109.165 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.56 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 0.1 OUTLIER -101.47 100.58 11.04 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.205 -0.935 . . . . 0.0 109.186 179.926 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 4' ' ' CYS . 73.5 m -143.18 89.76 2.13 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.042 -1.036 . . . . 0.0 110.255 -178.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.568 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 11.9 m -43.75 168.77 0.06 OUTLIER Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.568 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.4 Cg_endo -71.43 148.75 55.1 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.001 1.8 . . . . 0.0 110.621 179.41 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.568 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 1.6 p -55.08 -46.19 75.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 110.916 -178.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -59.12 -36.39 75.1 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.839 -1.163 . . . . 0.0 108.192 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.726 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 17.9 t90 -131.52 69.59 1.47 Allowed 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.424 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 4' ' ' CYS . . . -73.05 -26.51 70.75 Favored Glycine 0 N--CA 1.499 2.834 0 O-C-N 121.358 -0.839 . . . . 0.0 111.371 -178.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.48 15.19 31.09 Favored Glycine 0 N--CA 1.491 2.343 0 O-C-N 120.842 -1.387 . . . . 0.0 110.353 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.642 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -68.17 175.85 1.63 Allowed Pre-proline 0 C--N 1.296 -1.736 0 O-C-N 121.438 -1.036 . . . . 0.0 111.124 -178.735 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.726 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.0 Cg_endo -73.48 -60.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 123.31 2.673 . . . . 0.0 112.322 -177.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 17.5 p90 -73.29 122.93 22.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 0.0 109.287 -179.039 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.56 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 99.2 -166.62 21.11 Favored Glycine 0 N--CA 1.485 1.929 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.053 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -129.24 -147.91 0.36 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.466 -1.02 . . . . 0.0 109.65 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.42 64.83 0.62 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.562 ' SG ' ' HG2' ' A' ' 26' ' ' LYS . 1.6 m -87.56 -4.34 58.97 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.45 -0.781 . . . . 0.0 110.217 -178.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.563 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 57.2 m-85 -148.15 61.75 6.14 Favored Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 121.416 -0.803 . . . . 0.0 109.772 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 37.5 Cg_endo -82.27 -39.06 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.634 2.223 . . . . 0.0 111.536 -179.6 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -122.91 36.35 4.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.968 -1.082 . . . . 0.0 111.279 -178.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.19 113.48 0.46 Allowed Glycine 0 N--CA 1.483 1.829 0 C-N-CA 119.487 -1.34 . . . . 0.0 110.547 178.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.568 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 8.7 m -56.6 -41.61 77.32 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-O 122.074 0.94 . . . . 0.0 109.233 179.01 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 24' ' ' GLY . 1.8 t -81.33 -41.15 22.5 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.496 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -44.22 166.84 0.03 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.8 -159.64 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.341 2.027 . . . . 0.0 110.641 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.562 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 3.4 mtpp -69.84 175.31 4.41 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.592 0.71 . . . . 0.0 109.959 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.567 HG22 ' OXT' ' A' ' 27' ' ' VAL . 9.5 p . . . . . 0 C--N 1.302 -1.463 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.488 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.438 ' O ' ' OE1' ' A' ' 15' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.251 0.548 . . . . 0.0 109.54 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.47 ' OG ' ' HG3' ' A' ' 15' ' ' GLN . 0.0 OUTLIER 61.37 114.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.458 179.984 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 4' ' ' CYS . 69.9 m -143.75 91.74 2.27 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.994 0.902 . . . . 0.0 108.628 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.678 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 68.2 m -44.64 170.32 0.05 OUTLIER Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.678 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.7 Cg_endo -72.74 158.28 50.65 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 C-N-CA 121.87 1.713 . . . . 0.0 110.672 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.579 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -61.87 -47.82 83.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.331 -0.856 . . . . 0.0 110.464 -178.738 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -53.23 -31.53 43.72 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.45 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.75 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 14.6 t90 -139.26 74.59 1.48 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.693 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -76.45 -26.4 63.54 Favored Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.336 -178.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.49 26.79 6.13 Favored Glycine 0 N--CA 1.49 2.275 0 O-C-N 120.675 -1.485 . . . . 0.0 110.922 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.624 ' HA ' ' CZ2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.91 173.41 7.52 Favored Pre-proline 0 C--N 1.293 -1.879 0 O-C-N 121.314 -1.11 . . . . 0.0 111.379 -178.669 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.75 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.3 Cg_endo -75.8 -55.16 0.07 OUTLIER 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 123.771 2.98 . . . . 0.0 114.12 -177.012 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.591 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 29.4 p90 -74.73 28.47 0.09 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.718 -1.239 . . . . 0.0 112.274 -177.072 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.459 ' HA2' ' OG ' ' A' ' 2' ' ' SER . . . -177.2 179.67 47.93 Favored Glycine 0 N--CA 1.485 1.938 0 C-N-CA 118.61 -1.757 . . . . 0.0 110.197 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 9' ' ' GLY . 35.4 mt-30 -101.22 -163.96 1.06 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.425 -1.044 . . . . 0.0 109.553 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -106.5 65.49 0.68 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.571 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.6 m -87.48 9.22 21.62 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.313 0.578 . . . . 0.0 110.145 -177.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.575 ' CE1' ' O ' ' A' ' 26' ' ' LYS . 65.8 m-85 -150.76 62.85 5.5 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 120.69 -1.256 . . . . 0.0 109.844 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.8 Cg_endo -80.39 -62.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.637 2.225 . . . . 0.0 110.867 -179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.9 37.05 2.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.65 105.22 0.18 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.579 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 37.1 m -62.47 -32.88 73.84 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.697 0.76 . . . . 0.0 110.708 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.491 ' O ' ' C ' ' A' ' 24' ' ' GLY . 11.8 t -99.07 -89.29 0.32 Allowed 'General case' 0 C--N 1.287 -2.125 0 O-C-N 121.68 -0.638 . . . . 0.0 109.55 -179.521 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 33.47 -149.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 26' ' ' LYS . 34.4 Cg_endo -79.21 -166.97 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.4 2.067 . . . . 0.0 108.981 178.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.575 ' O ' ' CE1' ' A' ' 18' ' ' TYR . 2.6 ttmm -50.33 -58.71 5.05 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.622 -1.231 . . . . 0.0 107.928 178.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.552 ' HA ' ' CA ' ' A' ' 17' ' ' CYS . 14.4 m . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.487 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.342 0.591 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 3' ' ' CYS . 60.1 p -82.83 -143.88 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 109.389 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 89.2 m 32.87 91.9 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.95 0.881 . . . . 0.0 110.898 179.207 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 8' ' ' TRP . 58.4 m -43.35 168.1 0.07 OUTLIER Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.214 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 34.0 Cg_endo -77.03 146.35 25.6 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.19 1.926 . . . . 0.0 110.683 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.636 ' HA ' ' CB ' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -46.25 -63.95 0.87 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.086 -1.009 . . . . 0.0 110.587 -179.453 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -39.59 -37.93 0.55 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.874 0.845 . . . . 0.0 108.842 -179.737 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.747 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.2 t90 -134.97 70.11 1.44 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.633 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.0 -26.65 66.16 Favored Glycine 0 N--CA 1.501 2.986 0 O-C-N 121.275 -0.89 . . . . 0.0 111.387 -178.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.71 15.95 28.47 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.918 -1.343 . . . . 0.0 110.571 -179.086 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.613 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -66.99 174.75 1.76 Allowed Pre-proline 0 C--N 1.296 -1.735 0 O-C-N 121.295 -1.121 . . . . 0.0 111.04 -178.764 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.747 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 37.4 Cg_endo -74.1 -57.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 123.311 2.674 . . . . 0.0 112.833 -177.473 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 26.8 p90 -73.4 122.83 22.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.681 -1.262 . . . . 0.0 109.978 -178.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.432 ' C ' ' HG3' ' A' ' 15' ' ' GLN . . . 99.21 -147.39 18.41 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.432 ' HG3' ' C ' ' A' ' 14' ' ' GLY . 21.8 mt-30 -143.4 -149.86 0.29 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.466 -1.02 . . . . 0.0 109.793 -179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.69 63.74 0.61 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.507 ' SG ' ' HG2' ' A' ' 26' ' ' LYS . 1.7 m -87.21 8.05 25.67 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.401 -0.812 . . . . 0.0 109.594 -178.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.636 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 77.2 m-85 -149.21 64.98 7.75 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 18' ' ' TYR . 36.5 Cg_endo -80.75 -16.34 10.33 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.632 2.221 . . . . 0.0 111.809 -178.156 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.16 35.99 0.67 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.633 -1.292 . . . . 0.0 111.28 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 23' ' ' SER . . . 134.56 124.24 2.44 Favored Glycine 0 N--CA 1.476 1.328 0 C-N-CA 119.504 -1.332 . . . . 0.0 109.955 179.239 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.533 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 20.5 m -35.67 -34.58 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 122.442 1.115 . . . . 0.0 109.39 179.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.491 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 37.6 p 46.53 58.88 4.23 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.226 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' SER . . . 43.2 -101.75 0.03 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 23' ' ' SER . 33.8 Cg_endo -75.89 -160.39 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.29 1.993 . . . . 0.0 111.057 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.507 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -50.78 -172.59 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.365 0.603 . . . . 0.0 110.22 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 17' ' ' CYS . 9.8 p . . . . . 0 C--N 1.303 -1.442 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.532 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.443 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -94.98 76.83 3.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 109.779 -179.821 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.51 ' O ' ' O ' ' A' ' 4' ' ' CYS . 53.9 m -150.73 96.46 2.36 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.327 -0.858 . . . . 0.0 108.729 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.596 ' HB3' ' O ' ' A' ' 8' ' ' TRP . 55.7 m -39.23 165.69 0.05 OUTLIER Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.862 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.8 Cg_endo -71.24 173.32 12.44 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.286 1.991 . . . . 0.0 111.319 -179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.718 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -69.58 -48.0 61.67 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.427 -0.796 . . . . 0.0 111.511 -178.397 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.544 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -66.11 -29.78 70.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.737 -1.227 . . . . 0.0 109.773 -179.612 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.755 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 16.0 t90 -131.99 68.12 1.5 Allowed 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 118.679 -1.209 . . . . 0.0 109.933 -178.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.463 ' HA2' ' CB ' ' A' ' 4' ' ' CYS . . . -74.09 -26.24 69.17 Favored Glycine 0 N--CA 1.5 2.929 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.292 -179.141 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.06 13.95 35.46 Favored Glycine 0 N--CA 1.489 2.189 0 O-C-N 120.788 -1.419 . . . . 0.0 110.313 -179.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.651 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -66.27 175.1 1.39 Allowed Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 121.442 -1.034 . . . . 0.0 111.056 -178.78 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.755 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.9 Cg_endo -73.4 -58.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -1.019 0 C-N-CA 123.275 2.65 . . . . 0.0 112.485 -177.35 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 13' ' ' TRP . 23.9 p90 -72.79 122.12 21.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.74 -1.225 . . . . 0.0 109.121 -179.039 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' HA2' ' OG ' ' A' ' 2' ' ' SER . . . 88.17 174.77 47.74 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.473 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 12.7 mt-30 -103.2 -149.49 0.4 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.257 -1.143 . . . . 0.0 109.408 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.455 ' OD1' ' HA3' ' A' ' 9' ' ' GLY . 16.7 t-20 -108.67 68.9 0.7 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.531 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.7 m -86.87 -11.44 50.77 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.37 0.605 . . . . 0.0 109.944 -177.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.542 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 43.0 m-85 -132.46 77.15 70.69 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.51 ' HD2' ' HA ' ' A' ' 27' ' ' VAL . 35.2 Cg_endo -76.47 -48.44 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.586 2.19 . . . . 0.0 109.835 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -143.33 16.23 1.86 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -92.49 25.75 16.95 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.718 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -35.73 -31.5 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.22 0 CA-C-O 121.79 0.805 . . . . 0.0 110.196 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -125.37 -30.73 3.1 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.757 -0.59 . . . . 0.0 109.603 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.29 -148.87 0.04 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -78.18 -160.67 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.69 2.26 . . . . 0.0 110.738 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.531 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 20.5 ttpt -50.95 -76.26 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.527 -0.733 . . . . 0.0 109.165 179.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.51 ' HA ' ' HD2' ' A' ' 19' ' ' PRO . 5.2 m . . . . . 0 N--CA 1.49 1.556 0 O-C-N 120.955 -1.091 . . . . 0.0 109.43 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.463 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 2.1 mmm180 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.543 ' CA ' ' HA2' ' A' ' 14' ' ' GLY . 3.3 t -131.55 -1.56 3.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.349 -0.844 . . . . 0.0 109.659 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 89.2 m -148.44 91.87 1.95 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.128 -0.982 . . . . 0.0 109.635 -179.279 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.631 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 80.9 m -43.12 167.04 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.631 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 26.4 Cg_endo -65.28 152.67 81.38 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.123 1.215 . . . . 0.0 109.519 179.559 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.617 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 16.4 p -59.45 -42.48 92.08 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.141 -0.974 . . . . 0.0 110.088 -177.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -57.43 -28.62 63.47 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.099 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.763 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 15.1 t90 -136.06 72.63 1.44 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.041 -179.03 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 4' ' ' CYS . . . -79.73 -24.45 60.27 Favored Glycine 0 N--CA 1.5 2.929 0 O-C-N 121.12 -0.988 . . . . 0.0 111.121 -179.268 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.59 16.57 34.92 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.96 -1.318 . . . . 0.0 110.555 -179.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.618 ' HB2' ' CE3' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -63.77 174.18 1.11 Allowed Pre-proline 0 C--N 1.296 -1.742 0 O-C-N 121.272 -1.134 . . . . 0.0 111.042 -178.82 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.763 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 36.8 Cg_endo -73.05 -58.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 123.352 2.701 . . . . 0.0 112.222 -177.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.551 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 22.8 p90 -73.28 -167.76 0.45 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.768 -1.207 . . . . 0.0 109.153 -179.181 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.543 ' HA2' ' CA ' ' A' ' 2' ' ' SER . . . 37.86 -148.54 0.07 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.8 OUTLIER -139.69 -157.6 0.78 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.411 -1.052 . . . . 0.0 109.99 179.801 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.475 ' OD1' ' CG ' ' A' ' 19' ' ' PRO . 13.5 t-20 -109.23 70.83 0.75 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 179.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.532 ' C ' ' CG ' ' A' ' 18' ' ' TYR . 1.3 m -87.84 -2.05 58.36 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.453 0.644 . . . . 0.0 111.074 -177.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.617 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -165.83 76.84 1.24 Allowed Pre-proline 0 N--CA 1.496 1.825 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.101 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.475 ' CG ' ' OD1' ' A' ' 16' ' ' ASN . 37.6 Cg_endo -82.83 -54.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 123.028 2.485 . . . . 0.0 112.013 -178.038 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -94.18 15.98 15.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.102 -0.999 . . . . 0.0 111.563 -177.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 22' ' ' CYS . . . 149.03 120.25 1.06 Allowed Glycine 0 N--CA 1.475 1.241 0 C-N-CA 118.989 -1.577 . . . . 0.0 110.174 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.598 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.4 m -37.05 -46.18 0.65 Allowed 'General case' 0 C--N 1.288 -2.105 0 CA-C-O 122.364 1.078 . . . . 0.0 108.59 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.527 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER 46.28 36.55 3.39 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.446 179.067 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.04 -112.38 3.47 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 179.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 23' ' ' SER . 32.7 Cg_endo -74.76 -157.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.377 2.051 . . . . 0.0 111.109 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 25' ' ' PRO . 2.1 mtpt -46.16 177.91 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.67 0.747 . . . . 0.0 110.271 -179.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 17' ' ' CYS . 5.4 p . . . . . 0 C--N 1.301 -1.543 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.647 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.31 0.576 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 3' ' ' CYS . 6.6 t -76.32 -136.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.866 . . . . 0.0 109.303 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 75.1 m 35.34 95.63 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.26 1.029 . . . . 0.0 110.758 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.676 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 57.7 m -52.36 170.68 0.23 Allowed Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.676 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.0 Cg_endo -71.93 166.38 29.73 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.068 1.846 . . . . 0.0 111.355 -179.604 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.68 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -62.52 -44.48 96.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.54 -0.725 . . . . 0.0 110.696 -179.034 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -67.49 -34.38 77.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.273 -0.892 . . . . 0.0 110.012 -178.929 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.751 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 13.4 t90 -126.63 65.61 1.26 Allowed 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.574 -178.445 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 15' ' ' GLN . . . -65.66 -28.99 74.16 Favored Glycine 0 N--CA 1.498 2.77 0 O-C-N 121.344 -0.847 . . . . 0.0 111.542 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.09 29.89 4.54 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 120.68 -1.482 . . . . 0.0 111.283 -178.459 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.635 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -82.53 172.16 10.17 Favored Pre-proline 0 C--N 1.294 -1.836 0 O-C-N 121.211 -1.17 . . . . 0.0 111.427 -178.666 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.751 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.5 Cg_endo -75.55 -53.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 123.837 3.025 . . . . 0.0 113.997 -176.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.566 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 27.3 p90 -74.83 23.2 0.1 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.675 -1.266 . . . . 0.0 112.005 -177.294 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.409 ' C ' ' SG ' ' A' ' 4' ' ' CYS . . . -168.28 -174.92 37.5 Favored Glycine 0 N--CA 1.485 1.963 0 C-N-CA 118.949 -1.596 . . . . 0.0 110.028 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 9' ' ' GLY . 35.8 mt-30 -116.99 -149.25 0.44 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.554 -0.968 . . . . 0.0 109.16 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.414 ' ND2' ' HA3' ' A' ' 9' ' ' GLY . 0.1 OUTLIER -108.82 62.44 0.6 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.624 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.7 m -87.01 -19.95 27.94 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.258 -0.901 . . . . 0.0 109.147 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.618 ' CG ' ' HB2' ' A' ' 26' ' ' LYS . 6.6 m-85 -116.66 71.31 5.04 Favored Pre-proline 0 C--N 1.296 -1.723 0 O-C-N 121.666 -0.647 . . . . 0.0 109.815 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.513 ' HD3' ' C ' ' A' ' 17' ' ' CYS . 34.7 Cg_endo -74.99 -44.54 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.159 1.906 . . . . 0.0 110.195 179.572 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -144.86 15.38 1.56 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.375 -0.828 . . . . 0.0 109.092 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 25' ' ' PRO . . . -93.36 23.52 29.59 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.68 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.6 m -36.0 -29.45 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.361 0.601 . . . . 0.0 111.231 -179.675 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' GLY . 2.5 p -113.1 -74.15 0.64 Allowed 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.436 -0.79 . . . . 0.0 110.778 -178.759 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -59.47 -131.86 0.01 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.145 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.52 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 33.4 Cg_endo -74.98 -158.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.2 1.933 . . . . 0.0 109.836 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 1.006 ' HG2' HG13 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -138.32 -36.85 0.57 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.184 -0.947 . . . . 0.0 109.935 -179.859 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.006 HG13 ' HG2' ' A' ' 26' ' ' LYS . 3.5 m . . . . . 0 N--CA 1.493 1.678 0 O-C-N 120.733 -1.229 . . . . 0.0 109.3 178.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 2' ' ' SER . 5.2 mtp180 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 3' ' ' CYS . 0.8 OUTLIER 52.21 175.63 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.229 -0.92 . . . . 0.0 109.502 -179.926 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.48 ' C ' ' O ' ' A' ' 2' ' ' SER . 73.8 m 33.15 91.78 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 122.133 0.968 . . . . 0.0 110.905 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.747 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 86.3 m -49.71 173.94 0.07 OUTLIER Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.061 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.747 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.4 Cg_endo -72.9 165.73 31.98 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.599 1.532 . . . . 0.0 111.35 -179.293 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.727 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -56.34 -46.95 79.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.453 -0.78 . . . . 0.0 111.343 -178.383 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -63.75 -40.08 95.84 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.034 -1.041 . . . . 0.0 110.375 -179.248 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.734 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.8 t90 -117.6 62.77 0.74 Allowed 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.24 -178.25 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -71.93 5.67 12.14 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.163 -0.961 . . . . 0.0 111.522 -179.242 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.68 28.64 5.88 Favored Glycine 0 N--CA 1.486 1.969 0 O-C-N 120.508 -1.583 . . . . 0.0 109.617 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.658 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -80.4 176.66 3.57 Favored Pre-proline 0 C--N 1.294 -1.848 0 O-C-N 121.654 -0.909 . . . . 0.0 111.664 -178.207 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.734 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.4 Cg_endo -76.63 -50.21 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 123.569 2.846 . . . . 0.0 113.181 -177.015 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.633 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 34.6 p90 -78.58 34.79 0.22 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.675 -1.266 . . . . 0.0 111.585 -177.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.81 -163.26 32.1 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.834 -1.65 . . . . 0.0 110.502 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' GLY . 2.1 tt0 -128.3 -152.11 0.5 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.538 -0.978 . . . . 0.0 110.073 -179.337 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 12.7 t30 -109.21 64.59 0.61 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.536 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 1.6 m -87.46 -11.07 50.12 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.428 -0.795 . . . . 0.0 109.703 -179.0 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.527 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 96.9 m-85 -130.84 73.04 81.52 Favored Pre-proline 0 C--N 1.296 -1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 109.723 -179.232 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.524 ' CD ' ' O ' ' A' ' 27' ' ' VAL . 35.1 Cg_endo -77.67 -40.95 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.442 2.095 . . . . 0.0 109.477 179.581 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -141.2 13.03 2.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.352 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 23' ' ' SER . . . -94.9 25.67 22.5 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.557 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.727 ' HA ' ' CB ' ' A' ' 6' ' ' CYS . 1.7 m -38.67 -29.7 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.286 0 CA-C-O 121.751 0.786 . . . . 0.0 109.952 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 21' ' ' GLY . 48.5 t -147.97 54.58 1.04 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -157.24 -132.36 1.45 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -78.66 -160.58 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.388 2.059 . . . . 0.0 111.018 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.536 ' HG3' ' HB3' ' A' ' 17' ' ' CYS . 3.3 ttpt -122.64 87.61 2.78 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.753 -0.592 . . . . 0.0 109.545 179.598 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.524 ' O ' ' CD ' ' A' ' 19' ' ' PRO . 42.4 t . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.642 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.531 ' CB ' ' HA2' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -59.96 -76.95 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.369 -179.95 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.468 ' C ' ' O ' ' A' ' 2' ' ' SER . 71.6 m 34.36 95.98 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.127 0.965 . . . . 0.0 111.031 179.013 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.658 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 97.9 m -55.13 169.78 0.42 Allowed Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.658 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 30.5 Cg_endo -72.03 156.26 56.22 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.772 1.648 . . . . 0.0 111.068 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.596 ' HA ' ' HB2' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -48.17 -70.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.453 -0.779 . . . . 0.0 111.109 -178.487 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.599 ' CE2' ' HB2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -41.16 -34.14 0.43 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.436 -0.79 . . . . 0.0 109.852 -178.886 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.736 ' CZ2' ' HD3' ' A' ' 12' ' ' PRO . 10.1 t90 -126.0 66.47 1.2 Allowed 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.732 -179.31 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 16' ' ' ASN . . . -78.32 5.95 53.32 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 120.162 -1.018 . . . . 0.0 110.871 -179.202 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.72 26.7 6.78 Favored Glycine 0 N--CA 1.485 1.955 0 O-C-N 120.773 -1.427 . . . . 0.0 109.637 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.643 ' CB ' ' CD2' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.91 176.47 3.42 Favored Pre-proline 0 C--N 1.294 -1.845 0 O-C-N 121.733 -0.863 . . . . 0.0 111.344 -178.402 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.736 ' HD3' ' CZ2' ' A' ' 8' ' ' TRP . 38.8 Cg_endo -76.18 -52.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 123.423 2.748 . . . . 0.0 113.153 -177.154 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.583 ' CH2' ' CZ3' ' A' ' 8' ' ' TRP . 28.9 p90 -78.0 31.73 0.17 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.745 -1.222 . . . . 0.0 111.625 -177.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.531 ' HA2' ' CB ' ' A' ' 2' ' ' SER . . . -179.15 -171.73 42.62 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 118.595 -1.764 . . . . 0.0 110.595 179.555 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 9' ' ' GLY . 1.3 tt0 -118.87 -151.69 0.49 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.558 -0.966 . . . . 0.0 110.142 -179.522 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.582 ' O ' HG21 ' A' ' 27' ' ' VAL . 27.0 t-20 -109.24 64.19 0.61 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.53 ' SG ' ' CG ' ' A' ' 26' ' ' LYS . 1.7 m -87.73 4.26 44.87 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.396 -0.815 . . . . 0.0 110.015 -178.516 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.596 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 73.0 m-85 -147.07 62.27 7.2 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.282 -0.886 . . . . 0.0 109.742 -178.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.582 ' CG ' HG22 ' A' ' 27' ' ' VAL . 35.4 Cg_endo -78.66 -38.8 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.587 2.191 . . . . 0.0 110.324 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -132.61 49.85 2.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 109.422 -179.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.25 112.31 0.26 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 179.71 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 6' ' ' CYS . 1.7 m -64.9 -81.87 0.03 OUTLIER 'General case' 0 C--N 1.285 -2.232 0 CA-C-O 122.111 0.958 . . . . 0.0 109.079 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 24' ' ' GLY . 6.4 t -70.81 -8.77 54.92 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.314 179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 23' ' ' SER . . . -52.88 -173.44 0.04 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -78.96 -160.15 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.543 2.162 . . . . 0.0 110.952 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.53 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 2.1 ttmm -89.31 176.22 7.02 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.302 0.572 . . . . 0.0 109.581 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.582 HG21 ' O ' ' A' ' 16' ' ' ASN . 45.6 t . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.42 179.962 . . . . . . . . 1 1 . 1 stop_ save_